data_1qk9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qk9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 5.0 Cg_exo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 120.779 0.241 . . . . 0.0 112.119 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.71 105.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.81 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 3.2 m-30 -67.35 -19.04 65.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.92 73.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.299 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -97.71 111.38 58.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -106.04 13.99 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.001 3.134 . . . . 0.0 112.617 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.426 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 1.1 p -90.65 50.06 1.76 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 30' ' ' ARG . 72.0 mt -154.17 160.33 31.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -22.79 145.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.653 3.569 . . . . 0.0 114.543 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.51 148.43 0.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.203 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.98 -58.36 2.24 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.785 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.493 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 78.7 m95 -47.42 133.44 12.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 112.087 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.52 167.72 20.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -138.76 159.62 41.67 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.628 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 9.7 ttmm -157.32 167.59 29.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.994 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.459 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 6.7 mt -137.03 175.88 9.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.478 0.656 . . . . 0.0 112.258 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.0 tttm -147.81 106.59 3.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.157 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.766 -179.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HB3' ' CG1' ' A' ' 83' ' ' VAL . 24.3 m-85 -100.09 164.49 11.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 5.7 m-20 -120.47 166.98 12.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.31 -1.768 . . . . 0.0 108.428 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.427 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 54.2 t -128.07 147.94 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.201 0.524 . . . . 0.0 111.766 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 33.5 m-85 -149.05 102.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.139 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 6.1 mt -93.04 106.08 18.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 109.601 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.8 mt -82.3 123.62 38.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.956 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.445 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 t-20 -80.81 137.96 50.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.801 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 73.5 Cg_exo -34.02 -54.84 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.521 2.814 . . . . 0.0 113.456 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -50.99 -31.61 18.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 111.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 117.48 48.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.806 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.89 122.58 15.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -177.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.69 152.29 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.177 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 1.2 m-85 -129.78 167.97 17.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.64 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.16 3.49 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.87 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.422 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.49 171.63 19.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.43 -43.25 41.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.168 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 9.1 p -53.22 -44.39 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 109.873 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 1.1 tt0 -60.87 -27.83 68.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.3 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -69.6 -64.6 0.85 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.446 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.9 mp -65.9 -39.43 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.255 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.71 -58.0 8.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.478 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 3.0 t80 -68.86 -49.21 60.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 110.843 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 5.1 m-85 -46.82 -26.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.3 mm-40 -72.82 -57.06 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -16.1 63.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.48 -40.18 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.174 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.62 43.73 2.86 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.514 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD2' ' CD1' ' A' ' 74' ' ' LEU . 11.4 p-10 -74.3 141.97 45.23 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 122.535 0.334 . . . . 0.0 111.562 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 t -149.86 23.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.372 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.88 52.37 0.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -44.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 63.66 100.81 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.435 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.419 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 86.4 Cg_exo -47.75 -31.55 15.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.469 2.112 . . . . 0.0 112.582 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -8.49 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 1.04 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CD2' HD23 ' A' ' 62' ' ' LEU . 66.7 m-85 -109.37 130.89 55.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.857 0.361 . . . . 0.0 111.257 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -124.17 147.64 47.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.736 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 22.7 m-85 -105.96 77.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.33 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.1 p -140.71 111.64 7.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 44' ' ' TYR . 3.4 m -64.69 -41.27 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.642 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.467 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.473 0.29 0 CA-C-O 120.768 0.237 . . . . 0.0 112.029 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtm -145.65 94.46 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.7 m-30 -67.18 -70.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.443 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -64.08 79.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' TYR . 3.2 m-20 -114.92 88.53 17.14 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -97.22 14.38 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.393 2.728 . . . . 0.0 112.442 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -87.97 49.6 1.83 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.826 0.346 . . . . 0.0 111.426 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD11 ' CA ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -129.65 176.23 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 94.2 Cg_exo -45.43 169.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.421 2.081 . . . . 0.0 112.824 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.16 124.09 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.141 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . 75.77 -4.68 43.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.749 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.485 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 45.0 m95 -94.68 118.16 31.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.229 0.538 . . . . 0.0 112.069 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.413 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -118.01 -173.95 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 1.8 ttt180 -155.35 163.7 39.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' N ' ' CG ' ' A' ' 30' ' ' ARG . 7.5 tttt -172.78 158.61 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.359 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.445 HD12 ' CA ' ' A' ' 83' ' ' VAL . 6.2 mt -129.89 174.42 9.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 111.51 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 110.94 5.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.074 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.792 -179.891 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.872 0.368 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 26.2 m-85 -106.63 163.73 12.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.872 0.844 . . . . 0.0 113.11 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.93 132.74 45.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.664 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.427 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 7.7 p -91.53 148.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 3.4 m-85 -143.7 103.38 4.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.403 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 19.7 mt -92.96 110.78 22.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -85.19 124.65 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.463 0.649 . . . . 0.0 112.064 -173.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.6 p-10 -85.67 151.07 54.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.754 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 81.9 Cg_exo -37.17 -53.68 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.565 2.843 . . . . 0.0 113.259 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -45.72 -26.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.253 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.73 47.22 1.2 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.764 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.955 0.407 . . . . 0.0 111.286 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -91.35 150.26 21.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.94 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.55 119.49 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.82 5.47 43.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.569 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.2 p -154.44 159.98 41.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.167 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.44 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.6 -39.5 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.167 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 4.2 p -51.83 -48.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.787 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 3.6 mm-40 -61.88 -29.91 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.07 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 1.1 tp -63.37 -60.42 3.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -67.81 -42.84 86.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.683 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.94 41.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CE1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -67.35 -50.77 58.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.333 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.48 ' CD2' HD12 ' A' ' 74' ' ' LEU . 23.0 m-30 -53.67 -26.76 23.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -69.12 -60.65 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.329 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.11 -27.71 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -177.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 21.2 m -86.61 -44.47 16.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' VAL . . . 93.93 44.06 3.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.967 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.27 143.55 29.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.262 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -145.95 22.87 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -124.45 33.42 5.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.48 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.39 -43.48 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.8 107.9 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 88.0 Cg_exo -48.13 -31.89 17.56 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.324 2.016 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.97 -7.45 40.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.614 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.38 -4.02 59.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.293 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD2' HD23 ' A' ' 62' ' ' LEU . 82.8 m-85 -107.62 123.41 48.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.735 0.303 . . . . 0.0 111.172 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.99 137.13 51.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -95.71 79.16 3.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.042 0.449 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -138.42 94.83 2.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.936 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.445 ' CA ' HD12 ' A' ' 32' ' ' LEU . 23.6 m -48.29 -48.51 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.761 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.443 ' N ' HG22 ' A' ' 83' ' ' VAL . 20.6 p . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 95.5 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 CA-C-O 120.578 0.157 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.436 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -157.92 -40.58 0.07 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.549 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 17' ' ' PRO . 1.9 m-85 75.14 -65.89 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.555 0.217 . . . . 0.0 111.068 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.57 89.3 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.469 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 34.4 m-20 -131.8 65.66 76.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 29' ' ' THR . 8.9 Cg_endo -82.27 9.28 4.06 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.82 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 t -85.52 55.71 3.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.029 0.443 . . . . 0.0 110.681 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' CD ' ' A' ' 25' ' ' PRO . 12.4 mt -126.39 167.08 18.22 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.028 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' CD ' HD21 ' A' ' 24' ' ' LEU . 76.1 Cg_exo -40.79 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.751 2.3 . . . . 0.0 112.631 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.01 121.85 3.49 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.136 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 -2.2 49.59 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.798 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 48.9 m95 -96.85 140.96 30.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.237 0.519 . . . . 0.0 112.158 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -140.38 176.07 9.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 17.0 ttm105 -147.36 154.01 40.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.19 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 12.1 ttmt -168.7 164.4 12.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.228 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.438 ' CD1' HG11 ' A' ' 83' ' ' VAL . 3.7 mt -128.66 161.27 30.07 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.157 0.503 . . . . 0.0 111.836 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.99 125.86 32.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.922 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.135 -179.581 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.877 0.37 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 20.5 m-85 -105.52 162.81 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -134.26 144.94 48.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.353 176.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -88.06 146.89 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.896 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -142.82 98.65 3.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.0 111.291 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.4 mt -92.97 113.21 25.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.461 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 37.3 mt -92.16 127.94 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 34.7 p-10 -85.58 150.05 52.93 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.901 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -32.91 -58.74 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.928 3.085 . . . . 0.0 113.383 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -44.62 -27.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.21 51.18 0.89 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.813 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -139.75 130.68 26.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.931 0.395 . . . . 0.0 110.743 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -92.37 158.43 16.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.875 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -136.96 120.15 16.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.22 10.05 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.439 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -154.51 163.35 40.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.984 -177.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 3.8 tptp -79.75 -49.27 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.881 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 12.2 t -51.96 -33.6 16.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.216 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -70.36 -29.96 66.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.03 177.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 66' ' ' PHE . 1.1 tp -63.06 -59.55 4.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.0 mp -70.33 -46.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.401 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -50.14 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 1.5 t80 -68.97 -57.78 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 110.477 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 13.6 m-30 -42.54 -33.38 0.68 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.36 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.5 mm-40 -76.18 -56.47 4.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.407 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.81 -21.82 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.667 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 3.7 m -92.37 -25.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.012 0.434 . . . . 0.0 109.933 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 71' ' ' ASP . . . 94.83 -30.81 7.51 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.821 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 49.2 157.91 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' SER . 39.9 p -90.11 -22.77 21.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.32 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.434 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 10.9 p 165.06 -76.74 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.455 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 49.57 -166.16 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.631 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -162.93 92.38 1.2 Allowed Pre-proline 0 C--N 1.31 -1.137 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 81.8 Cg_exo -47.39 -33.26 16.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.319 2.013 . . . . 0.0 111.732 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.01 -19.41 63.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.54 0.22 56.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.648 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CB ' HD23 ' A' ' 62' ' ' LEU . 96.9 m-85 -105.18 100.61 10.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 111.459 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.17 129.22 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.384 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 46' ' ' VAL . 20.3 m-85 -88.32 87.45 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 111.202 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 104.12 7.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 32' ' ' LEU . 95.2 t -73.09 -67.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.644 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.546 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 88.4 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 N-CA-C 112.362 0.101 . . . . 0.0 112.362 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.81 134.48 3.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.742 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -94.52 48.34 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.0 110.184 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -175.44 79.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.84 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' HB3' ' NH1' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -112.73 85.26 7.36 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.596 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -89.0 25.96 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.98 2.453 . . . . 0.0 112.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -93.9 23.66 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -99.79 -178.26 0.67 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.7 Cg_exo -49.17 179.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.236 1.958 . . . . 0.0 112.18 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.5 120.78 7.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.157 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.8 50.68 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.818 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 51.8 m95 -93.75 131.34 39.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 111.689 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -132.32 179.92 5.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.645 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.438 ' NH1' ' HB3' ' A' ' 21' ' ' ASP . 7.1 ttp-105 -139.88 165.53 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.225 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -169.83 168.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.546 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -138.1 167.48 21.72 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.335 0.588 . . . . 0.0 112.399 -178.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 10.7 tttp -147.81 110.73 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.232 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 54.4 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.076 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.8 m-85 -88.6 144.13 26.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 61.0 m-20 -110.62 172.16 7.03 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 113.892 -1.503 . . . . 0.0 109.519 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 70.6 t -131.64 145.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.7 m-85 -146.03 105.61 3.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.073 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 15.3 mt -90.29 107.35 19.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 49' ' ' ILE . 3.0 mt -82.86 123.26 38.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.112 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 6.3 t-20 -76.05 144.67 75.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.704 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 70.5 Cg_exo -37.01 -28.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.13 2.553 . . . . 0.0 113.113 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' ASN . 4.3 mm-40 -90.4 30.45 1.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 55.74 26.25 46.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.447 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -98.74 124.5 43.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.914 0.388 . . . . 0.0 110.427 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 138.15 34.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.8 m-85 -124.43 126.14 45.44 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 18.6 mtp180 -96.41 -58.36 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.497 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.35 171.9 9.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.92 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -80.58 -41.72 23.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.176 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 10.9 t -51.79 -31.58 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 -29.29 63.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 110.025 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.506 HD22 ' CG ' ' A' ' 79' ' ' PHE . 1.4 tp -66.52 -60.72 2.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 4.5 mp -65.59 -45.92 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.17 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.86 -49.01 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 2.5 t80 -70.15 -57.65 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.115 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.492 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 20.8 m-30 -46.83 -28.93 1.72 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -72.74 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.103 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.17 -23.93 50.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.495 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 12.7 m -91.56 -44.18 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.975 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.52 51.29 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.101 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -84.9 137.92 32.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 111.103 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 p -124.02 22.63 8.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.144 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -128.42 29.76 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.54 174.77 14.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -158.63 114.13 1.67 Allowed Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.358 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 93.0 Cg_exo -46.41 -32.71 11.45 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.456 2.104 . . . . 0.0 112.0 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.04 -19.78 63.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.57 -1.94 58.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CG ' HD22 ' A' ' 62' ' ' LEU . 94.9 m-85 -107.21 110.6 22.69 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.832 0.348 . . . . 0.0 111.085 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.38 131.75 53.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 20.3 m-30 -87.5 80.67 8.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.09 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.79 118.86 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.356 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.435 ' HA ' ' CD2' ' A' ' 32' ' ' LEU . 52.2 t -65.65 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.235 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.3 . . . . 0.0 111.021 -178.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 7.8 Cg_exo . . . . . 0 N--CA 1.474 0.363 0 CA-C-O 120.871 0.28 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mtm -148.28 102.54 3.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -79.85 -67.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.776 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.2 83.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.579 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -118.75 85.39 27.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.389 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.66 14.03 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.239 2.626 . . . . 0.0 112.503 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 p -86.16 51.2 2.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.33 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -132.3 179.07 1.47 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.073 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 95.6 Cg_exo -45.14 166.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.362 2.041 . . . . 0.0 112.546 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 126.0 5.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.847 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.4 -52.66 4.37 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.488 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.1 m95 -44.86 142.29 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 112.323 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.85 -169.98 3.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.731 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 43.8 ttp180 -156.9 161.96 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' TYR . 5.4 ttmt -168.97 160.11 9.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.249 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD12 ' CG1' ' A' ' 83' ' ' VAL . 1.6 mt -131.31 163.51 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.169 0.509 . . . . 0.0 111.368 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.24 116.89 12.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.18 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.499 179.276 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.862 0.363 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 10.8 m-85 -103.68 163.21 12.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.679 0.752 . . . . 0.0 112.977 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.97 140.16 48.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.743 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 7.0 p -91.98 148.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.3 m-85 -146.19 103.42 3.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.685 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mt -92.62 114.44 26.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -87.35 127.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.804 0.811 . . . . 0.0 113.149 -171.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -82.44 135.01 47.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.495 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 85.6 Cg_exo -32.86 -51.7 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.666 2.91 . . . . 0.0 113.631 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -46.94 -26.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.374 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.12 18.14 6.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.332 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.6 tttt -96.67 147.91 23.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.552 0.215 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 54' ' ' LYS . . . -114.97 108.8 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.991 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.494 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.5 m-85 -92.72 124.2 36.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -93.14 -9.45 39.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.416 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.58 176.71 11.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.984 0.421 . . . . 0.0 111.558 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 2.2 mmtp -79.15 -42.72 25.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.166 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.85 -35.48 18.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.676 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' OE1' ' CA ' ' A' ' 61' ' ' GLU . 2.3 mm-40 -72.79 -27.08 61.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.092 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -68.17 -65.45 0.69 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.6 mp -56.4 -41.17 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.92 -66.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.76 -50.2 74.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.423 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.4 m-30 -51.79 -29.69 20.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.391 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.2 mm-40 -67.0 -64.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.053 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.26 -24.68 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.6 -177.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.42 -33.28 5.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 42.69 9.96 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.715 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.96 121.65 27.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.716 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -127.37 34.25 4.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.16 25.7 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -39.51 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 60.45 101.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.513 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 85.6 Cg_exo -47.52 -31.29 13.46 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.35 2.033 . . . . 0.0 112.404 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -7.79 43.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -19.46 35.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.614 0.245 . . . . 0.0 110.858 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.488 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 63.5 m-85 -96.63 116.47 29.17 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.8 151.46 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.555 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -109.18 88.84 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 111.378 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 142.43 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.65 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.437 ' CG1' HD12 ' A' ' 32' ' ' LEU . 94.7 t -114.07 -34.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.817 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.45 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 96.7 Cg_endo . . . . . 0 C--O 1.232 0.194 0 N-CA-C 111.822 -0.107 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.444 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -136.74 -14.84 1.61 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 52.94 46.03 27.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.281 0.562 . . . . 0.0 110.0 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 21.8 t0 -137.7 77.68 1.65 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.564 ' CB ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 56.09 -96.46 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.777 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' CA ' ' CB ' ' A' ' 21' ' ' ASP . 8.7 Cg_endo -92.11 -5.0 46.16 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 CA-C-N 123.14 2.157 . . . . 0.0 113.739 -8.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.7 t -156.43 15.68 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -53.27 160.39 1.74 Allowed Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.085 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.77 172.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.371 2.048 . . . . 0.0 111.993 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 123.24 6.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.696 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.54 -44.22 3.31 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.862 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.504 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 64.9 m95 -54.05 142.55 24.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.145 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -143.22 167.77 21.34 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.489 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 2.0 ptm85 -122.09 153.27 38.9 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.103 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 1.3 tttt -151.17 152.06 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.356 1.66 . . . . 0.0 109.612 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 9.7 mt -131.39 157.33 43.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.7 115.94 18.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.326 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.989 178.617 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 120.934 0.397 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 83' ' ' VAL . 7.1 m-85 -106.69 164.57 11.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -133.54 147.37 51.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.362 176.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.448 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 5.8 p -89.04 146.69 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.018 0.437 . . . . 0.0 112.025 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 11.9 m-85 -146.09 101.05 3.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.363 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -91.03 108.22 19.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 3.6 mt -82.23 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.061 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.483 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.4 t-20 -83.69 135.99 42.58 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.747 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 77.3 Cg_exo -34.47 -54.68 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.531 2.821 . . . . 0.0 113.261 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -50.35 -32.61 17.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 119.9 49.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.526 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -138.84 129.14 25.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.76 150.88 22.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.938 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 49.4 m-85 -133.85 131.67 39.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.955 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -105.84 -9.38 17.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.764 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.26 172.16 18.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 111.384 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.08 -39.74 75.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.728 -177.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 3.2 t -55.29 -44.32 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.04 -27.5 69.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -65.41 -65.17 0.71 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.001 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.499 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.4 mp -62.94 -42.38 96.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.48 -47.76 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.486 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.0 t80 -72.72 -59.23 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.415 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 18.5 m-30 -44.03 -32.61 1.21 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.24 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.6 mm-40 -65.68 -60.96 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.87 -21.13 41.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.125 -178.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.462 ' CG1' ' HD3' ' A' ' 68' ' ' LYS . 20.2 m -95.35 -48.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.16 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.426 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 106.92 34.54 2.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -89.39 142.2 27.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.988 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -148.41 25.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.03 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.73 31.81 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -130.31 -32.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.559 -178.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.02 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.469 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.425 ' HA ' HD13 ' A' ' 62' ' ' LEU . 44.6 Cg_exo -52.06 -35.86 63.32 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.185 1.923 . . . . 0.0 112.279 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.03 -12.09 61.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.537 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.67 10.58 15.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.508 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 67.8 m-85 -113.18 92.93 4.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.26 134.88 35.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 33.5 m-85 -96.76 99.44 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.07 92.17 2.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.442 HG12 ' HB3' ' A' ' 44' ' ' TYR . 60.7 t -54.7 -21.14 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.436 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 -179.655 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.47 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 97.6 Cg_endo . . . . . 0 N--CA 1.475 0.386 0 N-CA-C 112.509 0.157 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.432 ' HE2' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -145.2 101.75 3.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.737 0.304 . . . . 0.0 111.274 -178.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -91.98 64.25 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.5 t70 175.65 72.19 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB2' ' CA ' ' A' ' 22' ' ' PRO 0.254 0.0 OUTLIER 55.69 -94.12 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.475 0 CA-C-O 115.598 -2.144 . . . . 0.0 106.97 -171.659 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' CA ' ' HB2' ' A' ' 21' ' ' ASP . 7.7 Cg_endo -96.69 -2.62 32.5 Favored 'Cis proline' 0 N--CA 1.479 0.668 0 CA-C-N 122.772 2.026 . . . . 0.0 113.403 -10.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.55 66.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 111.114 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.24 165.36 15.09 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.54 170.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.492 2.128 . . . . 0.0 112.269 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.03 123.22 9.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.819 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.92 -1.71 58.0 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.501 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.471 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 53.5 m95 -99.45 138.52 36.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.454 HG23 ' CA ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -138.43 166.91 23.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.631 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.43 ' HG3' ' CD1' ' A' ' 48' ' ' LEU . 24.3 ttm180 -135.49 154.48 51.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -159.5 157.51 30.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.977 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 5.0 mt -131.34 155.56 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.041 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -125.57 117.16 22.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.691 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 -179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -106.77 163.77 12.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.49 0.662 . . . . 0.0 112.773 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -134.22 144.01 48.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 175.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.447 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 p -86.31 149.76 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.318 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.1 102.54 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.43 ' CD1' ' HG3' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -92.98 112.72 24.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.7 mt -88.49 122.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.354 -176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.471 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 p-10 -84.66 159.83 57.36 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.41 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 88.2 Cg_exo -40.03 -27.75 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.26 2.64 . . . . 0.0 113.163 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.62 32.84 1.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.997 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.17 28.21 12.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.166 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -99.07 121.4 40.93 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.059 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.06 149.25 21.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.546 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 68.7 m-85 -147.82 129.69 15.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.662 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -103.57 -52.12 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.64 177.91 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.669 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -90.82 -42.89 10.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.641 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 48.3 t -51.89 -29.55 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.897 0.38 . . . . 0.0 110.697 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.88 -29.69 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -68.61 -68.32 0.4 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.481 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.435 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.6 mp -54.99 -40.49 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -54.99 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.263 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -67.45 -58.92 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' CD1' ' A' ' 74' ' ' LEU . 16.4 m-30 -44.65 -28.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.783 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.0 mm-40 -61.13 -69.8 0.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.68 -16.99 18.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.991 0.424 . . . . 0.0 110.676 177.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 65' ' ' TYR . 87.1 t -84.39 -69.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.663 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.32 56.17 0.33 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD2' ' CD1' ' A' ' 74' ' ' LEU . 4.7 p-10 -74.23 134.9 42.7 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 111.852 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -149.97 26.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.037 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -164.64 45.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.524 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -154.53 -35.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.01 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.27 102.33 0.03 OUTLIER Pre-proline 0 C--O 1.231 0.117 0 CA-C-O 120.519 0.2 . . . . 0.0 111.35 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 74.9 Cg_exo -43.61 -32.94 4.21 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.386 2.057 . . . . 0.0 112.432 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.34 -20.41 64.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.26 -7.68 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.539 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' HD23 ' A' ' 62' ' ' LEU . 72.2 m-85 -102.65 97.86 7.99 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.7 134.04 35.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 16.6 m-30 -96.08 70.83 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.011 0.434 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 84' ' ' THR . 6.3 p -101.92 -9.53 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.359 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.451 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 54.6 t 67.59 -58.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 82' ' ' THR . 73.1 p . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.527 ' CG ' ' CE2' ' A' ' 44' ' ' TYR . 97.0 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 N-CA-C 111.594 -0.195 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.467 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -129.05 -18.73 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 66.97 -74.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 -1.29 76.15 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CA ' ' A' ' 22' ' ' PRO 0.251 0.0 OUTLIER 46.35 -93.3 0.0 OUTLIER Pre-proline 0 CA--C 1.494 -1.179 0 CA-C-O 116.677 -1.63 . . . . 0.0 109.666 -179.49 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' CA ' ' HB2' ' A' ' 21' ' ' ASP . 8.3 Cg_endo -100.84 -2.26 18.28 Favored 'Cis proline' 0 N--CA 1.477 0.532 0 CA-C-N 122.688 1.996 . . . . 0.0 113.452 -5.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.37 82.72 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.125 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 ' CD ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -126.28 156.33 72.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -179.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.857 2.371 . . . . 0.0 112.551 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.79 120.86 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.44 -5.73 49.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.291 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 59.9 m95 -96.71 143.41 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.992 0.396 . . . . 0.0 111.15 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.58 172.36 15.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.733 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' CD ' HD23 ' A' ' 24' ' ' LEU . 2.3 mtp180 -132.07 142.17 49.44 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 1.4 ttmt -151.71 160.56 43.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.516 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 31' ' ' LYS . 10.2 mt -131.88 153.25 50.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.26 0.552 . . . . 0.0 111.901 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -120.33 118.34 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.514 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 50.1 tt0 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.542 0.687 . . . . 0.0 111.3 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.527 ' CE2' ' CG ' ' A' ' 17' ' ' PRO . 10.1 m-85 -97.7 153.07 18.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -129.97 147.04 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.461 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.49 HG13 ' CD1' ' A' ' 81' ' ' PHE . 8.2 p -87.47 145.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 13.2 m-85 -146.1 102.14 3.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.086 0.469 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 10.3 mt -92.93 110.38 21.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 29' ' ' THR . 4.3 mt -85.25 125.11 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.047 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.502 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.9 p-10 -85.81 153.55 57.9 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.868 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 87.2 Cg_exo -39.78 -51.97 2.8 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 113.169 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -48.16 -24.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.88 49.05 1.19 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.996 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.94 135.47 31.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.862 0.363 . . . . 0.0 111.568 -178.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.52 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.152 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 96.3 m-85 -130.46 133.86 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.117 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mtp180 -99.32 -60.58 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 24.9 p -88.49 177.11 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.933 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -85.98 -41.33 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -51.98 -28.43 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.659 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 1.6 mm-40 -74.88 -32.4 61.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.282 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -65.35 -61.38 2.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.446 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -59.77 -38.06 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.497 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.94 -66.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.9 -48.22 80.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.0 m-30 -53.02 -30.36 35.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.799 0.333 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.4 mm-40 -69.31 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.968 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.2 -25.57 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.702 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 m -86.79 -44.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.813 0.34 . . . . 0.0 111.153 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.94 43.77 3.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.482 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.9 134.89 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 p -139.83 27.83 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 t -128.07 30.66 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -140.0 -41.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.18 109.04 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.5 Cg_exo -50.59 -31.42 31.67 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.321 2.014 . . . . 0.0 112.176 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.16 -8.62 51.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.505 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.18 -13.47 41.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.224 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.488 ' CD2' HD23 ' A' ' 62' ' ' LEU . 86.0 m-85 -99.0 114.28 26.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.804 0.335 . . . . 0.0 111.133 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.29 145.51 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.01 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.49 ' CD1' HG13 ' A' ' 46' ' ' VAL . 14.4 m-85 -102.73 96.14 6.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.17 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.04 88.43 2.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.906 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 44' ' ' TYR . 62.5 t -52.29 -32.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 111.063 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.633 -178.323 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 41.9 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 120.902 0.293 . . . . 0.0 112.2 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 102.79 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.32 -73.91 0.13 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -177.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.04 83.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.544 0.211 . . . . 0.0 110.665 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' CB ' ' HB2' ' A' ' 30' ' ' ARG . 2.4 t0 -113.07 88.77 12.69 Favored Pre-proline 0 C--N 1.332 -0.159 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.426 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -93.3 18.75 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.194 2.596 . . . . 0.0 112.641 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.5 p -92.82 21.74 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.507 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.0 mt -98.63 164.04 17.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.895 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 3.2 Cg_exo -40.86 167.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.19 2.593 . . . . 0.0 112.597 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.24 126.33 7.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.2 -1.27 56.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.665 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 64.2 m95 -100.85 143.89 30.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.349 0.574 . . . . 0.0 112.152 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.72 -178.93 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.008 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 5.3 mtm180 -144.14 170.79 15.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 0.0 111.326 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 9.0 ttmt -177.91 159.25 1.35 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.421 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.495 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 4.5 mt -128.24 173.74 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.826 0.822 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.34 106.39 3.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.688 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.831 -178.629 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 tttt . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.912 0.387 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 30.3 m-85 -106.11 160.51 15.26 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -127.1 142.14 51.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.676 174.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 44.9 t -91.39 148.05 4.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.79 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.9 m-85 -146.05 91.18 2.04 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.85 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.422 HD21 ' CG ' ' A' ' 30' ' ' ARG . 5.6 mt -93.04 109.82 21.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.323 0.582 . . . . 0.0 109.464 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 10.8 mt -84.77 122.78 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.104 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.4 p-10 -85.61 163.22 45.16 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.361 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -37.79 -29.48 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.248 2.632 . . . . 0.0 113.288 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -91.69 34.54 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.649 0.262 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 47.79 25.45 3.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.102 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 51.7 tptt -99.1 121.94 41.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.23 147.82 23.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.08 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.3 m-85 -134.04 149.7 51.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.822 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.7 -39.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 8.4 t -85.63 -77.43 0.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.968 -176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER 161.18 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 28.3 t -55.2 -29.09 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.16 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.7 -33.58 74.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.991 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -65.15 -68.38 0.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.48 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.3 mp -54.26 -45.14 67.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.86 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.75 -54.11 38.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.6 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CD2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -66.27 -53.02 41.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.431 -179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.573 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 10.9 m-30 -53.18 -23.02 7.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.9 mm-40 -71.19 -61.85 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.864 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -54.68 -26.23 32.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.636 -177.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.456 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 9.6 m -91.1 -45.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.901 0.382 . . . . 0.0 111.062 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 95.56 37.27 5.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.294 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.0 146.41 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -148.99 18.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.75 23.52 11.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.037 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -154.48 67.54 0.71 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER 60.85 -174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.149 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' CA ' ' CB ' ' A' ' 75' ' ' ASP . 84.6 Cg_exo -75.83 -158.08 1.56 Allowed 'Cis proline' 0 C--N 1.308 -1.598 0 N-CA-C 115.385 1.264 . . . . 0.0 115.385 17.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 20.49 9.25 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.866 -177.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 2.2 m-20 -146.2 -12.17 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.658 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 50.3 m-85 -86.76 83.07 7.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.028 0.376 . . . . 0.0 110.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.21 98.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 57' ' ' ARG . 4.3 m-30 -85.47 52.92 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -115.2 131.51 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.438 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.485 ' CG1' ' CB ' ' A' ' 44' ' ' TYR . 23.1 m -64.56 -49.23 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.745 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.425 ' N ' HG22 ' A' ' 83' ' ' VAL . 16.8 p . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.131 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 12.3 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 CA-C-O 120.607 0.17 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.443 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -169.19 109.07 0.45 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.453 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -78.43 80.22 4.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 39.1 t70 -154.57 64.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.038 -170.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.641 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 64.88 -103.39 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -0.993 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 Cg_endo -84.04 130.91 16.13 Favored 'Cis proline' 0 N--CA 1.479 0.64 0 CA-C-N 123.617 2.327 . . . . 0.0 113.803 -6.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.489 ' N ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 41.37 84.05 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.131 173.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.456 ' CD1' ' HG3' ' A' ' 30' ' ' ARG . 8.0 mt -124.53 166.65 18.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -47.45 165.59 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 125.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.234 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.66 -2.7 53.02 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.964 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.5 m95 -100.17 139.94 35.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.366 0.583 . . . . 0.0 112.067 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.41 171.64 16.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.19 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HG3' ' CD1' ' A' ' 24' ' ' LEU . 14.7 mtm180 -132.62 144.44 50.36 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' CD ' ' HB3' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -135.16 177.04 8.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.977 -177.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 15.0 mt -148.74 155.71 41.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.254 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.75 118.78 8.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.274 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.492 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.4 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.164 0.507 . . . . 0.0 110.718 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 6.5 m-85 -88.71 133.16 34.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -104.92 156.28 18.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.566 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' CG2' HG22 ' A' ' 83' ' ' VAL . 44.7 t -95.11 147.42 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 10.3 m-85 -147.2 102.37 3.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.797 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 5.9 mt -92.79 106.77 18.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.6 mt -82.18 122.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.106 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 16.6 p-10 -85.95 146.27 42.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.307 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -36.0 -48.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.451 2.767 . . . . 0.0 113.087 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -46.09 -26.86 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.16 6.58 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.109 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.1 tttt -98.99 170.83 8.44 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.49 0.186 . . . . 0.0 110.995 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.82 96.79 3.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.0 m-85 -95.13 122.78 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.775 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -91.6 -46.09 8.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 50.7 p -87.24 165.73 15.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.965 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.22 -36.34 34.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 61' ' ' GLU . 4.1 p -52.04 -42.34 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.16 0.505 . . . . 0.0 110.52 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 2.4 mm-40 -61.12 -32.04 71.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.639 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -67.5 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.6 mp -58.13 -37.24 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.415 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.81 -70.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -38.29 81.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.458 ' CE2' HD12 ' A' ' 74' ' ' LEU . 12.8 m-30 -58.6 -28.79 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.8 mm-40 -72.47 -60.18 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.779 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -25.81 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.265 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 70' ' ' GLY . 4.5 m -88.61 -45.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.089 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 94.43 42.19 4.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.551 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.06 133.25 34.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.779 0.323 . . . . 0.0 110.846 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.2 p -140.02 25.84 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -126.09 24.66 6.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.458 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -135.23 -40.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.29 107.65 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.104 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.2 Cg_exo -49.49 -32.53 27.37 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.464 2.11 . . . . 0.0 112.474 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.77 -13.98 62.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.02 -9.47 58.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.232 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 78.6 m-85 -100.64 97.25 7.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.55 140.09 29.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.964 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-30 -94.13 110.61 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -145.67 131.26 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG22 ' CG2' ' A' ' 46' ' ' VAL . 77.8 t -96.25 -37.17 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.113 -179.294 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 74.4 Cg_endo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.959 0.316 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 97.83 2.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.201 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.1 m-30 -67.9 -71.33 0.21 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.311 -178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -55.64 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -129.73 85.42 58.28 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.361 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -92.61 14.86 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.16 2.573 . . . . 0.0 112.224 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 p -87.81 49.24 1.77 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -126.13 -178.42 0.72 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.983 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 71.7 Cg_exo -48.4 168.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.009 1.806 . . . . 0.0 111.917 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.41 123.99 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 110.757 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 51' ' ' PRO . . . 92.08 -64.64 2.33 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 76.1 m95 -32.47 136.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.57 175.85 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.354 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 27.4 ttm180 -147.36 156.06 42.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.958 0.409 . . . . 0.0 111.28 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 26.3 tttm -166.0 161.32 17.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 46' ' ' VAL . 6.0 mt -129.59 163.25 26.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.897 0.38 . . . . 0.0 111.355 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.9 tttt -143.7 118.99 10.19 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.991 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.529 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.9 tt0 . . . . . 0 CA--C 1.518 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 112.311 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 C--O 1.224 -0.248 0 CA-C-O 121.364 0.602 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 9.3 m-85 -83.56 134.94 34.8 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -117.66 148.67 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.383 177.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 5.6 p -90.33 149.29 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.007 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 12.1 m-85 -146.07 95.85 2.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.934 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 11.9 mt -91.61 113.15 25.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.8 mt -90.58 117.46 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.028 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.583 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 6.6 p-10 -96.82 123.52 53.42 Favored Pre-proline 0 CA--C 1.491 -1.321 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.498 ' CB ' ' HA2' ' A' ' 27' ' ' GLY . 4.7 Cg_exo -71.04 -31.97 4.55 Favored 'Cis proline' 0 C--N 1.309 -1.544 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 -26.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 49' ' ' ILE . 19.2 mt-30 -141.61 -27.75 0.66 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.707 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.21 -31.1 6.33 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.172 -1.013 . . . . 0.0 114.389 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HG3' ' CE1' ' A' ' 56' ' ' PHE . 41.9 tptt -99.15 125.18 44.65 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.137 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' O ' ' CD1' ' A' ' 56' ' ' PHE . . . -105.22 140.98 37.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.56 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 21.9 m-85 -135.07 136.74 42.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.558 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.85 -50.63 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.379 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 177.56 7.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.201 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 1.4 tmtp? -85.04 -43.0 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.544 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 t -51.81 -32.43 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.517 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -68.79 -32.06 71.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.48 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 1.7 tp -64.57 -64.88 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.299 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.425 HG13 ' CG ' ' A' ' 76' ' ' PRO . 3.5 mp -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.88 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.453 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -63.2 -41.38 99.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 110.728 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.53 ' CE2' ' CD1' ' A' ' 74' ' ' LEU . 4.8 m-30 -45.45 -32.35 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mm-40 -72.69 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.107 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.78 23.88 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 70' ' ' GLY . 23.1 m -86.56 -27.75 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.259 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 69' ' ' VAL . . . 83.37 46.07 6.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.163 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.32 133.97 42.55 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.772 0.32 . . . . 0.0 111.514 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 t -149.98 25.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.347 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.93 32.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.53 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.29 -46.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.865 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.34 125.99 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.261 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -56.64 -31.07 86.05 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.496 2.131 . . . . 0.0 112.287 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.04 -7.82 44.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.644 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.5 -7.29 58.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.473 0.178 . . . . 0.0 111.406 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.58 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 51.4 m-85 -107.58 148.17 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 111.393 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.29 159.47 41.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.069 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 57' ' ' ARG . 22.4 m-30 -120.72 91.42 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.0 -10.37 8.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.823 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t 61.33 -81.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 82' ' ' THR . 18.7 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.888 0.286 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -161.76 129.36 4.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.216 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -94.79 -68.23 0.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.179 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.17 81.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.823 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 4.2 m-20 -117.97 91.45 39.65 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.77 13.54 1.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.058 2.505 . . . . 0.0 112.669 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 p -88.53 55.11 3.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.413 . . . . 0.0 110.887 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.6 mt -133.27 165.23 38.25 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.582 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 73.1 Cg_exo -38.81 164.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.768 2.312 . . . . 0.0 112.909 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.2 127.11 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.34 -54.79 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.573 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 47.6 m95 -41.6 148.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.58 -178.41 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.837 178.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 20.9 ttt180 -148.2 159.59 43.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 111.635 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 9.6 tttt -174.25 162.85 3.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.526 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' LYS . 6.0 mt -131.27 161.34 32.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.034 0.445 . . . . 0.0 111.411 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 8.2 tttp -136.18 117.45 14.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.082 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.244 179.14 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.975 0.417 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -106.05 159.46 16.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.671 0.748 . . . . 0.0 112.912 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -129.7 145.84 51.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.778 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.526 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -90.45 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.958 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -144.87 96.98 2.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.97 109.77 21.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 4.2 mt -85.8 134.76 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' OD1' ' CZ2' ' A' ' 28' ' ' TRP . 3.4 t30 -75.22 149.68 84.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.139 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -39.6 -59.45 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.823 2.348 . . . . 0.0 112.789 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -50.89 -25.1 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 114.86 31.56 2.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.239 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.504 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -101.01 117.02 34.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 111.614 -178.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.87 140.69 30.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.835 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.7 m-85 -129.17 127.03 40.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.488 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.483 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -52.42 2.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.779 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 6.1 p -86.07 173.46 9.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.359 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -85.77 -40.28 16.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.955 0.407 . . . . 0.0 110.839 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 46.6 t -51.86 -39.84 26.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.688 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -63.23 -28.2 69.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.161 0.505 . . . . 0.0 109.959 177.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD22 ' CD1' ' A' ' 79' ' ' PHE . 1.7 tp -70.66 -61.64 1.69 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.777 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.3 mp -72.79 -57.92 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.477 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -46.54 -43.8 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.316 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.495 ' CD1' ' HD2' ' A' ' 68' ' ' LYS . 2.4 t80 -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.565 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.475 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 18.8 m-30 -45.61 -35.29 3.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.679 0.276 . . . . 0.0 111.283 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 65.3 mt-10 -61.22 -68.12 0.34 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.016 0.436 . . . . 0.0 110.527 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HD2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -56.01 -19.73 13.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.71 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.457 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 7.4 t -86.36 -42.22 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.889 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.66 37.65 10.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.807 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 127.78 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 0.0 110.756 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -123.5 28.69 6.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -131.3 31.64 4.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 pp -154.46 -179.03 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.451 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -158.62 108.32 1.64 Allowed Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.647 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 80.1 Cg_exo -45.3 -35.47 11.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.658 2.239 . . . . 0.0 112.508 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.62 -20.0 63.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.867 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.45 -9.44 59.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.485 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 47.8 m-85 -104.85 135.09 46.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.948 0.404 . . . . 0.0 111.455 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.06 161.32 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.51 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.526 ' CD1' ' CG1' ' A' ' 46' ' ' VAL . 19.8 m-85 -121.82 88.5 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 p -119.1 -15.1 9.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 32' ' ' LEU . 54.8 t 63.15 -79.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' THR . 12.5 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.438 ' CB ' HD11 ' A' ' 32' ' ' LEU . 77.2 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 CA-C-O 120.661 0.192 . . . . 0.0 112.02 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.432 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -172.61 18.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.569 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 36.23 48.39 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.433 0.635 . . . . 0.0 111.794 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 t0 -132.38 69.91 1.47 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.97 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' CB ' ' CA ' ' A' ' 22' ' ' PRO . 7.5 m-20 67.31 -99.41 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.334 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -171.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.553 ' CA ' ' CB ' ' A' ' 21' ' ' ASP . 26.2 Cg_endo -82.2 153.44 76.82 Favored 'Cis proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.252 2.197 . . . . 0.0 112.93 -13.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 2.8 t 45.34 83.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.962 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' CD1' ' CA ' ' A' ' 29' ' ' THR . 79.5 mt -138.92 154.58 72.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.92 -170.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.63 2.22 . . . . 0.0 112.257 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.5 125.45 25.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.81 -4.35 52.89 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.811 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.516 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 83.5 m95 -99.6 138.96 35.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.366 0.583 . . . . 0.0 111.711 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.58 178.73 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.027 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.5 mtm180 -142.44 141.35 32.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 11.7 ttmt -140.73 153.3 45.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.11 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.438 HD11 ' CB ' ' A' ' 17' ' ' PRO . 4.1 mt -128.43 153.86 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.124 0.487 . . . . 0.0 111.636 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.38 117.37 21.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.231 178.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttt . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.277 0.561 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 10.7 m-85 -106.46 153.51 22.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.713 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -121.54 143.45 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.075 175.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 5.2 p -87.87 148.51 4.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.745 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.0 m-85 -146.92 103.26 3.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.545 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.541 ' CD2' ' CE1' ' A' ' 81' ' ' PHE . 2.3 mp -89.43 110.63 21.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.894 -172.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.2 t-20 -87.27 137.63 32.64 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.358 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 82.4 Cg_exo -32.11 -58.56 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.774 2.982 . . . . 0.0 113.752 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -45.02 -27.72 0.59 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 111.308 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.71 22.67 3.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.503 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 4.4 tttt -94.35 174.45 7.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.733 0.301 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.07 133.96 27.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 19.8 m-85 -127.59 127.17 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.865 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -102.19 6.51 40.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.467 177.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 61' ' ' GLU . 6.4 p -154.15 167.1 30.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 4.2 tptp -74.55 -36.87 63.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.169 0.509 . . . . 0.0 111.526 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 96.8 t -52.4 -43.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.828 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.406 ' HG2' ' OG ' ' A' ' 58' ' ' SER . 5.6 mm-40 -65.92 -29.88 70.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.992 0.425 . . . . 0.0 110.154 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.556 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.87 -66.14 0.58 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.105 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 4.8 mp -61.58 -40.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.67 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -65.46 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.582 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -57.78 -44.34 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.666 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 8.0 m-30 -55.78 -24.38 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.75 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.4 mm-40 -73.79 -53.89 9.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 111.836 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.78 -18.51 62.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.929 -177.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 m -86.32 -43.96 16.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.717 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.72 54.0 1.72 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.511 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD2' ' CD2' ' A' ' 66' ' ' PHE . 35.2 p-10 -74.36 138.02 43.16 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.701 0.4 . . . . 0.0 111.852 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.4 p -149.95 22.56 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.035 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -143.47 33.03 1.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.489 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -154.54 -177.31 6.38 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -158.58 101.02 1.67 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.47 ' HG3' ' CD2' ' A' ' 66' ' ' PHE . 99.5 Cg_exo -44.08 -27.76 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.428 2.085 . . . . 0.0 112.107 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.93 -23.06 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.633 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.46 8.5 24.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.087 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.503 ' CE2' HD12 ' A' ' 62' ' ' LEU . 9.6 m-85 -93.74 124.15 37.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.771 0.319 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 116.44 29.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 48' ' ' LEU . 8.5 m-85 -88.72 74.46 8.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.41 111.41 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 44' ' ' TYR . 92.4 t -79.55 -14.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.495 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.115 -179.537 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.0 Cg_endo . . . . . 0 C--O 1.23 0.123 0 N-CA-C 111.54 -0.215 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.438 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -134.54 -34.47 0.93 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 62.39 18.07 9.99 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 9.4 m-20 -118.72 84.89 2.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 7.1 m-20 44.62 -94.39 0.0 OUTLIER Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-O 116.781 -1.58 . . . . 0.0 109.727 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 58.6 Cg_endo -77.0 -55.8 0.14 OUTLIER 'Cis proline' 0 N--CA 1.484 0.95 0 CA-C-N 122.908 2.074 . . . . 0.0 113.834 -6.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 32.9 p -159.35 78.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -94.11 -175.54 0.49 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.666 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.8 Cg_exo -42.77 165.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.026 1.818 . . . . 0.0 112.508 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.29 125.39 14.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.007 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.79 -0.14 52.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.344 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.488 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 62.8 m95 -101.22 127.13 47.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.124 0.487 . . . . 0.0 111.469 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.442 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -134.35 172.72 12.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.608 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 11.7 ttm180 -140.17 150.77 44.62 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.8 0.81 . . . . 0.0 111.6 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -157.78 160.88 38.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.237 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 1.3 mt -130.85 169.79 15.28 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.9 tttt -147.91 114.14 5.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.421 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 52.1 tt0 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.756 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.919 0.39 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.493 ' CE2' ' OH ' ' A' ' 19' ' ' TYR . 7.2 m-85 -89.77 141.51 28.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.16 137.21 54.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.341 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -85.85 154.7 3.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.617 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 12.5 m-85 -145.08 100.88 3.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 41.9 mt -92.51 104.88 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -82.37 126.39 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.619 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.488 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 30.8 p-10 -85.59 148.51 49.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.394 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -33.8 -54.55 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.764 2.976 . . . . 0.0 113.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -44.85 -27.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.37 49.32 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.047 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.41 132.43 27.82 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.017 0.437 . . . . 0.0 111.129 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.75 137.68 32.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.488 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 60.1 m-85 -122.17 121.58 37.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 5.0 mtm180 -89.92 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.23 173.54 8.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.95 -38.69 24.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.414 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 10.7 p -51.79 -43.17 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.351 0.596 . . . . 0.0 110.217 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 mt-10 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.31 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD2' ' A' ' 79' ' ' PHE . 1.4 tp -70.42 -63.08 1.16 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.387 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -62.27 -36.53 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.83 -72.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -42.93 84.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 7.4 m-30 -52.07 -31.49 30.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.178 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.6 mm-40 -74.24 -59.56 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.745 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.63 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.737 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 m -86.46 -31.94 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 0.0 111.35 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.54 43.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -79.31 128.92 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.871 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 t -119.36 20.08 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -125.85 26.52 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 0.0 110.656 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -154.53 175.9 13.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.671 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -158.57 129.19 3.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.436 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.442 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 51.4 Cg_exo -55.13 -36.32 92.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.427 2.085 . . . . 0.0 112.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.0 -18.09 63.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.996 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.95 -4.2 59.15 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.515 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.498 ' CD2' HD22 ' A' ' 62' ' ' LEU . 87.3 m-85 -107.66 85.36 2.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.016 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -80.38 128.75 33.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.533 ' CD1' ' CG1' ' A' ' 46' ' ' VAL . 9.0 m-85 -84.04 90.56 7.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.38 88.71 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.796 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.431 ' CG1' HD12 ' A' ' 32' ' ' LEU . 88.3 t -47.09 -27.64 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.076 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 111.051 -179.513 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.48 0.686 0 CA-C-O 120.939 0.308 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.83 94.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.551 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.26 -70.55 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.129 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.27 89.98 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.081 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' CG ' ' A' ' 30' ' ' ARG . 6.4 t0 -118.93 83.86 24.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.808 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -102.17 21.58 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.649 2.899 . . . . 0.0 113.018 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -81.54 -33.35 31.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.235 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.6 mt -41.87 160.41 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.573 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.4 Cg_exo -40.33 162.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.652 2.235 . . . . 0.0 112.317 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.89 136.62 2.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.083 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.48 -45.8 2.96 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.73 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.611 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 63.2 m95 -68.92 149.1 49.25 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.56 -179.65 7.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.58 175.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.13 169.7 23.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 110.728 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 9.2 ttmt -170.42 162.25 8.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' A' ' 46' ' ' VAL . 5.7 mt -131.26 157.09 44.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.958 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -139.29 124.66 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.621 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.473 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 59.0 tt0 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.065 0.46 . . . . 0.0 110.707 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -90.87 142.07 28.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -118.83 148.95 42.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.644 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG12 ' CD1' ' A' ' 81' ' ' PHE . 6.7 p -91.42 148.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.378 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.11 103.25 3.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' N ' HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -91.89 116.81 29.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -91.2 138.79 18.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.423 -175.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -154.32 148.72 19.37 Favored Pre-proline 0 CA--C 1.484 -1.571 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -96.39 30.27 14.1 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 N-CA-C 108.305 -1.46 . . . . 0.0 108.305 -25.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 51' ' ' PRO . 48.3 mt-30 -157.02 -44.26 0.07 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.904 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 10.04 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.906 -1.14 . . . . 0.0 115.285 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.487 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tmtt? -92.04 115.34 27.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.759 1.779 . . . . 0.0 110.42 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.418 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -92.01 154.21 18.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.251 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 42.1 m-85 -150.55 136.02 18.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 1.5 mtm-85 -97.61 -57.16 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.176 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -87.56 171.46 10.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.381 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HE2' ' CA ' ' A' ' 76' ' ' PRO . 7.3 tptp -81.24 -38.0 27.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.369 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.81 -42.12 31.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.55 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -33.2 73.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.751 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.484 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.3 tp -66.49 -61.01 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.469 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.429 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 4.8 mp -62.96 -36.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.496 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.88 -62.91 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.989 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.48 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -61.16 -53.08 61.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.257 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 21.6 m-30 -50.13 -25.02 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.821 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.5 mm-40 -71.08 -63.6 1.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.695 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -23.23 65.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.56 -38.33 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.353 . . . . 0.0 111.137 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.47 46.99 8.4 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.158 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -74.56 135.86 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -127.88 23.64 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.252 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 24.04 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.883 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.446 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.1 pp -154.5 178.26 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.668 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -158.64 117.8 1.77 Allowed Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.491 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' CA ' ' HE2' ' A' ' 59' ' ' LYS . 88.9 Cg_exo -46.3 -33.03 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.381 2.054 . . . . 0.0 112.051 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -19.13 63.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.058 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.84 11.21 18.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.451 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.34 72.1 1.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.985 0.421 . . . . 0.0 111.761 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 162.0 29.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.457 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 15.5 m-85 -115.68 124.59 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 111.753 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.29 93.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.673 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -50.94 -28.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.698 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 179.782 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 2.7 Cg_endo . . . . . 0 N--CA 1.472 0.21 0 CA-C-O 120.473 0.114 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.483 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -156.42 97.88 1.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.33 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -70.71 68.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.5 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 28.3 t70 -156.7 85.93 0.98 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.943 -171.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.534 ' HB2' ' C ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 34.95 -88.98 0.0 OUTLIER Pre-proline 0 CA--C 1.498 -1.028 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.429 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.534 ' C ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 Cg_endo -94.44 1.46 49.64 Favored 'Cis proline' 0 N--CA 1.486 1.065 0 CA-C-N 121.851 1.697 . . . . 0.0 113.74 -2.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.431 ' N ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -159.25 -83.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.883 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 mt 59.42 163.3 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.339 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.38 -179.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.07 2.513 . . . . 0.0 112.78 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.45 122.69 16.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.16 -1.92 53.82 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.55 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 58.0 m95 -98.83 140.51 32.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 111.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -143.55 166.36 25.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.399 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 24.1 ttm105 -136.17 154.48 50.94 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.288 0.566 . . . . 0.0 110.466 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -162.99 164.33 25.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.773 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.482 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -133.44 167.52 20.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.483 0.658 . . . . 0.0 112.697 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -147.8 112.04 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.184 178.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.458 -179.335 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.046 0.451 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.474 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 5.2 m-85 -99.23 150.93 21.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.561 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -116.9 142.11 47.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.546 176.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' CG2' ' CG2' ' A' ' 83' ' ' VAL . 65.5 t -85.12 152.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.894 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.7 m-85 -146.14 90.6 1.98 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 9.6 mt -91.22 103.36 16.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 12.6 mt -82.37 117.24 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.655 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 36.7 p-10 -84.61 152.88 60.93 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.484 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -34.97 -56.15 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.732 2.955 . . . . 0.0 113.447 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -44.65 -27.02 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.58 49.07 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.037 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.97 132.02 26.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.962 0.41 . . . . 0.0 111.479 -178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.82 144.3 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.783 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 55.9 m-85 -132.5 126.25 32.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.89 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 19.4 mtm180 -100.92 -52.82 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.262 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.89 171.78 10.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.909 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -81.81 -39.77 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.299 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 9.3 p -51.78 -42.22 31.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.307 0.575 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -29.34 69.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.384 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -70.4 -67.29 0.51 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.482 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -58.22 -37.67 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.611 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.74 -58.5 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -66.25 -46.37 77.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.711 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 18.9 m-85 -52.08 -26.13 10.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.6 mm-40 -72.4 -62.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.772 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.09 63.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.698 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.64 -37.56 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 0.0 111.689 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.14 48.61 9.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.047 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 -74.62 0.19 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.927 0.87 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p 60.19 18.63 8.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.546 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -120.05 25.92 9.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.472 HD23 ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -138.72 -36.6 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.6 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.97 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.651 0.263 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -51.69 -34.46 53.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.344 2.03 . . . . 0.0 112.344 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.12 -8.9 49.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.413 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -83.19 -9.51 59.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.903 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.534 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 52.6 m-85 -107.26 116.43 31.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.759 0.314 . . . . 0.0 110.554 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.99 146.88 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 22.1 m-30 -100.91 85.65 2.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.4 p -101.95 -16.22 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.452 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' CG2' ' CG2' ' A' ' 46' ' ' VAL . 53.5 t 67.62 -61.02 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.367 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.9 p . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.432 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 N--CA 1.481 0.768 0 CA-C-O 120.847 0.27 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 102.03 2.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.48 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.83 -69.36 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.199 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.55 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.437 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -115.49 89.71 23.11 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.543 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -93.48 18.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.094 2.529 . . . . 0.0 112.835 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.3 p -92.8 43.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.034 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.476 ' CD1' ' CG ' ' A' ' 30' ' ' ARG . 11.2 mt -123.02 166.57 17.42 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.312 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 96.0 Cg_exo -45.34 173.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.786 2.324 . . . . 0.0 112.752 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 125.84 18.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.915 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.49 -2.8 51.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.694 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.506 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 50.8 m95 -99.02 139.03 35.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -144.19 -179.66 6.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.814 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 24' ' ' LEU . 1.2 mtp180 -145.85 163.73 34.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.937 0.399 . . . . 0.0 111.401 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -170.07 158.36 6.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.129 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.436 HD12 ' CG1' ' A' ' 83' ' ' VAL . 3.4 mt -131.29 155.96 46.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.496 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -129.57 120.41 25.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.154 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.759 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmp? . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -107.84 163.66 12.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.09 144.0 46.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.281 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.428 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.4 p -88.0 149.51 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.899 0.381 . . . . 0.0 111.78 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 10.6 m-85 -146.06 97.32 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.255 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mt -93.01 109.27 20.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -83.81 123.74 39.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.649 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 32.4 p-10 -85.65 152.99 57.97 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -36.19 -54.74 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.741 2.96 . . . . 0.0 113.161 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.34 -26.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.34 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 48.85 1.17 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.799 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -140.86 135.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.354 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.66 134.88 33.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -115.51 123.21 47.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -104.33 -4.4 22.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.36 177.47 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.822 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 1.3 mmtp -78.84 -45.08 21.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.906 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 29.2 t -51.85 -31.42 13.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.219 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -30.87 59.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.883 176.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.579 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -63.32 -66.17 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.425 178.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -59.96 -41.94 87.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.0 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.49 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -54.71 43.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.18 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 6.1 m-30 -46.58 -31.5 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 111.732 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.8 mm-40 -67.82 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.71 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -25.6 59.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.638 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.38 -30.79 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 111.254 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.71 81.66 0.52 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.682 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD2' ' CD1' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -149.91 126.9 11.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -177.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -132.38 20.37 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.76 22.14 15.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.748 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -154.58 65.48 0.68 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.674 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.5 OUTLIER 61.07 -173.87 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.146 0 C-N-CA 118.512 -1.275 . . . . 0.0 107.752 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 80.8 Cg_exo -75.73 -157.68 1.46 Allowed 'Cis proline' 0 C--N 1.312 -1.381 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 17.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.81 19.67 9.86 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.694 -176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -145.59 -5.17 0.65 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.674 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 50.7 m-85 -97.57 90.94 5.2 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.229 -0.294 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.39 119.24 11.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.817 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 46' ' ' VAL . 8.3 m-85 -89.46 69.47 7.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.3 107.61 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.436 ' CG1' HD12 ' A' ' 32' ' ' LEU . 93.8 t -59.8 -38.79 77.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.392 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.307 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.797 0.249 . . . . 0.0 112.373 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.49 135.69 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.358 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' CA ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -112.98 56.29 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -178.24 67.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.589 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.87 85.85 12.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.337 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -96.15 18.1 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.273 2.649 . . . . 0.0 112.63 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -83.11 -20.16 35.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.409 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 28' ' ' TRP . 51.2 mt -48.46 162.18 0.36 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -38.37 161.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.707 2.272 . . . . 0.0 112.72 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.72 129.57 5.5 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.478 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.91 -44.78 2.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.485 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.612 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 62.7 m95 -68.95 150.44 47.72 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 179.64 7.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.295 176.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' LYS . 58.2 ttp180 -153.29 163.06 40.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.36 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HG3' ' CA ' ' A' ' 19' ' ' TYR . 29.9 ttpt -174.68 164.95 3.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.414 ' CD1' HG11 ' A' ' 83' ' ' VAL . 6.1 mt -131.38 161.11 33.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.919 0.39 . . . . 0.0 111.474 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -138.51 120.87 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.405 -178.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.813 177.915 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.7 164.03 11.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.554 0.692 . . . . 0.0 112.64 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -133.39 146.7 51.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.204 177.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.8 p -86.86 146.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.704 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 4.9 m-85 -142.84 95.97 2.86 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.027 0.441 . . . . 0.0 110.954 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' CD2' ' HG3' ' A' ' 30' ' ' ARG . 7.7 mt -92.89 110.44 21.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 23.0 mt -86.29 141.35 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.515 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.566 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -153.3 145.64 17.16 Favored Pre-proline 0 CA--C 1.482 -1.645 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 7.2 Cg_endo -93.9 24.04 25.61 Favored 'Cis proline' 0 N--CA 1.455 -0.737 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 -24.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -154.34 -43.72 0.09 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.543 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.11 1.85 0.11 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 119.66 -1.257 . . . . 0.0 115.661 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HG3' ' CD2' ' A' ' 65' ' ' TYR . 1.2 tmtt? -88.44 119.68 29.1 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.974 1.887 . . . . 0.0 110.741 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -101.79 148.77 24.9 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.485 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 9.2 m-85 -142.61 144.9 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.691 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.36 18.84 6.94 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 10.1 t -145.96 -86.02 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.068 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HG2' ' CE1' ' A' ' 81' ' ' PHE . 0.5 OUTLIER 166.25 -41.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 1.7 p -56.85 -39.18 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.122 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -27.56 66.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.335 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.424 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.1 tp -68.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.405 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.25 -38.26 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.72 -49.95 64.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -73.04 -61.53 1.78 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.467 ' CE1' HD23 ' A' ' 74' ' ' LEU . 23.3 m-85 -42.71 -34.95 0.99 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -61.66 -69.3 0.25 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.21 -19.05 18.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.484 -176.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.492 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 33.9 m -91.99 -30.19 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.733 0.302 . . . . 0.0 111.158 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' HG21 ' A' ' 69' ' ' VAL . . . 57.48 64.21 4.59 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.8 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' O ' ' CG2' ' A' ' 72' ' ' THR . 10.5 t0 -74.39 -45.92 43.68 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.788 0.804 . . . . 0.0 111.541 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 71' ' ' ASP . 5.9 t 52.69 18.42 1.01 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.596 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.39 19.23 8.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 110.716 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' CE1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.6 -177.34 6.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -158.58 118.04 1.79 Allowed Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.916 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 89.1 Cg_exo -47.62 -32.5 16.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.198 1.932 . . . . 0.0 112.165 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.71 -20.16 63.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.141 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.51 9.26 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.612 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.03 86.7 2.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.438 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -63.73 -175.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.001 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 37.2 m-85 -145.38 73.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.94 117.47 28.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.915 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG11 ' CD1' ' A' ' 32' ' ' LEU . 58.8 t -68.72 -56.64 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.474 0.358 0 CA-C-O 120.747 0.228 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.13 134.61 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.644 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -116.07 48.61 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.677 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.33 67.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.606 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -112.2 94.29 25.52 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.18 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.78 -6.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.439 2.759 . . . . 0.0 112.67 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 t -84.06 53.67 2.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.93 0.395 . . . . 0.0 111.007 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.55 164.51 15.64 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.59 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.56 166.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.612 2.208 . . . . 0.0 112.371 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.0 121.47 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . 77.95 53.24 4.99 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.681 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 56.9 m95 -157.02 151.33 25.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 179.61 7.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.608 175.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.441 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 22.3 ttt180 -153.62 160.04 42.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.213 0.53 . . . . 0.0 112.134 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.01 166.24 2.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.453 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD1' HG12 ' A' ' 83' ' ' VAL . 10.6 mt -131.3 166.55 20.97 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.03 0.443 . . . . 0.0 111.583 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -135.11 118.08 16.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.149 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.354 179.273 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -107.6 161.03 15.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.641 0.734 . . . . 0.0 112.582 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.52 147.77 52.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.73 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 p -87.13 143.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.84 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 5.4 m-85 -143.16 97.06 3.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 82.1 mt -91.31 116.11 28.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 174.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.446 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 5.6 mt -91.5 137.53 21.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.536 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.9 p-10 -153.32 147.71 19.1 Favored Pre-proline 0 CA--C 1.49 -1.346 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 93.0 Cg_endo -91.67 -3.08 52.77 Favored 'Cis proline' 0 N--CA 1.448 -1.182 0 C-N-CA 125.239 -0.734 . . . . 0.0 110.863 -23.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -116.8 -35.62 4.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.999 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' HA3' ' CG2' ' A' ' 49' ' ' ILE . . . -176.64 21.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.741 -1.218 . . . . 0.0 114.881 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -96.81 115.71 27.9 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.348 1.574 . . . . 0.0 111.139 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.03 146.64 24.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.992 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 9.0 m-85 -150.66 137.37 18.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.728 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -105.95 11.59 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.151 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -154.49 170.17 22.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -80.41 -41.83 23.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.007 -176.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.6 p -50.36 -41.54 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.148 0.499 . . . . 0.0 110.606 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.08 -29.6 67.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.61 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -64.32 -63.67 1.08 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.1 mp -65.12 -38.01 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.352 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.69 -58.05 8.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.749 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -65.28 -53.71 40.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.627 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 6.1 m-30 -43.97 -26.06 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.612 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.8 mm-40 -75.33 -65.97 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.36 -15.41 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.48 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 19.7 m -88.27 -28.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.227 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.99 59.69 10.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.249 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.02 -68.33 0.68 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.871 0.844 . . . . 0.0 111.899 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p 65.17 14.28 9.29 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.692 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -115.61 22.78 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 110.592 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -154.59 -174.25 4.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 13.5 t0 -158.61 113.12 1.66 Allowed Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.007 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 80.9 Cg_exo -46.02 -34.87 13.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.317 2.012 . . . . 0.0 111.954 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.539 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.6 8.1 30.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 8.6 m-85 -129.81 88.56 2.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 111.676 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 156.84 34.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.323 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 18.4 m-85 -109.89 104.04 12.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 111.598 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -148.46 100.48 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.639 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 32' ' ' LEU . 78.7 t -46.46 -38.5 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.99 179.658 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.404 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.8 Cg_endo . . . . . 0 N--CA 1.472 0.263 0 CA-C-O 120.762 0.234 . . . . 0.0 112.435 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.9 113.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -92.92 52.68 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.719 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -176.37 64.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.24 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -109.41 95.85 20.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.313 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -91.54 10.53 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.117 2.544 . . . . 0.0 112.519 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -85.48 52.77 2.55 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.881 0.372 . . . . 0.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -127.82 165.08 32.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.07 177.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.561 2.174 . . . . 0.0 112.606 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.32 129.37 18.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.819 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 63.42 11.03 38.88 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.804 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.577 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 73.2 m95 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 0.0 111.742 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.66 178.69 6.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.107 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' NH2' HD13 ' A' ' 32' ' ' LEU . 4.1 ttt85 -145.37 162.35 37.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 0.0 111.661 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 34.8 ttmt -175.08 158.32 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.602 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.424 HD13 ' NH2' ' A' ' 30' ' ' ARG . 8.0 mt -131.34 163.12 28.56 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.12 0.486 . . . . 0.0 111.811 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.3 ttpt -137.76 113.18 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.169 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.245 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.675 0.274 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 7.2 m-85 -107.49 161.89 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -131.31 143.6 50.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.92 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 81' ' ' PHE . 6.3 p -89.4 147.19 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.062 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.1 m-85 -144.98 94.32 2.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.321 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 70.0 mt -92.95 113.23 25.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 55' ' ' ALA . 2.6 mt -89.63 122.83 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.218 -173.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 38.6 p-10 -85.71 155.66 58.88 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.569 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 27' ' ' GLY . 97.8 Cg_exo -36.73 -53.21 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.661 2.908 . . . . 0.0 113.286 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -47.56 -25.57 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.981 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.28 46.59 1.54 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.681 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.848 0.356 . . . . 0.0 111.264 -177.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.436 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -105.27 154.48 20.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.886 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 67.4 m-85 -131.07 150.18 52.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.457 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 20.18 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.64 -4.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 77.14 -50.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.982 0.356 . . . . 0.0 111.957 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.1 p -52.49 -41.18 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.695 -0.628 . . . . 0.0 109.51 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' N ' HG11 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -62.98 -30.29 71.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.085 177.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.558 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -62.77 -72.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.041 179.197 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 7.9 mt -52.81 -43.57 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' CD ' ' A' ' 68' ' ' LYS . . . -52.82 -47.03 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.196 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.446 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -71.51 -57.55 4.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.69 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.573 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 27.6 m-85 -44.42 -29.73 0.74 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.136 0.493 . . . . 0.0 110.922 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.73 -47.3 85.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.91 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.8 -33.02 74.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.84 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 m -93.5 -30.12 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.18 10.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.937 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.97 126.46 35.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.9 p -140.83 32.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -125.56 16.91 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -154.58 72.36 0.86 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.654 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 2.5 m-20 60.31 -152.93 0.01 OUTLIER Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' CD2' ' A' ' 66' ' ' PHE . 83.9 Cg_endo -68.19 -152.77 0.49 Allowed 'Cis proline' 0 C--N 1.311 -1.402 0 CA-C-N 121.78 1.671 . . . . 0.0 111.568 4.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 63.69 13.26 7.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.354 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.58 7.34 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.353 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 37.9 m-85 -99.87 63.74 1.21 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.677 0.275 . . . . 0.0 110.271 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -44.58 128.1 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.639 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.488 ' CD2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-30 -88.37 85.26 6.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 1.5 p -98.34 93.34 6.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.99 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.419 ' HA ' HD12 ' A' ' 32' ' ' LEU . 77.8 t -66.82 -28.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.082 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 179.746 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 1.7 Cg_endo . . . . . 0 N--CA 1.472 0.24 0 N-CA-C 111.841 -0.099 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.68 -36.2 0.44 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.117 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 81.17 -56.86 0.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -38.36 99.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.146 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -1.3 -65.42 0.0 OUTLIER Pre-proline 0 CA--C 1.477 -1.84 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -179.092 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ASP . 63.1 Cg_endo -104.6 -4.49 8.97 Favored 'Cis proline' 0 C--N 1.314 -1.265 0 O-C-N 123.334 1.176 . . . . 0.0 112.115 -2.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -161.19 21.19 0.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.424 -174.334 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -44.15 166.85 0.1 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 0.0 111.857 -177.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.9 Cg_exo -39.58 166.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.103 2.536 . . . . 0.0 113.272 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.44 119.5 2.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 76.9 -4.2 54.11 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.064 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.574 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 68.6 m95 -101.64 134.69 44.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.46 -0.435 . . . . 0.0 111.457 -178.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -147.92 142.96 27.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.244 -178.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 44.9 ttp180 -110.33 163.39 13.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.821 0.82 . . . . 0.0 112.345 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.417 ' N ' ' CG ' ' A' ' 30' ' ' ARG . 9.4 ttmt -169.31 149.38 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.466 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 1.8 mt -124.5 164.87 18.85 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.0 111.648 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -137.7 123.2 19.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.94 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.444 179.2 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 10.5 m-85 -102.04 168.9 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -142.83 140.4 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.242 176.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 9.9 p -88.66 152.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.371 . . . . 0.0 111.281 -178.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 23.6 m-85 -146.05 101.01 3.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.544 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 81' ' ' PHE . 21.2 mt -92.93 105.48 17.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.801 0.81 . . . . 0.0 109.006 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' THR . 2.8 mt -82.22 121.16 35.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.135 -174.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -85.62 152.86 57.87 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.759 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' GLY . 89.6 Cg_exo -35.29 -57.23 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 0.0 113.275 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -43.9 -27.52 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.234 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.04 49.9 1.04 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.891 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -140.83 133.66 28.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.989 0.424 . . . . 0.0 111.279 -178.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -89.26 146.96 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.332 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -128.28 126.36 40.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 ttp180 -92.01 -59.22 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.67 172.7 8.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -81.75 -42.84 19.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.381 -178.676 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 t -51.8 -26.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.32 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.63 -31.27 59.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.488 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -68.01 -60.87 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -61.3 -40.24 85.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.074 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.74 -62.06 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.657 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.493 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -59.05 -57.95 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.66 178.381 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.9 m-30 -39.67 -38.8 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.114 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.7 mm-40 -61.04 -56.14 24.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.034 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.46 -16.41 63.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -86.03 -50.52 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -178.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 153.75 -31.4 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.455 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.67 -161.33 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.066 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 71' ' ' ASP . 3.0 t 59.47 25.42 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.915 -178.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -141.1 17.47 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.67 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -39.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 -178.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.97 103.59 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.593 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.3 Cg_exo -48.59 -32.48 21.31 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.439 2.093 . . . . 0.0 112.549 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.1 -10.95 60.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.603 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.55 -3.51 58.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.511 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 56.1 m-85 -109.51 64.4 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.566 -178.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.19 137.42 58.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.519 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CZ ' ' O ' ' A' ' 57' ' ' ARG . 8.3 m-85 -87.27 91.51 8.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.073 0.463 . . . . 0.0 111.075 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 98.77 7.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.747 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 ' CG1' ' CB ' ' A' ' 44' ' ' TYR . 93.0 t -72.0 -7.64 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.602 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.6 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.919 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.498 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 4.9 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.886 0.286 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -168.91 106.01 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.502 178.854 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -68.66 66.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.997 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 179.05 74.75 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -177.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.6 m-20 -115.7 80.48 8.43 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.632 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.43 22.37 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.852 2.368 . . . . 0.0 112.713 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -94.8 46.43 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.408 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -125.1 176.66 2.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.479 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 81.5 Cg_exo -49.35 -179.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.729 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.52 126.83 28.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.817 -179.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.61 55.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.276 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 70.8 m95 -106.38 128.14 53.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.238 0.542 . . . . 0.0 111.787 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.95 -179.89 5.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.152 179.36 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 29.9 ttp180 -142.09 163.08 33.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.785 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.453 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 13.4 ttmt -165.17 170.84 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.492 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -138.38 162.94 33.13 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.085 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -148.0 117.17 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.829 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 48.3 tt0 . . . . . 0 CA--C 1.515 -0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.954 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -77.93 122.85 26.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -175.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -103.01 149.47 24.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.319 176.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 41.7 t -93.86 151.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.1 m-85 -146.05 99.88 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.606 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 7.1 mt -92.88 106.8 18.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 109.624 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.1 mt -82.23 122.5 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.688 -174.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 31.2 p-10 -85.71 153.4 58.07 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.594 -178.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -37.61 -27.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.082 3.188 . . . . 0.0 113.699 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ASN . 2.6 mt-30 -80.61 12.38 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 70.98 15.94 74.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.972 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -99.05 137.51 37.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.494 0.188 . . . . 0.0 111.389 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.28 130.76 41.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.345 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 26.4 m-85 -115.8 117.83 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' CD ' ' CE2' ' A' ' 47' ' ' TYR . 8.1 mtm180 -105.03 10.06 34.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.453 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.45 164.84 38.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.836 0.351 . . . . 0.0 111.189 -178.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -76.66 -35.91 57.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 0.0 111.122 -178.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 8.2 p -54.0 -46.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.63 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 4.7 mt-10 -61.3 -30.59 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.88 -64.73 0.83 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -64.91 -42.42 94.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.72 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -57.04 11.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.417 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.478 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -66.69 -50.74 61.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.544 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 14.7 m-30 -48.81 -38.32 21.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.798 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 33.1 mt-10 -61.06 -66.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HE2' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -54.17 -26.98 30.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -177.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.444 HG11 ' CD ' ' A' ' 68' ' ' LYS . 28.4 m -86.45 -29.32 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.786 178.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.31 55.3 28.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.881 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -83.46 153.22 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -131.2 3.61 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.43 27.38 8.81 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.889 0.376 . . . . 0.0 110.807 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.486 HD11 ' CE2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -154.43 173.19 16.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.872 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -158.63 111.86 1.65 Allowed Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.219 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 84.5 Cg_exo -45.17 -41.22 16.56 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.116 1.877 . . . . 0.0 112.241 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -69.97 -9.05 53.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -88.64 -6.49 57.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.13 178.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.463 ' CE2' HD12 ' A' ' 62' ' ' LEU . 45.9 m-85 -109.39 127.39 54.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.638 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.24 134.16 50.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.127 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.446 ' CE2' ' C ' ' A' ' 58' ' ' SER . 4.1 m-85 -97.45 90.2 4.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 p -141.43 142.56 33.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 32' ' ' LEU . 87.0 t -95.5 -64.12 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.539 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 Cg_endo . . . . . 0 N--CA 1.456 -0.693 0 CA-C-O 120.884 0.285 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.99 103.73 0.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.287 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -69.5 64.64 0.18 Allowed 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.683 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -178.5 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.49 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.8 t70 -114.67 82.64 8.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.19 0.24 8.21 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.116 2.544 . . . . 0.0 112.935 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.4 p -80.64 -23.17 39.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.771 0.319 . . . . 0.0 111.09 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 13.3 mt -46.38 161.29 0.28 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 49.1 Cg_exo -35.71 159.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.107 2.538 . . . . 0.0 113.404 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.79 120.82 2.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.183 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.78 -14.02 27.39 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.499 178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 67.4 m95 -90.69 137.05 32.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.64 177.94 7.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.946 179.311 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 19.3 ttp180 -141.02 160.91 39.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.518 . . . . 0.0 111.421 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -161.19 166.93 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.946 -179.36 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.875 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.42 117.33 8.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.96 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 58.2 tt0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.722 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.925 0.393 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -94.12 135.0 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.307 0.575 . . . . 0.0 112.385 -177.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -109.59 156.09 20.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.608 176.757 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.439 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 18.3 t -98.28 149.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.509 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.484 ' CD2' ' CG ' ' A' ' 57' ' ' ARG . 14.9 m-85 -146.01 99.5 3.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.453 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 20.0 mt -90.85 107.91 19.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.2 mt -82.35 127.86 39.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.415 -171.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.3 t-20 -81.39 137.27 48.63 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.997 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 76.9 Cg_exo -33.27 -53.54 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.852 3.035 . . . . 0.0 113.322 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.23 -26.95 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.332 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.05 17.07 5.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.354 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.507 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 7.6 tttp -97.28 168.35 10.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.679 0.276 . . . . 0.0 111.119 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -134.95 130.42 35.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 29.2 m-85 -126.37 121.23 31.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.484 ' CG ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.13 -52.58 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.443 . . . . 0.0 110.139 177.695 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.4 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -88.03 177.09 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.918 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -83.77 -41.49 17.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.338 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 21.6 t -51.81 -27.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.61 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.81 -31.69 59.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.303 178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -62.84 -66.58 0.52 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.976 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.2 mp -57.66 -38.4 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -58.51 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.98 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.468 ' CG ' ' HD3' ' A' ' 54' ' ' LYS . 1.5 t80 -66.37 -52.61 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.271 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.536 ' CZ ' ' CD1' ' A' ' 62' ' ' LEU . 12.6 m-30 -44.79 -41.65 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 21.9 mt-10 -61.16 -63.9 1.13 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.886 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.67 -23.52 28.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.67 -177.522 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.453 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 12.4 m -92.54 -39.88 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.422 ' N ' HG21 ' A' ' 69' ' ' VAL . . . 99.13 33.95 5.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.586 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -89.95 135.86 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.945 179.756 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -144.99 26.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.161 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -125.84 7.84 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.967 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -106.23 -31.87 8.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.845 0.355 . . . . 0.0 110.577 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.53 95.75 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 82.1 Cg_exo -44.39 -30.61 3.88 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.494 2.129 . . . . 0.0 112.227 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.12 -7.97 45.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.54 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.39 -18.52 38.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.608 0.242 . . . . 0.0 111.144 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.467 ' CE2' HD12 ' A' ' 62' ' ' LEU . 22.7 m-85 -97.77 125.13 42.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 111.341 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.71 144.41 41.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-85 -101.95 102.47 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.395 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.7 110.81 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 46' ' ' VAL . 64.4 t -65.57 -71.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.83 179.742 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.49 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo . . . . . 0 N--CA 1.473 0.303 0 CA-C-O 120.755 0.231 . . . . 0.0 111.918 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.467 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.28 -26.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.252 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 84.17 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.433 0.293 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.54 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' O ' ' NH1' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -114.63 112.42 45.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.197 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -109.11 37.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.943 3.095 . . . . 0.0 112.728 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.5 p -98.3 -53.72 3.27 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.7 mt -51.65 -177.53 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 121.489 -0.085 . . . . 0.0 111.051 -176.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 40.0 Cg_exo -41.29 157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.987 2.458 . . . . 0.0 114.6 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.23 149.98 3.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.94 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -59.29 1.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.867 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 75.8 m95 -47.8 150.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.349 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -149.09 178.11 9.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.879 178.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.482 ' NH2' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -144.22 165.7 27.12 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.406 177.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm -176.37 154.59 1.34 Allowed 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.597 -176.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.49 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 10.0 mt -116.47 173.79 6.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.546 0.689 . . . . 0.0 112.828 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.83 116.94 6.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.45 176.77 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.086 179.01 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.046 0.451 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -99.99 159.19 15.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -132.51 153.83 50.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.641 177.247 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 52.5 t -101.15 148.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.517 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 8.3 m-85 -144.61 103.26 3.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.718 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.441 ' CD2' ' CG ' ' A' ' 30' ' ' ARG . 71.3 mt -92.93 108.05 19.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.6 mt -88.23 130.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.661 -174.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 7.4 p-10 -82.73 154.31 68.05 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.663 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -32.51 -60.45 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.896 3.064 . . . . 0.0 113.827 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.24 -25.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 25.28 5.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.687 -179.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 47.2 tptt -99.1 124.75 44.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.19 140.26 31.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -177.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.564 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.4 m-85 -133.26 135.35 44.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.155 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -102.58 -53.54 2.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.097 178.144 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -87.0 174.19 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.486 178.337 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' HE3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.41 -42.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.337 . . . . 0.0 111.756 -178.364 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 50.9 t -51.83 -25.17 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.02 -26.27 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.203 178.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.503 HD22 ' CD2' ' A' ' 79' ' ' PHE . 1.1 mp -76.1 -65.55 0.9 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.907 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.42 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -55.81 -38.42 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.82 -66.98 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.341 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.89 -45.63 89.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.189 -179.166 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 20.4 m-30 -53.41 -34.54 58.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 111.57 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.24 -70.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.674 -176.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.06 -21.04 28.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 110.357 178.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 65' ' ' TYR . 36.6 t -86.46 -25.08 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.927 -177.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 48.49 56.08 9.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.342 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.46 134.52 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.6 16.22 15.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.284 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 25.13 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.839 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -154.65 175.23 13.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.482 179.452 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.64 123.59 2.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.073 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HA ' HD21 ' A' ' 62' ' ' LEU . 39.3 Cg_exo -56.07 -33.39 89.71 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.068 1.845 . . . . 0.0 112.27 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.435 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -70.61 -15.6 62.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.59 -16.42 32.57 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 0.0 111.584 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.503 ' CD2' HD22 ' A' ' 62' ' ' LEU . 54.9 m-85 -98.46 126.97 44.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.5 152.74 43.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.058 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.8 m-85 -107.46 84.64 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -125.05 95.37 4.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 32' ' ' LEU . 2.6 t -49.45 -48.13 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.293 -179.082 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo . . . . . 0 N--CA 1.472 0.207 0 CA-C-O 120.913 0.297 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.16 102.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.756 179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -70.98 63.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.583 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 179.38 82.15 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -176.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 1.7 m-20 -118.42 80.6 16.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.263 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -89.9 23.5 0.69 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.176 2.584 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 p -92.02 -20.5 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.437 -179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.491 ' CD1' ' CG ' ' A' ' 30' ' ' ARG . 12.4 mt -56.69 165.23 1.75 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.868 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 79.8 Cg_exo -48.59 178.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.698 2.265 . . . . 0.0 113.183 -178.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.86 125.32 11.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.287 -178.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.09 0.32 55.98 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.639 178.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.495 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 63.7 m95 -101.81 135.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.166 0.508 . . . . 0.0 111.989 -178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.82 179.15 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.809 179.468 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.491 ' CG ' ' CD1' ' A' ' 24' ' ' LEU . 3.1 mtp180 -142.91 165.44 27.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.079 0.466 . . . . 0.0 111.726 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 12.7 tttm -166.09 161.53 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.98 -178.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -131.3 166.5 21.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.216 0.531 . . . . 0.0 112.12 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -147.24 115.85 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.082 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.522 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 tttt . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.291 0.567 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 3.6 m-85 -108.54 149.61 28.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.219 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.93 148.13 40.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.33 176.542 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 40.4 t -90.46 148.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.837 -178.243 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 22.4 m-85 -146.16 95.64 2.65 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.25 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 1.7 mt -92.95 109.15 20.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.394 0.616 . . . . 0.0 109.754 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 55' ' ' ALA . 6.2 mt -82.64 121.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.482 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 46.8 p-10 -85.66 154.87 59.15 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.201 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -33.62 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.918 3.079 . . . . 0.0 113.347 -179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.86 -26.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.414 -178.997 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 44.77 1.72 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.967 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CD ' ' CE2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.83 138.15 33.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.955 -178.469 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.442 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -103.64 145.28 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CE2' ' CD ' ' A' ' 54' ' ' LYS . 2.0 m-85 -127.83 144.94 51.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.316 177.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -48.45 3.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.88 174.68 8.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.2 tmtp? -85.69 -39.19 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.289 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 55.8 t -52.11 -38.39 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.949 0.405 . . . . 0.0 110.309 178.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 3.4 mm-40 -67.18 -30.08 69.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.469 178.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.84 -62.21 1.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 109.637 178.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.4 mp -67.83 -42.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.356 178.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.63 -58.98 5.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.756 -178.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.431 ' O ' ' CD ' ' A' ' 68' ' ' LYS . 4.1 t80 -62.62 -55.37 27.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 110.581 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 62' ' ' LEU . 5.0 m-30 -41.2 -38.47 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.897 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -63.25 -60.55 3.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.571 -178.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.22 -18.37 15.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.23 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.454 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 49.8 t -86.42 -33.68 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 107.38 -35.3 5.1 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -176.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CB ' ' HB3' ' A' ' 66' ' ' PHE . 0.0 OUTLIER 32.5 107.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 175.884 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -148.72 31.06 0.8 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.677 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 76.7 p -179.43 49.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.321 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.52 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.5 -36.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.992 -179.135 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.58 109.79 0.02 OUTLIER Pre-proline 0 N--CA 1.462 0.171 0 C-N-CA 122.593 0.357 . . . . 0.0 111.786 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 50.0 Cg_exo -50.95 -32.43 38.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.144 1.896 . . . . 0.0 112.044 178.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.84 -16.08 63.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.777 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -10.47 59.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.051 177.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 41.9 m-85 -106.92 152.26 24.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.447 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.53 148.95 40.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.603 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.7 m-30 -109.28 85.99 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.4 p -120.87 -12.44 8.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.3 t 63.49 -78.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 110.617 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' THR . 25.6 p . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 57.6 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.826 0.261 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.6 mtm -151.8 105.85 3.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -70.81 -75.24 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.117 -178.247 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -61.31 83.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.715 0.293 . . . . 0.0 110.533 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -115.11 84.64 11.28 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.762 -178.509 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.83 30.77 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.193 2.596 . . . . 0.0 112.591 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.7 p -81.28 -31.58 33.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 111.007 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 87.8 mt -50.79 165.12 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.0 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.4 Cg_exo -47.2 178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.591 2.194 . . . . 0.0 112.967 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 128.11 19.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.386 -178.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.34 54.84 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.75 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.517 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 60.6 m95 -101.0 133.82 44.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.188 0.494 . . . . 0.0 112.019 -178.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.75 179.19 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 14.9 mtm180 -143.38 170.04 16.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.727 178.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm 178.57 162.37 0.7 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.189 -178.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 14.2 mt -128.13 173.36 10.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.27 0.557 . . . . 0.0 112.168 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -147.8 113.18 5.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.26 176.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 52.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.804 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.176 0 CA-C-O 121.057 0.456 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -86.72 151.22 23.58 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -174.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-20 -119.53 173.27 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.071 177.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.475 ' CG2' ' CG2' ' A' ' 83' ' ' VAL . 54.0 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.4 -178.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.2 m-85 -146.36 103.27 3.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.074 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD2' ' HG2' ' A' ' 30' ' ' ARG . 62.3 mt -92.99 107.81 19.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 54' ' ' LYS . 4.3 mt -82.33 121.77 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.549 -173.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.517 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 18.8 p-10 -85.73 144.59 39.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.535 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -35.39 -44.71 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.614 2.876 . . . . 0.0 112.857 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 3.5 mt-30 -49.12 -23.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.234 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.61 20.32 11.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.753 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.75 -179.99 4.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 111.679 -178.638 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.87 131.87 21.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.708 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 64.7 m-85 -123.28 133.25 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 0.0 111.729 -178.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.0 mtm180 -105.98 1.04 26.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.672 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.35 164.22 38.95 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -178.176 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.44 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -69.53 -47.21 64.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -176.221 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 t -51.9 -35.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.777 -179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -28.06 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.119 178.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' CD2' ' CG ' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -67.41 -69.16 0.33 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.549 179.359 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 mp -55.45 -36.1 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.77 -64.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.923 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.486 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -62.34 -59.57 4.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.008 0.432 . . . . 0.0 110.681 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.552 ' CE2' ' CD1' ' A' ' 74' ' ' LEU . 20.7 m-30 -35.29 -39.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.767 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 11.6 mt-10 -61.19 -66.69 0.5 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.877 0.37 . . . . 0.0 111.928 -177.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.19 -19.96 23.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.58 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -86.53 -37.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.297 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.67 -32.28 3.22 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.801 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' A' ' 66' ' ' PHE . 0.0 OUTLIER 39.44 -159.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.832 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 71' ' ' ASP . 0.6 OUTLIER 75.91 26.92 0.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.093 0.557 . . . . 0.0 110.51 -177.014 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -150.16 27.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.426 177.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.552 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -147.95 -41.96 0.17 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.889 -178.23 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 70.14 86.24 0.12 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.433 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.44 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 81.3 Cg_exo -49.96 -24.92 11.38 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -69.6 -18.6 63.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.545 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -88.52 12.49 14.34 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.833 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CG ' ' CD2' ' A' ' 62' ' ' LEU . 3.8 m-85 -108.11 79.45 1.27 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.727 0.298 . . . . 0.0 111.004 -179.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' THR . 0.4 OUTLIER -84.57 8.0 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.751 179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.476 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 10.3 m-85 49.33 -88.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.289 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' ASP . 2.1 p 58.28 161.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.406 . . . . 0.0 111.298 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.475 ' CG2' ' CG2' ' A' ' 46' ' ' VAL . 16.9 t -132.53 -51.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.221 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.953 -179.841 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 62.2 Cg_endo . . . . . 0 N--CA 1.475 0.426 0 N-CA-C 113.097 0.384 . . . . 0.0 113.097 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -136.18 -36.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.142 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.5 ' CD1' HD13 ' A' ' 32' ' ' LEU . 8.5 m-85 63.44 28.24 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -175.75 82.55 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -113.31 87.94 12.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.143 178.344 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HA ' ' CG2' ' A' ' 29' ' ' THR . 96.3 Cg_endo -88.11 9.03 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.012 2.475 . . . . 0.0 112.649 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 p -86.83 51.85 2.35 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD13 ' CG ' ' A' ' 30' ' ' ARG . 29.4 mt -128.97 164.08 41.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.155 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.51 170.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.384 2.056 . . . . 0.0 112.556 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 126.24 8.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.466 -178.479 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.57 0.56 58.92 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.731 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.505 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 66.0 m95 -101.41 137.28 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 112.087 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.434 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -147.89 -172.15 3.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.789 179.902 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 1.7 mtm180 -151.33 176.27 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 111.43 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -175.53 173.52 2.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.354 -178.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.5 HD13 ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -142.97 167.14 22.77 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.325 0.583 . . . . 0.0 112.409 179.879 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -148.04 101.32 3.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.979 177.792 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.936 179.732 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CE2' ' OH ' ' A' ' 19' ' ' TYR . 9.1 m-85 -105.42 137.04 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -105.98 137.94 43.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.641 174.712 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p -93.91 154.46 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.038 0.447 . . . . 0.0 111.468 -177.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.2 m-85 -146.04 99.22 3.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 8.1 mt -91.78 111.43 22.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.442 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -82.39 120.89 34.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.211 -171.75 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.505 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 6.5 p-10 -86.18 144.76 39.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.216 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -34.7 -51.72 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.64 2.893 . . . . 0.0 113.429 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -44.62 -27.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.389 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.24 25.07 5.97 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.602 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.5 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 2.0 tttt -99.17 172.47 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 111.31 -178.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 96.56 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.366 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.5 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 22.9 m-85 -90.29 129.15 36.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 111.647 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -104.85 4.27 31.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.335 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -154.41 170.77 20.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 -177.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -73.23 -37.98 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -178.517 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 3.9 p -51.84 -46.48 40.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.683 -179.191 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -62.11 -31.99 72.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.221 178.594 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.544 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.51 -68.6 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 178.959 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.3 mp -56.98 -40.42 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.696 178.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.26 -64.87 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.102 -178.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.14 93.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 62' ' ' LEU . 9.8 m-30 -59.8 -32.22 70.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 23.3 mt-10 -60.9 -70.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 111.522 -177.289 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -21.79 33.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.559 178.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.41 -25.9 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -177.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 59.84 45.19 96.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.698 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 136.39 33.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.8 p -138.75 23.38 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 p -124.0 24.13 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.529 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -133.51 -41.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 -179.35 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.96 102.54 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.957 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.6 Cg_exo -46.59 -34.69 15.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.422 2.081 . . . . 0.0 112.424 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.03 -7.55 41.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.24 -14.92 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.657 0.265 . . . . 0.0 110.946 178.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CE2' HD12 ' A' ' 62' ' ' LEU . 47.7 m-85 -99.05 99.11 10.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.244 -179.235 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -84.78 132.31 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.689 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.16 74.24 6.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.476 -178.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 124.7 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.664 179.086 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.0 t -73.59 -67.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.285 -179.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.424 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.472 0.263 0 CA-C-O 120.819 0.258 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.8 118.29 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.575 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -97.38 47.44 1.03 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.67 -178.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 179.4 71.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.431 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.49 93.98 21.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.341 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.9 23.66 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.319 2.679 . . . . 0.0 112.293 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -92.31 42.83 1.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.281 -178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CD1' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -130.31 178.55 1.67 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.377 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 85.1 Cg_exo -46.9 174.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.489 2.126 . . . . 0.0 112.737 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.86 44.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.16 -178.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.42 -0.12 60.97 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.393 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 55.0 m95 -102.57 133.43 47.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.942 -178.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -140.44 -176.53 4.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.416 179.789 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.466 ' CG ' ' CD1' ' A' ' 24' ' ' LEU . 2.5 mtp180 -143.25 156.98 44.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.596 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 3.8 ttpt -166.49 161.05 15.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.996 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' HG11 ' A' ' 83' ' ' VAL . 5.4 mt -130.28 166.8 19.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.252 0.549 . . . . 0.0 112.217 -178.224 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.6 tttt -139.31 115.49 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.861 -179.383 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.332 178.955 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -104.75 153.96 20.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -120.31 144.21 47.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.215 176.245 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.458 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.6 p -85.92 148.61 4.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.13 -178.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 9.7 m-85 -145.35 97.95 3.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 7.6 mt -92.57 109.64 21.05 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.076 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.479 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 8.0 mt -82.23 126.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -171.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.5 p-10 -85.58 150.28 53.46 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.329 -178.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -38.57 -55.45 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.171 2.58 . . . . 0.0 112.802 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -46.77 -26.79 1.02 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.31 28.91 3.14 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.602 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -92.33 -178.84 5.05 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.368 0.604 . . . . 0.0 112.094 -179.406 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.2 88.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.076 177.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.535 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 83.2 m-85 -92.02 122.05 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.457 -177.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.496 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -92.84 -48.73 6.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.051 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 171.78 9.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.323 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 7.8 tptp -88.68 -47.19 8.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 -179.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 t -51.88 -26.85 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 110.147 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.59 -32.07 63.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.661 177.257 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -64.43 -62.66 1.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.84 179.371 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -61.56 -40.87 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -68.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.122 -179.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CE2' ' HE3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -59.79 -40.55 88.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.102 -179.632 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 9.6 m-30 -56.47 -30.9 63.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.345 . . . . 0.0 110.641 178.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.9 mm-40 -70.42 -60.28 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.915 -177.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.36 -26.05 62.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.597 -178.124 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.58 -39.92 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.317 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.4 38.99 4.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.323 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.1 117.53 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.3 p -134.95 33.93 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 p -132.53 33.6 3.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.531 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.403 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -137.64 -39.04 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.494 -179.092 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 66.75 93.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 110.57 -179.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 97.9 Cg_exo -44.97 -29.0 3.42 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.95 -7.94 44.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.386 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.25 -11.49 46.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.478 0.18 . . . . 0.0 111.291 178.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CD2' HD23 ' A' ' 62' ' ' LEU . 74.2 m-85 -103.4 102.36 12.29 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.485 -179.11 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -94.0 160.35 14.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.294 178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.496 ' CZ ' ' O ' ' A' ' 57' ' ' ARG . 22.0 m-30 -115.44 85.0 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.38 96.38 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.688 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 32' ' ' LEU . 86.5 t -66.12 -32.43 58.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.334 -179.548 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.861 0.362 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.8 p -154.74 118.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.49 160.08 37.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.3 m -159.65 59.62 1.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.86 -169.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.751 2.301 . . . . 0.0 112.298 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt 43.09 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.057 0.456 . . . . 0.0 111.058 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -122.39 131.28 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.224 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 67.6 mtm-85 -93.67 128.59 39.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -122.04 82.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -164.62 65.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.841 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.4 145.25 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.32 40.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.449 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 78.97 121.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.6 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -45.54 96.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.441 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 137.31 29.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.46 -154.26 20.56 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.235 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.459 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 5.0 Cg_exo -79.62 -155.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.174 2.582 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.71 105.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.81 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 3.2 m-30 -67.35 -19.04 65.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.92 73.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.299 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -97.71 111.38 58.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -106.04 13.99 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.001 3.134 . . . . 0.0 112.617 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.426 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 1.1 p -90.65 50.06 1.76 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 30' ' ' ARG . 72.0 mt -154.17 160.33 31.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -22.79 145.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.653 3.569 . . . . 0.0 114.543 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.51 148.43 0.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.203 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.98 -58.36 2.24 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.785 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.493 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 78.7 m95 -47.42 133.44 12.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 112.087 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.52 167.72 20.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -138.76 159.62 41.67 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.628 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 9.7 ttmm -157.32 167.59 29.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.994 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.459 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 6.7 mt -137.03 175.88 9.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.478 0.656 . . . . 0.0 112.258 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.0 tttm -147.81 106.59 3.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.157 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.38 169.3 9.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.766 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.0 ttp180 -152.92 129.03 10.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.615 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.458 ' CE ' ' CB ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -124.38 110.09 14.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 110.921 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.5 p -105.37 -31.31 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.228 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.51 -23.67 7.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.112 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -70.29 0.8 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.013 0.435 . . . . 0.0 109.889 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -98.72 31.89 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.533 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' CB ' ' CE ' ' A' ' 36' ' ' LYS . . . -52.5 166.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.784 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 73.22 22.35 78.95 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.511 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 133.92 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.432 ' HB3' ' CG1' ' A' ' 83' ' ' VAL . 24.3 m-85 -100.09 164.49 11.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 5.7 m-20 -120.47 166.98 12.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.31 -1.768 . . . . 0.0 108.428 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.427 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 54.2 t -128.07 147.94 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.201 0.524 . . . . 0.0 111.766 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 33.5 m-85 -149.05 102.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.139 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 6.1 mt -93.04 106.08 18.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 109.601 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.8 mt -82.3 123.62 38.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.956 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.445 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 t-20 -80.81 137.96 50.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.801 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 73.5 Cg_exo -34.02 -54.84 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.521 2.814 . . . . 0.0 113.456 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -50.99 -31.61 18.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 111.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 117.48 48.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.806 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.506 ' HD3' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.89 122.58 15.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -177.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.69 152.29 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.177 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 1.2 m-85 -129.78 167.97 17.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.64 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.16 3.49 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.87 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.422 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.49 171.63 19.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.43 -43.25 41.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.168 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 9.1 p -53.22 -44.39 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 109.873 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 1.1 tt0 -60.87 -27.83 68.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.3 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.487 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -69.6 -64.6 0.85 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.446 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.9 mp -65.9 -39.43 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.255 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.71 -58.0 8.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.478 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 3.0 t80 -68.86 -49.21 60.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 110.843 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 5.1 m-85 -46.82 -26.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.3 mm-40 -72.82 -57.06 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -16.1 63.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.5 m -86.48 -40.18 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.174 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.62 43.73 2.86 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.514 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD2' ' CD1' ' A' ' 74' ' ' LEU . 11.4 p-10 -74.3 141.97 45.23 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 122.535 0.334 . . . . 0.0 111.562 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 t -149.86 23.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.372 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.88 52.37 0.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.473 HD12 ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -44.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 63.66 100.81 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.435 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.419 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 86.4 Cg_exo -47.75 -31.55 15.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.469 2.112 . . . . 0.0 112.582 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -8.49 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 1.04 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.48 ' CD2' HD23 ' A' ' 62' ' ' LEU . 66.7 m-85 -109.37 130.89 55.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.857 0.361 . . . . 0.0 111.257 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -124.17 147.64 47.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.736 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 22.7 m-85 -105.96 77.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.33 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.1 p -140.71 111.64 7.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 44' ' ' TYR . 3.4 m -64.69 -41.27 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.642 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.3 p -99.39 46.14 0.98 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 -175.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.74 -156.0 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.69 -103.88 0.4 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.79 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 p 58.17 25.3 12.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.764 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.01 -41.63 5.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.49 -29.38 15.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.92 6.09 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.914 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t 58.56 88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.22 143.66 10.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 t -157.07 71.78 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -87.07 24.66 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.967 2.445 . . . . 0.0 113.075 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.69 79.14 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.746 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -108.67 -54.43 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -101.88 174.97 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.955 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.84 63.05 1.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.43 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -76.81 59.19 1.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.8 tt -138.23 119.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.899 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.1 mm -93.43 52.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 54.81 82.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -115.16 50.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.15 -170.51 2.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.719 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -145.21 -101.83 0.33 Allowed Glycine 0 CA--C 1.488 -1.601 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.142 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -79.8 -170.26 8.53 Favored 'Cis proline' 0 N--CA 1.473 0.29 0 C-N-CA 125.465 -0.64 . . . . 0.0 112.029 1.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtm -145.65 94.46 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.7 m-30 -67.18 -70.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.443 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -64.08 79.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' TYR . 3.2 m-20 -114.92 88.53 17.14 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -97.22 14.38 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.393 2.728 . . . . 0.0 112.442 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -87.97 49.6 1.83 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.826 0.346 . . . . 0.0 111.426 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD11 ' CA ' ' A' ' 29' ' ' THR . 0.7 OUTLIER -129.65 176.23 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 94.2 Cg_exo -45.43 169.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.421 2.081 . . . . 0.0 112.824 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.16 124.09 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.141 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . 75.77 -4.68 43.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.749 177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.485 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 45.0 m95 -94.68 118.16 31.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.229 0.538 . . . . 0.0 112.069 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.413 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -118.01 -173.95 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 1.8 ttt180 -155.35 163.7 39.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' N ' ' CG ' ' A' ' 30' ' ' ARG . 7.5 tttt -172.78 158.61 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.359 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 HD12 ' CA ' ' A' ' 83' ' ' VAL . 6.2 mt -129.89 174.42 9.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 111.51 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 110.94 5.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.074 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -73.63 169.71 16.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.5 ttm180 -153.06 146.06 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.972 0.415 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.415 ' CE ' ' HA3' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.02 -71.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.742 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.29 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.051 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.415 ' HA3' ' CE ' ' A' ' 36' ' ' LYS . . . 165.09 -34.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.768 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 127.8 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 39.43 28.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.067 0.461 . . . . 0.0 109.902 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.53 179.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.203 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 60.06 27.64 65.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.185 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 135.35 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.0 110.676 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 26.2 m-85 -106.63 163.73 12.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.872 0.844 . . . . 0.0 113.11 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.93 132.74 45.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.664 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.427 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 7.7 p -91.53 148.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 3.4 m-85 -143.7 103.38 4.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.403 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 19.7 mt -92.96 110.78 22.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -85.19 124.65 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.463 0.649 . . . . 0.0 112.064 -173.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.6 p-10 -85.67 151.07 54.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.754 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 81.9 Cg_exo -37.17 -53.68 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.565 2.843 . . . . 0.0 113.259 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -45.72 -26.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.253 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.73 47.22 1.2 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.764 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.955 0.407 . . . . 0.0 111.286 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -91.35 150.26 21.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.94 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.55 119.49 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.82 5.47 43.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.569 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.2 p -154.44 159.98 41.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.167 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.44 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.6 -39.5 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.167 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 4.2 p -51.83 -48.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.787 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 3.6 mm-40 -61.88 -29.91 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.07 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 1.1 tp -63.37 -60.42 3.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -67.81 -42.84 86.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.683 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.94 41.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.406 ' CE1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -67.35 -50.77 58.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.333 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.48 ' CD2' HD12 ' A' ' 74' ' ' LEU . 23.0 m-30 -53.67 -26.76 23.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -69.12 -60.65 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.329 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.11 -27.71 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -177.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 21.2 m -86.61 -44.47 16.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 69' ' ' VAL . . . 93.93 44.06 3.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.967 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.27 143.55 29.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.262 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -145.95 22.87 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -124.45 33.42 5.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.39 -43.48 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.8 107.9 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 88.0 Cg_exo -48.13 -31.89 17.56 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.324 2.016 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.97 -7.45 40.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.614 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.38 -4.02 59.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.293 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD2' HD23 ' A' ' 62' ' ' LEU . 82.8 m-85 -107.62 123.41 48.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.735 0.303 . . . . 0.0 111.172 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.99 137.13 51.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -95.71 79.16 3.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.042 0.449 . . . . 0.0 111.352 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -138.42 94.83 2.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.936 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.445 ' CA ' HD12 ' A' ' 32' ' ' LEU . 23.6 m -48.29 -48.51 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.761 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.443 ' N ' HG22 ' A' ' 83' ' ' VAL . 20.6 p -66.45 -44.28 83.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 135.29 173.8 13.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.637 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 -154.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.32 101.3 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.724 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.1 p -147.17 20.39 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.872 0.368 . . . . 0.0 110.509 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.15 -57.26 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.528 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m 62.36 119.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.96 0.41 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.12 -134.4 52.27 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.663 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.938 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -146.59 160.87 41.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.05 2.87 23.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.471 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -163.55 -64.44 0.01 OUTLIER Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 55.3 Cg_endo -89.73 -39.09 0.52 Allowed 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.565 -1.015 . . . . 0.0 112.872 -1.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -108.44 -158.99 0.67 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.506 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 63.09 87.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.194 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -67.95 136.65 54.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -133.3 58.54 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.7 80.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.055 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 tt -86.53 138.32 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.46 67.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.77 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 63.87 175.63 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.72 81.95 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.364 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 157.95 20.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.93 145.08 4.39 Favored Glycine 0 CA--C 1.488 -1.654 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.904 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 95.5 Cg_endo -77.18 -164.77 4.07 Favored 'Cis proline' 0 N--CA 1.476 0.476 0 C-N-CA 125.097 -0.793 . . . . 0.0 112.205 2.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.436 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -157.92 -40.58 0.07 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.549 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 17' ' ' PRO . 1.9 m-85 75.14 -65.89 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.555 0.217 . . . . 0.0 111.068 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.57 89.3 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.469 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 34.4 m-20 -131.8 65.66 76.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' CG2' ' A' ' 29' ' ' THR . 8.9 Cg_endo -82.27 9.28 4.06 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.82 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 t -85.52 55.71 3.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.029 0.443 . . . . 0.0 110.681 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD21 ' CD ' ' A' ' 25' ' ' PRO . 12.4 mt -126.39 167.08 18.22 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.028 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' CD ' HD21 ' A' ' 24' ' ' LEU . 76.1 Cg_exo -40.79 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.751 2.3 . . . . 0.0 112.631 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.01 121.85 3.49 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.136 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 -2.2 49.59 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.798 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 48.9 m95 -96.85 140.96 30.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.237 0.519 . . . . 0.0 112.158 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.446 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -140.38 176.07 9.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 17.0 ttm105 -147.36 154.01 40.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.19 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 12.1 ttmt -168.7 164.4 12.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.228 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.438 ' CD1' HG11 ' A' ' 83' ' ' VAL . 3.7 mt -128.66 161.27 30.07 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.157 0.503 . . . . 0.0 111.836 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.99 125.86 32.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.922 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -77.97 167.13 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.135 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 34.2 ttm180 -152.98 164.78 37.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.935 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' N ' ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -136.97 110.73 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.671 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.29 -163.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.1 30.51 8.94 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.217 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.628 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -95.21 49.44 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.474 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.2 115.06 2.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.56 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 110.19 36.3 1.99 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.754 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -87.52 136.85 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 111.092 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 20.5 m-85 -105.52 162.81 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.487 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -134.26 144.94 48.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.353 176.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -88.06 146.89 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.896 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -142.82 98.65 3.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.0 111.291 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.4 mt -92.97 113.21 25.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.461 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 37.3 mt -92.16 127.94 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 34.7 p-10 -85.58 150.05 52.93 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.901 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -32.91 -58.74 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.928 3.085 . . . . 0.0 113.383 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -44.62 -27.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.21 51.18 0.89 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.813 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -139.75 130.68 26.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.931 0.395 . . . . 0.0 110.743 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -92.37 158.43 16.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.875 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -136.96 120.15 16.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.22 10.05 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.439 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -154.51 163.35 40.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.984 -177.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.428 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 3.8 tptp -79.75 -49.27 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.881 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 12.2 t -51.96 -33.6 16.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.216 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -70.36 -29.96 66.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.03 177.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 66' ' ' PHE . 1.1 tp -63.06 -59.55 4.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.0 mp -70.33 -46.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.401 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -50.14 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.423 ' HA ' ' CG ' ' A' ' 68' ' ' LYS . 1.5 t80 -68.97 -57.78 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 110.477 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.47 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 13.6 m-30 -42.54 -33.38 0.68 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.36 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.5 mm-40 -76.18 -56.47 4.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.407 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.81 -21.82 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.667 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 3.7 m -92.37 -25.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.012 0.434 . . . . 0.0 109.933 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 71' ' ' ASP . . . 94.83 -30.81 7.51 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.821 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER 49.2 157.91 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 73' ' ' SER . 39.9 p -90.11 -22.77 21.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.32 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.434 ' N ' ' OD1' ' A' ' 71' ' ' ASP . 10.9 p 165.06 -76.74 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.455 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 49.57 -166.16 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.631 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -162.93 92.38 1.2 Allowed Pre-proline 0 C--N 1.31 -1.137 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 81.8 Cg_exo -47.39 -33.26 16.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.319 2.013 . . . . 0.0 111.732 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.01 -19.41 63.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.54 0.22 56.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.648 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CB ' HD23 ' A' ' 62' ' ' LEU . 96.9 m-85 -105.18 100.61 10.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 111.459 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.17 129.22 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.384 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.481 ' CD1' HG13 ' A' ' 46' ' ' VAL . 20.3 m-85 -88.32 87.45 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 111.202 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 104.12 7.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 32' ' ' LEU . 95.2 t -73.09 -67.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.644 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.8 p -58.29 -20.74 45.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . 126.33 163.94 11.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.307 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.68 89.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 110.788 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' GLY . . . -98.81 89.23 0.9 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.732 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.8 p -89.45 14.98 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.588 0.233 . . . . 0.0 111.208 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.44 30.16 67.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.599 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.18 112.93 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.36 109.82 3.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.503 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.943 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.759 0.314 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -150.24 55.02 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.922 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.85 171.45 13.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.4 69.03 9.5 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.67 -12.07 30.61 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.66 2.24 . . . . 0.0 112.756 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.79 82.09 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -129.4 153.7 47.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 174.52 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.923 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.64 88.63 2.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m 70.22 76.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.1 tt -86.25 143.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 mm -89.22 52.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.785 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.2 mtt85 53.35 -172.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -51.5 129.89 26.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.791 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.23 134.56 41.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 162.32 152.88 6.91 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.696 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.546 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 88.4 Cg_endo -80.69 -160.19 2.27 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 124.738 -0.943 . . . . 0.0 112.362 3.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.81 134.48 3.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.742 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.6 m-30 -94.52 48.34 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.0 110.184 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -175.44 79.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.84 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' HB3' ' NH1' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -112.73 85.26 7.36 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.596 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -89.0 25.96 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.98 2.453 . . . . 0.0 112.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -93.9 23.66 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -99.79 -178.26 0.67 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.7 Cg_exo -49.17 179.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.236 1.958 . . . . 0.0 112.18 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.5 120.78 7.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.157 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.8 50.68 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.818 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.489 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 51.8 m95 -93.75 131.34 39.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 111.689 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -132.32 179.92 5.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.645 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.438 ' NH1' ' HB3' ' A' ' 21' ' ' ASP . 7.1 ttp-105 -139.88 165.53 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.225 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -169.83 168.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.546 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -138.1 167.48 21.72 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.335 0.588 . . . . 0.0 112.399 -178.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 10.7 tttp -147.81 110.73 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.232 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 54.4 tt0 -67.77 166.47 15.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 1.8 ttm180 90.08 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.694 0.798 . . . . 0.0 112.304 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.41 85.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.0 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m 54.96 -158.71 0.2 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.83 -21.22 21.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.838 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -78.1 -39.63 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.377 . . . . 0.0 111.032 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -120.42 33.4 5.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.792 178.46 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.4 85.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.106 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 139.02 58.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -138.65 146.91 42.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.8 m-85 -88.6 144.13 26.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 61.0 m-20 -110.62 172.16 7.03 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 113.892 -1.503 . . . . 0.0 109.519 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 70.6 t -131.64 145.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.7 m-85 -146.03 105.61 3.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.073 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 15.3 mt -90.29 107.35 19.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 49' ' ' ILE . 3.0 mt -82.86 123.26 38.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.112 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.489 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 6.3 t-20 -76.05 144.67 75.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.704 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 70.5 Cg_exo -37.01 -28.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.13 2.553 . . . . 0.0 113.113 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' ASN . 4.3 mm-40 -90.4 30.45 1.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 55.74 26.25 46.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.447 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -98.74 124.5 43.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.914 0.388 . . . . 0.0 110.427 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 138.15 34.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.8 m-85 -124.43 126.14 45.44 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 18.6 mtp180 -96.41 -58.36 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.497 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.35 171.9 9.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.92 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -80.58 -41.72 23.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.176 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 10.9 t -51.79 -31.58 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 -29.29 63.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 110.025 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.506 HD22 ' CG ' ' A' ' 79' ' ' PHE . 1.4 tp -66.52 -60.72 2.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 4.5 mp -65.59 -45.92 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.17 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.86 -49.01 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 2.5 t80 -70.15 -57.65 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.115 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.492 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 20.8 m-30 -46.83 -28.93 1.72 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -72.74 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.103 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.17 -23.93 50.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.495 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 12.7 m -91.56 -44.18 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.975 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.52 51.29 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.101 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -84.9 137.92 32.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 111.103 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 p -124.02 22.63 8.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.144 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -128.42 29.76 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.485 HD11 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.54 174.77 14.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -158.63 114.13 1.67 Allowed Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.358 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 93.0 Cg_exo -46.41 -32.71 11.45 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.456 2.104 . . . . 0.0 112.0 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.04 -19.78 63.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.57 -1.94 58.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CG ' HD22 ' A' ' 62' ' ' LEU . 94.9 m-85 -107.21 110.6 22.69 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.832 0.348 . . . . 0.0 111.085 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.38 131.75 53.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 20.3 m-30 -87.5 80.67 8.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.09 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.79 118.86 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.356 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.435 ' HA ' ' CD2' ' A' ' 32' ' ' LEU . 52.2 t -65.65 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.235 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 p -58.18 -28.26 64.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.3 . . . . 0.0 111.021 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.43 -165.36 24.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.726 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -89.84 -148.08 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.23 44.0 91.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.314 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.82 10.89 21.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.476 0.179 . . . . 0.0 111.465 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.76 81.92 0.07 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.7 t 60.15 125.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.147 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.37 26.95 21.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.449 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.949 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.806 0.336 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t 60.18 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.604 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.48 74.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.41 -57.62 1.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.64 -21.43 7.25 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.61 2.207 . . . . 0.0 112.141 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 70.75 10.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -157.72 55.15 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -97.35 153.02 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -135.32 172.58 12.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.9 91.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 tp -83.37 140.37 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.2 mm -94.28 57.45 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 45.07 47.72 9.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -97.52 -166.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.168 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.74 164.33 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.475 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.04 -142.51 3.6 Favored Glycine 0 CA--C 1.49 -1.495 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.766 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 7.8 Cg_exo -69.36 -179.75 19.31 Favored 'Cis proline' 0 N--CA 1.474 0.363 0 C-N-CA 125.097 -0.793 . . . . 0.0 112.085 -3.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mtm -148.28 102.54 3.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -79.85 -67.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.776 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.2 83.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.579 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -118.75 85.39 27.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.389 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.66 14.03 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.239 2.626 . . . . 0.0 112.503 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.0 p -86.16 51.2 2.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.33 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -132.3 179.07 1.47 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.073 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 95.6 Cg_exo -45.14 166.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.362 2.041 . . . . 0.0 112.546 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 126.0 5.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.847 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.4 -52.66 4.37 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.488 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.1 m95 -44.86 142.29 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 112.323 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.85 -169.98 3.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.731 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 43.8 ttp180 -156.9 161.96 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' TYR . 5.4 ttmt -168.97 160.11 9.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.249 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD12 ' CG1' ' A' ' 83' ' ' VAL . 1.6 mt -131.31 163.51 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.169 0.509 . . . . 0.0 111.368 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.24 116.89 12.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.18 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 167.65 19.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.499 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 42' ' ' GLY . 17.3 ttp85 -153.06 133.32 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 111.163 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.9 tptt -87.37 -40.64 14.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.488 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.42 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.385 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . 158.77 -24.6 0.35 Allowed Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.988 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -123.66 -49.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.586 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.02 48.67 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.085 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.44 177.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.598 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 53.57 23.93 22.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.636 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 131.91 34.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.0 110.529 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 10.8 m-85 -103.68 163.21 12.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.679 0.752 . . . . 0.0 112.977 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.97 140.16 48.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.743 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 7.0 p -91.98 148.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.3 m-85 -146.19 103.42 3.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.685 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mt -92.62 114.44 26.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -87.35 127.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.804 0.811 . . . . 0.0 113.149 -171.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -82.44 135.01 47.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.495 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.48 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 85.6 Cg_exo -32.86 -51.7 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.666 2.91 . . . . 0.0 113.631 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -46.94 -26.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.374 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.12 18.14 6.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.332 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.6 tttt -96.67 147.91 23.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.552 0.215 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 54' ' ' LYS . . . -114.97 108.8 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.991 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.494 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.5 m-85 -92.72 124.2 36.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -93.14 -9.45 39.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.416 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.58 176.71 11.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.984 0.421 . . . . 0.0 111.558 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 2.2 mmtp -79.15 -42.72 25.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.166 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.2 t -51.85 -35.48 18.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.676 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' OE1' ' CA ' ' A' ' 61' ' ' GLU . 2.3 mm-40 -72.79 -27.08 61.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.092 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -68.17 -65.45 0.69 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.6 mp -56.4 -41.17 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.92 -66.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD2' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.76 -50.2 74.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.423 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.494 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.4 m-30 -51.79 -29.69 20.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.391 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.2 mm-40 -67.0 -64.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.053 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.26 -24.68 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.6 -177.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.42 -33.28 5.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 42.69 9.96 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.715 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.96 121.65 27.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.716 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -127.37 34.25 4.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.16 25.7 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.65 -39.51 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 60.45 101.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.513 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 85.6 Cg_exo -47.52 -31.29 13.46 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.35 2.033 . . . . 0.0 112.404 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -7.79 43.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -19.46 35.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.614 0.245 . . . . 0.0 110.858 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.488 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 63.5 m-85 -96.63 116.47 29.17 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.8 151.46 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.555 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -109.18 88.84 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 111.378 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 142.43 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.65 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.437 ' CG1' HD12 ' A' ' 32' ' ' LEU . 94.7 t -114.07 -34.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 p -95.37 35.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.18 -174.61 53.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.378 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -131.6 -158.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.503 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.63 -62.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.412 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m 55.6 24.57 7.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.327 . . . . 0.0 110.897 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.97 -83.27 1.72 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.5 p -85.52 74.27 10.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.19 -124.72 2.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.961 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.787 0.327 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 t -90.31 91.21 8.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.951 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.44 71.88 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.042 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.1 p -151.6 88.87 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.42 3.19 6.99 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.696 2.264 . . . . 0.0 112.998 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.86 91.02 5.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -128.21 -162.73 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 -73.88 125.64 28.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.062 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -96.13 83.26 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.032 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 94.2 p -83.81 57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 11' ' ' ILE . 2.6 tt 47.01 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 111.376 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.9 mm -90.5 57.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.951 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 49.08 60.22 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -114.75 51.19 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.041 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.27 141.09 48.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.893 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.44 97.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.968 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.45 ' HB3' ' CD1' ' A' ' 32' ' ' LEU . 96.7 Cg_endo -76.23 154.23 36.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.444 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -136.74 -14.84 1.61 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 52.94 46.03 27.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.281 0.562 . . . . 0.0 110.0 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 21.8 t0 -137.7 77.68 1.65 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.564 ' CB ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 56.09 -96.46 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.777 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' CA ' ' CB ' ' A' ' 21' ' ' ASP . 8.7 Cg_endo -92.11 -5.0 46.16 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 CA-C-N 123.14 2.157 . . . . 0.0 113.739 -8.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.7 t -156.43 15.68 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -53.27 160.39 1.74 Allowed Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.085 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.77 172.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.371 2.048 . . . . 0.0 111.993 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 123.24 6.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.696 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.54 -44.22 3.31 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.862 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.504 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 64.9 m95 -54.05 142.55 24.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.145 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -143.22 167.77 21.34 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.489 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 2.0 ptm85 -122.09 153.27 38.9 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.103 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 1.3 tttt -151.17 152.06 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.356 1.66 . . . . 0.0 109.612 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 9.7 mt -131.39 157.33 43.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.7 115.94 18.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.326 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.2 tt0 -70.21 171.31 9.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.989 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -151.57 143.59 23.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.064 0.459 . . . . 0.0 110.902 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 41' ' ' ALA . 16.4 tptm -137.08 128.82 28.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.26 -51.19 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.322 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.2 45.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.215 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.55 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.44 32.98 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.936 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.425 ' HB3' ' CD ' ' A' ' 36' ' ' LYS . . . -52.57 -170.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.571 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 50.86 24.42 8.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.961 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.54 133.03 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.442 ' HB3' HG12 ' A' ' 83' ' ' VAL . 7.1 m-85 -106.69 164.57 11.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -133.54 147.37 51.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.362 176.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 5.8 p -89.04 146.69 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.018 0.437 . . . . 0.0 112.025 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 11.9 m-85 -146.09 101.05 3.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.363 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -91.03 108.22 19.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 3.6 mt -82.23 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.061 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.483 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.4 t-20 -83.69 135.99 42.58 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.747 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 77.3 Cg_exo -34.47 -54.68 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.531 2.821 . . . . 0.0 113.261 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -50.35 -32.61 17.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 119.9 49.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.526 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -138.84 129.14 25.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.76 150.88 22.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.938 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 49.4 m-85 -133.85 131.67 39.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.955 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -105.84 -9.38 17.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.764 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.26 172.16 18.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 111.384 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.08 -39.74 75.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.728 -177.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 3.2 t -55.29 -44.32 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.04 -27.5 69.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -65.41 -65.17 0.71 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.001 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.499 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.4 mp -62.94 -42.38 96.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.48 -47.76 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.486 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 3.0 t80 -72.72 -59.23 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.415 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 18.5 m-30 -44.03 -32.61 1.21 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.24 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.6 mm-40 -65.68 -60.96 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.87 -21.13 41.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.125 -178.253 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.462 ' CG1' ' HD3' ' A' ' 68' ' ' LYS . 20.2 m -95.35 -48.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.16 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.426 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 106.92 34.54 2.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -89.39 142.2 27.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.988 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -148.41 25.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.03 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.73 31.81 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -130.31 -32.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.559 -178.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.02 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.469 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.425 ' HA ' HD13 ' A' ' 62' ' ' LEU . 44.6 Cg_exo -52.06 -35.86 63.32 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.185 1.923 . . . . 0.0 112.279 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.03 -12.09 61.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.537 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.67 10.58 15.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.508 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 67.8 m-85 -113.18 92.93 4.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.26 134.88 35.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 33.5 m-85 -96.76 99.44 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.07 92.17 2.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.442 HG12 ' HB3' ' A' ' 44' ' ' TYR . 60.7 t -54.7 -21.14 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.436 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -105.9 51.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.53 -141.86 3.32 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.056 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 173.63 162.73 0.16 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.95 0.405 . . . . 0.0 110.168 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.44 47.08 3.68 Favored Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -19.28 44.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.658 0.266 . . . . 0.0 111.024 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.82 -84.07 1.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t 62.59 85.89 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 -103.29 2.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.631 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.434 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 t 61.77 96.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.94 53.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.457 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -163.55 -64.28 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 50.2 Cg_endo -90.08 -36.77 0.74 Allowed 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.596 -1.002 . . . . 0.0 113.03 -1.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 80.76 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.1 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -127.25 123.38 36.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -69.96 165.18 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.931 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -121.23 63.46 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 4.7 m -156.79 91.46 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 48.69 103.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.415 0.626 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -79.79 70.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 59.7 -176.07 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -50.47 121.23 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.8 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 140.52 30.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.96 146.67 4.9 Favored Glycine 0 CA--C 1.487 -1.704 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.603 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.47 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 97.6 Cg_endo -78.05 176.91 41.22 Favored 'Cis proline' 0 N--CA 1.475 0.386 0 C-N-CA 125.014 -0.828 . . . . 0.0 112.509 3.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.432 ' HE2' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -145.2 101.75 3.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.737 0.304 . . . . 0.0 111.274 -178.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -91.98 64.25 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.5 t70 175.65 72.19 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB2' ' CA ' ' A' ' 22' ' ' PRO 0.254 0.0 OUTLIER 55.69 -94.12 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.475 0 CA-C-O 115.598 -2.144 . . . . 0.0 106.97 -171.659 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' CA ' ' HB2' ' A' ' 21' ' ' ASP . 7.7 Cg_endo -96.69 -2.62 32.5 Favored 'Cis proline' 0 N--CA 1.479 0.668 0 CA-C-N 122.772 2.026 . . . . 0.0 113.403 -10.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.55 66.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 111.114 -178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.24 165.36 15.09 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.54 170.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.492 2.128 . . . . 0.0 112.269 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.03 123.22 9.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.819 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.92 -1.71 58.0 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.501 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.471 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 53.5 m95 -99.45 138.52 36.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.454 HG23 ' CA ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -138.43 166.91 23.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.631 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.43 ' HG3' ' CD1' ' A' ' 48' ' ' LEU . 24.3 ttm180 -135.49 154.48 51.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -159.5 157.51 30.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.977 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 5.0 mt -131.34 155.56 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.041 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -125.57 117.16 22.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.691 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -72.77 171.34 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.427 ' HG3' ' N ' ' A' ' 36' ' ' LYS . 1.2 tpt85 -153.08 152.69 31.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -123.2 108.82 13.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.566 0.698 . . . . 0.0 111.803 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 41' ' ' ALA . 1.9 m -134.65 132.4 38.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.122 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.74 -26.96 1.23 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.015 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -48.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.291 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -102.22 47.3 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.542 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -52.81 96.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.687 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 98.8 43.55 2.63 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.813 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.54 136.46 33.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.866 0.365 . . . . 0.0 110.515 179.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -106.77 163.77 12.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.49 0.662 . . . . 0.0 112.773 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -134.22 144.01 48.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 175.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.447 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 p -86.31 149.76 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.318 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.47 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.1 102.54 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.43 ' CD1' ' HG3' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -92.98 112.72 24.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.7 mt -88.49 122.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.354 -176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.471 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 p-10 -84.66 159.83 57.36 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.41 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 88.2 Cg_exo -40.03 -27.75 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.26 2.64 . . . . 0.0 113.163 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.62 32.84 1.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.997 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.17 28.21 12.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.166 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -99.07 121.4 40.93 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.059 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.06 149.25 21.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.546 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 68.7 m-85 -147.82 129.69 15.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.662 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -103.57 -52.12 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.64 177.91 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.669 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -90.82 -42.89 10.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.641 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 48.3 t -51.89 -29.55 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.897 0.38 . . . . 0.0 110.697 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.88 -29.69 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -68.61 -68.32 0.4 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.481 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.435 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.6 mp -54.99 -40.49 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -54.99 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.263 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.521 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -67.45 -58.92 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.524 ' CE2' ' CD1' ' A' ' 74' ' ' LEU . 16.4 m-30 -44.65 -28.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.783 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.0 mm-40 -61.13 -69.8 0.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.68 -16.99 18.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.991 0.424 . . . . 0.0 110.676 177.124 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 65' ' ' TYR . 87.1 t -84.39 -69.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.663 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.32 56.17 0.33 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.425 ' OD2' ' CD1' ' A' ' 74' ' ' LEU . 4.7 p-10 -74.23 134.9 42.7 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 111.852 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -149.97 26.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.037 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -164.64 45.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.524 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -154.53 -35.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.01 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 50.27 102.33 0.03 OUTLIER Pre-proline 0 C--O 1.231 0.117 0 CA-C-O 120.519 0.2 . . . . 0.0 111.35 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 74.9 Cg_exo -43.61 -32.94 4.21 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.386 2.057 . . . . 0.0 112.432 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.34 -20.41 64.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.26 -7.68 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.539 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CD2' HD23 ' A' ' 62' ' ' LEU . 72.2 m-85 -102.65 97.86 7.99 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.7 134.04 35.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.486 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 16.6 m-30 -96.08 70.83 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.011 0.434 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 84' ' ' THR . 6.3 p -101.92 -9.53 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.359 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.451 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 54.6 t 67.59 -58.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 82' ' ' THR . 73.1 p -83.52 28.25 0.56 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.41 168.11 2.06 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.848 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 -155.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.07 109.12 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.412 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.93 22.14 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 111.205 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.82 98.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.426 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.7 m -82.95 142.16 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.043 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.25 -154.53 29.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 88.2 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.861 179.943 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -141.91 138.57 32.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.63 154.31 24.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.23 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.02 88.9 4.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.58 -170.05 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp 40.08 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -138.39 143.54 39.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.033 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -102.49 128.04 49.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 176.02 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 10.9 t -166.6 38.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.639 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 13' ' ' ARG . 3.8 tt 50.54 119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.466 0.706 . . . . 0.0 112.46 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 8.0 tp -84.85 48.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.888 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 35.5 mtt180 -148.14 92.38 2.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.4 98.06 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.39 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.23 175.62 7.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.308 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.54 83.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.239 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.527 ' CG ' ' CE2' ' A' ' 44' ' ' TYR . 97.0 Cg_endo -84.18 137.93 7.49 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.888 2.392 . . . . 0.0 111.594 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.467 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -129.05 -18.73 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 66.97 -74.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 -1.29 76.15 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.573 ' HB2' ' CA ' ' A' ' 22' ' ' PRO 0.251 0.0 OUTLIER 46.35 -93.3 0.0 OUTLIER Pre-proline 0 CA--C 1.494 -1.179 0 CA-C-O 116.677 -1.63 . . . . 0.0 109.666 -179.49 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' CA ' ' HB2' ' A' ' 21' ' ' ASP . 8.3 Cg_endo -100.84 -2.26 18.28 Favored 'Cis proline' 0 N--CA 1.477 0.532 0 CA-C-N 122.688 1.996 . . . . 0.0 113.452 -5.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.37 82.72 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.125 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 ' CD ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -126.28 156.33 72.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -179.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.857 2.371 . . . . 0.0 112.551 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.79 120.86 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.44 -5.73 49.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.291 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 59.9 m95 -96.71 143.41 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.992 0.396 . . . . 0.0 111.15 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.58 172.36 15.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.733 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' CD ' HD23 ' A' ' 24' ' ' LEU . 2.3 mtp180 -132.07 142.17 49.44 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 1.4 ttmt -151.71 160.56 43.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.516 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 31' ' ' LYS . 10.2 mt -131.88 153.25 50.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.26 0.552 . . . . 0.0 111.901 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -120.33 118.34 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.514 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 50.1 tt0 -80.15 136.78 36.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.542 0.687 . . . . 0.0 111.3 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.06 88.02 7.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.316 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -29.94 -89.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.026 0.829 . . . . 0.0 111.885 177.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.36 -84.3 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.825 0.345 . . . . 0.0 110.194 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' ARG . . . 72.85 -65.91 1.45 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 164.1 -34.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.14 -16.25 22.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.936 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . 56.75 128.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.576 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.3 57.07 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.258 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.75 124.67 33.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.122 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.527 ' CE2' ' CG ' ' A' ' 17' ' ' PRO . 10.1 m-85 -97.7 153.07 18.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -129.97 147.04 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.461 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 HG13 ' CD1' ' A' ' 81' ' ' PHE . 8.2 p -87.47 145.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 13.2 m-85 -146.1 102.14 3.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.086 0.469 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 10.3 mt -92.93 110.38 21.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 29' ' ' THR . 4.3 mt -85.25 125.11 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.047 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.502 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.9 p-10 -85.81 153.55 57.9 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.868 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.406 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 87.2 Cg_exo -39.78 -51.97 2.8 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 113.169 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -48.16 -24.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.88 49.05 1.19 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.996 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.94 135.47 31.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.862 0.363 . . . . 0.0 111.568 -178.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.07 149.52 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.152 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 96.3 m-85 -130.46 133.86 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.117 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mtp180 -99.32 -60.58 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 24.9 p -88.49 177.11 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.933 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -85.98 -41.33 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.9 t -51.98 -28.43 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.659 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 1.6 mm-40 -74.88 -32.4 61.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.282 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -65.35 -61.38 2.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.446 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.401 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -59.77 -38.06 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.497 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.94 -66.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.9 -48.22 80.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.487 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.0 m-30 -53.02 -30.36 35.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.799 0.333 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.4 mm-40 -69.31 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.968 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.2 -25.57 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.702 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 m -86.79 -44.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.813 0.34 . . . . 0.0 111.153 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.94 43.77 3.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.482 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.9 134.89 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 p -139.83 27.83 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 t -128.07 30.66 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -140.0 -41.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.18 109.04 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.5 Cg_exo -50.59 -31.42 31.67 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.321 2.014 . . . . 0.0 112.176 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.16 -8.62 51.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.505 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.18 -13.47 41.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.224 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.488 ' CD2' HD23 ' A' ' 62' ' ' LEU . 86.0 m-85 -99.0 114.28 26.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.804 0.335 . . . . 0.0 111.133 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.29 145.51 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.01 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.49 ' CD1' HG13 ' A' ' 46' ' ' VAL . 14.4 m-85 -102.73 96.14 6.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.17 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.04 88.43 2.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.906 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 44' ' ' TYR . 62.5 t -52.29 -32.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 111.063 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.8 p -90.31 43.76 1.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.633 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.53 -160.24 0.03 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.227 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -151.39 -155.27 0.6 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.42 66.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.34 -18.89 54.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.24 . . . . 0.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 60.53 97.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.487 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.5 t -152.66 -64.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.994 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.1 -150.95 42.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.373 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.966 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p -142.17 117.68 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.93 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.0 81.45 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.92 -167.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.567 2.178 . . . . 0.0 112.264 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mttp 41.94 82.47 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.391 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -132.22 -51.06 0.95 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.127 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.31 176.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.702 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -118.28 115.02 23.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.038 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 t 68.61 71.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.4 tt -137.54 108.9 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.6 mm -94.3 53.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.295 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 46.46 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.973 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -134.32 50.04 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.08 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -75.73 -177.06 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.987 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.91 172.22 15.04 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.408 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 41.9 Cg_endo -66.72 -166.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.783 2.322 . . . . 0.0 112.2 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 102.79 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.32 -73.91 0.13 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -177.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -62.04 83.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.544 0.211 . . . . 0.0 110.665 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' CB ' ' HB2' ' A' ' 30' ' ' ARG . 2.4 t0 -113.07 88.77 12.69 Favored Pre-proline 0 C--N 1.332 -0.159 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.426 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -93.3 18.75 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.194 2.596 . . . . 0.0 112.641 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.5 p -92.82 21.74 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.507 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.0 mt -98.63 164.04 17.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.895 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 3.2 Cg_exo -40.86 167.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.19 2.593 . . . . 0.0 112.597 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.24 126.33 7.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.2 -1.27 56.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.665 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 64.2 m95 -100.85 143.89 30.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.349 0.574 . . . . 0.0 112.152 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.72 -178.93 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.008 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 5.3 mtm180 -144.14 170.79 15.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 0.0 111.326 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 9.0 ttmt -177.91 159.25 1.35 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.421 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.495 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 4.5 mt -128.24 173.74 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.826 0.822 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.34 106.39 3.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.688 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.13 172.1 8.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.831 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.84 125.46 8.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.537 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -93.21 -88.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.54 -67.97 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 110.957 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.51 -76.42 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.0 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 110.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.33 . . . . 0.0 110.545 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.96 34.81 19.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.405 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.5 151.58 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.124 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.15 24.05 23.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.058 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -85.0 136.15 33.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.532 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 30.3 m-85 -106.11 160.51 15.26 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -127.1 142.14 51.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.676 174.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 44.9 t -91.39 148.05 4.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.79 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.9 m-85 -146.05 91.18 2.04 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.85 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.422 HD21 ' CG ' ' A' ' 30' ' ' ARG . 5.6 mt -93.04 109.82 21.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.323 0.582 . . . . 0.0 109.464 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 10.8 mt -84.77 122.78 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.104 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.4 p-10 -85.61 163.22 45.16 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.361 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -37.79 -29.48 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.248 2.632 . . . . 0.0 113.288 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -91.69 34.54 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.649 0.262 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 47.79 25.45 3.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.102 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 51.7 tptt -99.1 121.94 41.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.23 147.82 23.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.08 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.3 m-85 -134.04 149.7 51.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.822 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.7 -39.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 8.4 t -85.63 -77.43 0.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.968 -176.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER 161.18 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 28.3 t -55.2 -29.09 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.16 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.7 -33.58 74.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.991 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -65.15 -68.38 0.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.48 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.3 mp -54.26 -45.14 67.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.86 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.75 -54.11 38.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.6 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CD2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -66.27 -53.02 41.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.431 -179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.573 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 10.9 m-30 -53.18 -23.02 7.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.9 mm-40 -71.19 -61.85 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.864 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -54.68 -26.23 32.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.636 -177.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.456 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 9.6 m -91.1 -45.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.901 0.382 . . . . 0.0 111.062 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 95.56 37.27 5.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.294 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.0 146.41 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.033 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -148.99 18.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.75 23.52 11.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.037 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -154.48 67.54 0.71 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.658 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER 60.85 -174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.149 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' CA ' ' CB ' ' A' ' 75' ' ' ASP . 84.6 Cg_exo -75.83 -158.08 1.56 Allowed 'Cis proline' 0 C--N 1.308 -1.598 0 N-CA-C 115.385 1.264 . . . . 0.0 115.385 17.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 20.49 9.25 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.866 -177.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 2.2 m-20 -146.2 -12.17 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.658 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 50.3 m-85 -86.76 83.07 7.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.028 0.376 . . . . 0.0 110.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.21 98.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 57' ' ' ARG . 4.3 m-30 -85.47 52.92 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -115.2 131.51 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.438 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.485 ' CG1' ' CB ' ' A' ' 44' ' ' TYR . 23.1 m -64.56 -49.23 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.745 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.425 ' N ' HG22 ' A' ' 83' ' ' VAL . 16.8 p -88.18 45.48 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.131 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.27 -150.68 3.08 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.55 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -133.72 49.41 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.092 0.472 . . . . 0.0 110.805 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -91.64 64.2 2.52 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 p -82.16 -18.55 42.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.48 103.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.3 m 57.13 61.76 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 110.764 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.09 178.11 51.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.611 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.941 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -88.4 -178.32 5.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.42 76.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t 65.53 72.47 0.46 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.62 -170.83 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.639 2.226 . . . . 0.0 112.279 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 41.08 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.509 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -128.92 -165.15 1.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -105.4 -179.56 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.84 27.48 8.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.009 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.87 43.72 25.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.9 tt -92.49 105.85 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.9 mm -89.46 69.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' ARG . 46.0 mtm180 64.31 -178.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -52.06 90.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.95 156.12 34.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.208 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.09 77.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.011 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 12.3 Cg_endo -87.29 179.28 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.008 2.472 . . . . 0.0 112.157 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.443 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -169.19 109.07 0.45 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.453 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -78.43 80.22 4.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 39.1 t70 -154.57 64.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.038 -170.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.641 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 64.88 -103.39 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -0.993 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.607 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 Cg_endo -84.04 130.91 16.13 Favored 'Cis proline' 0 N--CA 1.479 0.64 0 CA-C-N 123.617 2.327 . . . . 0.0 113.803 -6.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.489 ' N ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 41.37 84.05 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.131 173.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.456 ' CD1' ' HG3' ' A' ' 30' ' ' ARG . 8.0 mt -124.53 166.65 18.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -47.45 165.59 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 125.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.234 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.66 -2.7 53.02 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.964 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.5 m95 -100.17 139.94 35.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.366 0.583 . . . . 0.0 112.067 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.41 171.64 16.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.19 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HG3' ' CD1' ' A' ' 24' ' ' LEU . 14.7 mtm180 -132.62 144.44 50.36 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' CD ' ' HB3' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -135.16 177.04 8.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.977 -177.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . 15.0 mt -148.74 155.71 41.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.254 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.75 118.78 8.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.274 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.492 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.4 tt0 -69.0 166.49 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.164 0.507 . . . . 0.0 110.718 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HA ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 88.28 -174.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.801 177.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.19 -88.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.828 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -155.07 -56.99 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.987 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.31 -40.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.67 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -67.31 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.009 0.433 . . . . 0.0 110.413 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -96.23 43.2 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.96 80.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 151.91 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 35' ' ' ARG . 2.8 mtpt -141.0 152.34 44.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 6.5 m-85 -88.71 133.16 34.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -104.92 156.28 18.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.566 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' CG2' HG22 ' A' ' 83' ' ' VAL . 44.7 t -95.11 147.42 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 10.3 m-85 -147.2 102.37 3.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.797 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 5.9 mt -92.79 106.77 18.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.6 mt -82.18 122.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.106 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 16.6 p-10 -85.95 146.27 42.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.307 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -36.0 -48.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.451 2.767 . . . . 0.0 113.087 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -46.09 -26.86 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.16 6.58 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.109 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.1 tttt -98.99 170.83 8.44 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.49 0.186 . . . . 0.0 110.995 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.82 96.79 3.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.499 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.0 m-85 -95.13 122.78 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.775 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -91.6 -46.09 8.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 50.7 p -87.24 165.73 15.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.965 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.22 -36.34 34.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 61' ' ' GLU . 4.1 p -52.04 -42.34 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.16 0.505 . . . . 0.0 110.52 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 2.4 mm-40 -61.12 -32.04 71.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.639 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -67.5 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.6 mp -58.13 -37.24 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.415 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.81 -70.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.89 -38.29 81.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.458 ' CE2' HD12 ' A' ' 74' ' ' LEU . 12.8 m-30 -58.6 -28.79 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.8 mm-40 -72.47 -60.18 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.779 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -25.81 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.265 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 70' ' ' GLY . 4.5 m -88.61 -45.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.089 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 94.43 42.19 4.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.551 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.06 133.25 34.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.779 0.323 . . . . 0.0 110.846 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.2 p -140.02 25.84 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -126.09 24.66 6.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.458 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -135.23 -40.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.29 107.65 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.104 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.2 Cg_exo -49.49 -32.53 27.37 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.464 2.11 . . . . 0.0 112.474 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.77 -13.98 62.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.02 -9.47 58.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.232 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 78.6 m-85 -100.64 97.25 7.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.55 140.09 29.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.964 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-30 -94.13 110.61 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -145.67 131.26 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG22 ' CG2' ' A' ' 46' ' ' VAL . 77.8 t -96.25 -37.17 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 p -92.69 42.61 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.113 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -174.46 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.947 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -136.67 -148.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.51 50.85 52.81 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.932 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 p -92.66 34.33 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.657 0.265 . . . . 0.0 111.307 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.73 118.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.409 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m 63.34 57.46 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.23 -133.01 2.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.457 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.984 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m 60.2 48.07 8.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.23 164.35 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER 55.98 53.34 7.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.192 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 4' ' ' SER . 66.4 Cg_endo -72.42 -19.73 24.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.57 2.18 . . . . 0.0 112.233 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -77.32 60.71 2.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -135.64 -72.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.69 150.38 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 45.35 27.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.43 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.9 p -78.84 59.23 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.645 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.2 tt 49.54 106.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.494 0.664 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.18 58.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.886 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 71.15 168.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.9 102.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.283 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.05 132.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.88 -107.57 2.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 74.4 Cg_endo -75.91 178.92 6.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.444 2.096 . . . . 0.0 112.392 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 97.83 2.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.201 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.1 m-30 -67.9 -71.33 0.21 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.311 -178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -55.64 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -129.73 85.42 58.28 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.361 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -92.61 14.86 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.16 2.573 . . . . 0.0 112.224 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 p -87.81 49.24 1.77 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -126.13 -178.42 0.72 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.983 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 71.7 Cg_exo -48.4 168.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.009 1.806 . . . . 0.0 111.917 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.41 123.99 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 110.757 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 51' ' ' PRO . . . 92.08 -64.64 2.33 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 76.1 m95 -32.47 136.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.57 175.85 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.354 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 27.4 ttm180 -147.36 156.06 42.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.958 0.409 . . . . 0.0 111.28 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 26.3 tttm -166.0 161.32 17.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 46' ' ' VAL . 6.0 mt -129.59 163.25 26.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.897 0.38 . . . . 0.0 111.355 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.9 tttt -143.7 118.99 10.19 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.991 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.529 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.9 tt0 -80.71 107.16 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 112.311 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER 178.85 -173.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.994 173.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.65 35.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.31 -94.23 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.156 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.31 -31.26 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.682 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 108.92 14.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 111.375 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.48 47.41 21.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.944 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.34 143.34 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.829 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.05 67.24 0.84 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -149.62 140.58 22.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.364 0.602 . . . . 0.0 110.536 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 9.3 m-85 -83.56 134.94 34.8 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -117.66 148.67 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.383 177.07 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 5.6 p -90.33 149.29 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.007 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 12.1 m-85 -146.07 95.85 2.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.934 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 11.9 mt -91.61 113.15 25.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.8 mt -90.58 117.46 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.028 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.583 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 6.6 p-10 -96.82 123.52 53.42 Favored Pre-proline 0 CA--C 1.491 -1.321 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.498 ' CB ' ' HA2' ' A' ' 27' ' ' GLY . 4.7 Cg_exo -71.04 -31.97 4.55 Favored 'Cis proline' 0 C--N 1.309 -1.544 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 -26.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' O ' HG23 ' A' ' 49' ' ' ILE . 19.2 mt-30 -141.61 -27.75 0.66 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.707 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.21 -31.1 6.33 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.172 -1.013 . . . . 0.0 114.389 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HG3' ' CE1' ' A' ' 56' ' ' PHE . 41.9 tptt -99.15 125.18 44.65 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.137 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' O ' ' CD1' ' A' ' 56' ' ' PHE . . . -105.22 140.98 37.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.56 ' CE2' ' OD1' ' A' ' 50' ' ' ASN . 21.9 m-85 -135.07 136.74 42.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.558 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.85 -50.63 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.379 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 177.56 7.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.201 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 1.4 tmtp? -85.04 -43.0 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.544 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 t -51.81 -32.43 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.517 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -68.79 -32.06 71.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.48 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 1.7 tp -64.57 -64.88 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.299 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.425 HG13 ' CG ' ' A' ' 76' ' ' PRO . 3.5 mp -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.88 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.453 ' CD2' ' HE2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -63.2 -41.38 99.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 110.728 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.53 ' CE2' ' CD1' ' A' ' 74' ' ' LEU . 4.8 m-30 -45.45 -32.35 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mm-40 -72.69 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.107 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -19.78 23.88 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 70' ' ' GLY . 23.1 m -86.56 -27.75 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.259 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 69' ' ' VAL . . . 83.37 46.07 6.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.163 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -74.32 133.97 42.55 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.772 0.32 . . . . 0.0 111.514 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 t -149.98 25.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.347 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.93 32.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.53 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.29 -46.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.865 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.34 125.99 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.261 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -56.64 -31.07 86.05 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.496 2.131 . . . . 0.0 112.287 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.04 -7.82 44.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.644 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.5 -7.29 58.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.473 0.178 . . . . 0.0 111.406 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.58 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 51.4 m-85 -107.58 148.17 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 111.393 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.29 159.47 41.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.069 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CZ ' ' O ' ' A' ' 57' ' ' ARG . 22.4 m-30 -120.72 91.42 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.0 -10.37 8.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.823 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t 61.33 -81.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 82' ' ' THR . 18.7 p -56.41 -31.21 63.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.94 -173.66 14.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.547 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -154.21 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.58 -62.89 1.02 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 m 59.15 28.47 17.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.78 87.46 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.536 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.0 m -92.46 143.62 26.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.76 -80.34 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.573 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.02 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.56 173.92 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.72 65.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.349 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -78.87 -63.75 0.39 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.783 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 73.6 Cg_endo -74.71 -12.05 22.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.701 2.267 . . . . 0.0 112.755 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.0 84.49 3.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.644 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -118.42 -41.8 2.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 159.71 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -89.99 -178.4 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.195 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 7.1 t 52.57 42.85 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.994 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.9 tt 50.05 119.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.442 0.697 . . . . 0.0 112.488 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.447 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 7.6 tp -85.51 49.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.465 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 49.6 mtm180 -154.33 -172.66 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.482 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -125.5 88.08 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.96 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -163.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.74 158.29 31.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.55 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.59 -165.87 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -161.76 129.36 4.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.216 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -94.79 -68.23 0.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.179 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.17 81.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.823 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 4.2 m-20 -117.97 91.45 39.65 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.77 13.54 1.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.058 2.505 . . . . 0.0 112.669 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 p -88.53 55.11 3.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.413 . . . . 0.0 110.887 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.6 mt -133.27 165.23 38.25 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.582 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 73.1 Cg_exo -38.81 164.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.768 2.312 . . . . 0.0 112.909 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.2 127.11 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.34 -54.79 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.573 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 47.6 m95 -41.6 148.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.58 -178.41 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.837 178.473 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 20.9 ttt180 -148.2 159.59 43.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 111.635 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 9.6 tttt -174.25 162.85 3.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.526 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.406 ' CD2' ' O ' ' A' ' 31' ' ' LYS . 6.0 mt -131.27 161.34 32.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.034 0.445 . . . . 0.0 111.411 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 8.2 tttp -136.18 117.45 14.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.082 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -70.68 171.68 9.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.244 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 43' ' ' LYS . 41.4 ttm180 -152.62 160.64 43.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.961 0.41 . . . . 0.0 111.367 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' CE ' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.77 114.58 14.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.267 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 m -101.33 -20.63 15.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.719 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.91 -32.28 6.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.118 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.67 -52.47 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.929 0.395 . . . . 0.0 110.115 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.87 36.32 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.952 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.43 ' HB1' ' CE ' ' A' ' 36' ' ' LYS . . . -52.56 136.12 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.574 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.54 27.87 4.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.387 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.51 132.99 33.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.975 0.417 . . . . 0.0 110.961 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -106.05 159.46 16.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.671 0.748 . . . . 0.0 112.912 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.452 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -129.7 145.84 51.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.778 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.526 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -90.45 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.958 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -144.87 96.98 2.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.97 109.77 21.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 4.2 mt -85.8 134.76 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' OD1' ' CZ2' ' A' ' 28' ' ' TRP . 3.4 t30 -75.22 149.68 84.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.139 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -39.6 -59.45 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.823 2.348 . . . . 0.0 112.789 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -50.89 -25.1 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 114.86 31.56 2.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.239 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.504 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -101.01 117.02 34.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 111.614 -178.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.87 140.69 30.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.835 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.7 m-85 -129.17 127.03 40.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.488 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.483 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -52.42 2.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.779 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 6.1 p -86.07 173.46 9.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.359 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER -85.77 -40.28 16.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.955 0.407 . . . . 0.0 110.839 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 46.6 t -51.86 -39.84 26.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.688 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -63.23 -28.2 69.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.161 0.505 . . . . 0.0 109.959 177.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD22 ' CD1' ' A' ' 79' ' ' PHE . 1.7 tp -70.66 -61.64 1.69 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.777 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.3 mp -72.79 -57.92 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.477 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -46.54 -43.8 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.316 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.495 ' CD1' ' HD2' ' A' ' 68' ' ' LYS . 2.4 t80 -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.565 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.475 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 18.8 m-30 -45.61 -35.29 3.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.679 0.276 . . . . 0.0 111.283 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 65.3 mt-10 -61.22 -68.12 0.34 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.016 0.436 . . . . 0.0 110.527 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HD2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -56.01 -19.73 13.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.71 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.457 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 7.4 t -86.36 -42.22 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.889 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.66 37.65 10.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.807 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 127.78 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 0.0 110.756 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -123.5 28.69 6.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -131.3 31.64 4.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 pp -154.46 -179.03 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.451 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -158.62 108.32 1.64 Allowed Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.647 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 80.1 Cg_exo -45.3 -35.47 11.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.658 2.239 . . . . 0.0 112.508 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.62 -20.0 63.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.867 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.45 -9.44 59.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.485 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 47.8 m-85 -104.85 135.09 46.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.948 0.404 . . . . 0.0 111.455 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.06 161.32 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.51 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.526 ' CD1' ' CG1' ' A' ' 46' ' ' VAL . 19.8 m-85 -121.82 88.5 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 p -119.1 -15.1 9.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.402 HG11 HD12 ' A' ' 32' ' ' LEU . 54.8 t 63.15 -79.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' THR . 12.5 p -52.81 -29.15 26.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.019 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 176.93 28.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -154.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.593 0.235 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.27 92.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 p -87.56 -16.99 33.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.61 0.243 . . . . 0.0 111.299 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.81 22.34 36.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.681 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.6 p -96.11 122.34 38.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.94 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.85 -176.48 18.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.518 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.883 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 p -137.73 -175.71 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.33 69.57 9.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -156.76 54.48 0.88 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.47 -76.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.746 2.297 . . . . 0.0 112.136 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -112.87 30.29 7.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.668 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -126.02 62.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.76 164.89 12.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -77.4 121.97 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.92 0.391 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.6 t -159.46 42.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 51.54 117.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.545 0.688 . . . . 0.0 112.441 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mm -80.63 59.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.838 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 63.35 -175.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.816 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -56.38 117.4 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.02 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.35 164.56 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.15 156.19 7.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.438 ' CB ' HD11 ' A' ' 32' ' ' LEU . 77.2 Cg_endo -77.26 -167.42 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.826 2.35 . . . . 0.0 112.02 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.432 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -172.61 18.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.569 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 36.23 48.39 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.433 0.635 . . . . 0.0 111.794 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 t0 -132.38 69.91 1.47 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.97 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' CB ' ' CA ' ' A' ' 22' ' ' PRO . 7.5 m-20 67.31 -99.41 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.334 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -171.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.553 ' CA ' ' CB ' ' A' ' 21' ' ' ASP . 26.2 Cg_endo -82.2 153.44 76.82 Favored 'Cis proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.252 2.197 . . . . 0.0 112.93 -13.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 2.8 t 45.34 83.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.962 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' CD1' ' CA ' ' A' ' 29' ' ' THR . 79.5 mt -138.92 154.58 72.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.92 -170.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.63 2.22 . . . . 0.0 112.257 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.5 125.45 25.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.81 -4.35 52.89 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.811 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.516 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 83.5 m95 -99.6 138.96 35.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.366 0.583 . . . . 0.0 111.711 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.58 178.73 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.027 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 10.5 mtm180 -142.44 141.35 32.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 11.7 ttmt -140.73 153.3 45.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.11 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.438 HD11 ' CB ' ' A' ' 17' ' ' PRO . 4.1 mt -128.43 153.86 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.124 0.487 . . . . 0.0 111.636 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.38 117.37 21.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -71.35 164.55 25.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.231 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -156.87 153.23 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.424 ' CD ' ' CB ' ' A' ' 41' ' ' ALA . 10.5 tptm -126.47 109.93 12.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.394 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -169.52 1.55 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.497 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.91 35.02 4.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.0 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.2 120.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.33 46.14 8.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 109.886 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.424 ' CB ' ' CD ' ' A' ' 36' ' ' LYS . . . -54.12 179.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.769 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 62.43 36.83 93.69 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.773 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 35' ' ' ARG . 12.3 tttt -87.5 142.52 27.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.277 0.561 . . . . 0.0 111.224 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HB2' ' CG1' ' A' ' 83' ' ' VAL . 10.7 m-85 -106.46 153.51 22.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.713 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -121.54 143.45 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.075 175.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 5.2 p -87.87 148.51 4.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.745 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.0 m-85 -146.92 103.26 3.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.545 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.541 ' CD2' ' CE1' ' A' ' 81' ' ' PHE . 2.3 mp -89.43 110.63 21.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.894 -172.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.2 t-20 -87.27 137.63 32.64 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.358 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 82.4 Cg_exo -32.11 -58.56 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.774 2.982 . . . . 0.0 113.752 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -45.02 -27.72 0.59 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 111.308 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.71 22.67 3.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.503 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 4.4 tttt -94.35 174.45 7.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.733 0.301 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -142.07 133.96 27.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.519 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 19.8 m-85 -127.59 127.17 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.865 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -102.19 6.51 40.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.467 177.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.406 ' OG ' ' HG2' ' A' ' 61' ' ' GLU . 6.4 p -154.15 167.1 30.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 4.2 tptp -74.55 -36.87 63.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.169 0.509 . . . . 0.0 111.526 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 96.8 t -52.4 -43.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.828 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.406 ' HG2' ' OG ' ' A' ' 58' ' ' SER . 5.6 mm-40 -65.92 -29.88 70.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.992 0.425 . . . . 0.0 110.154 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.556 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.87 -66.14 0.58 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.105 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 4.8 mp -61.58 -40.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.67 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -65.46 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.582 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -57.78 -44.34 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.666 179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.556 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 8.0 m-30 -55.78 -24.38 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.75 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.4 mm-40 -73.79 -53.89 9.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 111.836 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.78 -18.51 62.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.929 -177.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 m -86.32 -43.96 16.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.717 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.72 54.0 1.72 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.511 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD2' ' CD2' ' A' ' 66' ' ' PHE . 35.2 p-10 -74.36 138.02 43.16 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.701 0.4 . . . . 0.0 111.852 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.4 p -149.95 22.56 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.035 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -143.47 33.03 1.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.489 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -154.54 -177.31 6.38 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -158.58 101.02 1.67 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.47 ' HG3' ' CD2' ' A' ' 66' ' ' PHE . 99.5 Cg_exo -44.08 -27.76 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.428 2.085 . . . . 0.0 112.107 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.93 -23.06 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.633 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.46 8.5 24.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.087 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.503 ' CE2' HD12 ' A' ' 62' ' ' LEU . 9.6 m-85 -93.74 124.15 37.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.771 0.319 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 116.44 29.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.541 ' CE1' ' CD2' ' A' ' 48' ' ' LEU . 8.5 m-85 -88.72 74.46 8.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.41 111.41 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' A' ' 44' ' ' TYR . 92.4 t -79.55 -14.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.495 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.0 p -121.12 47.73 1.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.115 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.08 151.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.59 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -121.42 -83.88 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.395 0.617 . . . . 0.0 110.712 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.05 93.37 0.03 OUTLIER Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.552 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -147.17 20.46 1.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 0.0 110.527 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.08 44.4 0.67 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.383 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.1 t -89.08 -47.07 8.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.381 . . . . 0.0 111.079 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.41 -129.18 42.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.511 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.21 179.5 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.76 177.18 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -147.82 59.76 4.86 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.621 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.91 -68.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.699 2.266 . . . . 0.0 112.419 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -108.05 61.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -133.03 108.05 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -80.75 149.05 29.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.615 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.34 167.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -168.77 80.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.139 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 48.36 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.396 0.617 . . . . 0.0 111.522 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 mm -77.75 66.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.82 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 68.02 162.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.739 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.05 162.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.108 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.53 12.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.856 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.74 92.2 0.1 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.0 Cg_endo -77.31 168.91 22.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.854 2.369 . . . . 0.0 111.54 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.438 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -134.54 -34.47 0.93 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 62.39 18.07 9.99 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 9.4 m-20 -118.72 84.89 2.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 7.1 m-20 44.62 -94.39 0.0 OUTLIER Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-O 116.781 -1.58 . . . . 0.0 109.727 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.556 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 58.6 Cg_endo -77.0 -55.8 0.14 OUTLIER 'Cis proline' 0 N--CA 1.484 0.95 0 CA-C-N 122.908 2.074 . . . . 0.0 113.834 -6.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 32.9 p -159.35 78.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -94.11 -175.54 0.49 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.666 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.8 Cg_exo -42.77 165.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.026 1.818 . . . . 0.0 112.508 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.29 125.39 14.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.007 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.79 -0.14 52.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.344 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.488 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 62.8 m95 -101.22 127.13 47.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.124 0.487 . . . . 0.0 111.469 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.442 ' CA ' HD11 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -134.35 172.72 12.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.608 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 11.7 ttm180 -140.17 150.77 44.62 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.8 0.81 . . . . 0.0 111.6 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -157.78 160.88 38.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.237 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 1.3 mt -130.85 169.79 15.28 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.9 tttt -147.91 114.14 5.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.421 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 52.1 tt0 -71.86 165.84 23.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.756 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 88.84 -177.8 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.554 0.742 . . . . 0.0 112.383 177.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 1.7 mmtt -153.22 -88.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.78 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.3 m -155.12 -159.62 0.96 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.016 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.98 -31.44 25.13 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.126 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.59 149.42 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.712 0.292 . . . . 0.0 110.258 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.81 23.47 11.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.5 99.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.18 0.514 . . . . 0.0 111.263 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 139.23 59.68 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.825 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -141.3 147.83 38.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.919 0.39 . . . . 0.0 110.231 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.493 ' CE2' ' OH ' ' A' ' 19' ' ' TYR . 7.2 m-85 -89.77 141.51 28.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.16 137.21 54.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.341 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -85.85 154.7 3.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.617 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 12.5 m-85 -145.08 100.88 3.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 41.9 mt -92.51 104.88 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -82.37 126.39 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.619 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.488 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 30.8 p-10 -85.59 148.51 49.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.394 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -33.8 -54.55 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.764 2.976 . . . . 0.0 113.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -44.85 -27.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.37 49.32 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.047 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.41 132.43 27.82 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.017 0.437 . . . . 0.0 111.129 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.75 137.68 32.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.488 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 60.1 m-85 -122.17 121.58 37.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 5.0 mtm180 -89.92 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.23 173.54 8.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 0.2 OUTLIER -81.95 -38.69 24.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.414 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 10.7 p -51.79 -43.17 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.351 0.596 . . . . 0.0 110.217 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 1.2 mt-10 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.31 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD2' ' A' ' 79' ' ' PHE . 1.4 tp -70.42 -63.08 1.16 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.387 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -62.27 -36.53 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.83 -72.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.74 -42.93 84.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' CG ' ' O ' ' A' ' 62' ' ' LEU . 7.4 m-30 -52.07 -31.49 30.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.178 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.6 mm-40 -74.24 -59.56 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.745 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -23.63 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.737 -178.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 m -86.46 -31.94 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 0.0 111.35 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.54 43.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -79.31 128.92 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.871 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 t -119.36 20.08 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -125.85 26.52 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 0.0 110.656 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -154.53 175.9 13.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.671 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -158.57 129.19 3.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.436 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 51.4 Cg_exo -55.13 -36.32 92.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.427 2.085 . . . . 0.0 112.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.0 -18.09 63.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.996 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.95 -4.2 59.15 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.515 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.498 ' CD2' HD22 ' A' ' 62' ' ' LEU . 87.3 m-85 -107.66 85.36 2.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.016 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -80.38 128.75 33.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.533 ' CD1' ' CG1' ' A' ' 46' ' ' VAL . 9.0 m-85 -84.04 90.56 7.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.38 88.71 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.796 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.431 ' CG1' HD12 ' A' ' 32' ' ' LEU . 88.3 t -47.09 -27.64 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.076 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 p -91.96 43.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 111.051 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.98 -156.96 0.1 Allowed Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.894 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -131.64 -150.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.62 48.33 74.05 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.931 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.85 29.73 1.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.653 0.263 . . . . 0.0 111.334 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.51 66.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.587 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.2 83.17 6.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.78 -127.97 46.54 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.24 -0.885 . . . . 0.0 110.846 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t 59.83 163.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.57 144.13 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.83 77.47 1.88 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.0 -24.39 12.87 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.673 2.249 . . . . 0.0 112.646 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -97.84 88.24 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.068 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -125.36 18.57 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.23 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 161.05 13.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.717 0.294 . . . . 0.0 110.895 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.44 113.76 8.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.2 m 57.94 31.37 20.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 11' ' ' ILE . 2.6 tt 47.29 99.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.426 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.4 mm -78.61 69.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 mtt85 60.06 78.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.75 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -124.97 -162.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.224 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.17 156.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.384 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.47 -136.08 3.49 Favored Glycine 0 CA--C 1.488 -1.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.349 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.24 -174.07 9.61 Favored 'Cis proline' 0 N--CA 1.48 0.686 0 C-N-CA 125.229 -0.738 . . . . 0.0 112.395 -1.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.83 94.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.551 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.26 -70.55 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.129 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.27 89.98 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.081 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' HB3' ' CG ' ' A' ' 30' ' ' ARG . 6.4 t0 -118.93 83.86 24.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.808 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -102.17 21.58 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.649 2.899 . . . . 0.0 113.018 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -81.54 -33.35 31.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.235 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.6 mt -41.87 160.41 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.573 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.4 Cg_exo -40.33 162.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.652 2.235 . . . . 0.0 112.317 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.89 136.62 2.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.083 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.48 -45.8 2.96 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.73 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.611 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 63.2 m95 -68.92 149.1 49.25 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.56 -179.65 7.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.58 175.106 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.13 169.7 23.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 110.728 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 9.2 ttmt -170.42 162.25 8.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' A' ' 46' ' ' VAL . 5.7 mt -131.26 157.09 44.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.958 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -139.29 124.66 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.621 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.479 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 59.0 tt0 -74.94 166.71 23.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.065 0.46 . . . . 0.0 110.707 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER 86.69 -178.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 178.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' CD ' ' N ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -165.49 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.42 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.449 ' N ' ' CD ' ' A' ' 36' ' ' LYS . 35.8 t -155.12 -162.98 1.45 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.057 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -61.64 -23.37 62.88 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.59 121.78 44.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.737 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 m 60.79 31.43 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' SER . . . -53.64 114.27 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 35' ' ' ARG . . . 128.19 59.98 0.12 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -140.65 152.33 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -90.87 142.07 28.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -118.83 148.95 42.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.644 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG12 ' CD1' ' A' ' 81' ' ' PHE . 6.7 p -91.42 148.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.378 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.11 103.25 3.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' N ' HD11 ' A' ' 48' ' ' LEU . 0.6 OUTLIER -91.89 116.81 29.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -91.2 138.79 18.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.423 -175.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.568 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -154.32 148.72 19.37 Favored Pre-proline 0 CA--C 1.484 -1.571 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -96.39 30.27 14.1 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 N-CA-C 108.305 -1.46 . . . . 0.0 108.305 -25.415 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 51' ' ' PRO . 48.3 mt-30 -157.02 -44.26 0.07 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.904 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 10.04 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.906 -1.14 . . . . 0.0 115.285 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.487 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 1.3 tmtt? -92.04 115.34 27.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.759 1.779 . . . . 0.0 110.42 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.418 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -92.01 154.21 18.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.251 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 42.1 m-85 -150.55 136.02 18.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 1.5 mtm-85 -97.61 -57.16 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.176 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -87.56 171.46 10.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.381 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HE2' ' CA ' ' A' ' 76' ' ' PRO . 7.3 tptp -81.24 -38.0 27.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.369 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.81 -42.12 31.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.55 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -33.2 73.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.751 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.484 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.3 tp -66.49 -61.01 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.469 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.429 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 4.8 mp -62.96 -36.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.496 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.88 -62.91 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.989 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.48 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -61.16 -53.08 61.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.257 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 21.6 m-30 -50.13 -25.02 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.821 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.5 mm-40 -71.08 -63.6 1.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.695 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -23.23 65.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.56 -38.33 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.353 . . . . 0.0 111.137 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.47 46.99 8.4 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.158 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -74.56 135.86 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -127.88 23.64 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.252 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 24.04 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.883 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.446 HD11 ' CE2' ' A' ' 66' ' ' PHE . 1.1 pp -154.5 178.26 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.668 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -158.64 117.8 1.77 Allowed Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.491 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' CA ' ' HE2' ' A' ' 59' ' ' LYS . 88.9 Cg_exo -46.3 -33.03 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.381 2.054 . . . . 0.0 112.051 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -19.13 63.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.058 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.84 11.21 18.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.451 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.611 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.34 72.1 1.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.985 0.421 . . . . 0.0 111.761 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 162.0 29.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.457 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 15.5 m-85 -115.68 124.59 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 111.753 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.29 93.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.673 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -50.94 -28.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.698 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 p -109.91 31.34 5.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.05 170.84 0.11 Allowed Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -140.55 -154.25 0.51 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.91 -112.23 0.32 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.582 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t 57.69 21.03 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 0.0 111.197 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.65 22.93 48.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 m 63.23 122.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.19 -130.87 2.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.975 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.46 94.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.95 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.06 11.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -162.35 -66.27 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.137 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 55.7 Cg_endo -68.81 -22.2 37.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.463 2.109 . . . . 0.0 112.245 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -122.34 93.86 4.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.41 -44.64 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.68 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -92.82 146.52 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.757 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -88.68 113.65 24.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.066 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 65.68 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.6 tp -83.31 139.95 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.556 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.9 mm -93.86 50.03 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.505 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 72.76 130.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -58.26 107.3 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 113.44 22.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.75 142.1 4.9 Favored Glycine 0 CA--C 1.486 -1.779 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.402 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.482 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 2.7 Cg_endo -83.39 179.37 25.56 Favored 'Cis proline' 0 N--CA 1.472 0.21 0 C-N-CA 125.606 -0.581 . . . . 0.0 112.044 2.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.483 ' CE ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -156.42 97.88 1.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.33 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -70.71 68.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.5 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 28.3 t70 -156.7 85.93 0.98 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.943 -171.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.534 ' HB2' ' C ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 34.95 -88.98 0.0 OUTLIER Pre-proline 0 CA--C 1.498 -1.028 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.429 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' C ' ' HB2' ' A' ' 21' ' ' ASP . 15.1 Cg_endo -94.44 1.46 49.64 Favored 'Cis proline' 0 N--CA 1.486 1.065 0 CA-C-N 121.851 1.697 . . . . 0.0 113.74 -2.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.431 ' N ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -159.25 -83.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.883 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.8 mt 59.42 163.3 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.339 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.38 -179.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.07 2.513 . . . . 0.0 112.78 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.45 122.69 16.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.16 -1.92 53.82 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.55 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 58.0 m95 -98.83 140.51 32.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 111.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -143.55 166.36 25.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.399 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 21' ' ' ASP . 24.1 ttm105 -136.17 154.48 50.94 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.288 0.566 . . . . 0.0 110.466 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -162.99 164.33 25.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.773 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.482 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 0.3 OUTLIER -133.44 167.52 20.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.483 0.658 . . . . 0.0 112.697 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -147.8 112.04 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.184 178.573 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 45.5 tt0 -63.82 166.38 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.458 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 47.1 ttm-85 -153.05 164.35 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.815 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.449 ' N ' ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -112.08 -76.76 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.54 -65.13 0.24 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.655 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.58 -80.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.842 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.69 111.69 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.06 48.61 8.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.54 152.56 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.599 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 89.13 32.71 10.3 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.03 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 140.82 29.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.046 0.451 . . . . 0.0 111.064 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.474 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 5.2 m-85 -99.23 150.93 21.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.561 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.484 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -116.9 142.11 47.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.546 176.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' CG2' ' CG2' ' A' ' 83' ' ' VAL . 65.5 t -85.12 152.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.894 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.496 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.7 m-85 -146.14 90.6 1.98 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 9.6 mt -91.22 103.36 16.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 12.6 mt -82.37 117.24 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.655 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 36.7 p-10 -84.61 152.88 60.93 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.484 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -34.97 -56.15 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.732 2.955 . . . . 0.0 113.447 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -44.65 -27.02 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.58 49.07 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.037 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.97 132.02 26.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.962 0.41 . . . . 0.0 111.479 -178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.82 144.3 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.783 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 55.9 m-85 -132.5 126.25 32.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.89 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 19.4 mtm180 -100.92 -52.82 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.262 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.89 171.78 10.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.909 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -81.81 -39.77 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.299 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 9.3 p -51.78 -42.22 31.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.307 0.575 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.02 -29.34 69.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.384 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -70.4 -67.29 0.51 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.482 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -58.22 -37.67 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.611 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.74 -58.5 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -66.25 -46.37 77.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.711 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 18.9 m-85 -52.08 -26.13 10.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.6 mm-40 -72.4 -62.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.772 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.09 63.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.698 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 m -86.64 -37.56 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 0.0 111.689 -178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.14 48.61 9.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.047 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 -74.62 0.19 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.927 0.87 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p 60.19 18.63 8.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.546 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -120.05 25.92 9.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.472 HD23 ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -138.72 -36.6 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.6 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.97 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.651 0.263 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -51.69 -34.46 53.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.344 2.03 . . . . 0.0 112.344 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.12 -8.9 49.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.413 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -83.19 -9.51 59.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.903 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.534 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 52.6 m-85 -107.26 116.43 31.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.759 0.314 . . . . 0.0 110.554 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.99 146.88 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 22.1 m-30 -100.91 85.65 2.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.4 p -101.95 -16.22 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.452 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' CG2' ' CG2' ' A' ' 46' ' ' VAL . 53.5 t 67.62 -61.02 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.367 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.9 p -73.36 -2.33 21.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 169.82 18.29 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.642 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -158.86 0.68 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.946 0.403 . . . . 0.0 110.559 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.33 -83.86 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.431 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.1 m 59.3 22.63 10.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 0.0 111.095 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.04 -31.64 6.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.488 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -51.48 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.7 -155.6 6.67 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.948 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.65 123.46 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.04 60.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.7 t 54.73 68.53 2.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.005 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.63 -30.11 15.19 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.215 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 7' ' ' GLN . 64.5 mmtt -99.0 -167.9 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.437 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 13.1 pt20 43.42 80.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.823 0.344 . . . . 0.0 111.301 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -60.47 160.93 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.21 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -128.3 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.026 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 23.3 t -85.23 52.05 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 11' ' ' ILE . 2.4 tt 48.1 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.484 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.66 57.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.166 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 53.06 70.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -127.14 50.13 2.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.78 122.34 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.74 92.06 1.45 Allowed Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.417 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -69.5 178.93 23.12 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 125.034 -0.819 . . . . 0.0 112.291 -3.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 102.03 2.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.48 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.83 -69.36 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.199 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.55 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.437 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -115.49 89.71 23.11 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.543 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -93.48 18.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.094 2.529 . . . . 0.0 112.835 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.3 p -92.8 43.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.034 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.476 ' CD1' ' CG ' ' A' ' 30' ' ' ARG . 11.2 mt -123.02 166.57 17.42 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.312 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 96.0 Cg_exo -45.34 173.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.786 2.324 . . . . 0.0 112.752 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 125.84 18.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.915 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.49 -2.8 51.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.694 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.506 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 50.8 m95 -99.02 139.03 35.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -144.19 -179.66 6.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.814 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 24' ' ' LEU . 1.2 mtp180 -145.85 163.73 34.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.937 0.399 . . . . 0.0 111.401 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -170.07 158.36 6.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.129 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.436 HD12 ' CG1' ' A' ' 83' ' ' VAL . 3.4 mt -131.29 155.96 46.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.496 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -129.57 120.41 25.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.154 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -74.41 171.26 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -151.91 124.24 8.25 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -90.63 -78.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 0.0 111.431 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.99 -67.09 0.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.954 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.06 -28.68 1.84 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -62.02 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.973 0.416 . . . . 0.0 110.321 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 41.02 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.21 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . -52.56 114.97 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.479 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 20.23 7.88 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.348 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmp? -87.58 132.39 34.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -107.84 163.66 12.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.09 144.0 46.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.281 177.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.428 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.4 p -88.0 149.51 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.899 0.381 . . . . 0.0 111.78 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' ARG . 10.6 m-85 -146.06 97.32 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.255 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mt -93.01 109.27 20.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -83.81 123.74 39.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.649 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 32.4 p-10 -85.65 152.99 57.97 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -36.19 -54.74 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.741 2.96 . . . . 0.0 113.161 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.34 -26.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.34 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 48.85 1.17 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.799 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -140.86 135.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.354 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.66 134.88 33.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -115.51 123.21 47.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -104.33 -4.4 22.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.36 177.47 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.822 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 1.3 mmtp -78.84 -45.08 21.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.906 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 29.2 t -51.85 -31.42 13.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.219 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -30.87 59.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.883 176.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.579 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -63.32 -66.17 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.425 178.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -59.96 -41.94 87.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.0 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.49 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.72 -54.71 43.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.18 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 6.1 m-30 -46.58 -31.5 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 111.732 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.8 mm-40 -67.82 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.71 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -25.6 59.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.638 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -88.38 -30.79 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 111.254 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.71 81.66 0.52 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.682 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.42 ' OD2' ' CD1' ' A' ' 74' ' ' LEU . 0.4 OUTLIER -149.91 126.9 11.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -177.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -132.38 20.37 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.76 22.14 15.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.748 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -154.58 65.48 0.68 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.674 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.5 OUTLIER 61.07 -173.87 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.146 0 C-N-CA 118.512 -1.275 . . . . 0.0 107.752 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 80.8 Cg_exo -75.73 -157.68 1.46 Allowed 'Cis proline' 0 C--N 1.312 -1.381 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 17.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.81 19.67 9.86 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.694 -176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -145.59 -5.17 0.65 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.077 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.674 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 50.7 m-85 -97.57 90.94 5.2 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.229 -0.294 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.39 119.24 11.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.817 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' HG13 ' A' ' 46' ' ' VAL . 8.3 m-85 -89.46 69.47 7.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.3 107.61 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.436 ' CG1' HD12 ' A' ' 32' ' ' LEU . 93.8 t -59.8 -38.79 77.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.392 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -104.38 32.6 3.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.08 -171.46 2.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -123.89 43.83 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.101 0.477 . . . . 0.0 110.996 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -91.85 21.47 36.32 Favored Glycine 0 C--N 1.32 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.85 21.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.164 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.81 -49.61 1.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.357 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.41 -38.64 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.802 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.26 -75.09 1.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.898 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.86 36.46 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.415 ' CA ' ' O ' ' A' ' 5' ' ' PRO . . . -106.55 116.62 32.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.6 p -163.61 58.14 0.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.95 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.415 ' O ' ' CA ' ' A' ' 3' ' ' ALA . 19.0 Cg_endo -93.38 -65.42 0.02 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.366 -1.097 . . . . 0.0 112.577 2.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 78.12 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.886 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -108.59 -67.6 0.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.745 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.35 142.13 33.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 145.6 41.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.06 44.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.185 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -95.82 138.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.942 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.28 60.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.665 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 61.9 156.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.608 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -56.71 99.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.131 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.98 168.09 9.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.749 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.58 169.98 11.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.72 -164.96 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.806 2.337 . . . . 0.0 112.373 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.49 135.69 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.358 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' CA ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -112.98 56.29 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -178.24 67.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.589 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.87 85.85 12.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.337 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -96.15 18.1 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.273 2.649 . . . . 0.0 112.63 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -83.11 -20.16 35.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.409 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 28' ' ' TRP . 51.2 mt -48.46 162.18 0.36 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -38.37 161.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.707 2.272 . . . . 0.0 112.72 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.72 129.57 5.5 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.478 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.91 -44.78 2.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.485 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.612 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 62.7 m95 -68.95 150.44 47.72 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.57 179.64 7.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.295 176.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' A' ' 31' ' ' LYS . 58.2 ttp180 -153.29 163.06 40.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.36 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HG3' ' CA ' ' A' ' 19' ' ' TYR . 29.9 ttpt -174.68 164.95 3.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.414 ' CD1' HG11 ' A' ' 83' ' ' VAL . 6.1 mt -131.38 161.11 33.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.919 0.39 . . . . 0.0 111.474 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.492 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -138.51 120.87 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.405 -178.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 50.5 tt0 -67.91 172.85 5.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -150.36 136.0 18.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 111.337 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' HG2' ' CB ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -138.69 117.28 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.355 179.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.96 20.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.584 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.54 59.34 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.959 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 116.47 18.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.54 39.1 28.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' CB ' ' HG2' ' A' ' 36' ' ' LYS . . . -54.53 151.06 8.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.783 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.18 21.1 50.72 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.342 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.61 134.79 33.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 110.854 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.7 164.03 11.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.554 0.692 . . . . 0.0 112.64 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -133.39 146.7 51.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.204 177.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.8 p -86.86 146.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.704 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 4.9 m-85 -142.84 95.97 2.86 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.027 0.441 . . . . 0.0 110.954 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' CD2' ' HG3' ' A' ' 30' ' ' ARG . 7.7 mt -92.89 110.44 21.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 23.0 mt -86.29 141.35 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.515 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.566 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -153.3 145.64 17.16 Favored Pre-proline 0 CA--C 1.482 -1.645 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 7.2 Cg_endo -93.9 24.04 25.61 Favored 'Cis proline' 0 N--CA 1.455 -0.737 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 -24.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -154.34 -43.72 0.09 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.543 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.11 1.85 0.11 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 119.66 -1.257 . . . . 0.0 115.661 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HG3' ' CD2' ' A' ' 65' ' ' TYR . 1.2 tmtt? -88.44 119.68 29.1 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.974 1.887 . . . . 0.0 110.741 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -101.79 148.77 24.9 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.485 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 9.2 m-85 -142.61 144.9 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.691 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.36 18.84 6.94 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 10.1 t -145.96 -86.02 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.068 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.493 ' HG2' ' CE1' ' A' ' 81' ' ' PHE . 0.5 OUTLIER 166.25 -41.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 1.7 p -56.85 -39.18 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.122 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -27.56 66.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.335 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.424 ' HG ' ' CE2' ' A' ' 66' ' ' PHE . 1.1 tp -68.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.405 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.25 -38.26 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.72 -49.95 64.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -73.04 -61.53 1.78 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.467 ' CE1' HD23 ' A' ' 74' ' ' LEU . 23.3 m-85 -42.71 -34.95 0.99 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -61.66 -69.3 0.25 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.21 -19.05 18.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.484 -176.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.492 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 33.9 m -91.99 -30.19 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.733 0.302 . . . . 0.0 111.158 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' HG21 ' A' ' 69' ' ' VAL . . . 57.48 64.21 4.59 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.8 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' O ' ' CG2' ' A' ' 72' ' ' THR . 10.5 t0 -74.39 -45.92 43.68 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.788 0.804 . . . . 0.0 111.541 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 71' ' ' ASP . 5.9 t 52.69 18.42 1.01 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.596 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.39 19.23 8.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 110.716 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' CE1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.6 -177.34 6.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -158.58 118.04 1.79 Allowed Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.916 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 89.1 Cg_exo -47.62 -32.5 16.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.198 1.932 . . . . 0.0 112.165 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.71 -20.16 63.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.141 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.51 9.26 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.612 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.03 86.7 2.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' C ' ' CD1' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -63.73 -175.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.001 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 37.2 m-85 -145.38 73.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.94 117.47 28.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.915 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.414 HG11 ' CD1' ' A' ' 32' ' ' LEU . 58.8 t -68.72 -56.64 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -85.77 52.28 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.44 156.69 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.47 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 88' ' ' SER . 39.6 tpt85 -77.37 95.66 4.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.44 -80.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.6 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ARG . 6.2 t 56.08 28.07 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.842 0.353 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.71 -94.9 2.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.46 66.8 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.879 0.371 . . . . 0.0 110.954 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.78 79.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.446 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -93.38 140.44 29.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.0 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.5 171.6 8.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.5 73.65 0.61 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.989 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 -22.26 16.65 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.232 . . . . 0.0 112.571 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -105.14 97.1 7.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.794 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.3 113.05 15.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.014 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -117.51 160.61 20.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.07 111.28 23.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.205 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.5 p -166.18 45.43 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 13' ' ' ARG . 10.9 pt -89.92 15.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.452 ' CG2' ' O ' ' A' ' 12' ' ' ILE . 5.0 mp 45.08 27.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.763 0.792 . . . . 0.0 110.515 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.438 ' HB2' HG13 ' A' ' 11' ' ' ILE . 5.3 mtm180 -142.59 132.9 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.77 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -103.11 108.15 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.33 153.55 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.078 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 17' ' ' PRO . . . 107.0 102.51 2.81 Favored Glycine 0 CA--C 1.489 -1.558 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.929 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HA ' ' HA3' ' A' ' 16' ' ' GLY . 3.4 Cg_exo -72.42 -153.84 0.78 Allowed 'Cis proline' 0 N--CA 1.474 0.358 0 CA-C-N 117.5 0.65 . . . . 0.0 112.165 -2.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.13 134.61 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.644 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -116.07 48.61 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.677 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.33 67.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.606 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -112.2 94.29 25.52 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.18 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.78 -6.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.439 2.759 . . . . 0.0 112.67 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 t -84.06 53.67 2.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.93 0.395 . . . . 0.0 111.007 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.8 mt -113.55 164.51 15.64 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.59 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -41.56 166.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.612 2.208 . . . . 0.0 112.371 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.0 121.47 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . 77.95 53.24 4.99 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.681 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 56.9 m95 -157.02 151.33 25.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 179.61 7.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.608 175.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.441 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 22.3 ttt180 -153.62 160.04 42.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.213 0.53 . . . . 0.0 112.134 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -176.01 166.24 2.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.453 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.441 ' CD1' HG12 ' A' ' 83' ' ' VAL . 10.6 mt -131.3 166.55 20.97 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.03 0.443 . . . . 0.0 111.583 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -135.11 118.08 16.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.149 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -69.37 171.43 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.354 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -153.06 148.17 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HE2' ' CA ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -131.73 124.0 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.843 0.83 . . . . 0.0 111.749 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.13 -161.25 1.14 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.615 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.7 38.27 3.36 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.241 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.665 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.51 36.29 1.66 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.552 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' CA ' ' HE2' ' A' ' 36' ' ' LYS . . . -52.79 114.17 1.32 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.42 8.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.004 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -87.57 133.93 33.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.814 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -107.6 161.03 15.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.641 0.734 . . . . 0.0 112.582 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.521 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.52 147.77 52.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.73 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.7 p -87.13 143.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.84 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 5.4 m-85 -143.16 97.06 3.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.419 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 82.1 mt -91.31 116.11 28.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 174.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.446 ' CG2' ' HA3' ' A' ' 53' ' ' GLY . 5.6 mt -91.5 137.53 21.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.536 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.9 p-10 -153.32 147.71 19.1 Favored Pre-proline 0 CA--C 1.49 -1.346 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 93.0 Cg_endo -91.67 -3.08 52.77 Favored 'Cis proline' 0 N--CA 1.448 -1.182 0 C-N-CA 125.239 -0.734 . . . . 0.0 110.863 -23.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -116.8 -35.62 4.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.999 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' HA3' ' CG2' ' A' ' 49' ' ' ILE . . . -176.64 21.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.741 -1.218 . . . . 0.0 114.881 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -96.81 115.71 27.9 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.348 1.574 . . . . 0.0 111.139 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.03 146.64 24.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.992 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 9.0 m-85 -150.66 137.37 18.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.728 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -105.95 11.59 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.151 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -154.49 170.17 22.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -80.41 -41.83 23.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.007 -176.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.6 p -50.36 -41.54 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.148 0.499 . . . . 0.0 110.606 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.08 -29.6 67.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.61 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -64.32 -63.67 1.08 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.1 mp -65.12 -38.01 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.352 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.69 -58.05 8.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.749 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.483 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -65.28 -53.71 40.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.627 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.55 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 6.1 m-30 -43.97 -26.06 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.612 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.8 mm-40 -75.33 -65.97 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.36 -15.41 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.48 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 19.7 m -88.27 -28.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.227 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.99 59.69 10.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.249 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.02 -68.33 0.68 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.871 0.844 . . . . 0.0 111.899 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p 65.17 14.28 9.29 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.692 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -115.61 22.78 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 110.592 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' CD2' ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -154.59 -174.25 4.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 13.5 t0 -158.61 113.12 1.66 Allowed Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.007 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 80.9 Cg_exo -46.02 -34.87 13.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.317 2.012 . . . . 0.0 111.954 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.539 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.6 8.1 30.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 8.6 m-85 -129.81 88.56 2.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 111.676 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 156.84 34.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.323 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 18.4 m-85 -109.89 104.04 12.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 111.598 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -148.46 100.48 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.639 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 32' ' ' LEU . 78.7 t -46.46 -38.5 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 p -117.54 57.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.99 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.54 166.19 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.75 21.51 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.52 100.34 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.622 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.93 22.39 4.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.702 0.287 . . . . 0.0 111.048 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 60.41 48.37 86.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.1 m -85.97 138.61 31.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.4 -87.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.28 154.55 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.31 31.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.464 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 3.6 m -163.15 49.62 0.24 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.068 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 4' ' ' SER . 53.4 Cg_endo -69.8 -45.73 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.621 2.214 . . . . 0.0 112.411 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -99.31 73.76 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -147.69 175.35 10.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.11 169.31 15.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 52.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.51 72.21 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 tt -137.77 144.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.2 62.52 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 58.46 177.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.913 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.88 134.76 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 100.1 11.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.55 6.14 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.497 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.404 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.8 Cg_endo -79.53 -177.39 20.6 Favored 'Cis proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.975 -0.844 . . . . 0.0 112.435 2.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.9 113.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -92.92 52.68 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.719 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -176.37 64.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.24 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -109.41 95.85 20.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.313 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -91.54 10.53 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.117 2.544 . . . . 0.0 112.519 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -85.48 52.77 2.55 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.881 0.372 . . . . 0.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -127.82 165.08 32.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.592 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.07 177.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.561 2.174 . . . . 0.0 112.606 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.32 129.37 18.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.819 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 63.42 11.03 38.88 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.804 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.577 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 73.2 m95 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 0.0 111.742 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.66 178.69 6.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.107 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' NH2' HD13 ' A' ' 32' ' ' LEU . 4.1 ttt85 -145.37 162.35 37.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 0.0 111.661 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 34.8 ttmt -175.08 158.32 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.602 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.424 HD13 ' NH2' ' A' ' 30' ' ' ARG . 8.0 mt -131.34 163.12 28.56 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.12 0.486 . . . . 0.0 111.811 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.3 ttpt -137.76 113.18 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.169 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.87 172.72 8.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 7.9 tpt180 -150.8 123.01 8.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.951 0.405 . . . . 0.0 111.523 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' CE ' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.86 104.61 9.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.482 178.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -108.21 -15.52 14.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.548 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.07 35.46 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.653 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.71 -62.9 1.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.21 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.71 36.39 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.019 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.438 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . . . -52.71 142.55 18.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.06 22.07 33.85 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.234 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.53 129.02 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.675 0.274 . . . . 0.0 110.523 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 7.2 m-85 -107.49 161.89 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -131.31 143.6 50.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.92 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 81' ' ' PHE . 6.3 p -89.4 147.19 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.062 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.1 m-85 -144.98 94.32 2.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.321 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 70.0 mt -92.95 113.23 25.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 55' ' ' ALA . 2.6 mt -89.63 122.83 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.218 -173.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 38.6 p-10 -85.71 155.66 58.88 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.569 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 27' ' ' GLY . 97.8 Cg_exo -36.73 -53.21 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.661 2.908 . . . . 0.0 113.286 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -47.56 -25.57 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.981 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.28 46.59 1.54 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.681 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.848 0.356 . . . . 0.0 111.264 -177.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.436 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -105.27 154.48 20.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.886 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 67.4 m-85 -131.07 150.18 52.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.457 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 20.18 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.64 -4.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 77.14 -50.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.982 0.356 . . . . 0.0 111.957 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.1 p -52.49 -41.18 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.695 -0.628 . . . . 0.0 109.51 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' N ' HG11 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -62.98 -30.29 71.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.085 177.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.558 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -62.77 -72.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.041 179.197 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.445 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 7.9 mt -52.81 -43.57 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' CD ' ' A' ' 68' ' ' LYS . . . -52.82 -47.03 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.196 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.446 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -71.51 -57.55 4.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.69 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.573 ' CD2' ' HD3' ' A' ' 76' ' ' PRO . 27.6 m-85 -44.42 -29.73 0.74 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.136 0.493 . . . . 0.0 110.922 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.73 -47.3 85.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.91 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.446 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.8 -33.02 74.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.84 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.4 m -93.5 -30.12 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.18 10.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.937 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.97 126.46 35.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.9 p -140.83 32.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -125.56 16.91 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' O ' ' CD1' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -154.58 72.36 0.86 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.654 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 2.5 m-20 60.31 -152.93 0.01 OUTLIER Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' HD3' ' CD2' ' A' ' 66' ' ' PHE . 83.9 Cg_endo -68.19 -152.77 0.49 Allowed 'Cis proline' 0 C--N 1.311 -1.402 0 CA-C-N 121.78 1.671 . . . . 0.0 111.568 4.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 63.69 13.26 7.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.354 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.58 7.34 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.353 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.654 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 37.9 m-85 -99.87 63.74 1.21 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.677 0.275 . . . . 0.0 110.271 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -44.58 128.1 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.639 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.488 ' CD2' HG13 ' A' ' 46' ' ' VAL . 11.8 m-30 -88.37 85.26 6.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 1.5 p -98.34 93.34 6.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.99 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.419 ' HA ' HD12 ' A' ' 32' ' ' LEU . 77.8 t -66.82 -28.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.082 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.6 p -124.79 52.18 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.17 -171.36 28.16 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.408 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 -149.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 10.2 57.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.938 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' SER . 23.8 t 58.99 17.94 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.782 0.291 . . . . 0.0 111.077 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.45 -67.38 0.16 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.725 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.9 t 59.87 99.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.354 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.33 -111.61 3.8 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.354 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.906 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.71 46.59 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.7 81.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 3.6 t -152.75 53.54 1.06 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 4' ' ' SER . 72.1 Cg_endo -76.73 -16.72 16.35 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.632 2.221 . . . . 0.0 112.684 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -85.88 54.04 2.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -124.06 -55.39 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.252 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -112.15 169.48 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.222 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.74 48.92 2.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.79 74.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.264 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 ' CD1' ' NE ' ' A' ' 15' ' ' ARG . 12.3 tt -147.85 101.82 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.199 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.4 mm -94.28 41.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.717 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 43.91 61.94 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.287 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -123.67 44.51 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' NE ' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -133.95 176.06 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 17' ' ' PRO . . . 179.33 -141.48 4.82 Favored Glycine 0 CA--C 1.488 -1.599 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.667 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 1.7 Cg_endo -77.26 -170.73 9.0 Favored 'Cis proline' 0 N--CA 1.472 0.24 0 CA-C-N 117.596 0.698 . . . . 0.0 111.841 -4.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.68 -36.2 0.44 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.117 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 81.17 -56.86 0.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.751 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -38.36 99.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.146 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -1.3 -65.42 0.0 OUTLIER Pre-proline 0 CA--C 1.477 -1.84 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -179.092 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ASP . 63.1 Cg_endo -104.6 -4.49 8.97 Favored 'Cis proline' 0 C--N 1.314 -1.265 0 O-C-N 123.334 1.176 . . . . 0.0 112.115 -2.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -161.19 21.19 0.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.424 -174.334 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -44.15 166.85 0.1 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 0.0 111.857 -177.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.9 Cg_exo -39.58 166.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.103 2.536 . . . . 0.0 113.272 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.44 119.5 2.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 76.9 -4.2 54.11 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.064 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.574 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 68.6 m95 -101.64 134.69 44.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.46 -0.435 . . . . 0.0 111.457 -178.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -147.92 142.96 27.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.244 -178.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 44.9 ttp180 -110.33 163.39 13.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.821 0.82 . . . . 0.0 112.345 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' N ' ' CG ' ' A' ' 30' ' ' ARG . 9.4 ttmt -169.31 149.38 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.466 ' CD1' ' HB3' ' A' ' 17' ' ' PRO . 1.8 mt -124.5 164.87 18.85 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.0 111.648 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -137.7 123.2 19.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.94 -178.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.3 tt0 -78.75 164.36 24.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.444 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 -179.417 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -125.59 105.73 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.384 0.611 . . . . 0.0 110.472 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 t -105.15 149.97 25.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.633 178.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.97 -27.73 1.09 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.774 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 134.12 49.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.426 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.71 54.59 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.47 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' CB ' ' CD ' ' A' ' 36' ' ' LYS . . . -52.44 170.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.265 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 58.96 42.04 96.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.739 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.5 136.4 32.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 10.5 m-85 -102.04 168.9 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -142.83 140.4 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.242 176.934 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 81' ' ' PHE . 9.9 p -88.66 152.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.371 . . . . 0.0 111.281 -178.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 23.6 m-85 -146.05 101.01 3.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.544 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 81' ' ' PHE . 21.2 mt -92.93 105.48 17.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.801 0.81 . . . . 0.0 109.006 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' THR . 2.8 mt -82.22 121.16 35.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.135 -174.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -85.62 152.86 57.87 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.759 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' GLY . 89.6 Cg_exo -35.29 -57.23 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 0.0 113.275 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -43.9 -27.52 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.234 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.04 49.9 1.04 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.891 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -140.83 133.66 28.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.989 0.424 . . . . 0.0 111.279 -178.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -89.26 146.96 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.332 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -128.28 126.36 40.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 ttp180 -92.01 -59.22 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.67 172.7 8.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -81.75 -42.84 19.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.381 -178.676 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 t -51.8 -26.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.32 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.63 -31.27 59.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.488 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.493 HD23 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -68.01 -60.87 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -61.3 -40.24 85.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.074 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.74 -62.06 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.657 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.493 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -59.05 -57.95 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.66 178.381 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 74' ' ' LEU . 10.9 m-30 -39.67 -38.8 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.114 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.7 mm-40 -61.04 -56.14 24.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.034 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.46 -16.41 63.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.873 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' A' ' 70' ' ' GLY . 0.8 OUTLIER -86.03 -50.52 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -178.729 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 153.75 -31.4 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.455 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' ' CG2' ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.67 -161.33 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.066 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 71' ' ' ASP . 3.0 t 59.47 25.42 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.915 -178.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -141.1 17.47 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.67 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -39.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 -178.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 71.97 103.59 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.593 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.3 Cg_exo -48.59 -32.48 21.31 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.439 2.093 . . . . 0.0 112.549 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.1 -10.95 60.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.603 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.55 -3.51 58.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.511 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CZ ' ' CE2' ' A' ' 28' ' ' TRP . 56.1 m-85 -109.51 64.4 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.566 -178.032 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.19 137.42 58.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.519 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CZ ' ' O ' ' A' ' 57' ' ' ARG . 8.3 m-85 -87.27 91.51 8.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.073 0.463 . . . . 0.0 111.075 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 98.77 7.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.747 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 ' CG1' ' CB ' ' A' ' 44' ' ' TYR . 93.0 t -72.0 -7.64 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.602 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.6 p -116.94 37.37 3.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.75 -178.04 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.967 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -135.7 -155.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.227 . . . . 0.0 110.404 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.16 -29.35 10.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.601 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.9 23.77 14.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.727 0.298 . . . . 0.0 110.933 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.57 75.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.57 168.19 13.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.75 160.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.906 179.971 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.84 0.353 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -83.24 88.53 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.66 92.11 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.463 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 2.3 m -163.59 -64.23 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 38.9 Cg_endo -93.2 -166.38 2.09 Favored 'Cis proline' 0 C--N 1.35 0.612 0 C-N-CA 124.544 -1.023 . . . . 0.0 112.616 -1.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 48.58 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.062 0.458 . . . . 0.0 111.005 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.63 152.0 48.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.09 -177.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 155.75 18.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -116.04 19.86 14.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.189 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 4.0 t 66.85 34.56 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 tt 47.67 103.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.611 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.9 mm -91.06 54.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.177 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 57.51 55.07 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.7 52.32 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.77 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.72 176.94 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.934 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.7 143.44 3.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.29 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.498 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 4.9 Cg_exo -72.02 -164.86 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.321 2.014 . . . . 0.0 112.135 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -168.91 106.01 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.502 178.854 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.527 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -68.66 66.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.997 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 37.4 t70 179.05 74.75 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -177.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.6 m-20 -115.7 80.48 8.43 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.632 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -88.43 22.37 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.852 2.368 . . . . 0.0 112.713 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.2 p -94.8 46.43 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -125.1 176.66 2.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.479 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 81.5 Cg_exo -49.35 -179.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.729 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.52 126.83 28.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.817 -179.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.61 55.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.276 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 70.8 m95 -106.38 128.14 53.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.238 0.542 . . . . 0.0 111.787 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.95 -179.89 5.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.152 179.36 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 29.9 ttp180 -142.09 163.08 33.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.785 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 13.4 ttmt -165.17 170.84 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.492 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -138.38 162.94 33.13 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.085 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -148.0 117.17 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.829 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.531 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 48.3 tt0 -75.87 107.67 8.21 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.954 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -178.02 -177.35 0.61 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.111 174.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.97 33.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 m 59.88 -162.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.25 -22.22 72.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.61 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 115.9 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 111.061 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.18 35.42 18.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.47 140.65 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.0 110.908 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.45 67.6 0.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.555 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -151.55 137.51 18.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 -179.129 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -77.93 122.85 26.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -175.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -103.01 149.47 24.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.319 176.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 41.7 t -93.86 151.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.1 m-85 -146.05 99.88 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.606 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 7.1 mt -92.88 106.8 18.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 109.624 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.1 mt -82.23 122.5 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.688 -174.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 31.2 p-10 -85.71 153.4 58.07 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.594 -178.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -37.61 -27.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.082 3.188 . . . . 0.0 113.699 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ASN . 2.6 mt-30 -80.61 12.38 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 70.98 15.94 74.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.972 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -99.05 137.51 37.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.494 0.188 . . . . 0.0 111.389 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.28 130.76 41.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.345 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 26.4 m-85 -115.8 117.83 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' CD ' ' CE2' ' A' ' 47' ' ' TYR . 8.1 mtm180 -105.03 10.06 34.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.453 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.45 164.84 38.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.836 0.351 . . . . 0.0 111.189 -178.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -76.66 -35.91 57.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 0.0 111.122 -178.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 8.2 p -54.0 -46.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.63 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 4.7 mt-10 -61.3 -30.59 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.88 -64.73 0.83 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.427 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -64.91 -42.42 94.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.72 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -57.04 11.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.417 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.478 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -66.69 -50.74 61.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.544 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.548 ' CE2' ' CD1' ' A' ' 62' ' ' LEU . 14.7 m-30 -48.81 -38.32 21.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.798 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 33.1 mt-10 -61.06 -66.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HE2' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -54.17 -26.98 30.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -177.348 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.444 HG11 ' CD ' ' A' ' 68' ' ' LYS . 28.4 m -86.45 -29.32 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.786 178.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.31 55.3 28.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.881 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -83.46 153.22 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -131.2 3.61 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.43 27.38 8.81 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.889 0.376 . . . . 0.0 110.807 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.486 HD11 ' CE2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -154.43 173.19 16.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.872 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -158.63 111.86 1.65 Allowed Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.219 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 84.5 Cg_exo -45.17 -41.22 16.56 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.116 1.877 . . . . 0.0 112.241 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -69.97 -9.05 53.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -88.64 -6.49 57.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.13 178.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.463 ' CE2' HD12 ' A' ' 62' ' ' LEU . 45.9 m-85 -109.39 127.39 54.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.638 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' CB ' ' HD2' ' A' ' 86' ' ' ARG . 3.2 t0 -107.24 134.16 50.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.127 177.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.446 ' CE2' ' C ' ' A' ' 58' ' ' SER . 4.1 m-85 -97.45 90.2 4.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 p -141.43 142.56 33.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.431 ' CG1' HD23 ' A' ' 32' ' ' LEU . 87.0 t -95.5 -64.12 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -49.9 -25.38 3.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.68 -179.46 16.25 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.445 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' A' ' 80' ' ' ASP . 3.2 mtp180 -111.65 -162.19 0.79 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.564 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.23 -65.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.549 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.5 26.73 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.11 -40.84 2.96 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 m 58.39 90.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.352 . . . . 0.0 110.814 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.17 -120.3 22.18 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.899 179.879 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.78 0.324 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 p 59.22 -173.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.767 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.97 55.13 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.0 58.54 1.11 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.65 -4.76 15.92 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.678 2.252 . . . . 0.0 112.933 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.51 81.74 3.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.78 134.05 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 39.71 -164.33 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.532 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.3 52.48 8.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.4 t -169.53 82.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.6 tt 49.79 111.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.473 0.654 . . . . 0.0 111.971 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.5 mm -77.81 61.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.68 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 71.31 157.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.964 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -55.66 143.24 31.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.055 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.88 162.24 13.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.9 99.74 1.02 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.635 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 Cg_endo -87.68 -167.68 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.255 2.637 . . . . 0.0 112.449 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.99 103.73 0.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.287 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -69.5 64.64 0.18 Allowed 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.683 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -178.5 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.49 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.8 t70 -114.67 82.64 8.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.19 0.24 8.21 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.116 2.544 . . . . 0.0 112.935 -179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.4 p -80.64 -23.17 39.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.771 0.319 . . . . 0.0 111.09 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 13.3 mt -46.38 161.29 0.28 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 49.1 Cg_exo -35.71 159.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.107 2.538 . . . . 0.0 113.404 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.79 120.82 2.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.183 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.78 -14.02 27.39 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.499 178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 67.4 m95 -90.69 137.05 32.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.64 177.94 7.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.946 179.311 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 19.3 ttp180 -141.02 160.91 39.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.518 . . . . 0.0 111.421 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -161.19 166.93 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.946 -179.36 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 0.5 OUTLIER -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.875 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.42 117.33 8.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.96 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 58.2 tt0 -71.14 166.18 22.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.722 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.494 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 91.34 174.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.8 177.788 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' HB3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 178.54 70.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.106 -177.89 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.415 ' CB ' ' HE2' ' A' ' 36' ' ' LYS . 20.0 m 53.49 -161.43 0.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.53 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.03 8.02 80.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.501 -0.856 . . . . 0.0 113.251 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 40' ' ' SER . 8.3 ptp180 -101.37 -46.37 5.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.153 0.476 . . . . 0.0 110.529 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -119.91 38.95 3.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.074 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.72 81.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.182 -177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 141.44 53.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.831 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -137.33 147.94 45.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.686 -179.685 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.419 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -94.12 135.0 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.307 0.575 . . . . 0.0 112.385 -177.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -109.59 156.09 20.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.608 176.757 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.439 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 18.3 t -98.28 149.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.509 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.484 ' CD2' ' CG ' ' A' ' 57' ' ' ARG . 14.9 m-85 -146.01 99.5 3.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.453 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 20.0 mt -90.85 107.91 19.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.2 mt -82.35 127.86 39.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.415 -171.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.479 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.3 t-20 -81.39 137.27 48.63 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.997 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 76.9 Cg_exo -33.27 -53.54 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.852 3.035 . . . . 0.0 113.322 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.23 -26.95 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.332 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.05 17.07 5.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.354 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.507 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 7.6 tttp -97.28 168.35 10.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.679 0.276 . . . . 0.0 111.119 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -134.95 130.42 35.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 29.2 m-85 -126.37 121.23 31.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.484 ' CG ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.13 -52.58 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.443 . . . . 0.0 110.139 177.695 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.4 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -88.03 177.09 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.918 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -83.77 -41.49 17.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.338 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 21.6 t -51.81 -27.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.61 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -75.81 -31.69 59.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.303 178.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -62.84 -66.58 0.52 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.976 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.2 mp -57.66 -38.4 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -58.51 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.98 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.468 ' CG ' ' HD3' ' A' ' 54' ' ' LYS . 1.5 t80 -66.37 -52.61 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.271 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.536 ' CZ ' ' CD1' ' A' ' 62' ' ' LEU . 12.6 m-30 -44.79 -41.65 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 21.9 mt-10 -61.16 -63.9 1.13 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.886 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.67 -23.52 28.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.67 -177.522 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.453 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 12.4 m -92.54 -39.88 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.422 ' N ' HG21 ' A' ' 69' ' ' VAL . . . 99.13 33.95 5.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.586 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 0.6 OUTLIER -89.95 135.86 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.945 179.756 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -144.99 26.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.161 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -125.84 7.84 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.967 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -106.23 -31.87 8.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.845 0.355 . . . . 0.0 110.577 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.53 95.75 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 82.1 Cg_exo -44.39 -30.61 3.88 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.494 2.129 . . . . 0.0 112.227 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.12 -7.97 45.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.54 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.39 -18.52 38.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.608 0.242 . . . . 0.0 111.144 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.467 ' CE2' HD12 ' A' ' 62' ' ' LEU . 22.7 m-85 -97.77 125.13 42.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 111.341 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.71 144.41 41.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-85 -101.95 102.47 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.395 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.7 110.81 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 46' ' ' VAL . 64.4 t -65.57 -71.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.1 p -49.58 -28.46 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.83 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.37 -169.47 13.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.29 -155.49 0.63 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.38 38.93 0.67 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.91 26.4 2.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.704 0.287 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.7 -4.98 57.85 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.101 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.0 p 57.14 107.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.957 0.379 . . . . 0.0 110.621 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.23 150.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.255 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.085 -179.597 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t 60.89 144.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.41 155.83 24.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.16 77.28 0.42 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.987 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.01 -62.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -91.61 45.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -120.35 -61.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.29 177.33 4.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.232 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.89 134.26 55.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -167.01 76.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.16 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 HG21 ' O ' ' A' ' 11' ' ' ILE . 2.4 tt 48.0 103.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.426 0.631 . . . . 0.0 111.547 179.094 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.13 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.059 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 55.94 45.68 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.07 61.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.68 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.91 165.64 10.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.222 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.32 -126.79 1.6 Allowed Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.62 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.49 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo -71.67 -166.75 4.11 Favored 'Cis proline' 0 N--CA 1.473 0.303 0 CA-C-N 117.699 0.749 . . . . 0.0 111.918 -2.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.467 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.28 -26.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.252 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 84.17 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.433 0.293 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.54 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' O ' ' NH1' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -114.63 112.42 45.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.197 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -109.11 37.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.943 3.095 . . . . 0.0 112.728 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.5 p -98.3 -53.72 3.27 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.7 mt -51.65 -177.53 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 121.489 -0.085 . . . . 0.0 111.051 -176.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 40.0 Cg_exo -41.29 157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.987 2.458 . . . . 0.0 114.6 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.23 149.98 3.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.94 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -59.29 1.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.867 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 75.8 m95 -47.8 150.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.349 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -149.09 178.11 9.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.879 178.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.482 ' NH2' ' HB2' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -144.22 165.7 27.12 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.406 177.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm -176.37 154.59 1.34 Allowed 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.597 -176.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 10.0 mt -116.47 173.79 6.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.546 0.689 . . . . 0.0 112.828 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.83 116.94 6.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.45 176.77 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 43.8 tt0 -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.086 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -152.94 127.75 9.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 -178.338 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HD2' ' CB ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.79 -67.79 0.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.287 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' CE ' ' A' ' 36' ' ' LYS . 1.7 t 56.77 -177.6 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.713 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.75 39.43 2.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.16 133.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.724 0.297 . . . . 0.0 110.803 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.0 50.48 10.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' CB ' ' HD2' ' A' ' 36' ' ' LYS . . . -63.48 150.48 43.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 84.94 26.07 38.88 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.608 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.64 136.88 32.76 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.046 0.451 . . . . 0.0 110.66 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -99.99 159.19 15.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -132.51 153.83 50.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.641 177.247 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.441 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 52.5 t -101.15 148.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.517 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 8.3 m-85 -144.61 103.26 3.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.718 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.441 ' CD2' ' CG ' ' A' ' 30' ' ' ARG . 71.3 mt -92.93 108.05 19.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.6 mt -88.23 130.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.661 -174.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 7.4 p-10 -82.73 154.31 68.05 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.663 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -32.51 -60.45 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.896 3.064 . . . . 0.0 113.827 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.24 -25.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 25.28 5.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.687 -179.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 47.2 tptt -99.1 124.75 44.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.19 140.26 31.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -177.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.564 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.4 m-85 -133.26 135.35 44.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.155 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -102.58 -53.54 2.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.097 178.144 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -87.0 174.19 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.486 178.337 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' HE3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.41 -42.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.337 . . . . 0.0 111.756 -178.364 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 50.9 t -51.83 -25.17 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.02 -26.27 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.203 178.25 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.503 HD22 ' CD2' ' A' ' 79' ' ' PHE . 1.1 mp -76.1 -65.55 0.9 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.907 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.42 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -55.81 -38.42 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.82 -66.98 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.341 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.89 -45.63 89.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.189 -179.166 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.477 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 20.4 m-30 -53.41 -34.54 58.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 111.57 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.24 -70.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.674 -176.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.06 -21.04 28.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 110.357 178.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 65' ' ' TYR . 36.6 t -86.46 -25.08 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.927 -177.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 48.49 56.08 9.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.342 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.46 134.52 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.511 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.6 16.22 15.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.284 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 25.13 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.839 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -154.65 175.23 13.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.482 179.452 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.64 123.59 2.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.073 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' HA ' HD21 ' A' ' 62' ' ' LEU . 39.3 Cg_exo -56.07 -33.39 89.71 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.068 1.845 . . . . 0.0 112.27 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.435 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -70.61 -15.6 62.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.59 -16.42 32.57 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 0.0 111.584 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.503 ' CD2' HD22 ' A' ' 62' ' ' LEU . 54.9 m-85 -98.46 126.97 44.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.5 152.74 43.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.058 -179.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.8 m-85 -107.46 84.64 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.422 ' OG1' ' CG ' ' A' ' 86' ' ' ARG . 6.9 p -125.05 95.37 4.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.449 HG12 ' CD1' ' A' ' 32' ' ' LEU . 2.6 t -49.45 -48.13 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 p -89.74 51.76 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.293 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.18 -170.61 0.03 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.081 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.422 ' CG ' ' OG1' ' A' ' 82' ' ' THR . 10.0 mtp-105 -136.66 -154.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.78 84.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.283 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.43 -13.46 58.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.552 0.215 . . . . 0.0 111.522 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.77 -94.6 0.64 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.677 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 m -157.34 103.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.971 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.13 -136.65 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.6 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.953 -179.932 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t 60.01 62.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.095 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -110.53 102.44 11.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.485 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -161.69 -66.05 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.154 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 10.3 Cg_endo -52.08 -70.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -113.16 41.09 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.211 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -145.26 175.92 9.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -173.61 4.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -141.73 177.16 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.9 m 59.65 77.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.315 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.2 tt 48.27 106.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.298 0.57 . . . . 0.0 111.97 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.3 mm -79.91 59.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.431 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mtp85 72.08 170.12 0.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.141 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -49.37 115.72 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.075 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.85 137.51 33.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.21 141.58 3.25 Favored Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo -83.19 -176.03 15.54 Favored 'Cis proline' 0 N--CA 1.472 0.207 0 C-N-CA 125.487 -0.63 . . . . 0.0 112.401 2.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.16 102.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.756 179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -70.98 63.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.583 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 179.38 82.15 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -176.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 1.7 m-20 -118.42 80.6 16.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.263 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -89.9 23.5 0.69 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.176 2.584 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 p -92.02 -20.5 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.437 -179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.491 ' CD1' ' CG ' ' A' ' 30' ' ' ARG . 12.4 mt -56.69 165.23 1.75 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.868 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 79.8 Cg_exo -48.59 178.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.698 2.265 . . . . 0.0 113.183 -178.235 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.86 125.32 11.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.287 -178.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.09 0.32 55.98 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.639 178.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.495 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 63.7 m95 -101.81 135.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.166 0.508 . . . . 0.0 111.989 -178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -145.82 179.15 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.809 179.468 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.491 ' CG ' ' CD1' ' A' ' 24' ' ' LEU . 3.1 mtp180 -142.91 165.44 27.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.079 0.466 . . . . 0.0 111.726 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 12.7 tttm -166.09 161.53 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.98 -178.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.44 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -131.3 166.5 21.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.216 0.531 . . . . 0.0 112.12 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -147.24 115.85 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.082 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.9 168.31 8.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -153.1 147.03 25.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.026 0.441 . . . . 0.0 110.896 -178.381 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' CD ' ' CB ' ' A' ' 41' ' ' ALA . 17.7 tptm -144.01 123.63 13.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.071 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.68 43.81 1.09 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.76 36.84 13.77 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.423 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.6 109.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.685 0.278 . . . . 0.0 110.428 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.64 28.3 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.0 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' CB ' ' CD ' ' A' ' 36' ' ' LYS . . . -52.6 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.454 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 58.73 22.34 53.16 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.255 -178.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 35' ' ' ARG . 8.0 tttt -87.63 141.69 28.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.291 0.567 . . . . 0.0 110.953 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.408 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 3.6 m-85 -108.54 149.61 28.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.219 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.93 148.13 40.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.33 176.542 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 40.4 t -90.46 148.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.837 -178.243 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 22.4 m-85 -146.16 95.64 2.65 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.25 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 1.7 mt -92.95 109.15 20.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.394 0.616 . . . . 0.0 109.754 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 55' ' ' ALA . 6.2 mt -82.64 121.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.482 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 46.8 p-10 -85.66 154.87 59.15 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.201 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -33.62 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.918 3.079 . . . . 0.0 113.347 -179.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.86 -26.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.414 -178.997 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 44.77 1.72 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.967 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CD ' ' CE2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.83 138.15 33.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.955 -178.469 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.442 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -103.64 145.28 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CE2' ' CD ' ' A' ' 54' ' ' LYS . 2.0 m-85 -127.83 144.94 51.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.316 177.299 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -48.45 3.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.88 174.68 8.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.2 tmtp? -85.69 -39.19 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.289 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 55.8 t -52.11 -38.39 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.949 0.405 . . . . 0.0 110.309 178.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 3.4 mm-40 -67.18 -30.08 69.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.469 178.471 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.84 -62.21 1.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 109.637 178.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.4 mp -67.83 -42.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.356 178.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.63 -58.98 5.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.756 -178.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' O ' ' CD ' ' A' ' 68' ' ' LYS . 4.1 t80 -62.62 -55.37 27.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 110.581 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 62' ' ' LEU . 5.0 m-30 -41.2 -38.47 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.897 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -63.25 -60.55 3.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.571 -178.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HD3' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.22 -18.37 15.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.23 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.454 ' N ' ' HD3' ' A' ' 68' ' ' LYS . 49.8 t -86.42 -33.68 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 107.38 -35.3 5.1 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -176.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' CB ' ' HB3' ' A' ' 66' ' ' PHE . 0.0 OUTLIER 32.5 107.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 175.884 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -148.72 31.06 0.8 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.677 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 76.7 p -179.43 49.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.321 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.52 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.5 -36.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.992 -179.135 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 51.58 109.79 0.02 OUTLIER Pre-proline 0 N--CA 1.462 0.171 0 C-N-CA 122.593 0.357 . . . . 0.0 111.786 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 50.0 Cg_exo -50.95 -32.43 38.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.144 1.896 . . . . 0.0 112.044 178.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.84 -16.08 63.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.777 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -10.47 59.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.051 177.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' HB3' ' CD1' ' A' ' 48' ' ' LEU . 41.9 m-85 -106.92 152.26 24.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.447 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.53 148.95 40.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.603 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.7 m-30 -109.28 85.99 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.4 p -120.87 -12.44 8.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 78.3 t 63.49 -78.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 110.617 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' THR . 25.6 p -54.74 -35.44 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.3 -154.99 21.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.668 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -125.25 -154.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.76 -63.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.55 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.2 26.44 15.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.741 0.305 . . . . 0.0 110.935 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.6 107.39 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -156.27 119.71 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.2 -66.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.436 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.956 179.921 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 57.75 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.982 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.66 107.16 11.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 5' ' ' PRO . 13.0 t -163.67 62.81 1.14 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 4' ' ' SER . 43.2 Cg_endo -93.78 -80.38 0.0 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.559 0 C-N-CA 124.313 -1.12 . . . . 0.0 112.753 2.408 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 39.24 77.62 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 121.097 0.475 . . . . 0.0 111.65 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.7 148.61 30.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.871 -177.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -76.5 -172.75 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -139.26 121.29 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.38 71.06 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 tt -137.55 130.28 42.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -92.11 70.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 61.49 172.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.741 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.65 118.74 12.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.52 137.73 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.91 149.53 10.95 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.806 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 57.6 Cg_endo -71.66 -164.49 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.855 2.37 . . . . 0.0 112.415 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.6 mtm -151.8 105.85 3.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -70.81 -75.24 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.117 -178.247 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -61.31 83.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.715 0.293 . . . . 0.0 110.533 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -115.11 84.64 11.28 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.762 -178.509 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -93.83 30.77 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.193 2.596 . . . . 0.0 112.591 179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.7 p -81.28 -31.58 33.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 111.007 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 87.8 mt -50.79 165.12 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.0 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.4 Cg_exo -47.2 178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.591 2.194 . . . . 0.0 112.967 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 128.11 19.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.386 -178.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.34 54.84 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.75 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.517 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 60.6 m95 -101.0 133.82 44.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.188 0.494 . . . . 0.0 112.019 -178.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.75 179.19 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 14.9 mtm180 -143.38 170.04 16.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.727 178.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm 178.57 162.37 0.7 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.189 -178.344 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' CD1' ' HB2' ' A' ' 17' ' ' PRO . 14.2 mt -128.13 173.36 10.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.27 0.557 . . . . 0.0 112.168 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -147.8 113.18 5.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.26 176.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 52.8 tt0 -66.36 167.06 11.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.804 179.059 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' HA ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 90.02 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.09 0.956 . . . . 0.0 112.475 178.078 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' CE ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -174.58 36.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.992 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.4 m 62.19 -165.98 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 111.677 178.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.3 82.1 0.68 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.658 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.66 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.8 m -99.25 38.41 1.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.21 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.97 80.86 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.314 -177.065 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 142.48 53.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.908 177.549 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' CB ' ' CE ' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -142.34 153.86 44.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 110.583 179.703 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -86.72 151.22 23.58 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -174.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-20 -119.53 173.27 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.071 177.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.475 ' CG2' ' CG2' ' A' ' 83' ' ' VAL . 54.0 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.4 -178.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.2 m-85 -146.36 103.27 3.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.074 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.409 ' CD2' ' HG2' ' A' ' 30' ' ' ARG . 62.3 mt -92.99 107.81 19.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.433 ' CG2' ' O ' ' A' ' 54' ' ' LYS . 4.3 mt -82.33 121.77 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.549 -173.18 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.517 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 18.8 p-10 -85.73 144.59 39.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.535 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -35.39 -44.71 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.614 2.876 . . . . 0.0 112.857 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 3.5 mt-30 -49.12 -23.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.234 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.61 20.32 11.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.753 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -100.75 -179.99 4.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 111.679 -178.638 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.87 131.87 21.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.708 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 64.7 m-85 -123.28 133.25 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 0.0 111.729 -178.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.0 mtm180 -105.98 1.04 26.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.672 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.35 164.22 38.95 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -178.176 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.44 ' HE2' ' CB ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -69.53 -47.21 64.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -176.221 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.2 t -51.9 -35.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.777 -179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -28.06 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.119 178.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' CD2' ' CG ' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -67.41 -69.16 0.33 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.549 179.359 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' CD1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 mp -55.45 -36.1 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.77 -64.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.923 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.486 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -62.34 -59.57 4.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.008 0.432 . . . . 0.0 110.681 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.552 ' CE2' ' CD1' ' A' ' 74' ' ' LEU . 20.7 m-30 -35.29 -39.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.767 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 11.6 mt-10 -61.19 -66.69 0.5 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.877 0.37 . . . . 0.0 111.928 -177.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.19 -19.96 23.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.58 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -86.53 -37.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.297 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.67 -32.28 3.22 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.801 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' CB ' ' HB3' ' A' ' 66' ' ' PHE . 0.0 OUTLIER 39.44 -159.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.832 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.444 ' CG2' ' O ' ' A' ' 71' ' ' ASP . 0.6 OUTLIER 75.91 26.92 0.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.093 0.557 . . . . 0.0 110.51 -177.014 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -150.16 27.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.426 177.557 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.552 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -147.95 -41.96 0.17 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.889 -178.23 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 70.14 86.24 0.12 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.433 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.44 ' CB ' ' HE2' ' A' ' 59' ' ' LYS . 81.3 Cg_exo -49.96 -24.92 11.38 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -69.6 -18.6 63.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.545 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -88.52 12.49 14.34 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.833 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.539 ' CG ' ' CD2' ' A' ' 62' ' ' LEU . 3.8 m-85 -108.11 79.45 1.27 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.727 0.298 . . . . 0.0 111.004 -179.097 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 82' ' ' THR . 0.4 OUTLIER -84.57 8.0 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.751 179.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.476 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 10.3 m-85 49.33 -88.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.289 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' ASP . 2.1 p 58.28 161.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.406 . . . . 0.0 111.298 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.475 ' CG2' ' CG2' ' A' ' 46' ' ' VAL . 16.9 t -132.53 -51.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.221 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.7 p -93.17 39.46 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.953 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.12 -110.01 3.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 110.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 110.949 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.73 32.33 69.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 90' ' ' SER . 5.2 t -92.76 24.3 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.51 -68.55 0.1 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.727 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.3 OUTLIER 58.62 173.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 -179.793 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.43 -166.36 7.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.427 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.914 179.788 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -147.65 143.32 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.64 42.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 73.94 8.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.87 0.52 8.74 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.713 2.275 . . . . 0.0 113.006 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -109.87 107.39 17.32 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.893 0.378 . . . . 0.0 110.829 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -135.25 87.28 2.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -116.59 169.23 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.036 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -113.93 152.5 30.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.851 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 t -81.68 56.19 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 tt -89.86 132.52 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.7 mm -91.67 50.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 50.0 45.77 24.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.022 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -130.5 61.51 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -173.29 2.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.54 148.07 15.24 Favored Glycine 0 CA--C 1.483 -1.938 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.254 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 62.2 Cg_endo -77.26 171.2 68.94 Favored 'Cis proline' 0 N--CA 1.475 0.426 0 C-N-CA 125.133 -0.778 . . . . 0.0 113.097 4.53 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -136.18 -36.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.142 -179.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.5 ' CD1' HD13 ' A' ' 32' ' ' LEU . 8.5 m-85 63.44 28.24 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -175.75 82.55 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -176.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.448 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -113.31 87.94 12.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.143 178.344 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HA ' ' CG2' ' A' ' 29' ' ' THR . 96.3 Cg_endo -88.11 9.03 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.012 2.475 . . . . 0.0 112.649 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 p -86.83 51.85 2.35 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD13 ' CG ' ' A' ' 30' ' ' ARG . 29.4 mt -128.97 164.08 41.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.155 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.51 170.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.384 2.056 . . . . 0.0 112.556 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 126.24 8.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.466 -178.479 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.57 0.56 58.92 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.731 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.505 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 66.0 m95 -101.41 137.28 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 112.087 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.434 ' CG2' ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -147.89 -172.15 3.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.789 179.902 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 47' ' ' TYR . 1.7 mtm180 -151.33 176.27 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 111.43 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -175.53 173.52 2.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.354 -178.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.5 HD13 ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -142.97 167.14 22.77 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.325 0.583 . . . . 0.0 112.409 179.879 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -148.04 101.32 3.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.979 177.792 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.6 tt0 -68.55 166.8 16.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.936 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -153.04 148.31 26.9 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.755 0.312 . . . . 0.0 110.169 179.259 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' HE2' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -105.14 65.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.498 0.666 . . . . 0.0 111.208 179.42 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -84.9 107.88 17.27 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.204 177.207 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -33.47 -34.17 0.02 OUTLIER Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.754 -176.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -96.48 110.9 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.694 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m 63.04 36.47 12.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 109.686 -176.622 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' CA ' ' O ' ' A' ' 37' ' ' SER . . . -52.59 166.34 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.448 -178.59 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' N ' ' HE2' ' A' ' 36' ' ' LYS . . . 68.16 33.56 78.75 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.716 -179.014 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 140.49 29.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.534 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.492 ' CE2' ' OH ' ' A' ' 19' ' ' TYR . 9.1 m-85 -105.42 137.04 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -105.98 137.94 43.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.641 174.712 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p -93.91 154.46 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.038 0.447 . . . . 0.0 111.468 -177.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.2 m-85 -146.04 99.22 3.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 8.1 mt -91.78 111.43 22.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.442 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -82.39 120.89 34.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.211 -171.75 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.505 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 6.5 p-10 -86.18 144.76 39.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.216 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -34.7 -51.72 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.64 2.893 . . . . 0.0 113.429 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -44.62 -27.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.389 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.24 25.07 5.97 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.602 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.5 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 2.0 tttt -99.17 172.47 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 111.31 -178.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 96.56 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.366 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.5 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 22.9 m-85 -90.29 129.15 36.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 111.647 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -104.85 4.27 31.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.335 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 99.7 p -154.41 170.77 20.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 -177.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -73.23 -37.98 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -178.517 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 3.9 p -51.84 -46.48 40.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.683 -179.191 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -62.11 -31.99 72.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.221 178.594 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.544 ' CD1' ' CZ ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.51 -68.6 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 178.959 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' O ' ' HG3' ' A' ' 67' ' ' GLU . 5.3 mp -56.98 -40.42 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.696 178.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.26 -64.87 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.102 -178.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.14 93.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 62' ' ' LEU . 9.8 m-30 -59.8 -32.22 70.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 23.3 mt-10 -60.9 -70.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 111.522 -177.289 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -21.79 33.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.559 178.393 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.41 -25.9 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -177.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 59.84 45.19 96.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.698 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 136.39 33.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.738 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.8 p -138.75 23.38 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 p -124.0 24.13 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.529 ' CD1' ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -133.51 -41.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 -179.35 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.96 102.54 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.957 179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.6 Cg_exo -46.59 -34.69 15.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.422 2.081 . . . . 0.0 112.424 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.03 -7.55 41.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.24 -14.92 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.657 0.265 . . . . 0.0 110.946 178.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.49 ' CE2' HD12 ' A' ' 62' ' ' LEU . 47.7 m-85 -99.05 99.11 10.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.244 -179.235 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' OD2' ' NE ' ' A' ' 86' ' ' ARG . 26.0 t0 -84.78 132.31 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.689 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.16 74.24 6.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.476 -178.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 124.7 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.664 179.086 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.0 t -73.59 -67.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.285 -179.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -49.82 -28.77 6.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.58 167.86 38.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.346 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' NE ' ' OD2' ' A' ' 80' ' ' ASP . 4.8 mtp180 -109.28 -154.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 110.624 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.54 -30.63 6.79 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.598 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m 65.78 22.23 11.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.65 0.262 . . . . 0.0 111.178 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 40.57 0.83 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.7 m 55.14 96.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -139.41 46.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.532 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 58.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.903 -179.906 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 t -100.77 165.69 11.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.99 149.51 43.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.448 ' N ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -163.61 -63.54 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.11 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HA ' ' N ' ' A' ' 4' ' ' SER . 48.0 Cg_endo -90.75 -18.98 13.91 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.518 -1.034 . . . . 0.0 112.506 -2.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.92 65.87 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.52 -65.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.31 171.85 11.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.037 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.69 120.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.62 179.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 73.38 60.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -101.64 142.39 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.045 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.7 mm -84.64 56.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.029 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 63.21 157.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.17 124.36 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.97 149.83 35.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.95 149.79 14.44 Favored Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.598 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -80.03 -174.4 14.4 Favored 'Cis proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.85 -0.896 . . . . 0.0 112.432 3.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.8 118.29 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.575 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -97.38 47.44 1.03 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.67 -178.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 179.4 71.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.431 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.49 93.98 21.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.341 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.9 23.66 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.319 2.679 . . . . 0.0 112.293 179.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 p -92.31 42.83 1.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.281 -178.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CD1' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -130.31 178.55 1.67 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.377 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 85.1 Cg_exo -46.9 174.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.489 2.126 . . . . 0.0 112.737 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.86 44.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.16 -178.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.42 -0.12 60.97 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.393 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 55.0 m95 -102.57 133.43 47.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.942 -178.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -140.44 -176.53 4.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.416 179.789 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' CG ' ' CD1' ' A' ' 24' ' ' LEU . 2.5 mtp180 -143.25 156.98 44.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.596 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 3.8 ttpt -166.49 161.05 15.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.996 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' HG11 ' A' ' 83' ' ' VAL . 5.4 mt -130.28 166.8 19.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.252 0.549 . . . . 0.0 112.217 -178.224 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.6 tttt -139.31 115.49 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.861 -179.383 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -65.89 167.87 8.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.332 178.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 20.7 ttm180 -153.18 163.92 39.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' N ' ' CG ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -137.0 99.53 4.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.399 178.672 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -21.45 13.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.18 -83.37 0.33 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -178.383 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -45.04 67.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 110.042 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.24 41.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.939 177.805 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' CA ' ' HD3' ' A' ' 36' ' ' LYS . . . -52.52 115.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 103.26 34.43 3.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.311 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.68 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.026 -179.405 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -104.75 153.96 20.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -120.31 144.21 47.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.215 176.245 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.458 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 4.6 p -85.92 148.61 4.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.13 -178.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 46' ' ' VAL . 9.7 m-85 -145.35 97.95 3.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 7.6 mt -92.57 109.64 21.05 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.076 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.479 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 8.0 mt -82.23 126.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -171.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.5 p-10 -85.58 150.28 53.46 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.329 -178.598 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -38.57 -55.45 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.171 2.58 . . . . 0.0 112.802 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -46.77 -26.79 1.02 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.31 28.91 3.14 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.602 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -92.33 -178.84 5.05 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.368 0.604 . . . . 0.0 112.094 -179.406 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.2 88.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.076 177.112 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.535 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 83.2 m-85 -92.02 122.05 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.457 -177.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.496 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -92.84 -48.73 6.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.051 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 171.78 9.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.323 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.426 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 7.8 tptp -88.68 -47.19 8.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 -179.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 t -51.88 -26.85 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 110.147 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.59 -32.07 63.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.661 177.257 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.485 HD23 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -64.43 -62.66 1.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.84 179.371 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 5.2 mp -61.56 -40.87 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -68.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.122 -179.133 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.489 ' CE2' ' HE3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -59.79 -40.55 88.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.102 -179.632 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.474 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 9.6 m-30 -56.47 -30.9 63.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.345 . . . . 0.0 110.641 178.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.9 mm-40 -70.42 -60.28 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.915 -177.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.36 -26.05 62.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.597 -178.124 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.1 m -86.58 -39.92 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.317 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.4 38.99 4.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.323 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -89.1 117.53 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.3 p -134.95 33.93 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 179.643 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 p -132.53 33.6 3.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.531 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.403 HD12 ' CD2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -137.64 -39.04 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.494 -179.092 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 66.75 93.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 110.57 -179.08 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 97.9 Cg_exo -44.97 -29.0 3.42 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.95 -7.94 44.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.386 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.25 -11.49 46.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.478 0.18 . . . . 0.0 111.291 178.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CD2' HD23 ' A' ' 62' ' ' LEU . 74.2 m-85 -103.4 102.36 12.29 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.485 -179.11 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -94.0 160.35 14.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.294 178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.496 ' CZ ' ' O ' ' A' ' 57' ' ' ARG . 22.0 m-30 -115.44 85.0 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.38 96.38 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.688 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.442 HG11 ' CD1' ' A' ' 32' ' ' LEU . 86.5 t -66.12 -32.43 58.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 p -107.87 47.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.334 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.77 -164.87 11.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.98 179.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 179.14 154.41 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.373 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 -43.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.583 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m 59.37 24.83 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.18 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.45 -120.73 1.94 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.495 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t -155.34 91.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.33 28.53 69.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.498 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.815 179.702 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 5.0 Cg_exo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 120.779 0.241 . . . . 0.0 112.119 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.406 ' HG2' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -171.71 105.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.81 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 3.2 m-30 -67.35 -19.04 65.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.92 73.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.299 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -97.71 111.38 58.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -106.04 13.99 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.001 3.134 . . . . 0.0 112.617 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.639 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 p -90.65 50.06 1.76 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 30' ' ' ARG . 72.0 mt -154.17 160.33 31.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -22.79 145.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.653 3.569 . . . . 0.0 114.543 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.51 148.43 0.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.203 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.98 -58.36 2.24 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.785 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.522 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 78.7 m95 -47.42 133.44 12.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 112.087 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.52 167.72 20.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.864 ' HD2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -138.76 159.62 41.67 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.628 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.7 ttmm -157.32 167.59 29.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.994 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.011 HD22 HG12 ' A' ' 83' ' ' VAL . 6.7 mt -137.03 175.88 9.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.478 0.656 . . . . 0.0 112.258 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.0 tttm -147.81 106.59 3.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.157 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.766 -179.213 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.981 ' HB3' HG11 ' A' ' 83' ' ' VAL . 24.3 m-85 -100.09 164.49 11.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 5.7 m-20 -120.47 166.98 12.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.31 -1.768 . . . . 0.0 108.428 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 81' ' ' PHE . 54.2 t -128.07 147.94 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.201 0.524 . . . . 0.0 111.766 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 33.5 m-85 -149.05 102.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.139 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 6.1 mt -93.04 106.08 18.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 109.601 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.8 mt -82.3 123.62 38.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.956 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.426 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 t-20 -80.81 137.96 50.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.801 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 73.5 Cg_exo -34.02 -54.84 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.521 2.814 . . . . 0.0 113.456 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -50.99 -31.61 18.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 111.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.48 48.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.89 122.58 15.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -177.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.69 152.29 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.177 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 1.2 m-85 -129.78 167.97 17.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.64 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.16 3.49 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.87 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.49 171.63 19.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.43 -43.25 41.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.168 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 9.1 p -53.22 -44.39 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 109.873 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.1 tt0 -60.87 -27.83 68.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.3 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -69.6 -64.6 0.85 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.9 mp -65.9 -39.43 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.255 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.71 -58.0 8.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.0 t80 -68.86 -49.21 60.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 110.843 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 5.1 m-85 -46.82 -26.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.3 mm-40 -72.82 -57.06 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -16.1 63.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 65' ' ' TYR . 13.5 m -86.48 -40.18 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.174 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.62 43.73 2.86 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.514 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.954 ' OD2' HD11 ' A' ' 74' ' ' LEU . 11.4 p-10 -74.3 141.97 45.23 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 122.535 0.334 . . . . 0.0 111.562 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 t -149.86 23.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.372 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.88 52.37 0.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.954 HD11 ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -154.53 -44.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 63.66 100.81 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.435 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 86.4 Cg_exo -47.75 -31.55 15.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.469 2.112 . . . . 0.0 112.582 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.08 -8.49 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.505 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 1.04 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 62' ' ' LEU . 66.7 m-85 -109.37 130.89 55.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.857 0.361 . . . . 0.0 111.257 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -124.17 147.64 47.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.736 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.494 ' HD1' HG11 ' A' ' 46' ' ' VAL . 22.7 m-85 -105.96 77.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.33 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.1 p -140.71 111.64 7.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.011 HG12 HD22 ' A' ' 32' ' ' LEU . 3.4 m -64.69 -41.27 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.642 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.656 HG23 HG23 ' A' ' 83' ' ' VAL . 16.3 p . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.522 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.473 0.29 0 CA-C-O 120.768 0.237 . . . . 0.0 112.029 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtm -145.65 94.46 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.7 m-30 -67.18 -70.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.443 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 33.5 t0 -64.08 79.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' TYR . 3.2 m-20 -114.92 88.53 17.14 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 77.8 Cg_endo -97.22 14.38 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.393 2.728 . . . . 0.0 112.442 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -87.97 49.6 1.83 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.826 0.346 . . . . 0.0 111.426 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -129.65 176.23 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 94.2 Cg_exo -45.43 169.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.421 2.081 . . . . 0.0 112.824 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.16 124.09 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.141 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.77 -4.68 43.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.749 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 45.0 m95 -94.68 118.16 31.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.229 0.538 . . . . 0.0 112.069 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -118.01 -173.95 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 29' ' ' THR . 1.8 ttt180 -155.35 163.7 39.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HD23 ' A' ' 32' ' ' LEU . 7.5 tttt -172.78 158.61 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.359 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.972 HD13 ' HB ' ' A' ' 83' ' ' VAL . 6.2 mt -129.89 174.42 9.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 111.51 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -146.94 110.94 5.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.074 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.792 -179.891 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.872 0.368 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 26.2 m-85 -106.63 163.73 12.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.872 0.844 . . . . 0.0 113.11 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.93 132.74 45.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.664 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.7 p -91.53 148.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.661 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 3.4 m-85 -143.7 103.38 4.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.403 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 79' ' ' PHE . 19.7 mt -92.96 110.78 22.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -85.19 124.65 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.463 0.649 . . . . 0.0 112.064 -173.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.496 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 24.6 p-10 -85.67 151.07 54.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.754 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -37.17 -53.68 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.565 2.843 . . . . 0.0 113.259 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -45.72 -26.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.253 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.73 47.22 1.2 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.764 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.955 0.407 . . . . 0.0 111.286 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -91.35 150.26 21.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.94 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.55 119.49 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.82 5.47 43.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.569 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.2 p -154.44 159.98 41.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.167 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.664 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.6 -39.5 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.167 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 61' ' ' GLU . 4.2 p -51.83 -48.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.787 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.6 mm-40 -61.88 -29.91 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.07 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -63.37 -60.42 3.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -67.81 -42.84 86.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.683 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.94 41.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -67.35 -50.77 58.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.333 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.703 ' CE2' HD13 ' A' ' 74' ' ' LEU . 23.0 m-30 -53.67 -26.76 23.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -69.12 -60.65 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.329 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.11 -27.71 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -177.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 68' ' ' LYS . 21.2 m -86.61 -44.47 16.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.93 44.06 3.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.967 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.27 143.55 29.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.262 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -145.95 22.87 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -124.45 33.42 5.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.39 -43.48 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.3 OUTLIER 62.8 107.9 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 88.0 Cg_exo -48.13 -31.89 17.56 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.324 2.016 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -69.97 -7.45 40.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.614 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.38 -4.02 59.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.293 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 62' ' ' LEU . 82.8 m-85 -107.62 123.41 48.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.735 0.303 . . . . 0.0 111.172 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.99 137.13 51.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-85 -95.71 79.16 3.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.042 0.449 . . . . 0.0 111.352 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -138.42 94.83 2.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.936 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.972 ' HB ' HD13 ' A' ' 32' ' ' LEU . 23.6 m -48.29 -48.51 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.761 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.517 ' N ' HG23 ' A' ' 83' ' ' VAL . 20.6 p . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.491 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 95.5 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 CA-C-O 120.578 0.157 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.436 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -157.92 -40.58 0.07 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.549 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 17' ' ' PRO . 1.9 m-85 75.14 -65.89 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.555 0.217 . . . . 0.0 111.068 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.57 89.3 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.469 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 34.4 m-20 -131.8 65.66 76.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 29' ' ' THR . 8.9 Cg_endo -82.27 9.28 4.06 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.82 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 t -85.52 55.71 3.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.029 0.443 . . . . 0.0 110.681 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.4 mt -126.39 167.08 18.22 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.028 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 76.1 Cg_exo -40.79 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.751 2.3 . . . . 0.0 112.631 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.01 121.85 3.49 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.136 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 -2.2 49.59 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.798 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 48.9 m95 -96.85 140.96 30.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.237 0.519 . . . . 0.0 112.158 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -140.38 176.07 9.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.529 ' HG3' HD23 ' A' ' 48' ' ' LEU . 17.0 ttm105 -147.36 154.01 40.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.19 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.892 ' C ' HD23 ' A' ' 32' ' ' LEU . 12.1 ttmt -168.7 164.4 12.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.228 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.079 HD13 HG13 ' A' ' 83' ' ' VAL . 3.7 mt -128.66 161.27 30.07 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.157 0.503 . . . . 0.0 111.836 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.99 125.86 32.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.922 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.135 -179.581 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.877 0.37 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 20.5 m-85 -105.52 162.81 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -134.26 144.94 48.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.353 176.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.713 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -88.06 146.89 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.896 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.519 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.5 m-85 -142.82 98.65 3.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.0 111.291 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.701 HD13 ' HD1' ' A' ' 79' ' ' PHE . 14.4 mt -92.97 113.21 25.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.461 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 37.3 mt -92.16 127.94 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 34.7 p-10 -85.58 150.05 52.93 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.901 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -32.91 -58.74 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.928 3.085 . . . . 0.0 113.383 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -44.62 -27.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.21 51.18 0.89 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.813 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -139.75 130.68 26.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.931 0.395 . . . . 0.0 110.743 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -92.37 158.43 16.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.875 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -136.96 120.15 16.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.22 10.05 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -154.51 163.35 40.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.984 -177.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 3.8 tptp -79.75 -49.27 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.881 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 12.2 t -51.96 -33.6 16.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.216 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -70.36 -29.96 66.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.03 177.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD21 ' CB ' ' A' ' 79' ' ' PHE . 1.1 tp -63.06 -59.55 4.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.0 mp -70.33 -46.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.401 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -50.14 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.5 t80 -68.97 -57.78 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 110.477 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.6 m-30 -42.54 -33.38 0.68 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.36 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.5 mm-40 -76.18 -56.47 4.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.407 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.81 -21.82 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.667 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.809 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.7 m -92.37 -25.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.012 0.434 . . . . 0.0 109.933 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 71' ' ' ASP . . . 94.83 -30.81 7.51 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.821 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.855 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 49.2 157.91 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.9 p -90.11 -22.77 21.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.32 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.62 ' O ' HD12 ' A' ' 74' ' ' LEU . 10.9 p 165.06 -76.74 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.455 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER 49.57 -166.16 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.631 -177.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -162.93 92.38 1.2 Allowed Pre-proline 0 C--N 1.31 -1.137 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 81.8 Cg_exo -47.39 -33.26 16.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.319 2.013 . . . . 0.0 111.732 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.01 -19.41 63.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.54 0.22 56.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.648 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.701 ' HD1' HD13 ' A' ' 48' ' ' LEU . 96.9 m-85 -105.18 100.61 10.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 111.459 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.17 129.22 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.384 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.3 m-85 -88.32 87.45 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 111.202 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 104.12 7.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.079 HG13 HD13 ' A' ' 32' ' ' LEU . 95.2 t -73.09 -67.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.644 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 88.4 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 N-CA-C 112.362 0.101 . . . . 0.0 112.362 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -165.81 134.48 3.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.633 ' CD1' HD12 ' A' ' 32' ' ' LEU . 1.6 m-30 -94.52 48.34 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.0 110.184 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 32.3 t70 -175.44 79.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.84 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -112.73 85.26 7.36 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.596 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HA ' HG23 ' A' ' 29' ' ' THR . 79.9 Cg_endo -89.0 25.96 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.98 2.453 . . . . 0.0 112.78 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -93.9 23.66 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -99.79 -178.26 0.67 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.7 Cg_exo -49.17 179.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.236 1.958 . . . . 0.0 112.18 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -55.5 120.78 7.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.157 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.8 50.68 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.818 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 51.8 m95 -93.75 131.34 39.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 111.689 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -132.32 179.92 5.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.645 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.487 ' H ' HG22 ' A' ' 29' ' ' THR . 7.1 ttp-105 -139.88 165.53 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.225 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -169.83 168.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.1 167.48 21.72 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.335 0.588 . . . . 0.0 112.399 -178.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 10.7 tttp -147.81 110.73 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.232 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 54.4 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.076 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.8 m-85 -88.6 144.13 26.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 61.0 m-20 -110.62 172.16 7.03 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 113.892 -1.503 . . . . 0.0 109.519 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 70.6 t -131.64 145.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.7 m-85 -146.03 105.61 3.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.073 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 79' ' ' PHE . 15.3 mt -90.29 107.35 19.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.0 mt -82.86 123.26 38.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.112 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 6.3 t-20 -76.05 144.67 75.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.704 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 70.5 Cg_exo -37.01 -28.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.13 2.553 . . . . 0.0 113.113 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' ASN . 4.3 mm-40 -90.4 30.45 1.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 55.74 26.25 46.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.447 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -98.74 124.5 43.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.914 0.388 . . . . 0.0 110.427 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 138.15 34.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.8 m-85 -124.43 126.14 45.44 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 18.6 mtp180 -96.41 -58.36 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.497 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.35 171.9 9.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.92 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.602 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -80.58 -41.72 23.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.176 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 10.9 t -51.79 -31.58 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 -29.29 63.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 110.025 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 ' HD3' ' A' ' 59' ' ' LYS . 1.4 tp -66.52 -60.72 2.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -65.59 -45.92 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.17 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.86 -49.01 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 2.5 t80 -70.15 -57.65 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.115 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CE2' HD13 ' A' ' 74' ' ' LEU . 20.8 m-30 -46.83 -28.93 1.72 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -72.74 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.103 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.17 -23.93 50.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.495 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.7 m -91.56 -44.18 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.975 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 87.52 51.29 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.101 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.574 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.5 t70 -84.9 137.92 32.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 111.103 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 p -124.02 22.63 8.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.144 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -128.42 29.76 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.601 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.54 174.77 14.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -158.63 114.13 1.67 Allowed Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.358 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 62' ' ' LEU . 93.0 Cg_exo -46.41 -32.71 11.45 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.456 2.104 . . . . 0.0 112.0 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.04 -19.78 63.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.57 -1.94 58.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.584 ' HB3' HD13 ' A' ' 48' ' ' LEU . 94.9 m-85 -107.21 110.6 22.69 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.832 0.348 . . . . 0.0 111.085 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.38 131.75 53.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 20.3 m-30 -87.5 80.67 8.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.09 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.79 118.86 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.356 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 32' ' ' LEU . 52.2 t -65.65 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.235 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.3 . . . . 0.0 111.021 -178.943 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 7.8 Cg_exo . . . . . 0 N--CA 1.474 0.363 0 CA-C-O 120.871 0.28 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mtm -148.28 102.54 3.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -79.85 -67.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.776 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.2 83.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.579 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 6.2 m-20 -118.75 85.39 27.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.389 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' HG23 ' A' ' 29' ' ' THR . 61.8 Cg_endo -95.66 14.03 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.239 2.626 . . . . 0.0 112.503 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HD23 ' A' ' 24' ' ' LEU . 5.0 p -86.16 51.2 2.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.33 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 23' ' ' THR . 1.1 mt -132.3 179.07 1.47 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.073 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 95.6 Cg_exo -45.14 166.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.362 2.041 . . . . 0.0 112.546 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 126.0 5.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.847 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.4 -52.66 4.37 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.506 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 m95 -44.86 142.29 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 112.323 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -144.85 -169.98 3.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.731 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 29' ' ' THR . 43.8 ttp180 -156.9 161.96 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.861 ' C ' HD23 ' A' ' 32' ' ' LEU . 5.4 ttmt -168.97 160.11 9.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.249 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.045 HD13 HG13 ' A' ' 83' ' ' VAL . 1.6 mt -131.31 163.51 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.169 0.509 . . . . 0.0 111.368 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.24 116.89 12.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.18 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.499 179.276 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.862 0.363 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.788 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.8 m-85 -103.68 163.21 12.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.679 0.752 . . . . 0.0 112.977 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.97 140.16 48.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.743 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.0 p -91.98 148.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.3 m-85 -146.19 103.42 3.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.685 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.903 HD13 ' HB3' ' A' ' 79' ' ' PHE . 7.0 mt -92.62 114.44 26.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -87.35 127.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.804 0.811 . . . . 0.0 113.149 -171.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 54' ' ' LYS . 13.0 t-20 -82.44 135.01 47.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.506 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 85.6 Cg_exo -32.86 -51.7 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.666 2.91 . . . . 0.0 113.631 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -46.94 -26.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.374 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.12 18.14 6.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.332 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.6 tttt -96.67 147.91 23.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.552 0.215 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' LYS . . . -114.97 108.8 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.991 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.5 m-85 -92.72 124.2 36.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -93.14 -9.45 39.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.416 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.58 176.71 11.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.984 0.421 . . . . 0.0 111.558 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HD2' HD11 ' A' ' 63' ' ' ILE . 2.2 mmtp -79.15 -42.72 25.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.166 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 20.2 t -51.85 -35.48 18.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.676 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' OE1' ' CA ' ' A' ' 61' ' ' GLU . 2.3 mm-40 -72.79 -27.08 61.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.092 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -68.17 -65.45 0.69 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -56.4 -41.17 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.92 -66.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.484 ' CD2' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.76 -50.2 74.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.423 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.4 m-30 -51.79 -29.69 20.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.391 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.2 mm-40 -67.0 -64.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.053 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.26 -24.68 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.6 -177.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.42 -33.28 5.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 42.69 9.96 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.715 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB3' HD21 ' A' ' 74' ' ' LEU . 1.1 t0 -82.96 121.65 27.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.716 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -127.37 34.25 4.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.16 25.7 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -133.65 -39.51 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 6.8 m-20 60.45 101.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.513 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 85.6 Cg_exo -47.52 -31.29 13.46 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.35 2.033 . . . . 0.0 112.404 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.01 -7.79 43.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -19.46 35.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.614 0.245 . . . . 0.0 110.858 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.5 m-85 -96.63 116.47 29.17 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.655 ' O ' HD11 ' A' ' 48' ' ' LEU . 7.4 t0 -103.8 151.46 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.555 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.578 ' CE1' HD12 ' A' ' 48' ' ' LEU . 16.9 m-85 -109.18 88.84 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 111.378 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 142.43 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.65 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.045 HG13 HD13 ' A' ' 32' ' ' LEU . 94.7 t -114.07 -34.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.817 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.905 ' CB ' HD12 ' A' ' 32' ' ' LEU . 96.7 Cg_endo . . . . . 0 C--O 1.232 0.194 0 N-CA-C 111.822 -0.107 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.416 ' CE ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -136.74 -14.84 1.61 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 52.94 46.03 27.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.281 0.562 . . . . 0.0 110.0 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.488 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.8 t0 -137.7 77.68 1.65 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.806 ' CG ' HG23 ' A' ' 29' ' ' THR . 2.5 m-20 56.09 -96.46 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.777 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.7 Cg_endo -92.11 -5.0 46.16 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 CA-C-N 123.14 2.157 . . . . 0.0 113.739 -8.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 22' ' ' PRO . 1.7 t -156.43 15.68 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' THR . 5.7 mt -53.27 160.39 1.74 Allowed Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.085 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.5 Cg_exo -44.77 172.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.371 2.048 . . . . 0.0 111.993 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 123.24 6.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.696 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.54 -44.22 3.31 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.862 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.536 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 64.9 m95 -54.05 142.55 24.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.145 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -143.22 167.77 21.34 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.489 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 2.0 ptm85 -122.09 153.27 38.9 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.103 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.963 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.3 tttt -151.17 152.06 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.356 1.66 . . . . 0.0 109.612 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 31' ' ' LYS . 9.7 mt -131.39 157.33 43.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.7 115.94 18.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.326 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.989 178.617 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 120.934 0.397 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.691 ' HB2' HG11 ' A' ' 83' ' ' VAL . 7.1 m-85 -106.69 164.57 11.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -133.54 147.37 51.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.362 176.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.63 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.8 p -89.04 146.69 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.018 0.437 . . . . 0.0 112.025 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m-85 -146.09 101.05 3.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.363 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -91.03 108.22 19.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 3.6 mt -82.23 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.061 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.4 t-20 -83.69 135.99 42.58 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.747 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 77.3 Cg_exo -34.47 -54.68 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.531 2.821 . . . . 0.0 113.261 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -50.35 -32.61 17.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.526 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HD2' ' CD2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -138.84 129.14 25.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.76 150.88 22.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.938 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 49.4 m-85 -133.85 131.67 39.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.955 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -105.84 -9.38 17.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.764 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.26 172.16 18.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 111.384 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.08 -39.74 75.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.728 -177.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 3.2 t -55.29 -44.32 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.04 -27.5 69.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.696 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -65.41 -65.17 0.71 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.001 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 ' HD2' ' A' ' 59' ' ' LYS . 4.4 mp -62.94 -42.38 96.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.48 -47.76 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 3.0 t80 -72.72 -59.23 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.415 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.014 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.5 m-30 -44.03 -32.61 1.21 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.24 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.6 mm-40 -65.68 -60.96 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.934 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.87 -21.13 41.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.125 -178.253 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.934 HG13 ' HD3' ' A' ' 68' ' ' LYS . 20.2 m -95.35 -48.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.16 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 106.92 34.54 2.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.9 t0 -89.39 142.2 27.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.988 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -148.41 25.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.03 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.73 31.81 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.014 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -130.31 -32.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.559 -178.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.02 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.469 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 44.6 Cg_exo -52.06 -35.86 63.32 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.185 1.923 . . . . 0.0 112.279 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.03 -12.09 61.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.537 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.67 10.58 15.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.508 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' HD12 ' A' ' 48' ' ' LEU . 67.8 m-85 -113.18 92.93 4.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.26 134.88 35.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 33.5 m-85 -96.76 99.44 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.07 92.17 2.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 44' ' ' TYR . 60.7 t -54.7 -21.14 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.436 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 -179.655 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.684 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.6 Cg_endo . . . . . 0 N--CA 1.475 0.386 0 N-CA-C 112.509 0.157 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.464 ' HE2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -145.2 101.75 3.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.737 0.304 . . . . 0.0 111.274 -178.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -91.98 64.25 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.5 t70 175.65 72.19 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.625 ' CB ' ' HA ' ' A' ' 22' ' ' PRO 0.254 0.0 OUTLIER 55.69 -94.12 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.475 0 CA-C-O 115.598 -2.144 . . . . 0.0 106.97 -171.659 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HG2' HG22 ' A' ' 23' ' ' THR . 7.7 Cg_endo -96.69 -2.62 32.5 Favored 'Cis proline' 0 N--CA 1.479 0.668 0 CA-C-N 122.772 2.026 . . . . 0.0 113.403 -10.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.658 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -148.55 66.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 111.114 -178.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 30' ' ' ARG . 12.5 mt -116.24 165.36 15.09 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.54 170.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.492 2.128 . . . . 0.0 112.269 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.03 123.22 9.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.819 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.92 -1.71 58.0 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.501 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 53.5 m95 -99.45 138.52 36.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.545 HG22 ' CA ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -138.43 166.91 23.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.631 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.568 ' HB2' HD11 ' A' ' 24' ' ' LEU . 24.3 ttm180 -135.49 154.48 51.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.937 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -159.5 157.51 30.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.977 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.937 HD23 ' O ' ' A' ' 31' ' ' LYS . 5.0 mt -131.34 155.56 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.041 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -125.57 117.16 22.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.691 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 -179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.7 m-85 -106.77 163.77 12.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.49 0.662 . . . . 0.0 112.773 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -134.22 144.01 48.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 175.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.658 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -86.31 149.76 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.318 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.1 102.54 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -92.98 112.72 24.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.7 mt -88.49 122.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.354 -176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 11.7 p-10 -84.66 159.83 57.36 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.41 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 88.2 Cg_exo -40.03 -27.75 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.26 2.64 . . . . 0.0 113.163 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.62 32.84 1.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.997 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.17 28.21 12.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.166 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -99.07 121.4 40.93 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.059 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.06 149.25 21.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.546 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 68.7 m-85 -147.82 129.69 15.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.662 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -103.57 -52.12 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.64 177.91 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.669 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.53 ' HE2' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.82 -42.89 10.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.641 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -51.89 -29.55 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.897 0.38 . . . . 0.0 110.697 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.88 -29.69 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -68.61 -68.32 0.4 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.481 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.616 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -54.99 -40.49 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -54.99 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.263 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -67.45 -58.92 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 74' ' ' LEU . 16.4 m-30 -44.65 -28.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.783 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.0 mm-40 -61.13 -69.8 0.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.68 -16.99 18.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.991 0.424 . . . . 0.0 110.676 177.124 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 65' ' ' TYR . 87.1 t -84.39 -69.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.663 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.32 56.17 0.33 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.758 ' OD2' HD11 ' A' ' 74' ' ' LEU . 4.7 p-10 -74.23 134.9 42.7 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 111.852 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -149.97 26.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.037 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -164.64 45.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -154.53 -35.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.01 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 50.27 102.33 0.03 OUTLIER Pre-proline 0 C--O 1.231 0.117 0 CA-C-O 120.519 0.2 . . . . 0.0 111.35 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 74.9 Cg_exo -43.61 -32.94 4.21 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.386 2.057 . . . . 0.0 112.432 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.34 -20.41 64.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.26 -7.68 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.539 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 62' ' ' LEU . 72.2 m-85 -102.65 97.86 7.99 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.406 ' OD1' HG23 ' A' ' 82' ' ' THR . 1.1 t70 -91.7 134.04 35.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.658 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-30 -96.08 70.83 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.011 0.434 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 p -101.92 -9.53 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.359 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.807 HG13 HD13 ' A' ' 32' ' ' LEU . 54.6 t 67.59 -58.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 82' ' ' THR . 73.1 p . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.652 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.0 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 N-CA-C 111.594 -0.195 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.458 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -129.05 -18.73 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 66.97 -74.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 -1.29 76.15 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR 0.251 0.0 OUTLIER 46.35 -93.3 0.0 OUTLIER Pre-proline 0 CA--C 1.494 -1.179 0 CA-C-O 116.677 -1.63 . . . . 0.0 109.666 -179.49 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.821 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.3 Cg_endo -100.84 -2.26 18.28 Favored 'Cis proline' 0 N--CA 1.477 0.532 0 CA-C-N 122.688 1.996 . . . . 0.0 113.452 -5.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.821 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -159.37 82.72 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.125 -176.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -126.28 156.33 72.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -179.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.857 2.371 . . . . 0.0 112.551 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -56.79 120.86 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.44 -5.73 49.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.291 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.513 ' HB3' HD12 ' A' ' 24' ' ' LEU . 59.9 m95 -96.71 143.41 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.992 0.396 . . . . 0.0 111.15 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -149.58 172.36 15.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.733 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' CD ' HD21 ' A' ' 24' ' ' LEU . 2.3 mtp180 -132.07 142.17 49.44 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.965 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.4 ttmt -151.71 160.56 43.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.516 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.974 HD13 HG13 ' A' ' 83' ' ' VAL . 10.2 mt -131.88 153.25 50.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.26 0.552 . . . . 0.0 111.901 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -120.33 118.34 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.514 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 50.1 tt0 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.542 0.687 . . . . 0.0 111.3 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.61 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.1 m-85 -97.7 153.07 18.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -129.97 147.04 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.461 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' HD22 ' A' ' 32' ' ' LEU . 8.2 p -87.47 145.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.767 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 13.2 m-85 -146.1 102.14 3.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.086 0.469 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 79' ' ' PHE . 10.3 mt -92.93 110.38 21.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 29' ' ' THR . 4.3 mt -85.25 125.11 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.047 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.508 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.9 p-10 -85.81 153.55 57.9 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.868 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 87.2 Cg_exo -39.78 -51.97 2.8 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 113.169 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -48.16 -24.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.88 49.05 1.19 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.996 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.94 135.47 31.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.862 0.363 . . . . 0.0 111.568 -178.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.767 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -90.07 149.52 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 96.3 m-85 -130.46 133.86 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.117 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mtp180 -99.32 -60.58 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 24.9 p -88.49 177.11 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.933 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -85.98 -41.33 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 24.9 t -51.98 -28.43 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.659 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 1.6 mm-40 -74.88 -32.4 61.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.282 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -65.35 -61.38 2.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.446 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.593 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.77 -38.06 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.497 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.94 -66.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CD1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -57.9 -48.22 80.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 74' ' ' LEU . 22.0 m-30 -53.02 -30.36 35.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.799 0.333 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.4 mm-40 -69.31 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.968 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.2 -25.57 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.702 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 70' ' ' GLY . 11.9 m -86.79 -44.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.813 0.34 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.94 43.77 3.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.482 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.9 134.89 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 p -139.83 27.83 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 t -128.07 30.66 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -140.0 -41.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.616 ' H ' HD12 ' A' ' 74' ' ' LEU . 3.4 m-20 64.18 109.04 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.5 Cg_exo -50.59 -31.42 31.67 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.321 2.014 . . . . 0.0 112.176 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.16 -8.62 51.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.505 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.18 -13.47 41.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.224 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.588 ' CD2' HD21 ' A' ' 62' ' ' LEU . 86.0 m-85 -99.0 114.28 26.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.804 0.335 . . . . 0.0 111.133 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.29 145.51 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.01 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.502 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.4 m-85 -102.73 96.14 6.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.17 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.04 88.43 2.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.906 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.974 HG13 HD13 ' A' ' 32' ' ' LEU . 62.5 t -52.29 -32.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 111.063 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.633 -178.323 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 41.9 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 120.902 0.293 . . . . 0.0 112.2 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 102.79 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.32 -73.91 0.13 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -177.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.0 m-20 -62.04 83.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.544 0.211 . . . . 0.0 110.665 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB2' ' A' ' 30' ' ' ARG . 2.4 t0 -113.07 88.77 12.69 Favored Pre-proline 0 C--N 1.332 -0.159 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.426 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 29' ' ' THR . 63.2 Cg_endo -93.3 18.75 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.194 2.596 . . . . 0.0 112.641 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.5 p -92.82 21.74 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.507 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.0 mt -98.63 164.04 17.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.895 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -40.86 167.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.19 2.593 . . . . 0.0 112.597 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.24 126.33 7.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.2 -1.27 56.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.665 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 64.2 m95 -100.85 143.89 30.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.349 0.574 . . . . 0.0 112.152 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -147.72 -178.93 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.008 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.594 ' CD ' HD22 ' A' ' 48' ' ' LEU . 5.3 mtm180 -144.14 170.79 15.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 0.0 111.326 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.704 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.0 ttmt -177.91 159.25 1.35 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.421 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 31' ' ' LYS . 4.5 mt -128.24 173.74 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.826 0.822 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.34 106.39 3.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.688 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.831 -178.629 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 tttt . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.912 0.387 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.701 ' CB ' HG11 ' A' ' 83' ' ' VAL . 30.3 m-85 -106.11 160.51 15.26 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -127.1 142.14 51.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.676 174.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 81' ' ' PHE . 44.9 t -91.39 148.05 4.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.79 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.9 m-85 -146.05 91.18 2.04 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.85 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -93.04 109.82 21.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.323 0.582 . . . . 0.0 109.464 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG12 ' HB2' ' A' ' 55' ' ' ALA . 10.8 mt -84.77 122.78 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.104 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.4 p-10 -85.61 163.22 45.16 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.361 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 66.0 Cg_exo -37.79 -29.48 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.248 2.632 . . . . 0.0 113.288 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -91.69 34.54 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.649 0.262 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 47.79 25.45 3.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.102 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 51.7 tptt -99.1 121.94 41.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -95.23 147.82 23.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.08 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.3 m-85 -134.04 149.7 51.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.822 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.7 -39.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.196 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 8.4 t -85.63 -77.43 0.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.968 -176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER 161.18 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 28.3 t -55.2 -29.09 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.16 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.7 -33.58 74.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.991 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -65.15 -68.38 0.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.48 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -54.26 -45.14 67.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.86 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.75 -54.11 38.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.6 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -66.27 -53.02 41.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.431 -179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.673 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -53.18 -23.02 7.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.9 mm-40 -71.19 -61.85 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.864 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.703 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -54.68 -26.23 32.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.636 -177.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.703 HG13 ' CD ' ' A' ' 68' ' ' LYS . 9.6 m -91.1 -45.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.901 0.382 . . . . 0.0 111.062 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 95.56 37.27 5.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.294 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.761 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -90.0 146.41 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.033 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -148.99 18.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.75 23.52 11.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.037 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -154.48 67.54 0.71 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER 60.85 -174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.149 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.743 ' HG3' HD12 ' A' ' 62' ' ' LEU . 84.6 Cg_exo -75.83 -158.08 1.56 Allowed 'Cis proline' 0 C--N 1.308 -1.598 0 N-CA-C 115.385 1.264 . . . . 0.0 115.385 17.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 20.49 9.25 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.866 -177.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 2.2 m-20 -146.2 -12.17 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 62' ' ' LEU . 50.3 m-85 -86.76 83.07 7.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.028 0.376 . . . . 0.0 110.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.21 98.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.575 ' HA ' HG11 ' A' ' 46' ' ' VAL . 4.3 m-30 -85.47 52.92 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -115.2 131.51 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.438 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.701 HG11 ' CB ' ' A' ' 44' ' ' TYR . 23.1 m -64.56 -49.23 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.745 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.496 ' N ' HG23 ' A' ' 83' ' ' VAL . 16.8 p . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.131 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 12.3 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 CA-C-O 120.607 0.17 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.501 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -169.19 109.07 0.45 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.453 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -78.43 80.22 4.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 39.1 t70 -154.57 64.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.038 -170.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.797 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 64.88 -103.39 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -0.993 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.607 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 Cg_endo -84.04 130.91 16.13 Favored 'Cis proline' 0 N--CA 1.479 0.64 0 CA-C-N 123.617 2.327 . . . . 0.0 113.803 -6.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.524 ' N ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 41.37 84.05 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.131 173.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.955 HD11 ' HG3' ' A' ' 30' ' ' ARG . 8.0 mt -124.53 166.65 18.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 87.0 Cg_exo -47.45 165.59 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 125.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.234 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.66 -2.7 53.02 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.964 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.5 m95 -100.17 139.94 35.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.366 0.583 . . . . 0.0 112.067 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.877 ' CA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.41 171.64 16.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.19 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.955 ' HG3' HD11 ' A' ' 24' ' ' LEU . 14.7 mtm180 -132.62 144.44 50.36 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.573 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -135.16 177.04 8.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.977 -177.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' LYS . 15.0 mt -148.74 155.71 41.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.254 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.75 118.78 8.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.274 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.4 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.164 0.507 . . . . 0.0 110.718 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 6.5 m-85 -88.71 133.16 34.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -104.92 156.28 18.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.566 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 83' ' ' VAL . 44.7 t -95.11 147.42 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.3 m-85 -147.2 102.37 3.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.797 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.9 mt -92.79 106.77 18.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.6 mt -82.18 122.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.106 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 16.6 p-10 -85.95 146.27 42.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.307 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -36.0 -48.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.451 2.767 . . . . 0.0 113.087 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -46.09 -26.86 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.16 6.58 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.109 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.1 tttt -98.99 170.83 8.44 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.49 0.186 . . . . 0.0 110.995 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.82 96.79 3.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.0 m-85 -95.13 122.78 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.775 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -91.6 -46.09 8.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 50.7 p -87.24 165.73 15.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.965 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.22 -36.34 34.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG12 ' OG ' ' A' ' 58' ' ' SER . 4.1 p -52.04 -42.34 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.16 0.505 . . . . 0.0 110.52 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 2.4 mm-40 -61.12 -32.04 71.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.639 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -67.5 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.6 mp -58.13 -37.24 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.415 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.81 -70.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.655 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.89 -38.29 81.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.8 m-30 -58.6 -28.79 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.8 mm-40 -72.47 -60.18 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.779 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.29 -25.81 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.265 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.5 m -88.61 -45.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.089 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.43 42.19 4.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.551 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.618 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.3 t0 -84.06 133.25 34.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.779 0.323 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.2 p -140.02 25.84 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -126.09 24.66 6.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.862 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -135.23 -40.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER 64.29 107.65 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.104 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.2 Cg_exo -49.49 -32.53 27.37 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.464 2.11 . . . . 0.0 112.474 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.77 -13.98 62.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.02 -9.47 58.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.232 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 78.6 m-85 -100.64 97.25 7.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.55 140.09 29.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.964 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-30 -94.13 110.61 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -145.67 131.26 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 46' ' ' VAL . 77.8 t -96.25 -37.17 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.113 -179.294 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 74.4 Cg_endo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.959 0.316 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 97.83 2.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.201 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.1 m-30 -67.9 -71.33 0.21 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.311 -178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -55.64 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -129.73 85.42 58.28 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.361 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -92.61 14.86 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.16 2.573 . . . . 0.0 112.224 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.435 ' C ' HD23 ' A' ' 24' ' ' LEU . 51.9 p -87.81 49.24 1.77 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -126.13 -178.42 0.72 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.983 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 71.7 Cg_exo -48.4 168.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.009 1.806 . . . . 0.0 111.917 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.41 123.99 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 110.757 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 51' ' ' PRO . . . 92.08 -64.64 2.33 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.632 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 76.1 m95 -32.47 136.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.57 175.85 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.354 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 27.4 ttm180 -147.36 156.06 42.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.958 0.409 . . . . 0.0 111.28 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.898 ' O ' HD23 ' A' ' 32' ' ' LEU . 26.3 tttm -166.0 161.32 17.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.022 HD13 HG13 ' A' ' 83' ' ' VAL . 6.0 mt -129.59 163.25 26.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.897 0.38 . . . . 0.0 111.355 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.9 tttt -143.7 118.99 10.19 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.991 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.515 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.9 tt0 . . . . . 0 CA--C 1.518 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 112.311 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 C--O 1.224 -0.248 0 CA-C-O 121.364 0.602 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 9.3 m-85 -83.56 134.94 34.8 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -117.66 148.67 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.383 177.07 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 81' ' ' PHE . 5.6 p -90.33 149.29 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.007 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 12.1 m-85 -146.07 95.85 2.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.934 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.63 HD23 ' HG3' ' A' ' 30' ' ' ARG . 11.9 mt -91.61 113.15 25.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.8 mt -90.58 117.46 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.028 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.632 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 6.6 p-10 -96.82 123.52 53.42 Favored Pre-proline 0 CA--C 1.491 -1.321 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.527 ' CB ' ' HA3' ' A' ' 27' ' ' GLY . 4.7 Cg_exo -71.04 -31.97 4.55 Favored 'Cis proline' 0 C--N 1.309 -1.544 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 -26.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' O ' HG21 ' A' ' 49' ' ' ILE . 19.2 mt-30 -141.61 -27.75 0.66 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.707 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.21 -31.1 6.33 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.172 -1.013 . . . . 0.0 114.389 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 56' ' ' PHE . 41.9 tptt -99.15 125.18 44.65 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.137 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' O ' ' CD1' ' A' ' 56' ' ' PHE . . . -105.22 140.98 37.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 54' ' ' LYS . 21.9 m-85 -135.07 136.74 42.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.558 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.85 -50.63 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.379 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 177.56 7.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.201 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HE2' HD23 ' A' ' 62' ' ' LEU . 1.4 tmtp? -85.04 -43.0 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.544 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 t -51.81 -32.43 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.517 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -68.79 -32.06 71.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.7 tp -64.57 -64.88 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.299 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.443 HG13 ' CG ' ' A' ' 76' ' ' PRO . 3.5 mp -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.476 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -63.2 -41.38 99.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 110.728 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 4.8 m-30 -45.45 -32.35 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mm-40 -72.69 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.107 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.27 -19.78 23.88 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.496 HG22 ' C ' ' A' ' 66' ' ' PHE . 23.1 m -86.56 -27.75 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.259 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.37 46.07 6.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.163 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.643 ' OD2' HD11 ' A' ' 74' ' ' LEU . 10.3 p-10 -74.32 133.97 42.55 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.772 0.32 . . . . 0.0 111.514 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 t -149.98 25.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.347 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.93 32.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.29 -46.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.865 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.5 OUTLIER 63.34 125.99 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.261 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' CG ' HG13 ' A' ' 63' ' ' ILE . 53.1 Cg_exo -56.64 -31.07 86.05 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.496 2.131 . . . . 0.0 112.287 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.04 -7.82 44.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.644 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.5 -7.29 58.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.473 0.178 . . . . 0.0 111.406 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD2' HD21 ' A' ' 62' ' ' LEU . 51.4 m-85 -107.58 148.17 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 111.393 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.29 159.47 41.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.069 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.4 m-30 -120.72 91.42 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.0 -10.37 8.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.823 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.022 HG13 HD13 ' A' ' 32' ' ' LEU . 61.4 t 61.33 -81.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 82' ' ' THR . 18.7 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HB2' HD12 ' A' ' 32' ' ' LEU . 63.8 Cg_endo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.888 0.286 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -161.76 129.36 4.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.216 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -94.79 -68.23 0.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.179 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.17 81.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.823 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 4.2 m-20 -117.97 91.45 39.65 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.77 13.54 1.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.058 2.505 . . . . 0.0 112.669 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 p -88.53 55.11 3.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.413 . . . . 0.0 110.887 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 28' ' ' TRP . 17.6 mt -133.27 165.23 38.25 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.582 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 73.1 Cg_exo -38.81 164.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.768 2.312 . . . . 0.0 112.909 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.2 127.11 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.34 -54.79 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.573 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 47.6 m95 -41.6 148.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.433 ' C ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -147.58 -178.41 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.837 178.473 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 20.9 ttt180 -148.2 159.59 43.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 111.635 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.6 tttt -174.25 162.85 3.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.526 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.0 mt -131.27 161.34 32.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.034 0.445 . . . . 0.0 111.411 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 8.2 tttp -136.18 117.45 14.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.082 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.244 179.14 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.975 0.417 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -106.05 159.46 16.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.671 0.748 . . . . 0.0 112.912 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -129.7 145.84 51.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.778 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -90.45 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.958 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -144.87 96.98 2.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 24' ' ' LEU . 33.1 mt -92.97 109.77 21.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 4.2 mt -85.8 134.76 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' OD1' ' CZ2' ' A' ' 28' ' ' TRP . 3.4 t30 -75.22 149.68 84.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.139 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -39.6 -59.45 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.823 2.348 . . . . 0.0 112.789 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -50.89 -25.1 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.86 31.56 2.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -101.01 117.02 34.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 111.614 -178.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.87 140.69 30.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 76.7 m-85 -129.17 127.03 40.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.488 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.483 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -52.42 2.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.779 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 6.1 p -86.07 173.46 9.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.359 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -85.77 -40.28 16.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.955 0.407 . . . . 0.0 110.839 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 46.6 t -51.86 -39.84 26.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.688 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -63.23 -28.2 69.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.161 0.505 . . . . 0.0 109.959 177.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.7 tp -70.66 -61.64 1.69 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.777 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -72.79 -57.92 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.477 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -46.54 -43.8 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.316 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' CD1' ' HD2' ' A' ' 68' ' ' LYS . 2.4 t80 -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.565 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.8 m-30 -45.61 -35.29 3.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.679 0.276 . . . . 0.0 111.283 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 65.3 mt-10 -61.22 -68.12 0.34 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.016 0.436 . . . . 0.0 110.527 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.651 ' CD ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.01 -19.73 13.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.71 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.651 HG23 ' CD ' ' A' ' 68' ' ' LYS . 7.4 t -86.36 -42.22 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.889 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.66 37.65 10.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.807 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 127.78 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 0.0 110.756 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -123.5 28.69 6.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -131.3 31.64 4.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.3 pp -154.46 -179.03 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.451 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -158.62 108.32 1.64 Allowed Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.647 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 80.1 Cg_exo -45.3 -35.47 11.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.658 2.239 . . . . 0.0 112.508 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.62 -20.0 63.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.867 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.45 -9.44 59.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.485 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 47.8 m-85 -104.85 135.09 46.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.948 0.404 . . . . 0.0 111.455 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.06 161.32 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.51 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.729 ' CD1' HG11 ' A' ' 46' ' ' VAL . 19.8 m-85 -121.82 88.5 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 p -119.1 -15.1 9.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.865 HG13 HD13 ' A' ' 32' ' ' LEU . 54.8 t 63.15 -79.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' THR . 12.5 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' CB ' HD12 ' A' ' 32' ' ' LEU . 77.2 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 CA-C-O 120.661 0.192 . . . . 0.0 112.02 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.61 18.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.569 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 36.23 48.39 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.433 0.635 . . . . 0.0 111.794 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 t0 -132.38 69.91 1.47 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.97 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 7.5 m-20 67.31 -99.41 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.334 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -171.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.672 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 26.2 Cg_endo -82.2 153.44 76.82 Favored 'Cis proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.252 2.197 . . . . 0.0 112.93 -13.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.599 ' O ' HD23 ' A' ' 24' ' ' LEU . 2.8 t 45.34 83.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.962 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 29' ' ' THR . 79.5 mt -138.92 154.58 72.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.92 -170.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.63 2.22 . . . . 0.0 112.257 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.5 125.45 25.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.81 -4.35 52.89 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.811 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 83.5 m95 -99.6 138.96 35.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.366 0.583 . . . . 0.0 111.711 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.907 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.58 178.73 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.027 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.882 ' CG ' HD11 ' A' ' 24' ' ' LEU . 10.5 mtm180 -142.44 141.35 32.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.878 ' C ' HD23 ' A' ' 32' ' ' LEU . 11.7 ttmt -140.73 153.3 45.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.11 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.878 HD23 ' C ' ' A' ' 31' ' ' LYS . 4.1 mt -128.43 153.86 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.124 0.487 . . . . 0.0 111.636 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -128.38 117.37 21.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.231 178.831 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttt . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.277 0.561 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.7 m-85 -106.46 153.51 22.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.713 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -121.54 143.45 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.075 175.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.572 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.2 p -87.87 148.51 4.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.745 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.0 m-85 -146.92 103.26 3.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.545 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.958 HD22 ' CE1' ' A' ' 81' ' ' PHE . 2.3 mp -89.43 110.63 21.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.894 -172.421 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.2 t-20 -87.27 137.63 32.64 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.358 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 82.4 Cg_exo -32.11 -58.56 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.774 2.982 . . . . 0.0 113.752 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -45.02 -27.72 0.59 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 111.308 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.71 22.67 3.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.503 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 tttt -94.35 174.45 7.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.733 0.301 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -142.07 133.96 27.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 62' ' ' LEU . 19.8 m-85 -127.59 127.17 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.865 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -102.19 6.51 40.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.467 177.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 61' ' ' GLU . 6.4 p -154.15 167.1 30.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 4.2 tptp -74.55 -36.87 63.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.169 0.509 . . . . 0.0 111.526 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 96.8 t -52.4 -43.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.828 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 58' ' ' SER . 5.6 mm-40 -65.92 -29.88 70.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.992 0.425 . . . . 0.0 110.154 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.87 -66.14 0.58 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.105 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -61.58 -40.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.67 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -65.46 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.582 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.78 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.1 t80 -57.78 -44.34 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.666 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 74' ' ' LEU . 8.0 m-30 -55.78 -24.38 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.75 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.4 mm-40 -73.79 -53.89 9.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 111.836 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' N ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.78 -18.51 62.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.929 -177.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.3 m -86.32 -43.96 16.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.717 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.72 54.0 1.72 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.511 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.743 ' OD2' HD11 ' A' ' 74' ' ' LEU . 35.2 p-10 -74.36 138.02 43.16 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.701 0.4 . . . . 0.0 111.852 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.4 p -149.95 22.56 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.035 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -143.47 33.03 1.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -154.54 -177.31 6.38 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -158.58 101.02 1.67 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 99.5 Cg_exo -44.08 -27.76 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.428 2.085 . . . . 0.0 112.107 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.93 -23.06 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.633 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.46 8.5 24.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.087 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' HD11 ' A' ' 62' ' ' LEU . 9.6 m-85 -93.74 124.15 37.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.771 0.319 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 116.44 29.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.958 ' CE1' HD22 ' A' ' 48' ' ' LEU . 8.5 m-85 -88.72 74.46 8.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.41 111.41 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 44' ' ' TYR . 92.4 t -79.55 -14.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.495 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.115 -179.537 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.803 ' CB ' HD12 ' A' ' 32' ' ' LEU . 84.0 Cg_endo . . . . . 0 C--O 1.23 0.123 0 N-CA-C 111.54 -0.215 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.492 ' HE3' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -134.54 -34.47 0.93 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 62.39 18.07 9.99 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' C ' ' HE3' ' A' ' 18' ' ' MET . 9.4 m-20 -118.72 84.89 2.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.806 ' HA ' HG22 ' A' ' 29' ' ' THR . 7.1 m-20 44.62 -94.39 0.0 OUTLIER Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-O 116.781 -1.58 . . . . 0.0 109.727 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.718 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 58.6 Cg_endo -77.0 -55.8 0.14 OUTLIER 'Cis proline' 0 N--CA 1.484 0.95 0 CA-C-N 122.908 2.074 . . . . 0.0 113.834 -6.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 32.9 p -159.35 78.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.634 HD12 ' CA ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -94.11 -175.54 0.49 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.666 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 74.8 Cg_exo -42.77 165.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.026 1.818 . . . . 0.0 112.508 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.29 125.39 14.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.007 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.79 -0.14 52.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.344 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 62.8 m95 -101.22 127.13 47.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.124 0.487 . . . . 0.0 111.469 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -134.35 172.72 12.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.608 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.801 ' HG3' HD23 ' A' ' 48' ' ' LEU . 11.7 ttm180 -140.17 150.77 44.62 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.8 0.81 . . . . 0.0 111.6 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.865 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -157.78 160.88 38.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.237 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.126 HD13 HG13 ' A' ' 83' ' ' VAL . 1.3 mt -130.85 169.79 15.28 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.9 tttt -147.91 114.14 5.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.421 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 52.1 tt0 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.756 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.919 0.39 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.694 ' HB3' HG11 ' A' ' 83' ' ' VAL . 7.2 m-85 -89.77 141.51 28.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.16 137.21 54.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.341 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.635 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -85.85 154.7 3.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.617 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 12.5 m-85 -145.08 100.88 3.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.801 HD23 ' HG3' ' A' ' 30' ' ' ARG . 41.9 mt -92.51 104.88 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -82.37 126.39 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.619 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 30.8 p-10 -85.59 148.51 49.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.394 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -33.8 -54.55 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.764 2.976 . . . . 0.0 113.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -44.85 -27.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.37 49.32 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.047 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.41 132.43 27.82 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.017 0.437 . . . . 0.0 111.129 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.75 137.68 32.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.488 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 60.1 m-85 -122.17 121.58 37.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 5.0 mtm180 -89.92 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.23 173.54 8.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.511 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -81.95 -38.69 24.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.414 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 61' ' ' GLU . 10.7 p -51.79 -43.17 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.351 0.596 . . . . 0.0 110.217 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.2 mt-10 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.31 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.4 tp -70.42 -63.08 1.16 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.387 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -62.27 -36.53 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.83 -72.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.727 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.74 -42.93 84.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.649 ' CE2' HD13 ' A' ' 74' ' ' LEU . 7.4 m-30 -52.07 -31.49 30.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.178 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.6 mm-40 -74.24 -59.56 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.745 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -61.83 -23.63 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.737 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.1 m -86.46 -31.94 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 0.0 111.35 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.54 43.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -79.31 128.92 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.871 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 t -119.36 20.08 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -125.85 26.52 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 0.0 110.656 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -154.53 175.9 13.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.671 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -158.57 129.19 3.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.436 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 51.4 Cg_exo -55.13 -36.32 92.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.427 2.085 . . . . 0.0 112.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -70.0 -18.09 63.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.996 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.95 -4.2 59.15 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.515 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CB ' HD21 ' A' ' 62' ' ' LEU . 87.3 m-85 -107.66 85.36 2.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.016 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -80.38 128.75 33.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 46' ' ' VAL . 9.0 m-85 -84.04 90.56 7.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.38 88.71 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.796 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.126 HG13 HD13 ' A' ' 32' ' ' LEU . 88.3 t -47.09 -27.64 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.076 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 111.051 -179.513 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.48 0.686 0 CA-C-O 120.939 0.308 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.83 94.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.551 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.26 -70.55 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.129 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.27 89.98 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.081 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB3' ' CG ' ' A' ' 30' ' ' ARG . 6.4 t0 -118.93 83.86 24.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.808 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -102.17 21.58 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.649 2.899 . . . . 0.0 113.018 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -81.54 -33.35 31.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.235 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 30' ' ' ARG . 16.6 mt -41.87 160.41 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.573 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.4 Cg_exo -40.33 162.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.652 2.235 . . . . 0.0 112.317 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.89 136.62 2.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.083 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.48 -45.8 2.96 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.73 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 63.2 m95 -68.92 149.1 49.25 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.56 -179.65 7.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.58 175.106 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.13 169.7 23.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 110.728 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.2 ttmt -170.42 162.25 8.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HG13 ' A' ' 83' ' ' VAL . 5.7 mt -131.26 157.09 44.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.958 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -139.29 124.66 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.621 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.462 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 59.0 tt0 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.065 0.46 . . . . 0.0 110.707 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.611 ' CB ' HG11 ' A' ' 83' ' ' VAL . 7.3 m-85 -90.87 142.07 28.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -118.83 148.95 42.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.644 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 81' ' ' PHE . 6.7 p -91.42 148.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.378 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.11 103.25 3.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -91.89 116.81 29.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -91.2 138.79 18.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.423 -175.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 0.2 OUTLIER -154.32 148.72 19.37 Favored Pre-proline 0 CA--C 1.484 -1.571 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -96.39 30.27 14.1 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 N-CA-C 108.305 -1.46 . . . . 0.0 108.305 -25.415 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' PRO . 48.3 mt-30 -157.02 -44.26 0.07 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.904 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 10.04 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.906 -1.14 . . . . 0.0 115.285 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 1.3 tmtt? -92.04 115.34 27.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.759 1.779 . . . . 0.0 110.42 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -92.01 154.21 18.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.251 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.568 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 42.1 m-85 -150.55 136.02 18.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 1.5 mtm-85 -97.61 -57.16 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.176 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -87.56 171.46 10.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.381 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 63' ' ' ILE . 7.3 tptp -81.24 -38.0 27.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.369 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 4.6 p -51.81 -42.12 31.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.55 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -33.2 73.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.751 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.3 tp -66.49 -61.01 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.469 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -62.96 -36.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.496 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -62.91 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.989 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.558 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.16 -53.08 61.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.257 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.507 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -50.13 -25.02 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.821 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.5 mm-40 -71.08 -63.6 1.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.695 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -23.23 65.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 65' ' ' TYR . 5.2 m -86.56 -38.33 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.353 . . . . 0.0 111.137 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.47 46.99 8.4 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.158 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.2 t0 -74.56 135.86 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -127.88 23.64 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.252 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 24.04 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.883 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 71' ' ' ASP . 1.1 pp -154.5 178.26 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.668 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -158.64 117.8 1.77 Allowed Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.491 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 62' ' ' LEU . 88.9 Cg_exo -46.3 -33.03 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.381 2.054 . . . . 0.0 112.051 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.01 -19.13 63.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.058 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.84 11.21 18.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.451 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' HB3' HD23 ' A' ' 48' ' ' LEU . 17.7 m-85 -130.34 72.1 1.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.985 0.421 . . . . 0.0 111.761 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 162.0 29.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.457 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-85 -115.68 124.59 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 111.753 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.29 93.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.673 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.991 HG13 HD13 ' A' ' 32' ' ' LEU . 90.6 t -50.94 -28.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.698 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 179.782 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HB3' HD13 ' A' ' 32' ' ' LEU . 2.7 Cg_endo . . . . . 0 N--CA 1.472 0.21 0 CA-C-O 120.473 0.114 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.545 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -156.42 97.88 1.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.33 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.63 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.71 68.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.258 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.5 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 28.3 t70 -156.7 85.93 0.98 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.943 -171.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' C ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 34.95 -88.98 0.0 OUTLIER Pre-proline 0 CA--C 1.498 -1.028 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.429 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.764 ' HG2' HG22 ' A' ' 23' ' ' THR . 15.1 Cg_endo -94.44 1.46 49.64 Favored 'Cis proline' 0 N--CA 1.486 1.065 0 CA-C-N 121.851 1.697 . . . . 0.0 113.74 -2.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.764 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -159.25 -83.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.883 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HH22 ' A' ' 30' ' ' ARG . 36.8 mt 59.42 163.3 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.339 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.38 -179.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.07 2.513 . . . . 0.0 112.78 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.45 122.69 16.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.16 -1.92 53.82 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.55 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 58.0 m95 -98.83 140.51 32.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 111.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -143.55 166.36 25.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.399 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.706 HH22 HD21 ' A' ' 24' ' ' LEU . 24.1 ttm105 -136.17 154.48 50.94 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.288 0.566 . . . . 0.0 110.466 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -162.99 164.33 25.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.773 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -133.44 167.52 20.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.483 0.658 . . . . 0.0 112.697 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -147.8 112.04 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.184 178.573 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.458 -179.335 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.046 0.451 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.539 ' HE2' ' HH ' ' A' ' 19' ' ' TYR . 5.2 m-85 -99.23 150.93 21.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.561 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -116.9 142.11 47.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.546 176.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG22 ' A' ' 83' ' ' VAL . 65.5 t -85.12 152.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.894 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.7 m-85 -146.14 90.6 1.98 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 79' ' ' PHE . 9.6 mt -91.22 103.36 16.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 12.6 mt -82.37 117.24 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.655 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 36.7 p-10 -84.61 152.88 60.93 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.484 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -34.97 -56.15 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.732 2.955 . . . . 0.0 113.447 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -44.65 -27.02 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.58 49.07 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.037 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.97 132.02 26.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.962 0.41 . . . . 0.0 111.479 -178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.82 144.3 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.783 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 55.9 m-85 -132.5 126.25 32.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.89 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 19.4 mtm180 -100.92 -52.82 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.262 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.89 171.78 10.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.909 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -81.81 -39.77 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.299 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 9.3 p -51.78 -42.22 31.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.307 0.575 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -61.02 -29.34 69.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.384 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -70.4 -67.29 0.51 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.482 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -58.22 -37.67 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.611 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.74 -58.5 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.64 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -66.25 -46.37 77.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.711 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.629 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 18.9 m-85 -52.08 -26.13 10.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.6 mm-40 -72.4 -62.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.772 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.09 63.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.698 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.3 m -86.64 -37.56 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 0.0 111.689 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.14 48.61 9.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.047 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 -74.62 0.19 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.927 0.87 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p 60.19 18.63 8.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.546 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -120.05 25.92 9.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.629 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -138.72 -36.6 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.6 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.97 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.651 0.263 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -51.69 -34.46 53.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.344 2.03 . . . . 0.0 112.344 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -69.12 -8.9 49.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.413 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -83.19 -9.51 59.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.903 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.621 ' CD2' HD21 ' A' ' 62' ' ' LEU . 52.6 m-85 -107.26 116.43 31.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.759 0.314 . . . . 0.0 110.554 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.99 146.88 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 22.1 m-30 -100.91 85.65 2.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.404 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 23.4 p -101.95 -16.22 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.669 HG13 HD22 ' A' ' 32' ' ' LEU . 53.5 t 67.62 -61.02 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.367 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.9 p . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.432 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 N--CA 1.481 0.768 0 CA-C-O 120.847 0.27 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 102.03 2.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.48 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.83 -69.36 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.199 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.55 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.437 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -115.49 89.71 23.11 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.543 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -93.48 18.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.094 2.529 . . . . 0.0 112.835 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.3 p -92.8 43.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.034 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.561 HD11 ' HG2' ' A' ' 30' ' ' ARG . 11.2 mt -123.02 166.57 17.42 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.312 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 96.0 Cg_exo -45.34 173.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.786 2.324 . . . . 0.0 112.752 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 125.84 18.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.915 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.49 -2.8 51.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.694 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.517 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 50.8 m95 -99.02 139.03 35.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -144.19 -179.66 6.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.814 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.561 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.2 mtp180 -145.85 163.73 34.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.937 0.399 . . . . 0.0 111.401 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.894 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.9 ttmt -170.07 158.36 6.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.129 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 83' ' ' VAL . 3.4 mt -131.29 155.96 46.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.496 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -129.57 120.41 25.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.154 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.759 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmp? . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CB ' HG11 ' A' ' 83' ' ' VAL . 6.9 m-85 -107.84 163.66 12.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -135.09 144.0 46.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.281 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.4 p -88.0 149.51 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.899 0.381 . . . . 0.0 111.78 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 10.6 m-85 -146.06 97.32 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.255 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.8 mt -93.01 109.27 20.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.4 mt -83.81 123.74 39.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.649 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.517 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 32.4 p-10 -85.65 152.99 57.97 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -36.19 -54.74 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.741 2.96 . . . . 0.0 113.161 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.34 -26.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.34 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 48.85 1.17 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.799 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -140.86 135.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.354 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.66 134.88 33.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -115.51 123.21 47.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -104.33 -4.4 22.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.36 177.47 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.822 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 1.3 mmtp -78.84 -45.08 21.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.906 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 29.2 t -51.85 -31.42 13.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.219 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -30.87 59.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.883 176.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.885 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -63.32 -66.17 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.425 178.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.96 -41.94 87.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.0 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.49 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.587 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.72 -54.71 43.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.18 -178.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -46.58 -31.5 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 111.732 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.8 mm-40 -67.82 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.71 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -25.6 59.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.638 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.3 m -88.38 -30.79 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 111.254 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.71 81.66 0.52 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.682 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.659 ' OD2' HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -149.91 126.9 11.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -177.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -132.38 20.37 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.76 22.14 15.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.748 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -154.58 65.48 0.68 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.709 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.5 OUTLIER 61.07 -173.87 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.146 0 C-N-CA 118.512 -1.275 . . . . 0.0 107.752 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.69 ' HG3' HD12 ' A' ' 62' ' ' LEU . 80.8 Cg_exo -75.73 -157.68 1.46 Allowed 'Cis proline' 0 C--N 1.312 -1.381 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 17.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.81 19.67 9.86 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.694 -176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -145.59 -5.17 0.65 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.077 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.885 ' CD2' HD11 ' A' ' 62' ' ' LEU . 50.7 m-85 -97.57 90.94 5.2 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.229 -0.294 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.39 119.24 11.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.817 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.525 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -89.46 69.47 7.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.3 107.61 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 32' ' ' LEU . 93.8 t -59.8 -38.79 77.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.392 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.307 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 32' ' ' LEU . 47.1 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.797 0.249 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -161.49 135.69 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.358 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CA ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -112.98 56.29 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.4 t0 -178.24 67.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.589 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.87 85.85 12.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.337 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HA ' HG23 ' A' ' 29' ' ' THR . 68.8 Cg_endo -96.15 18.1 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.273 2.649 . . . . 0.0 112.63 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -83.11 -20.16 35.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.409 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 29' ' ' THR . 51.2 mt -48.46 162.18 0.36 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 65.7 Cg_exo -38.37 161.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.707 2.272 . . . . 0.0 112.72 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.72 129.57 5.5 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . 90.91 -44.78 2.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.485 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.631 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 62.7 m95 -68.95 150.44 47.72 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -149.57 179.64 7.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.295 176.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 48' ' ' LEU . 58.2 ttp180 -153.29 163.06 40.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.36 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.92 ' O ' HD23 ' A' ' 32' ' ' LEU . 29.9 ttpt -174.68 164.95 3.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.92 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.1 mt -131.38 161.11 33.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.919 0.39 . . . . 0.0 111.474 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -138.51 120.87 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.405 -178.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.813 177.915 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HB2' HG11 ' A' ' 83' ' ' VAL . 5.3 m-85 -101.7 164.03 11.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.554 0.692 . . . . 0.0 112.64 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -133.39 146.7 51.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.204 177.171 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.8 p -86.86 146.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.704 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 4.9 m-85 -142.84 95.97 2.86 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.027 0.441 . . . . 0.0 110.954 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 80' ' ' ASP . 7.7 mt -92.89 110.44 21.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 23.0 mt -86.29 141.35 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.515 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.631 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -153.3 145.64 17.16 Favored Pre-proline 0 CA--C 1.482 -1.645 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 7.2 Cg_endo -93.9 24.04 25.61 Favored 'Cis proline' 0 N--CA 1.455 -0.737 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 -24.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -154.34 -43.72 0.09 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.543 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.11 1.85 0.11 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 119.66 -1.257 . . . . 0.0 115.661 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 65' ' ' TYR . 1.2 tmtt? -88.44 119.68 29.1 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.974 1.887 . . . . 0.0 110.741 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -101.79 148.77 24.9 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.622 ' CE1' ' ND2' ' A' ' 50' ' ' ASN . 9.2 m-85 -142.61 144.9 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.691 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.36 18.84 6.94 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 10.1 t -145.96 -86.02 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.068 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 166.25 -41.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.7 p -56.85 -39.18 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.122 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -27.56 66.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.335 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.1 tp -68.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.405 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.25 -38.26 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.72 -49.95 64.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -73.04 -61.53 1.78 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' C ' HG22 ' A' ' 69' ' ' VAL . 23.3 m-85 -42.71 -34.95 0.99 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -61.66 -69.3 0.25 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.8 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.21 -19.05 18.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.484 -176.659 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.8 HG13 ' HD3' ' A' ' 68' ' ' LYS . 33.9 m -91.99 -30.19 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.733 0.302 . . . . 0.0 111.158 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.48 64.21 4.59 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.8 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 72' ' ' THR . 10.5 t0 -74.39 -45.92 43.68 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.788 0.804 . . . . 0.0 111.541 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 71' ' ' ASP . 5.9 t 52.69 18.42 1.01 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.596 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.39 19.23 8.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 110.716 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.6 -177.34 6.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -158.58 118.04 1.79 Allowed Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.916 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HA ' HD23 ' A' ' 62' ' ' LEU . 89.1 Cg_exo -47.62 -32.5 16.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.198 1.932 . . . . 0.0 112.165 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.71 -20.16 63.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.141 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.51 9.26 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.612 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.03 86.7 2.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.692 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -63.73 -175.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.001 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 37.2 m-85 -145.38 73.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.94 117.47 28.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.915 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 32' ' ' LEU . 58.8 t -68.72 -56.64 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' CB ' HD12 ' A' ' 32' ' ' LEU . 3.4 Cg_exo . . . . . 0 N--CA 1.474 0.358 0 CA-C-O 120.747 0.228 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.13 134.61 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.644 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -116.07 48.61 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.677 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.33 67.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.606 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -112.2 94.29 25.52 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.18 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.78 -6.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.439 2.759 . . . . 0.0 112.67 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 t -84.06 53.67 2.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.93 0.395 . . . . 0.0 111.007 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 24' ' ' LEU . 14.8 mt -113.55 164.51 15.64 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 75.6 Cg_exo -41.56 166.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.612 2.208 . . . . 0.0 112.371 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.0 121.47 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 28' ' ' TRP . . . 77.95 53.24 4.99 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.681 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 56.9 m95 -157.02 151.33 25.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.37 179.61 7.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.608 175.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.477 ' HG3' HD23 ' A' ' 48' ' ' LEU . 22.3 ttt180 -153.62 160.04 42.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.213 0.53 . . . . 0.0 112.134 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.929 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -176.01 166.24 2.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.453 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.064 HD13 HG13 ' A' ' 83' ' ' VAL . 10.6 mt -131.3 166.55 20.97 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.03 0.443 . . . . 0.0 111.583 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -135.11 118.08 16.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.149 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.354 179.273 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.5 m-85 -107.6 161.03 15.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.641 0.734 . . . . 0.0 112.582 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.52 147.77 52.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.73 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.7 p -87.13 143.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.84 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 5.4 m-85 -143.16 97.06 3.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 30' ' ' ARG . 82.1 mt -91.31 116.11 28.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 174.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.6 mt -91.5 137.53 21.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 1.9 p-10 -153.32 147.71 19.1 Favored Pre-proline 0 CA--C 1.49 -1.346 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 93.0 Cg_endo -91.67 -3.08 52.77 Favored 'Cis proline' 0 N--CA 1.448 -1.182 0 C-N-CA 125.239 -0.734 . . . . 0.0 110.863 -23.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -116.8 -35.62 4.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.999 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' CG2' ' A' ' 49' ' ' ILE . . . -176.64 21.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.741 -1.218 . . . . 0.0 114.881 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -96.81 115.71 27.9 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.348 1.574 . . . . 0.0 111.139 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.03 146.64 24.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.992 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 9.0 m-85 -150.66 137.37 18.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.728 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -105.95 11.59 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.151 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -154.49 170.17 22.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -80.41 -41.83 23.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.007 -176.427 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 p -50.36 -41.54 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.148 0.499 . . . . 0.0 110.606 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.08 -29.6 67.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.61 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.626 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -64.32 -63.67 1.08 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.1 mp -65.12 -38.01 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.352 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.69 -58.05 8.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.749 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -65.28 -53.71 40.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.627 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.928 ' CE2' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -43.97 -26.06 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.612 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.8 mm-40 -75.33 -65.97 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.36 -15.41 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.754 HG13 ' HD3' ' A' ' 68' ' ' LYS . 19.7 m -88.27 -28.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.227 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.99 59.69 10.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.249 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.02 -68.33 0.68 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.871 0.844 . . . . 0.0 111.899 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p 65.17 14.28 9.29 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.692 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -115.61 22.78 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 110.592 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.928 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -154.59 -174.25 4.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 13.5 t0 -158.61 113.12 1.66 Allowed Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.007 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 80.9 Cg_exo -46.02 -34.87 13.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.317 2.012 . . . . 0.0 111.954 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.539 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.6 8.1 30.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 8.6 m-85 -129.81 88.56 2.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 111.676 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 156.84 34.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.323 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 46' ' ' VAL . 18.4 m-85 -109.89 104.04 12.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 111.598 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -148.46 100.48 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.639 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.064 HG13 HD13 ' A' ' 32' ' ' LEU . 78.7 t -46.46 -38.5 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.99 179.658 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.8 Cg_endo . . . . . 0 N--CA 1.472 0.263 0 CA-C-O 120.762 0.234 . . . . 0.0 112.435 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.9 113.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -92.92 52.68 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.719 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.1 t0 -176.37 64.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.24 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -109.41 95.85 20.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.313 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 80.2 Cg_endo -91.54 10.53 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.117 2.544 . . . . 0.0 112.519 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -85.48 52.77 2.55 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.881 0.372 . . . . 0.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD22 ' A' ' 48' ' ' LEU . 18.6 mt -127.82 165.08 32.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.592 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 88.1 Cg_exo -47.07 177.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.561 2.174 . . . . 0.0 112.606 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.32 129.37 18.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.819 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 63.42 11.03 38.88 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.804 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.577 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 73.2 m95 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 0.0 111.742 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.66 178.69 6.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.107 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.761 ' NH2' HD11 ' A' ' 32' ' ' LEU . 4.1 ttt85 -145.37 162.35 37.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 0.0 111.661 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.945 ' O ' HD23 ' A' ' 32' ' ' LEU . 34.8 ttmt -175.08 158.32 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.602 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.945 HD23 ' O ' ' A' ' 31' ' ' LYS . 8.0 mt -131.34 163.12 28.56 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.12 0.486 . . . . 0.0 111.811 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.3 ttpt -137.76 113.18 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.169 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.245 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.675 0.274 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 7.2 m-85 -107.49 161.89 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -131.31 143.6 50.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.92 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.744 HG11 ' CG ' ' A' ' 81' ' ' PHE . 6.3 p -89.4 147.19 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.062 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.1 m-85 -144.98 94.32 2.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.321 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 HD11 ' A' ' 24' ' ' LEU . 70.0 mt -92.95 113.23 25.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.782 HG12 ' HB2' ' A' ' 55' ' ' ALA . 2.6 mt -89.63 122.83 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.218 -173.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.528 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 38.6 p-10 -85.71 155.66 58.88 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.569 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 27' ' ' GLY . 97.8 Cg_exo -36.73 -53.21 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.661 2.908 . . . . 0.0 113.286 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -47.56 -25.57 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.981 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.28 46.59 1.54 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.681 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.848 0.356 . . . . 0.0 111.264 -177.557 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -105.27 154.48 20.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.886 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CB ' HD22 ' A' ' 62' ' ' LEU . 67.4 m-85 -131.07 150.18 52.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.457 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 20.18 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.64 -4.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 77.14 -50.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.982 0.356 . . . . 0.0 111.957 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.1 p -52.49 -41.18 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.695 -0.628 . . . . 0.0 109.51 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -30.29 71.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.085 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.054 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -62.77 -72.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.041 179.197 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.515 ' CG1' ' HG3' ' A' ' 76' ' ' PRO . 7.9 mt -52.81 -43.57 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' CD ' ' A' ' 68' ' ' LYS . . . -52.82 -47.03 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.196 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -71.51 -57.55 4.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.69 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.054 ' CE2' HD12 ' A' ' 62' ' ' LEU . 27.6 m-85 -44.42 -29.73 0.74 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.136 0.493 . . . . 0.0 110.922 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.73 -47.3 85.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.91 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.8 -33.02 74.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.84 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' PHE . 6.4 m -93.5 -30.12 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.18 10.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.937 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.97 126.46 35.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.9 p -140.83 32.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -125.56 16.91 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -154.58 72.36 0.86 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 2.5 m-20 60.31 -152.93 0.01 OUTLIER Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 83.9 Cg_endo -68.19 -152.77 0.49 Allowed 'Cis proline' 0 C--N 1.311 -1.402 0 CA-C-N 121.78 1.671 . . . . 0.0 111.568 4.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.401 ' H ' ' CE ' ' A' ' 59' ' ' LYS . 3.3 m120 63.69 13.26 7.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.354 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.58 7.34 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.353 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 37.9 m-85 -99.87 63.74 1.21 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.677 0.275 . . . . 0.0 110.271 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -44.58 128.1 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.639 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.744 ' CG ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-30 -88.37 85.26 6.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 1.5 p -98.34 93.34 6.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.99 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.619 HG13 HD13 ' A' ' 32' ' ' LEU . 77.8 t -66.82 -28.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.082 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 179.746 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.701 ' HB3' HD12 ' A' ' 32' ' ' LEU . 1.7 Cg_endo . . . . . 0 N--CA 1.472 0.24 0 N-CA-C 111.841 -0.099 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.68 -36.2 0.44 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.117 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 81.17 -56.86 0.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.751 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -38.36 99.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.146 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -1.3 -65.42 0.0 OUTLIER Pre-proline 0 CA--C 1.477 -1.84 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -179.092 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.758 ' HG2' HG22 ' A' ' 23' ' ' THR . 63.1 Cg_endo -104.6 -4.49 8.97 Favored 'Cis proline' 0 C--N 1.314 -1.265 0 O-C-N 123.334 1.176 . . . . 0.0 112.115 -2.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.758 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -161.19 21.19 0.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.424 -174.334 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.627 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -44.15 166.85 0.1 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 0.0 111.857 -177.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HD2' HD23 ' A' ' 24' ' ' LEU . 67.9 Cg_exo -39.58 166.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.103 2.536 . . . . 0.0 113.272 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.44 119.5 2.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 76.9 -4.2 54.11 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.064 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.685 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 68.6 m95 -101.64 134.69 44.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.46 -0.435 . . . . 0.0 111.457 -178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -147.92 142.96 27.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.244 -178.605 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 44.9 ttp180 -110.33 163.39 13.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.821 0.82 . . . . 0.0 112.345 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.898 ' C ' HD23 ' A' ' 32' ' ' LEU . 9.4 ttmt -169.31 149.38 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.898 HD23 ' C ' ' A' ' 31' ' ' LYS . 1.8 mt -124.5 164.87 18.85 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.0 111.648 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 ttmt -137.7 123.2 19.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.94 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.444 179.2 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.5 m-85 -102.04 168.9 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -142.83 140.4 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.242 176.934 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.9 p -88.66 152.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.371 . . . . 0.0 111.281 -178.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.647 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 23.6 m-85 -146.05 101.01 3.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.544 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 79' ' ' PHE . 21.2 mt -92.93 105.48 17.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.801 0.81 . . . . 0.0 109.006 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' THR . 2.8 mt -82.22 121.16 35.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.135 -174.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -85.62 152.86 57.87 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.759 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' GLY . 89.6 Cg_exo -35.29 -57.23 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 0.0 113.275 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -43.9 -27.52 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.234 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.04 49.9 1.04 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.891 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -140.83 133.66 28.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.989 0.424 . . . . 0.0 111.279 -178.418 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.647 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -89.26 146.96 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.332 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CG ' HD12 ' A' ' 62' ' ' LEU . 85.5 m-85 -128.28 126.36 40.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 ttp180 -92.01 -59.22 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.67 172.7 8.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -81.75 -42.84 19.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.381 -178.676 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 t -51.8 -26.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.32 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.63 -31.27 59.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.488 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -68.01 -60.87 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -61.3 -40.24 85.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.074 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.74 -62.06 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.657 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.886 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.05 -57.95 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.66 178.381 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.882 ' CE2' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -39.67 -38.8 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.114 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.7 mm-40 -61.04 -56.14 24.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.034 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.46 -16.41 63.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.873 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.03 -50.52 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -178.729 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 153.75 -31.4 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.455 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.67 -161.33 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.066 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 71' ' ' ASP . 3.0 t 59.47 25.42 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.915 -178.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -141.1 17.47 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.67 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.882 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -39.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 -178.392 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.625 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER 71.97 103.59 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.593 179.054 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.3 Cg_exo -48.59 -32.48 21.31 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.439 2.093 . . . . 0.0 112.549 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -70.1 -10.95 60.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.603 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.55 -3.51 58.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.511 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.1 m-85 -109.51 64.4 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.566 -178.032 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.19 137.42 58.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.519 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -87.27 91.51 8.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.073 0.463 . . . . 0.0 111.075 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 98.77 7.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.747 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 44' ' ' TYR . 93.0 t -72.0 -7.64 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.602 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.6 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.919 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 4.9 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.886 0.286 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -168.91 106.01 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.502 178.854 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.66 66.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.997 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' MET . 37.4 t70 179.05 74.75 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -177.026 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.6 m-20 -115.7 80.48 8.43 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.632 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.744 ' HA ' HG23 ' A' ' 29' ' ' THR . 94.0 Cg_endo -88.43 22.37 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.852 2.368 . . . . 0.0 112.713 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 24' ' ' LEU . 52.2 p -94.8 46.43 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -125.1 176.66 2.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.479 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 81.5 Cg_exo -49.35 -179.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.729 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.52 126.83 28.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.817 -179.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.61 55.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.276 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.537 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 70.8 m95 -106.38 128.14 53.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.238 0.542 . . . . 0.0 111.787 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -135.95 -179.89 5.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.152 179.36 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 48' ' ' LEU . 29.9 ttp180 -142.09 163.08 33.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.785 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 13.4 ttmt -165.17 170.84 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.492 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.69 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.38 162.94 33.13 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.085 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -148.0 117.17 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.829 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.519 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 48.3 tt0 . . . . . 0 CA--C 1.515 -0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.954 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -77.93 122.85 26.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -175.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 149.47 24.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.319 176.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 83' ' ' VAL . 41.7 t -93.86 151.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.1 m-85 -146.05 99.88 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.606 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 30' ' ' ARG . 7.1 mt -92.88 106.8 18.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 109.624 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.1 mt -82.23 122.5 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.688 -174.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.537 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 31.2 p-10 -85.71 153.4 58.07 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.594 -178.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -37.61 -27.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.082 3.188 . . . . 0.0 113.699 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ASN . 2.6 mt-30 -80.61 12.38 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 70.98 15.94 74.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.972 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -99.05 137.51 37.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.494 0.188 . . . . 0.0 111.389 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.28 130.76 41.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.345 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 26.4 m-85 -115.8 117.83 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' CD ' ' CE2' ' A' ' 47' ' ' TYR . 8.1 mtm180 -105.03 10.06 34.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.453 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.45 164.84 38.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.836 0.351 . . . . 0.0 111.189 -178.473 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.547 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.66 -35.91 57.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 0.0 111.122 -178.986 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 8.2 p -54.0 -46.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.63 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.7 mt-10 -61.3 -30.59 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.88 -64.73 0.83 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -64.91 -42.42 94.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.72 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -57.04 11.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.417 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -66.69 -50.74 61.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.544 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.897 ' CE2' HD13 ' A' ' 74' ' ' LEU . 14.7 m-30 -48.81 -38.32 21.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.798 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 33.1 mt-10 -61.06 -66.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.921 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -54.17 -26.98 30.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -177.348 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.921 HG13 ' HD2' ' A' ' 68' ' ' LYS . 28.4 m -86.45 -29.32 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.786 178.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.31 55.3 28.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.881 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.666 ' HB3' HD11 ' A' ' 74' ' ' LEU . 1.4 t0 -83.46 153.22 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -131.2 3.61 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.43 27.38 8.81 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.889 0.376 . . . . 0.0 110.807 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.897 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -154.43 173.19 16.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.872 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' ASP . 2.3 t0 -158.63 111.86 1.65 Allowed Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.219 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 84.5 Cg_exo -45.17 -41.22 16.56 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.116 1.877 . . . . 0.0 112.241 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.97 -9.05 53.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 41.7 t0 -88.64 -6.49 57.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.13 178.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.656 ' CD2' HD11 ' A' ' 62' ' ' LEU . 45.9 m-85 -109.39 127.39 54.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.638 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.24 134.16 50.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.127 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.446 ' CE2' ' C ' ' A' ' 58' ' ' SER . 4.1 m-85 -97.45 90.2 4.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 p -141.43 142.56 33.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.69 HG13 HD22 ' A' ' 32' ' ' LEU . 87.0 t -95.5 -64.12 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.539 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 Cg_endo . . . . . 0 N--CA 1.456 -0.693 0 CA-C-O 120.884 0.285 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.458 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.99 103.73 0.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.287 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.691 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -69.5 64.64 0.18 Allowed 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.683 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 18' ' ' MET . 25.3 t0 -178.5 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.8 t70 -114.67 82.64 8.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 29' ' ' THR . 85.1 Cg_endo -86.19 0.24 8.21 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.116 2.544 . . . . 0.0 112.935 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.4 p -80.64 -23.17 39.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.771 0.319 . . . . 0.0 111.09 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 13.3 mt -46.38 161.29 0.28 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 49.1 Cg_exo -35.71 159.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.107 2.538 . . . . 0.0 113.404 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.79 120.82 2.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.183 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.78 -14.02 27.39 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.499 178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 67.4 m95 -90.69 137.05 32.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -136.64 177.94 7.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.946 179.311 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 19.3 ttp180 -141.02 160.91 39.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.518 . . . . 0.0 111.421 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -161.19 166.93 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.946 -179.36 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.995 HD22 HG13 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.875 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.42 117.33 8.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.96 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 58.2 tt0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.722 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.925 0.393 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CB ' HG11 ' A' ' 83' ' ' VAL . 5.9 m-85 -94.12 135.0 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.307 0.575 . . . . 0.0 112.385 -177.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -109.59 156.09 20.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.608 176.757 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 83' ' ' VAL . 18.3 t -98.28 149.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.509 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.499 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 14.9 m-85 -146.01 99.5 3.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.453 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 79' ' ' PHE . 20.0 mt -90.85 107.91 19.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 54' ' ' LYS . 3.2 mt -82.35 127.86 39.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.415 -171.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.3 t-20 -81.39 137.27 48.63 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.997 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 76.9 Cg_exo -33.27 -53.54 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.852 3.035 . . . . 0.0 113.322 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.23 -26.95 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.332 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.05 17.07 5.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.354 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.6 tttp -97.28 168.35 10.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.679 0.276 . . . . 0.0 111.119 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -134.95 130.42 35.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 29.2 m-85 -126.37 121.23 31.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.13 -52.58 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.443 . . . . 0.0 110.139 177.695 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.4 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -88.03 177.09 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.918 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -83.77 -41.49 17.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.338 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 21.6 t -51.81 -27.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.61 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 8.7 mm-40 -75.81 -31.69 59.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.303 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -62.84 -66.58 0.52 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.976 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.623 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -57.66 -38.4 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -58.51 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.98 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.48 ' CG ' ' HD3' ' A' ' 54' ' ' LYS . 1.5 t80 -66.37 -52.61 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.271 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.953 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.6 m-30 -44.79 -41.65 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 21.9 mt-10 -61.16 -63.9 1.13 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.886 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.726 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.67 -23.52 28.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.67 -177.522 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.4 m -92.54 -39.88 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.13 33.95 5.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.586 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.923 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -89.95 135.86 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.945 179.756 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -144.99 26.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.161 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -125.84 7.84 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.967 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.953 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -106.23 -31.87 8.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.845 0.355 . . . . 0.0 110.577 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.53 95.75 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 82.1 Cg_exo -44.39 -30.61 3.88 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.494 2.129 . . . . 0.0 112.227 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.12 -7.97 45.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.54 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.39 -18.52 38.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.608 0.242 . . . . 0.0 111.144 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.766 ' HB3' HD13 ' A' ' 48' ' ' LEU . 22.7 m-85 -97.77 125.13 42.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 111.341 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.71 144.41 41.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-85 -101.95 102.47 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.395 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -151.7 110.81 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.995 HG13 HD22 ' A' ' 32' ' ' LEU . 64.4 t -65.57 -71.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.83 179.742 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.49 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo . . . . . 0 N--CA 1.473 0.303 0 CA-C-O 120.755 0.231 . . . . 0.0 111.918 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.467 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.28 -26.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.252 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 84.17 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.433 0.293 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.54 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -114.63 112.42 45.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.197 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -109.11 37.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.943 3.095 . . . . 0.0 112.728 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.5 p -98.3 -53.72 3.27 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 1.7 mt -51.65 -177.53 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 121.489 -0.085 . . . . 0.0 111.051 -176.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 40.0 Cg_exo -41.29 157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.987 2.458 . . . . 0.0 114.6 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.23 149.98 3.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.94 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -59.29 1.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.867 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 75.8 m95 -47.8 150.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.349 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -149.09 178.11 9.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.879 178.933 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.528 ' HE ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -144.22 165.7 27.12 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.406 177.511 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm -176.37 154.59 1.34 Allowed 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.597 -176.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.49 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 10.0 mt -116.47 173.79 6.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.546 0.689 . . . . 0.0 112.828 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.83 116.94 6.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.45 176.77 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.086 179.01 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.046 0.451 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.2 m-85 -99.99 159.19 15.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -132.51 153.83 50.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.641 177.247 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 83' ' ' VAL . 52.5 t -101.15 148.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 8.3 m-85 -144.61 103.26 3.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.718 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.574 HD11 ' O ' ' A' ' 80' ' ' ASP . 71.3 mt -92.93 108.05 19.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.6 mt -88.23 130.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.661 -174.581 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.502 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 7.4 p-10 -82.73 154.31 68.05 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.663 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -32.51 -60.45 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.896 3.064 . . . . 0.0 113.827 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.24 -25.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 25.28 5.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.687 -179.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 47.2 tptt -99.1 124.75 44.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.19 140.26 31.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -177.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.718 ' CD2' HD12 ' A' ' 62' ' ' LEU . 25.4 m-85 -133.26 135.35 44.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.155 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -102.58 -53.54 2.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.097 178.144 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -87.0 174.19 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.486 178.337 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.41 -42.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.337 . . . . 0.0 111.756 -178.364 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 50.9 t -51.83 -25.17 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.02 -26.27 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.203 178.25 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.718 HD12 ' CD2' ' A' ' 56' ' ' PHE . 1.1 mp -76.1 -65.55 0.9 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.907 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -55.81 -38.42 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.82 -66.98 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.341 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.89 -45.63 89.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.189 -179.166 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.4 m-30 -53.41 -34.54 58.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 111.57 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.24 -70.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.674 -176.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.06 -21.04 28.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 110.357 178.23 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' TYR . 36.6 t -86.46 -25.08 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.927 -177.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 48.49 56.08 9.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.342 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.46 134.52 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.6 16.22 15.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.284 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 25.13 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.839 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -154.65 175.23 13.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.482 179.452 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.64 123.59 2.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.073 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HA ' HD23 ' A' ' 62' ' ' LEU . 39.3 Cg_exo -56.07 -33.39 89.71 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.068 1.845 . . . . 0.0 112.27 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -15.6 62.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.59 -16.42 32.57 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 0.0 111.584 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD2' HD21 ' A' ' 62' ' ' LEU . 54.9 m-85 -98.46 126.97 44.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -124.5 152.74 43.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.058 -179.536 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HA ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-85 -107.46 84.64 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -125.05 95.37 4.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 46' ' ' VAL . 2.6 t -49.45 -48.13 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.293 -179.082 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HB3' HD13 ' A' ' 32' ' ' LEU . 4.4 Cg_exo . . . . . 0 N--CA 1.472 0.207 0 CA-C-O 120.913 0.297 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.514 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -160.16 102.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.756 179.457 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.725 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.98 63.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.583 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 179.38 82.15 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -176.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 1.7 m-20 -118.42 80.6 16.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.263 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.63 ' HA ' HG23 ' A' ' 29' ' ' THR . 91.1 Cg_endo -89.9 23.5 0.69 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.176 2.584 . . . . 0.0 112.54 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 p -92.02 -20.5 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.437 -179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.81 HD11 ' CG ' ' A' ' 30' ' ' ARG . 12.4 mt -56.69 165.23 1.75 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.868 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 79.8 Cg_exo -48.59 178.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.698 2.265 . . . . 0.0 113.183 -178.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.86 125.32 11.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.287 -178.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.09 0.32 55.98 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.639 178.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 63.7 m95 -101.81 135.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.166 0.508 . . . . 0.0 111.989 -178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -145.82 179.15 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.809 179.468 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.81 ' CG ' HD11 ' A' ' 24' ' ' LEU . 3.1 mtp180 -142.91 165.44 27.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.079 0.466 . . . . 0.0 111.726 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 12.7 tttm -166.09 161.53 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.98 -178.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.809 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -131.3 166.5 21.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.216 0.531 . . . . 0.0 112.12 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -147.24 115.85 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.082 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.522 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 tttt . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.291 0.567 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.6 m-85 -108.54 149.61 28.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.219 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.93 148.13 40.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.33 176.542 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 48' ' ' LEU . 40.4 t -90.46 148.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.837 -178.243 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 22.4 m-85 -146.16 95.64 2.65 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.25 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 79' ' ' PHE . 1.7 mt -92.95 109.15 20.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.394 0.616 . . . . 0.0 109.754 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.848 HG12 ' HB2' ' A' ' 55' ' ' ALA . 6.2 mt -82.64 121.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.482 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 46.8 p-10 -85.66 154.87 59.15 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.201 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -33.62 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.918 3.079 . . . . 0.0 113.347 -179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.86 -26.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.414 -178.997 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 44.77 1.72 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.967 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CD ' ' CE2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.83 138.15 33.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.955 -178.469 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.848 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -103.64 145.28 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CE2' ' CD ' ' A' ' 54' ' ' LYS . 2.0 m-85 -127.83 144.94 51.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.316 177.299 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -48.45 3.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.88 174.68 8.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 1.2 tmtp? -85.69 -39.19 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.289 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 55.8 t -52.11 -38.39 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.949 0.405 . . . . 0.0 110.309 178.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 3.4 mm-40 -67.18 -30.08 69.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.469 178.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.84 -62.21 1.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 109.637 178.851 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.4 mp -67.83 -42.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.356 178.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.63 -58.98 5.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.756 -178.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.1 t80 -62.62 -55.37 27.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 110.581 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.058 ' CE2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-30 -41.2 -38.47 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.897 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -63.25 -60.55 3.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.571 -178.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HD3' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.22 -18.37 15.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.23 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.584 HG23 ' HD3' ' A' ' 68' ' ' LYS . 49.8 t -86.42 -33.68 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 107.38 -35.3 5.1 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -176.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.66 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 32.5 107.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 175.884 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -148.72 31.06 0.8 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.677 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 76.7 p -179.43 49.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.321 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.058 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.5 -36.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.992 -179.135 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.63 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 51.58 109.79 0.02 OUTLIER Pre-proline 0 N--CA 1.462 0.171 0 C-N-CA 122.593 0.357 . . . . 0.0 111.786 179.328 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 50.0 Cg_exo -50.95 -32.43 38.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.144 1.896 . . . . 0.0 112.044 178.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -68.84 -16.08 63.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.777 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -10.47 59.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.051 177.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.754 ' HB3' HD12 ' A' ' 48' ' ' LEU . 41.9 m-85 -106.92 152.26 24.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.447 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.53 148.95 40.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.603 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.7 m-30 -109.28 85.99 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.4 p -120.87 -12.44 8.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.809 HG13 HD22 ' A' ' 32' ' ' LEU . 78.3 t 63.49 -78.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 110.617 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' THR . 25.6 p . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 57.6 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.826 0.261 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.6 mtm -151.8 105.85 3.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -70.81 -75.24 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.117 -178.247 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.5 p30 -61.31 83.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.715 0.293 . . . . 0.0 110.533 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -115.11 84.64 11.28 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.762 -178.509 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 29' ' ' THR . 87.7 Cg_endo -93.83 30.77 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.193 2.596 . . . . 0.0 112.591 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.7 p -81.28 -31.58 33.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 111.007 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.563 HD11 ' HG2' ' A' ' 30' ' ' ARG . 87.8 mt -50.79 165.12 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.0 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.4 Cg_exo -47.2 178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.591 2.194 . . . . 0.0 112.967 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 128.11 19.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.386 -178.651 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.34 54.84 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.75 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 60.6 m95 -101.0 133.82 44.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.188 0.494 . . . . 0.0 112.019 -178.589 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -138.75 179.19 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.275 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 24' ' ' LEU . 14.9 mtm180 -143.38 170.04 16.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.727 178.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.7 ttmm 178.57 162.37 0.7 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.189 -178.344 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.842 HD13 HG13 ' A' ' 83' ' ' VAL . 14.2 mt -128.13 173.36 10.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.27 0.557 . . . . 0.0 112.168 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -147.8 113.18 5.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.26 176.89 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 52.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.804 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.176 0 CA-C-O 121.057 0.456 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -86.72 151.22 23.58 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -174.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-20 -119.53 173.27 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.071 177.581 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.503 ' CG2' HG23 ' A' ' 83' ' ' VAL . 54.0 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.4 -178.268 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.2 m-85 -146.36 103.27 3.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.074 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 24' ' ' LEU . 62.3 mt -92.99 107.81 19.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.442 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 54' ' ' LYS . 4.3 mt -82.33 121.77 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.549 -173.18 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 18.8 p-10 -85.73 144.59 39.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.535 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -35.39 -44.71 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.614 2.876 . . . . 0.0 112.857 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 3.5 mt-30 -49.12 -23.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.234 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.61 20.32 11.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.753 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.835 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -100.75 -179.99 4.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 111.679 -178.638 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.87 131.87 21.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.708 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 64.7 m-85 -123.28 133.25 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 0.0 111.729 -178.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.0 mtm180 -105.98 1.04 26.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.672 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.35 164.22 38.95 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -178.176 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -69.53 -47.21 64.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -176.221 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 9.2 t -51.9 -35.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.777 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -28.06 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.119 178.277 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.073 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -67.41 -69.16 0.33 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.549 179.359 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -55.45 -36.1 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -64.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.923 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.838 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.34 -59.57 4.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.008 0.432 . . . . 0.0 110.681 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.576 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.7 m-30 -35.29 -39.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.767 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 11.6 mt-10 -61.19 -66.69 0.5 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.877 0.37 . . . . 0.0 111.928 -177.225 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HE3' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.19 -19.96 23.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.58 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.53 -37.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.297 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.67 -32.28 3.22 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.801 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.44 -159.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.832 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 71' ' ' ASP . 0.6 OUTLIER 75.91 26.92 0.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.093 0.557 . . . . 0.0 110.51 -177.014 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -150.16 27.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.426 177.557 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -147.95 -41.96 0.17 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.889 -178.23 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 70.14 86.24 0.12 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.433 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 81.3 Cg_exo -49.96 -24.92 11.38 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.6 -18.6 63.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.545 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -88.52 12.49 14.34 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.833 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 1.073 ' CD2' HD21 ' A' ' 62' ' ' LEU . 3.8 m-85 -108.11 79.45 1.27 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.727 0.298 . . . . 0.0 111.004 -179.097 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 82' ' ' THR . 0.4 OUTLIER -84.57 8.0 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.751 179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 10.3 m-85 49.33 -88.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.289 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 80' ' ' ASP . 2.1 p 58.28 161.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.406 . . . . 0.0 111.298 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 32' ' ' LEU . 16.9 t -132.53 -51.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.221 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.953 -179.841 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 62.2 Cg_endo . . . . . 0 N--CA 1.475 0.426 0 N-CA-C 113.097 0.384 . . . . 0.0 113.097 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.672 ' H ' HD11 ' A' ' 32' ' ' LEU . 8.1 mtm -136.18 -36.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.142 -179.105 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.723 ' CD1' HD12 ' A' ' 32' ' ' LEU . 8.5 m-85 63.44 28.24 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 35.4 t70 -175.75 82.55 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -176.401 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -113.31 87.94 12.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.143 178.344 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 29' ' ' THR . 96.3 Cg_endo -88.11 9.03 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.012 2.475 . . . . 0.0 112.649 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 p -86.83 51.85 2.35 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.53 HD11 ' CD ' ' A' ' 30' ' ' ARG . 29.4 mt -128.97 164.08 41.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.155 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.51 170.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.384 2.056 . . . . 0.0 112.556 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 126.24 8.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.466 -178.479 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.57 0.56 58.92 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.731 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 66.0 m95 -101.41 137.28 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 112.087 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -147.89 -172.15 3.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.789 179.902 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.581 ' H ' HG22 ' A' ' 29' ' ' THR . 1.7 mtm180 -151.33 176.27 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 111.43 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -175.53 173.52 2.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.354 -178.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -142.97 167.14 22.77 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.325 0.583 . . . . 0.0 112.409 179.879 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -148.04 101.32 3.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.979 177.792 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.936 179.732 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.542 ' CB ' HG11 ' A' ' 83' ' ' VAL . 9.1 m-85 -105.42 137.04 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -105.98 137.94 43.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.641 174.712 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p -93.91 154.46 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.038 0.447 . . . . 0.0 111.468 -177.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.2 m-85 -146.04 99.22 3.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 79' ' ' PHE . 8.1 mt -91.78 111.43 22.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.39 120.89 34.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.211 -171.75 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 6.5 p-10 -86.18 144.76 39.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.216 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -34.7 -51.72 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.64 2.893 . . . . 0.0 113.429 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -44.62 -27.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.389 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.24 25.07 5.97 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.602 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.751 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.0 tttt -99.17 172.47 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 111.31 -178.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 96.56 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.366 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 22.9 m-85 -90.29 129.15 36.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 111.647 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -104.85 4.27 31.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.335 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 60' ' ' VAL . 99.7 p -154.41 170.77 20.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 -177.021 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.23 -37.98 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -178.517 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 3.9 p -51.84 -46.48 40.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.683 -179.191 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -62.11 -31.99 72.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.221 178.594 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -65.51 -68.6 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 178.959 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -56.98 -40.42 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.696 178.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.26 -64.87 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.102 -178.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.49 -40.14 93.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.605 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 1.043 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.8 m-30 -59.8 -32.22 70.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 23.3 mt-10 -60.9 -70.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 111.522 -177.289 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.03 -21.79 33.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.559 178.393 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 65' ' ' TYR . 13.3 t -86.41 -25.9 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -177.552 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 59.84 45.19 96.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.698 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.778 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.06 136.39 33.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.738 179.395 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.8 p -138.75 23.38 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 p -124.0 24.13 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -133.51 -41.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 -179.35 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' H ' HD12 ' A' ' 74' ' ' LEU . 1.3 m-20 61.96 102.54 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.6 Cg_exo -46.59 -34.69 15.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.422 2.081 . . . . 0.0 112.424 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -70.03 -7.55 41.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.24 -14.92 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.657 0.265 . . . . 0.0 110.946 178.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 48' ' ' LEU . 47.7 m-85 -99.05 99.11 10.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.244 -179.235 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -84.78 132.31 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.689 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.16 74.24 6.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.476 -178.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 124.7 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.664 179.086 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.985 HG13 HD22 ' A' ' 32' ' ' LEU . 81.0 t -73.59 -67.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.285 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.424 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 32' ' ' LEU . 86.8 Cg_endo . . . . . 0 N--CA 1.472 0.263 0 CA-C-O 120.819 0.258 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.8 118.29 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.575 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -97.38 47.44 1.03 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.67 -178.966 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t0 179.4 71.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.431 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.49 93.98 21.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.341 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 68.2 Cg_endo -95.9 23.66 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.319 2.679 . . . . 0.0 112.293 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.854 ' C ' HD23 ' A' ' 24' ' ' LEU . 16.7 p -92.31 42.83 1.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.281 -178.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.021 HD11 ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -130.31 178.55 1.67 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.377 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.1 Cg_exo -46.9 174.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.489 2.126 . . . . 0.0 112.737 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.86 44.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.16 -178.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.42 -0.12 60.97 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.393 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 55.0 m95 -102.57 133.43 47.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.942 -178.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -140.44 -176.53 4.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.416 179.789 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 1.021 ' CG ' HD11 ' A' ' 24' ' ' LEU . 2.5 mtp180 -143.25 156.98 44.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.596 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.885 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.8 ttpt -166.49 161.05 15.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.996 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.98 HD13 HG13 ' A' ' 83' ' ' VAL . 5.4 mt -130.28 166.8 19.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.252 0.549 . . . . 0.0 112.217 -178.224 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.6 tttt -139.31 115.49 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.861 -179.383 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.332 178.955 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.776 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.6 m-85 -104.75 153.96 20.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.461 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -120.31 144.21 47.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.215 176.245 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.712 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.6 p -85.92 148.61 4.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.13 -178.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.7 m-85 -145.35 97.95 3.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD12 ' HB3' ' A' ' 79' ' ' PHE . 7.6 mt -92.57 109.64 21.05 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.076 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.0 mt -82.23 126.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -171.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.5 p-10 -85.58 150.28 53.46 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.329 -178.598 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -38.57 -55.45 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.171 2.58 . . . . 0.0 112.802 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -46.77 -26.79 1.02 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.31 28.91 3.14 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.602 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -92.33 -178.84 5.05 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.368 0.604 . . . . 0.0 112.094 -179.406 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.2 88.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.076 177.112 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 83.2 m-85 -92.02 122.05 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.457 -177.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.496 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -92.84 -48.73 6.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.051 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 171.78 9.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.323 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 63' ' ' ILE . 7.8 tptp -88.68 -47.19 8.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 -179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 t -51.88 -26.85 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 110.147 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.59 -32.07 63.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.661 177.257 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -64.43 -62.66 1.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.84 179.371 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -61.56 -40.87 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.8 -68.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.122 -179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.532 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.79 -40.55 88.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.102 -179.632 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.517 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.6 m-30 -56.47 -30.9 63.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.345 . . . . 0.0 110.641 178.766 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.9 mm-40 -70.42 -60.28 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.915 -177.87 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.36 -26.05 62.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.597 -178.124 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 65' ' ' TYR . 12.1 m -86.58 -39.92 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.4 38.99 4.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.323 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.515 ' CG ' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.1 117.53 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 -179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.3 p -134.95 33.93 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 179.643 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 p -132.53 33.6 3.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.531 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.535 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -137.64 -39.04 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.494 -179.092 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER 66.75 93.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 110.57 -179.08 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 97.9 Cg_exo -44.97 -29.0 3.42 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -69.95 -7.94 44.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.386 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.25 -11.49 46.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.478 0.18 . . . . 0.0 111.291 178.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 48' ' ' LEU . 74.2 m-85 -103.4 102.36 12.29 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.485 -179.11 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.553 ' O ' HD11 ' A' ' 48' ' ' LEU . 13.6 t70 -94.0 160.35 14.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.294 178.185 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.712 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.0 m-30 -115.44 85.0 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.38 96.38 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.688 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.98 HG13 HD13 ' A' ' 32' ' ' LEU . 86.5 t -66.12 -32.43 58.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.334 -179.548 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.861 0.362 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.8 p -154.74 118.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.49 160.08 37.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.3 m -159.65 59.62 1.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.86 -169.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.751 2.301 . . . . 0.0 112.298 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt 43.09 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.057 0.456 . . . . 0.0 111.058 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -122.39 131.28 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.224 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 67.6 mtm-85 -93.67 128.59 39.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -122.04 82.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -164.62 65.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.841 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.4 145.25 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -94.32 40.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.449 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 78.97 121.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.6 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -45.54 96.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.441 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 137.31 29.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.46 -154.26 20.56 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.235 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 5.0 Cg_exo -79.62 -155.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.174 2.582 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.406 ' HG2' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -171.71 105.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.81 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 3.2 m-30 -67.35 -19.04 65.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.92 73.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.299 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -97.71 111.38 58.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -106.04 13.99 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.001 3.134 . . . . 0.0 112.617 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.639 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 p -90.65 50.06 1.76 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 30' ' ' ARG . 72.0 mt -154.17 160.33 31.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -22.79 145.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.653 3.569 . . . . 0.0 114.543 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.51 148.43 0.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.203 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.98 -58.36 2.24 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.785 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.522 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 78.7 m95 -47.42 133.44 12.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 112.087 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.52 167.72 20.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.864 ' HD2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -138.76 159.62 41.67 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.628 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.7 ttmm -157.32 167.59 29.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.994 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.011 HD22 HG12 ' A' ' 83' ' ' VAL . 6.7 mt -137.03 175.88 9.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.478 0.656 . . . . 0.0 112.258 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.0 tttm -147.81 106.59 3.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.157 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.3 tt0 -67.38 169.3 9.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.766 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.0 ttp180 -152.92 129.03 10.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.615 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.902 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -124.38 110.09 14.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 110.921 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.5 p -105.37 -31.31 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.228 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 41' ' ' ALA . . . 122.51 -23.67 7.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.112 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -70.29 0.8 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.013 0.435 . . . . 0.0 109.889 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -98.72 31.89 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.533 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -52.5 166.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.784 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 73.22 22.35 78.95 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.511 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 133.92 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.981 ' HB3' HG11 ' A' ' 83' ' ' VAL . 24.3 m-85 -100.09 164.49 11.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 5.7 m-20 -120.47 166.98 12.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.31 -1.768 . . . . 0.0 108.428 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 81' ' ' PHE . 54.2 t -128.07 147.94 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.201 0.524 . . . . 0.0 111.766 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 33.5 m-85 -149.05 102.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.139 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 6.1 mt -93.04 106.08 18.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 109.601 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.8 mt -82.3 123.62 38.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.956 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.426 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 t-20 -80.81 137.96 50.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.801 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 73.5 Cg_exo -34.02 -54.84 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.521 2.814 . . . . 0.0 113.456 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -50.99 -31.61 18.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 111.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.48 48.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.89 122.58 15.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -177.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.69 152.29 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.177 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 1.2 m-85 -129.78 167.97 17.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.64 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.16 3.49 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.87 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.49 171.63 19.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.43 -43.25 41.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.168 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 9.1 p -53.22 -44.39 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 109.873 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.1 tt0 -60.87 -27.83 68.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.3 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -69.6 -64.6 0.85 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.9 mp -65.9 -39.43 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.255 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.71 -58.0 8.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.0 t80 -68.86 -49.21 60.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 110.843 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 5.1 m-85 -46.82 -26.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.3 mm-40 -72.82 -57.06 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -16.1 63.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 65' ' ' TYR . 13.5 m -86.48 -40.18 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.174 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.62 43.73 2.86 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.514 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.954 ' OD2' HD11 ' A' ' 74' ' ' LEU . 11.4 p-10 -74.3 141.97 45.23 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 122.535 0.334 . . . . 0.0 111.562 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 t -149.86 23.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.372 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.88 52.37 0.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.954 HD11 ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -154.53 -44.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 63.66 100.81 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.435 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 86.4 Cg_exo -47.75 -31.55 15.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.469 2.112 . . . . 0.0 112.582 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -70.08 -8.49 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.505 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 1.04 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 62' ' ' LEU . 66.7 m-85 -109.37 130.89 55.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.857 0.361 . . . . 0.0 111.257 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -124.17 147.64 47.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.736 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.494 ' HD1' HG11 ' A' ' 46' ' ' VAL . 22.7 m-85 -105.96 77.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.33 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.1 p -140.71 111.64 7.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.011 HG12 HD22 ' A' ' 32' ' ' LEU . 3.4 m -64.69 -41.27 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.642 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.656 HG23 HG23 ' A' ' 83' ' ' VAL . 16.3 p -99.39 46.14 0.98 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 -175.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.74 -156.0 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.69 -103.88 0.4 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.79 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 p 58.17 25.3 12.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.764 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.01 -41.63 5.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.49 -29.38 15.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.92 6.09 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.914 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t 58.56 88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.22 143.66 10.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 t -157.07 71.78 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -87.07 24.66 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.967 2.445 . . . . 0.0 113.075 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.69 79.14 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.746 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -108.67 -54.43 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -101.88 174.97 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.955 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER 45.84 63.05 1.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.43 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -76.81 59.19 1.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' A' ' 9' ' ' ARG . 3.8 tt -138.23 119.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.1 mm -93.43 52.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 54.81 82.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -115.16 50.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.15 -170.51 2.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.719 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -145.21 -101.83 0.33 Allowed Glycine 0 CA--C 1.488 -1.601 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.142 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.522 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -79.8 -170.26 8.53 Favored 'Cis proline' 0 N--CA 1.473 0.29 0 C-N-CA 125.465 -0.64 . . . . 0.0 112.029 1.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtm -145.65 94.46 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.7 m-30 -67.18 -70.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.443 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 33.5 t0 -64.08 79.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' TYR . 3.2 m-20 -114.92 88.53 17.14 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 77.8 Cg_endo -97.22 14.38 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.393 2.728 . . . . 0.0 112.442 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -87.97 49.6 1.83 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.826 0.346 . . . . 0.0 111.426 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -129.65 176.23 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 94.2 Cg_exo -45.43 169.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.421 2.081 . . . . 0.0 112.824 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.16 124.09 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.141 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.77 -4.68 43.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.749 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 45.0 m95 -94.68 118.16 31.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.229 0.538 . . . . 0.0 112.069 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -118.01 -173.95 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 29' ' ' THR . 1.8 ttt180 -155.35 163.7 39.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HD23 ' A' ' 32' ' ' LEU . 7.5 tttt -172.78 158.61 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.359 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.972 HD13 ' HB ' ' A' ' 83' ' ' VAL . 6.2 mt -129.89 174.42 9.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 111.51 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -146.94 110.94 5.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.074 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -73.63 169.71 16.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.5 ttm180 -153.06 146.06 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.972 0.415 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' CE ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.02 -71.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.742 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.29 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.051 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA2' ' CE ' ' A' ' 36' ' ' LYS . . . 165.09 -34.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.768 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 127.8 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 39.43 28.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.067 0.461 . . . . 0.0 109.902 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.53 179.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.203 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 60.06 27.64 65.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.185 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 135.35 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.0 110.676 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 26.2 m-85 -106.63 163.73 12.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.872 0.844 . . . . 0.0 113.11 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.93 132.74 45.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.664 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.7 p -91.53 148.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.661 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 3.4 m-85 -143.7 103.38 4.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.403 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 79' ' ' PHE . 19.7 mt -92.96 110.78 22.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -85.19 124.65 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.463 0.649 . . . . 0.0 112.064 -173.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.496 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 24.6 p-10 -85.67 151.07 54.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.754 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -37.17 -53.68 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.565 2.843 . . . . 0.0 113.259 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -45.72 -26.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.253 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.73 47.22 1.2 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.764 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.955 0.407 . . . . 0.0 111.286 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -91.35 150.26 21.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.94 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.55 119.49 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.82 5.47 43.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.569 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.2 p -154.44 159.98 41.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.167 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.664 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.6 -39.5 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.167 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 61' ' ' GLU . 4.2 p -51.83 -48.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.787 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.6 mm-40 -61.88 -29.91 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.07 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -63.37 -60.42 3.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -67.81 -42.84 86.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.683 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.94 41.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -67.35 -50.77 58.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.333 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.703 ' CE2' HD13 ' A' ' 74' ' ' LEU . 23.0 m-30 -53.67 -26.76 23.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -69.12 -60.65 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.329 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.11 -27.71 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -177.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 68' ' ' LYS . 21.2 m -86.61 -44.47 16.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.93 44.06 3.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.967 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.27 143.55 29.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.262 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -145.95 22.87 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -124.45 33.42 5.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.39 -43.48 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.3 OUTLIER 62.8 107.9 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 88.0 Cg_exo -48.13 -31.89 17.56 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.324 2.016 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -69.97 -7.45 40.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.614 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.38 -4.02 59.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.293 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 62' ' ' LEU . 82.8 m-85 -107.62 123.41 48.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.735 0.303 . . . . 0.0 111.172 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.99 137.13 51.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-85 -95.71 79.16 3.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.042 0.449 . . . . 0.0 111.352 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -138.42 94.83 2.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.936 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.972 ' HB ' HD13 ' A' ' 32' ' ' LEU . 23.6 m -48.29 -48.51 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.761 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.517 ' N ' HG23 ' A' ' 83' ' ' VAL . 20.6 p -66.45 -44.28 83.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 135.29 173.8 13.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.637 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 -154.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.32 101.3 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.724 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.1 p -147.17 20.39 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.872 0.368 . . . . 0.0 110.509 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.15 -57.26 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.528 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m 62.36 119.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.96 0.41 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.12 -134.4 52.27 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.663 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.938 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -146.59 160.87 41.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.05 2.87 23.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.471 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -163.55 -64.44 0.01 OUTLIER Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 55.3 Cg_endo -89.73 -39.09 0.52 Allowed 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.565 -1.015 . . . . 0.0 112.872 -1.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -108.44 -158.99 0.67 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.506 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 63.09 87.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.194 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -67.95 136.65 54.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -133.3 58.54 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.7 80.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.055 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 tt -86.53 138.32 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.46 67.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.77 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 63.87 175.63 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.72 81.95 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.364 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 157.95 20.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.93 145.08 4.39 Favored Glycine 0 CA--C 1.488 -1.654 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.904 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.491 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 95.5 Cg_endo -77.18 -164.77 4.07 Favored 'Cis proline' 0 N--CA 1.476 0.476 0 C-N-CA 125.097 -0.793 . . . . 0.0 112.205 2.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.436 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -157.92 -40.58 0.07 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.549 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 17' ' ' PRO . 1.9 m-85 75.14 -65.89 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.555 0.217 . . . . 0.0 111.068 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.57 89.3 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.469 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 34.4 m-20 -131.8 65.66 76.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 29' ' ' THR . 8.9 Cg_endo -82.27 9.28 4.06 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.82 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 t -85.52 55.71 3.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.029 0.443 . . . . 0.0 110.681 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.4 mt -126.39 167.08 18.22 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.028 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 76.1 Cg_exo -40.79 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.751 2.3 . . . . 0.0 112.631 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.01 121.85 3.49 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.136 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 -2.2 49.59 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.798 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 48.9 m95 -96.85 140.96 30.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.237 0.519 . . . . 0.0 112.158 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -140.38 176.07 9.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.529 ' HG3' HD23 ' A' ' 48' ' ' LEU . 17.0 ttm105 -147.36 154.01 40.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.19 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.892 ' C ' HD23 ' A' ' 32' ' ' LEU . 12.1 ttmt -168.7 164.4 12.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.228 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.079 HD13 HG13 ' A' ' 83' ' ' VAL . 3.7 mt -128.66 161.27 30.07 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.157 0.503 . . . . 0.0 111.836 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.99 125.86 32.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.922 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 50.9 tt0 -77.97 167.13 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.135 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 34.2 ttm180 -152.98 164.78 37.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.935 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' CE ' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -136.97 110.73 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.671 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.29 -163.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.1 30.51 8.94 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.217 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.628 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -95.21 49.44 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.474 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . . . -57.2 115.06 2.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.56 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 110.19 36.3 1.99 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.754 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -87.52 136.85 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 111.092 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 20.5 m-85 -105.52 162.81 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -134.26 144.94 48.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.353 176.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.713 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -88.06 146.89 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.896 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.519 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.5 m-85 -142.82 98.65 3.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.0 111.291 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.701 HD13 ' HD1' ' A' ' 79' ' ' PHE . 14.4 mt -92.97 113.21 25.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.461 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 37.3 mt -92.16 127.94 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 34.7 p-10 -85.58 150.05 52.93 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.901 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -32.91 -58.74 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.928 3.085 . . . . 0.0 113.383 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -44.62 -27.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.21 51.18 0.89 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.813 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -139.75 130.68 26.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.931 0.395 . . . . 0.0 110.743 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -92.37 158.43 16.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.875 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -136.96 120.15 16.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.22 10.05 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -154.51 163.35 40.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.984 -177.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 3.8 tptp -79.75 -49.27 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.881 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 12.2 t -51.96 -33.6 16.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.216 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -70.36 -29.96 66.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.03 177.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD21 ' CB ' ' A' ' 79' ' ' PHE . 1.1 tp -63.06 -59.55 4.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.0 mp -70.33 -46.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.401 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -50.14 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.5 t80 -68.97 -57.78 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 110.477 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.6 m-30 -42.54 -33.38 0.68 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.36 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.5 mm-40 -76.18 -56.47 4.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.407 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.81 -21.82 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.667 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.809 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.7 m -92.37 -25.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.012 0.434 . . . . 0.0 109.933 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 71' ' ' ASP . . . 94.83 -30.81 7.51 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.821 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.855 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 49.2 157.91 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.9 p -90.11 -22.77 21.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.32 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.62 ' O ' HD12 ' A' ' 74' ' ' LEU . 10.9 p 165.06 -76.74 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.455 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER 49.57 -166.16 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.631 -177.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -162.93 92.38 1.2 Allowed Pre-proline 0 C--N 1.31 -1.137 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 81.8 Cg_exo -47.39 -33.26 16.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.319 2.013 . . . . 0.0 111.732 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -70.01 -19.41 63.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.54 0.22 56.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.648 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.701 ' HD1' HD13 ' A' ' 48' ' ' LEU . 96.9 m-85 -105.18 100.61 10.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 111.459 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.17 129.22 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.384 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.3 m-85 -88.32 87.45 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 111.202 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.654 HG21 ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -126.78 104.12 7.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.079 HG13 HD13 ' A' ' 32' ' ' LEU . 95.2 t -73.09 -67.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.644 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.8 p -58.29 -20.74 45.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . 126.33 163.94 11.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.307 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.654 ' HA ' HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -53.68 89.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 110.788 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' GLY . . . -98.81 89.23 0.9 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.732 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.8 p -89.45 14.98 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.588 0.233 . . . . 0.0 111.208 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.44 30.16 67.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.599 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.18 112.93 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.36 109.82 3.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.503 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.943 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.759 0.314 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -150.24 55.02 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.922 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.85 171.45 13.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.4 69.03 9.5 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.67 -12.07 30.61 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.66 2.24 . . . . 0.0 112.756 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.79 82.09 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -129.4 153.7 47.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 174.52 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.923 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.64 88.63 2.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m 70.22 76.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.1 tt -86.25 143.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 mm -89.22 52.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.785 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.2 mtt85 53.35 -172.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -51.5 129.89 26.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.791 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.23 134.56 41.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 162.32 152.88 6.91 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.696 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 88.4 Cg_endo -80.69 -160.19 2.27 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 124.738 -0.943 . . . . 0.0 112.362 3.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -165.81 134.48 3.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.633 ' CD1' HD12 ' A' ' 32' ' ' LEU . 1.6 m-30 -94.52 48.34 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.0 110.184 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 32.3 t70 -175.44 79.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.84 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -112.73 85.26 7.36 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.596 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HA ' HG23 ' A' ' 29' ' ' THR . 79.9 Cg_endo -89.0 25.96 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.98 2.453 . . . . 0.0 112.78 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -93.9 23.66 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -99.79 -178.26 0.67 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.7 Cg_exo -49.17 179.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.236 1.958 . . . . 0.0 112.18 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -55.5 120.78 7.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.157 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.8 50.68 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.818 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 51.8 m95 -93.75 131.34 39.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 111.689 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -132.32 179.92 5.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.645 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' H ' HG22 ' A' ' 29' ' ' THR . 7.1 ttp-105 -139.88 165.53 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.225 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -169.83 168.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.1 167.48 21.72 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.335 0.588 . . . . 0.0 112.399 -178.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 10.7 tttp -147.81 110.73 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.232 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.5 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 54.4 tt0 -67.77 166.47 15.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 1.8 ttm180 90.08 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.694 0.798 . . . . 0.0 112.304 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 176.41 85.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.0 -178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 5.9 m 54.96 -158.71 0.2 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.83 -21.22 21.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.838 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -78.1 -39.63 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.377 . . . . 0.0 111.032 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -120.42 33.4 5.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.792 178.46 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -54.4 85.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.106 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 139.02 58.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -138.65 146.91 42.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.8 m-85 -88.6 144.13 26.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 61.0 m-20 -110.62 172.16 7.03 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 113.892 -1.503 . . . . 0.0 109.519 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 70.6 t -131.64 145.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.7 m-85 -146.03 105.61 3.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.073 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 79' ' ' PHE . 15.3 mt -90.29 107.35 19.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.0 mt -82.86 123.26 38.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.112 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 6.3 t-20 -76.05 144.67 75.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.704 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 70.5 Cg_exo -37.01 -28.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.13 2.553 . . . . 0.0 113.113 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' ASN . 4.3 mm-40 -90.4 30.45 1.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 55.74 26.25 46.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.447 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -98.74 124.5 43.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.914 0.388 . . . . 0.0 110.427 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 138.15 34.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.8 m-85 -124.43 126.14 45.44 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 18.6 mtp180 -96.41 -58.36 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.497 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.35 171.9 9.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.92 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.602 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -80.58 -41.72 23.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.176 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 10.9 t -51.79 -31.58 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 -29.29 63.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 110.025 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 ' HD3' ' A' ' 59' ' ' LYS . 1.4 tp -66.52 -60.72 2.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -65.59 -45.92 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.17 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.86 -49.01 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 2.5 t80 -70.15 -57.65 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.115 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CE2' HD13 ' A' ' 74' ' ' LEU . 20.8 m-30 -46.83 -28.93 1.72 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -72.74 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.103 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.17 -23.93 50.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.495 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.7 m -91.56 -44.18 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.975 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 87.52 51.29 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.101 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.574 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.5 t70 -84.9 137.92 32.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 111.103 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 p -124.02 22.63 8.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.144 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -128.42 29.76 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.601 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.54 174.77 14.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -158.63 114.13 1.67 Allowed Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.358 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 62' ' ' LEU . 93.0 Cg_exo -46.41 -32.71 11.45 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.456 2.104 . . . . 0.0 112.0 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.04 -19.78 63.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.57 -1.94 58.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.584 ' HB3' HD13 ' A' ' 48' ' ' LEU . 94.9 m-85 -107.21 110.6 22.69 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.832 0.348 . . . . 0.0 111.085 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.38 131.75 53.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 20.3 m-30 -87.5 80.67 8.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.09 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.79 118.86 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.356 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 32' ' ' LEU . 52.2 t -65.65 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.235 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 p -58.18 -28.26 64.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.3 . . . . 0.0 111.021 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.43 -165.36 24.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.726 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -89.84 -148.08 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.23 44.0 91.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.314 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.82 10.89 21.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.476 0.179 . . . . 0.0 111.465 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.76 81.92 0.07 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.7 t 60.15 125.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.147 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.37 26.95 21.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.449 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.949 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.806 0.336 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t 60.18 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.604 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.48 74.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.403 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -76.41 -57.62 1.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 4' ' ' SER . 84.6 Cg_endo -80.64 -21.43 7.25 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.61 2.207 . . . . 0.0 112.141 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 70.75 10.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -157.72 55.15 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -97.35 153.02 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -135.32 172.58 12.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.9 91.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 tp -83.37 140.37 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.2 mm -94.28 57.45 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 45.07 47.72 9.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -97.52 -166.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.168 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.74 164.33 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.475 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 17' ' ' PRO . . . -170.04 -142.51 3.6 Favored Glycine 0 CA--C 1.49 -1.495 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.766 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 7.8 Cg_exo -69.36 -179.75 19.31 Favored 'Cis proline' 0 N--CA 1.474 0.363 0 C-N-CA 125.097 -0.793 . . . . 0.0 112.085 -3.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mtm -148.28 102.54 3.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -79.85 -67.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.776 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.2 83.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.579 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 6.2 m-20 -118.75 85.39 27.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.389 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' HG23 ' A' ' 29' ' ' THR . 61.8 Cg_endo -95.66 14.03 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.239 2.626 . . . . 0.0 112.503 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HD23 ' A' ' 24' ' ' LEU . 5.0 p -86.16 51.2 2.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.33 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 23' ' ' THR . 1.1 mt -132.3 179.07 1.47 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.073 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 95.6 Cg_exo -45.14 166.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.362 2.041 . . . . 0.0 112.546 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 126.0 5.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.847 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.4 -52.66 4.37 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.506 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 m95 -44.86 142.29 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 112.323 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -144.85 -169.98 3.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.731 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 29' ' ' THR . 43.8 ttp180 -156.9 161.96 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.861 ' C ' HD23 ' A' ' 32' ' ' LEU . 5.4 ttmt -168.97 160.11 9.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.249 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.045 HD13 HG13 ' A' ' 83' ' ' VAL . 1.6 mt -131.31 163.51 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.169 0.509 . . . . 0.0 111.368 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.24 116.89 12.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.18 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 167.65 19.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.499 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 42' ' ' GLY . 17.3 ttp85 -153.06 133.32 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 111.163 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.9 tptt -87.37 -40.64 14.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.488 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.42 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.385 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . 158.77 -24.6 0.35 Allowed Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.988 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -123.66 -49.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.586 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.02 48.67 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.085 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.44 177.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.598 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 53.57 23.93 22.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.636 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 131.91 34.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.0 110.529 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.788 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.8 m-85 -103.68 163.21 12.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.679 0.752 . . . . 0.0 112.977 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.97 140.16 48.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.743 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.0 p -91.98 148.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.3 m-85 -146.19 103.42 3.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.685 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.903 HD13 ' HB3' ' A' ' 79' ' ' PHE . 7.0 mt -92.62 114.44 26.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -87.35 127.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.804 0.811 . . . . 0.0 113.149 -171.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 54' ' ' LYS . 13.0 t-20 -82.44 135.01 47.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.506 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 85.6 Cg_exo -32.86 -51.7 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.666 2.91 . . . . 0.0 113.631 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -46.94 -26.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.374 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.12 18.14 6.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.332 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.6 tttt -96.67 147.91 23.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.552 0.215 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' LYS . . . -114.97 108.8 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.991 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.5 m-85 -92.72 124.2 36.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -93.14 -9.45 39.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.416 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.58 176.71 11.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.984 0.421 . . . . 0.0 111.558 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HD2' HD11 ' A' ' 63' ' ' ILE . 2.2 mmtp -79.15 -42.72 25.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.166 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 20.2 t -51.85 -35.48 18.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.676 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' OE1' ' CA ' ' A' ' 61' ' ' GLU . 2.3 mm-40 -72.79 -27.08 61.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.092 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -68.17 -65.45 0.69 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -56.4 -41.17 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.92 -66.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.484 ' CD2' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.76 -50.2 74.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.423 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.4 m-30 -51.79 -29.69 20.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.391 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.2 mm-40 -67.0 -64.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.053 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.26 -24.68 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.6 -177.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.42 -33.28 5.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 42.69 9.96 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.715 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB3' HD21 ' A' ' 74' ' ' LEU . 1.1 t0 -82.96 121.65 27.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.716 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -127.37 34.25 4.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.16 25.7 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -133.65 -39.51 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 6.8 m-20 60.45 101.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.513 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 85.6 Cg_exo -47.52 -31.29 13.46 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.35 2.033 . . . . 0.0 112.404 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.01 -7.79 43.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -19.46 35.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.614 0.245 . . . . 0.0 110.858 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.5 m-85 -96.63 116.47 29.17 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.655 ' O ' HD11 ' A' ' 48' ' ' LEU . 7.4 t0 -103.8 151.46 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.555 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.578 ' CE1' HD12 ' A' ' 48' ' ' LEU . 16.9 m-85 -109.18 88.84 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 111.378 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 142.43 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.65 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.045 HG13 HD13 ' A' ' 32' ' ' LEU . 94.7 t -114.07 -34.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 p -95.37 35.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.18 -174.61 53.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.378 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -131.6 -158.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.503 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.63 -62.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.412 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m 55.6 24.57 7.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.327 . . . . 0.0 110.897 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.97 -83.27 1.72 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.5 p -85.52 74.27 10.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.19 -124.72 2.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.961 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.787 0.327 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 t -90.31 91.21 8.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.951 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.44 71.88 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.042 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.1 p -151.6 88.87 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.42 3.19 6.99 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.696 2.264 . . . . 0.0 112.998 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.86 91.02 5.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -128.21 -162.73 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 -73.88 125.64 28.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.062 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -96.13 83.26 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.032 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.448 ' C ' HG22 ' A' ' 11' ' ' ILE . 94.2 p -83.81 57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.599 HD11 ' NE ' ' A' ' 15' ' ' ARG . 2.6 tt 47.01 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 111.376 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.9 mm -90.5 57.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.951 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 49.08 60.22 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -114.75 51.19 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.041 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.599 ' NE ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -118.27 141.09 48.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.893 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.44 97.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.968 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.905 ' CB ' HD12 ' A' ' 32' ' ' LEU . 96.7 Cg_endo -76.23 154.23 36.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.416 ' CE ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -136.74 -14.84 1.61 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 52.94 46.03 27.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.281 0.562 . . . . 0.0 110.0 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.488 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.8 t0 -137.7 77.68 1.65 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.806 ' CG ' HG23 ' A' ' 29' ' ' THR . 2.5 m-20 56.09 -96.46 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.777 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.7 Cg_endo -92.11 -5.0 46.16 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 CA-C-N 123.14 2.157 . . . . 0.0 113.739 -8.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 22' ' ' PRO . 1.7 t -156.43 15.68 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' THR . 5.7 mt -53.27 160.39 1.74 Allowed Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.085 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.5 Cg_exo -44.77 172.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.371 2.048 . . . . 0.0 111.993 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 123.24 6.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.696 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.54 -44.22 3.31 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.862 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.536 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 64.9 m95 -54.05 142.55 24.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.145 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -143.22 167.77 21.34 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.489 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 2.0 ptm85 -122.09 153.27 38.9 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.103 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.963 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.3 tttt -151.17 152.06 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.356 1.66 . . . . 0.0 109.612 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 31' ' ' LYS . 9.7 mt -131.39 157.33 43.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.7 115.94 18.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.326 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.2 tt0 -70.21 171.31 9.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.989 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -151.57 143.59 23.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.064 0.459 . . . . 0.0 110.902 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 41' ' ' ALA . 16.4 tptm -137.08 128.82 28.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.26 -51.19 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.322 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.2 45.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.215 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.55 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.44 32.98 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.936 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . . . -52.57 -170.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.571 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 50.86 24.42 8.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.961 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.54 133.03 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.691 ' HB2' HG11 ' A' ' 83' ' ' VAL . 7.1 m-85 -106.69 164.57 11.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -133.54 147.37 51.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.362 176.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.63 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.8 p -89.04 146.69 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.018 0.437 . . . . 0.0 112.025 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m-85 -146.09 101.05 3.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.363 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -91.03 108.22 19.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 3.6 mt -82.23 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.061 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.4 t-20 -83.69 135.99 42.58 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.747 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 77.3 Cg_exo -34.47 -54.68 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.531 2.821 . . . . 0.0 113.261 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -50.35 -32.61 17.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.526 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HD2' ' CD2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -138.84 129.14 25.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.76 150.88 22.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.938 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 49.4 m-85 -133.85 131.67 39.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.955 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -105.84 -9.38 17.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.764 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.26 172.16 18.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 111.384 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.08 -39.74 75.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.728 -177.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 3.2 t -55.29 -44.32 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.04 -27.5 69.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.696 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -65.41 -65.17 0.71 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.001 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 ' HD2' ' A' ' 59' ' ' LYS . 4.4 mp -62.94 -42.38 96.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.48 -47.76 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 3.0 t80 -72.72 -59.23 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.415 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.014 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.5 m-30 -44.03 -32.61 1.21 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.24 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.6 mm-40 -65.68 -60.96 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.934 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.87 -21.13 41.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.125 -178.253 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.934 HG13 ' HD3' ' A' ' 68' ' ' LYS . 20.2 m -95.35 -48.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.16 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 106.92 34.54 2.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.9 t0 -89.39 142.2 27.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.988 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -148.41 25.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.03 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.73 31.81 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -130.31 -32.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.559 -178.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.02 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.469 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 44.6 Cg_exo -52.06 -35.86 63.32 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.185 1.923 . . . . 0.0 112.279 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.03 -12.09 61.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.537 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.67 10.58 15.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.508 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' HD12 ' A' ' 48' ' ' LEU . 67.8 m-85 -113.18 92.93 4.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.26 134.88 35.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 33.5 m-85 -96.76 99.44 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.07 92.17 2.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 44' ' ' TYR . 60.7 t -54.7 -21.14 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.436 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -105.9 51.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.53 -141.86 3.32 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.056 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 173.63 162.73 0.16 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.95 0.405 . . . . 0.0 110.168 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.44 47.08 3.68 Favored Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -19.28 44.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.658 0.266 . . . . 0.0 111.024 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.82 -84.07 1.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t 62.59 85.89 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 -103.29 2.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.631 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.434 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 t 61.77 96.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.94 53.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.457 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -163.55 -64.28 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 50.2 Cg_endo -90.08 -36.77 0.74 Allowed 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.596 -1.002 . . . . 0.0 113.03 -1.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 80.76 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.1 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -127.25 123.38 36.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -69.96 165.18 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.931 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -121.23 63.46 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 4.7 m -156.79 91.46 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 48.69 103.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.415 0.626 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -79.79 70.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 59.7 -176.07 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -50.47 121.23 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.8 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 140.52 30.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.96 146.67 4.9 Favored Glycine 0 CA--C 1.487 -1.704 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.603 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.684 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.6 Cg_endo -78.05 176.91 41.22 Favored 'Cis proline' 0 N--CA 1.475 0.386 0 C-N-CA 125.014 -0.828 . . . . 0.0 112.509 3.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.464 ' HE2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -145.2 101.75 3.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.737 0.304 . . . . 0.0 111.274 -178.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -91.98 64.25 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.5 t70 175.65 72.19 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.625 ' CB ' ' HA ' ' A' ' 22' ' ' PRO 0.254 0.0 OUTLIER 55.69 -94.12 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.475 0 CA-C-O 115.598 -2.144 . . . . 0.0 106.97 -171.659 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HG2' HG22 ' A' ' 23' ' ' THR . 7.7 Cg_endo -96.69 -2.62 32.5 Favored 'Cis proline' 0 N--CA 1.479 0.668 0 CA-C-N 122.772 2.026 . . . . 0.0 113.403 -10.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.658 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -148.55 66.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 111.114 -178.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 30' ' ' ARG . 12.5 mt -116.24 165.36 15.09 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.54 170.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.492 2.128 . . . . 0.0 112.269 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.03 123.22 9.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.819 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.92 -1.71 58.0 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.501 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 53.5 m95 -99.45 138.52 36.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.545 HG22 ' CA ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -138.43 166.91 23.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.631 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.568 ' HB2' HD11 ' A' ' 24' ' ' LEU . 24.3 ttm180 -135.49 154.48 51.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.937 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -159.5 157.51 30.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.977 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.937 HD23 ' O ' ' A' ' 31' ' ' LYS . 5.0 mt -131.34 155.56 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.041 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -125.57 117.16 22.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.691 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -72.77 171.34 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.417 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 1.2 tpt85 -153.08 152.69 31.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.2 108.82 13.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.566 0.698 . . . . 0.0 111.803 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 41' ' ' ALA . 1.9 m -134.65 132.4 38.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.122 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.74 -26.96 1.23 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.015 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -48.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.291 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -102.22 47.3 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.542 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -52.81 96.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.687 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 98.8 43.55 2.63 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.813 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.54 136.46 33.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.866 0.365 . . . . 0.0 110.515 179.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.7 m-85 -106.77 163.77 12.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.49 0.662 . . . . 0.0 112.773 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -134.22 144.01 48.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 175.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.658 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -86.31 149.76 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.318 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.1 102.54 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -92.98 112.72 24.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.7 mt -88.49 122.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.354 -176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 11.7 p-10 -84.66 159.83 57.36 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.41 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 88.2 Cg_exo -40.03 -27.75 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.26 2.64 . . . . 0.0 113.163 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.62 32.84 1.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.997 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.17 28.21 12.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.166 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -99.07 121.4 40.93 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.059 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.06 149.25 21.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.546 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 68.7 m-85 -147.82 129.69 15.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.662 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -103.57 -52.12 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.64 177.91 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.669 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.53 ' HE2' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.82 -42.89 10.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.641 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -51.89 -29.55 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.897 0.38 . . . . 0.0 110.697 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.88 -29.69 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -68.61 -68.32 0.4 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.481 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.616 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -54.99 -40.49 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -54.99 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.263 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -67.45 -58.92 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 74' ' ' LEU . 16.4 m-30 -44.65 -28.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.783 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.0 mm-40 -61.13 -69.8 0.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.68 -16.99 18.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.991 0.424 . . . . 0.0 110.676 177.124 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 65' ' ' TYR . 87.1 t -84.39 -69.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.663 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.32 56.17 0.33 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.758 ' OD2' HD11 ' A' ' 74' ' ' LEU . 4.7 p-10 -74.23 134.9 42.7 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 111.852 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -149.97 26.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.037 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -164.64 45.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -154.53 -35.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.01 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 50.27 102.33 0.03 OUTLIER Pre-proline 0 C--O 1.231 0.117 0 CA-C-O 120.519 0.2 . . . . 0.0 111.35 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 74.9 Cg_exo -43.61 -32.94 4.21 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.386 2.057 . . . . 0.0 112.432 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.34 -20.41 64.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.26 -7.68 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.539 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 62' ' ' LEU . 72.2 m-85 -102.65 97.86 7.99 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' OD1' HG23 ' A' ' 82' ' ' THR . 1.1 t70 -91.7 134.04 35.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.658 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-30 -96.08 70.83 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.011 0.434 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 p -101.92 -9.53 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.359 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.807 HG13 HD13 ' A' ' 32' ' ' LEU . 54.6 t 67.59 -58.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 82' ' ' THR . 73.1 p -83.52 28.25 0.56 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.41 168.11 2.06 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.848 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 -155.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.07 109.12 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.412 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.93 22.14 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 111.205 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.82 98.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.426 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.7 m -82.95 142.16 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.043 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.25 -154.53 29.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 88.2 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.861 179.943 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -141.91 138.57 32.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.63 154.31 24.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.23 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.02 88.9 4.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.58 -170.05 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp 40.08 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -138.39 143.54 39.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.033 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -102.49 128.04 49.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 176.02 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 10.9 t -166.6 38.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.639 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.668 HD11 ' HB2' ' A' ' 13' ' ' ARG . 3.8 tt 50.54 119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.466 0.706 . . . . 0.0 112.46 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 12' ' ' ILE . 8.0 tp -84.85 48.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.888 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.668 ' HB2' HD11 ' A' ' 11' ' ' ILE . 35.5 mtt180 -148.14 92.38 2.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.4 98.06 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.39 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.23 175.62 7.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.308 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.54 83.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.239 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.652 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.0 Cg_endo -84.18 137.93 7.49 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.888 2.392 . . . . 0.0 111.594 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.458 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -129.05 -18.73 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 66.97 -74.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 -1.29 76.15 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR 0.251 0.0 OUTLIER 46.35 -93.3 0.0 OUTLIER Pre-proline 0 CA--C 1.494 -1.179 0 CA-C-O 116.677 -1.63 . . . . 0.0 109.666 -179.49 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.3 Cg_endo -100.84 -2.26 18.28 Favored 'Cis proline' 0 N--CA 1.477 0.532 0 CA-C-N 122.688 1.996 . . . . 0.0 113.452 -5.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.821 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -159.37 82.72 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.125 -176.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -126.28 156.33 72.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -179.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.857 2.371 . . . . 0.0 112.551 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -56.79 120.86 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.44 -5.73 49.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.291 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.513 ' HB3' HD12 ' A' ' 24' ' ' LEU . 59.9 m95 -96.71 143.41 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.992 0.396 . . . . 0.0 111.15 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -149.58 172.36 15.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.733 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' CD ' HD21 ' A' ' 24' ' ' LEU . 2.3 mtp180 -132.07 142.17 49.44 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.965 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.4 ttmt -151.71 160.56 43.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.516 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.974 HD13 HG13 ' A' ' 83' ' ' VAL . 10.2 mt -131.88 153.25 50.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.26 0.552 . . . . 0.0 111.901 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -120.33 118.34 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.514 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 50.1 tt0 -80.15 136.78 36.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.542 0.687 . . . . 0.0 111.3 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.535 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.06 88.02 7.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.316 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -29.94 -89.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.026 0.829 . . . . 0.0 111.885 177.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.36 -84.3 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.825 0.345 . . . . 0.0 110.194 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' ARG . . . 72.85 -65.91 1.45 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 164.1 -34.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.14 -16.25 22.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.936 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . 56.75 128.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.576 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.3 57.07 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.258 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.75 124.67 33.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.122 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.61 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.1 m-85 -97.7 153.07 18.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -129.97 147.04 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.461 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' HD22 ' A' ' 32' ' ' LEU . 8.2 p -87.47 145.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.767 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 13.2 m-85 -146.1 102.14 3.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.086 0.469 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 79' ' ' PHE . 10.3 mt -92.93 110.38 21.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 29' ' ' THR . 4.3 mt -85.25 125.11 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.047 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.508 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.9 p-10 -85.81 153.55 57.9 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.868 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 87.2 Cg_exo -39.78 -51.97 2.8 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 113.169 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -48.16 -24.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.88 49.05 1.19 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.996 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.94 135.47 31.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.862 0.363 . . . . 0.0 111.568 -178.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.767 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -90.07 149.52 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 96.3 m-85 -130.46 133.86 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.117 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mtp180 -99.32 -60.58 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 24.9 p -88.49 177.11 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.933 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -85.98 -41.33 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 24.9 t -51.98 -28.43 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.659 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 1.6 mm-40 -74.88 -32.4 61.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.282 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -65.35 -61.38 2.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.446 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.593 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.77 -38.06 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.497 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.94 -66.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CD1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -57.9 -48.22 80.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 74' ' ' LEU . 22.0 m-30 -53.02 -30.36 35.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.799 0.333 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.4 mm-40 -69.31 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.968 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.2 -25.57 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.702 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 70' ' ' GLY . 11.9 m -86.79 -44.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.813 0.34 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.94 43.77 3.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.482 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.9 134.89 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 p -139.83 27.83 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 t -128.07 30.66 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -140.0 -41.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.616 ' H ' HD12 ' A' ' 74' ' ' LEU . 3.4 m-20 64.18 109.04 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.5 Cg_exo -50.59 -31.42 31.67 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.321 2.014 . . . . 0.0 112.176 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.16 -8.62 51.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.505 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.18 -13.47 41.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.224 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.588 ' CD2' HD21 ' A' ' 62' ' ' LEU . 86.0 m-85 -99.0 114.28 26.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.804 0.335 . . . . 0.0 111.133 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.29 145.51 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.01 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.502 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.4 m-85 -102.73 96.14 6.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.17 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.04 88.43 2.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.906 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.974 HG13 HD13 ' A' ' 32' ' ' LEU . 62.5 t -52.29 -32.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 111.063 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.8 p -90.31 43.76 1.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.633 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.53 -160.24 0.03 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.227 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -151.39 -155.27 0.6 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.42 66.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.34 -18.89 54.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.24 . . . . 0.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 60.53 97.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.487 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.5 t -152.66 -64.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.994 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.1 -150.95 42.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.373 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.966 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p -142.17 117.68 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.93 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.0 81.45 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.92 -167.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.567 2.178 . . . . 0.0 112.264 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mttp 41.94 82.47 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.391 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -132.22 -51.06 0.95 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.127 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.31 176.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.702 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -118.28 115.02 23.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.038 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 t 68.61 71.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 11' ' ' ILE . 4.4 tt -137.54 108.9 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 12' ' ' ILE . 27.6 mm -94.3 53.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.295 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 46.46 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.973 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -134.32 50.04 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.08 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -75.73 -177.06 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.987 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.91 172.22 15.04 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.408 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 41.9 Cg_endo -66.72 -166.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.783 2.322 . . . . 0.0 112.2 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 102.79 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.32 -73.91 0.13 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -177.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.0 m-20 -62.04 83.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.544 0.211 . . . . 0.0 110.665 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB2' ' A' ' 30' ' ' ARG . 2.4 t0 -113.07 88.77 12.69 Favored Pre-proline 0 C--N 1.332 -0.159 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.426 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 29' ' ' THR . 63.2 Cg_endo -93.3 18.75 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.194 2.596 . . . . 0.0 112.641 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.5 p -92.82 21.74 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.507 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.0 mt -98.63 164.04 17.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.895 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -40.86 167.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.19 2.593 . . . . 0.0 112.597 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.24 126.33 7.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.2 -1.27 56.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.665 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 64.2 m95 -100.85 143.89 30.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.349 0.574 . . . . 0.0 112.152 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -147.72 -178.93 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.008 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.594 ' CD ' HD22 ' A' ' 48' ' ' LEU . 5.3 mtm180 -144.14 170.79 15.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 0.0 111.326 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.704 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.0 ttmt -177.91 159.25 1.35 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.421 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 31' ' ' LYS . 4.5 mt -128.24 173.74 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.826 0.822 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.34 106.39 3.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.688 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.13 172.1 8.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.831 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.84 125.46 8.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.537 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 1.3 mmpt? -93.21 -88.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.54 -67.97 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 110.957 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . 154.51 -76.42 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.0 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 110.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.33 . . . . 0.0 110.545 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.96 34.81 19.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.405 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -52.5 151.58 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.124 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.15 24.05 23.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.058 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -85.0 136.15 33.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.532 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.701 ' CB ' HG11 ' A' ' 83' ' ' VAL . 30.3 m-85 -106.11 160.51 15.26 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -127.1 142.14 51.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.676 174.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 81' ' ' PHE . 44.9 t -91.39 148.05 4.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.79 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.9 m-85 -146.05 91.18 2.04 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.85 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -93.04 109.82 21.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.323 0.582 . . . . 0.0 109.464 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG12 ' HB2' ' A' ' 55' ' ' ALA . 10.8 mt -84.77 122.78 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.104 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.4 p-10 -85.61 163.22 45.16 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.361 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 66.0 Cg_exo -37.79 -29.48 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.248 2.632 . . . . 0.0 113.288 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -91.69 34.54 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.649 0.262 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 47.79 25.45 3.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.102 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 51.7 tptt -99.1 121.94 41.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -95.23 147.82 23.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.08 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.3 m-85 -134.04 149.7 51.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.822 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.7 -39.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 8.4 t -85.63 -77.43 0.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.968 -176.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER 161.18 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 28.3 t -55.2 -29.09 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.16 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.7 -33.58 74.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.991 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -65.15 -68.38 0.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.48 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -54.26 -45.14 67.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.86 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.75 -54.11 38.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.6 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -66.27 -53.02 41.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.431 -179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.673 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -53.18 -23.02 7.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.9 mm-40 -71.19 -61.85 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.864 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.703 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -54.68 -26.23 32.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.636 -177.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.703 HG13 ' CD ' ' A' ' 68' ' ' LYS . 9.6 m -91.1 -45.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.901 0.382 . . . . 0.0 111.062 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 95.56 37.27 5.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.294 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.761 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -90.0 146.41 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.033 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -148.99 18.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.75 23.52 11.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.037 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -154.48 67.54 0.71 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER 60.85 -174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.149 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.743 ' HG3' HD12 ' A' ' 62' ' ' LEU . 84.6 Cg_exo -75.83 -158.08 1.56 Allowed 'Cis proline' 0 C--N 1.308 -1.598 0 N-CA-C 115.385 1.264 . . . . 0.0 115.385 17.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 20.49 9.25 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.866 -177.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 2.2 m-20 -146.2 -12.17 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 62' ' ' LEU . 50.3 m-85 -86.76 83.07 7.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.028 0.376 . . . . 0.0 110.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.21 98.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.575 ' HA ' HG11 ' A' ' 46' ' ' VAL . 4.3 m-30 -85.47 52.92 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -115.2 131.51 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.438 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.701 HG11 ' CB ' ' A' ' 44' ' ' TYR . 23.1 m -64.56 -49.23 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.745 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.496 ' N ' HG23 ' A' ' 83' ' ' VAL . 16.8 p -88.18 45.48 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.131 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.27 -150.68 3.08 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.55 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.417 ' N ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -133.72 49.41 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.092 0.472 . . . . 0.0 110.805 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -91.64 64.2 2.52 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 p -82.16 -18.55 42.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.48 103.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.3 m 57.13 61.76 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 110.764 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.09 178.11 51.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.611 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.941 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -88.4 -178.32 5.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.42 76.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t 65.53 72.47 0.46 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.62 -170.83 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.639 2.226 . . . . 0.0 112.279 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 41.08 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.509 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -128.92 -165.15 1.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -105.4 -179.56 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.84 27.48 8.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.009 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.87 43.72 25.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 11' ' ' ILE . 10.9 tt -92.49 105.85 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.9 mm -89.46 69.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' ARG . 46.0 mtm180 64.31 -178.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -52.06 90.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.95 156.12 34.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.208 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.09 77.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.011 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 12.3 Cg_endo -87.29 179.28 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.008 2.472 . . . . 0.0 112.157 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.501 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -169.19 109.07 0.45 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.453 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -78.43 80.22 4.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 39.1 t70 -154.57 64.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.038 -170.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.797 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 64.88 -103.39 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -0.993 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.607 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 Cg_endo -84.04 130.91 16.13 Favored 'Cis proline' 0 N--CA 1.479 0.64 0 CA-C-N 123.617 2.327 . . . . 0.0 113.803 -6.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.524 ' N ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 41.37 84.05 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.131 173.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.955 HD11 ' HG3' ' A' ' 30' ' ' ARG . 8.0 mt -124.53 166.65 18.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 87.0 Cg_exo -47.45 165.59 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 125.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.234 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.66 -2.7 53.02 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.964 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.5 m95 -100.17 139.94 35.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.366 0.583 . . . . 0.0 112.067 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.877 ' CA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.41 171.64 16.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.19 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.955 ' HG3' HD11 ' A' ' 24' ' ' LEU . 14.7 mtm180 -132.62 144.44 50.36 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.573 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -135.16 177.04 8.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.977 -177.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' LYS . 15.0 mt -148.74 155.71 41.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.254 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.75 118.78 8.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.274 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.4 tt0 -69.0 166.49 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.164 0.507 . . . . 0.0 110.718 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.505 ' HA ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 88.28 -174.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.801 177.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.19 -88.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.828 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -155.07 -56.99 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.987 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.31 -40.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.67 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -67.31 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.009 0.433 . . . . 0.0 110.413 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -96.23 43.2 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.96 80.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.505 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 151.91 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 35' ' ' ARG . 2.8 mtpt -141.0 152.34 44.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 6.5 m-85 -88.71 133.16 34.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -104.92 156.28 18.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.566 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 83' ' ' VAL . 44.7 t -95.11 147.42 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.3 m-85 -147.2 102.37 3.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.797 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.9 mt -92.79 106.77 18.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.6 mt -82.18 122.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.106 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 16.6 p-10 -85.95 146.27 42.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.307 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -36.0 -48.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.451 2.767 . . . . 0.0 113.087 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -46.09 -26.86 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.16 6.58 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.109 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.1 tttt -98.99 170.83 8.44 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.49 0.186 . . . . 0.0 110.995 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.82 96.79 3.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.0 m-85 -95.13 122.78 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.775 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -91.6 -46.09 8.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 50.7 p -87.24 165.73 15.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.965 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.22 -36.34 34.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG12 ' OG ' ' A' ' 58' ' ' SER . 4.1 p -52.04 -42.34 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.16 0.505 . . . . 0.0 110.52 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 2.4 mm-40 -61.12 -32.04 71.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.639 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -67.5 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.6 mp -58.13 -37.24 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.415 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.81 -70.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.655 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.89 -38.29 81.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.8 m-30 -58.6 -28.79 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.8 mm-40 -72.47 -60.18 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.779 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.29 -25.81 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.265 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.5 m -88.61 -45.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.089 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.43 42.19 4.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.551 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.618 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.3 t0 -84.06 133.25 34.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.779 0.323 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.2 p -140.02 25.84 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -126.09 24.66 6.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.862 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -135.23 -40.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER 64.29 107.65 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.104 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.2 Cg_exo -49.49 -32.53 27.37 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.464 2.11 . . . . 0.0 112.474 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -69.77 -13.98 62.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.02 -9.47 58.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.232 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 78.6 m-85 -100.64 97.25 7.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.55 140.09 29.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.964 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-30 -94.13 110.61 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -145.67 131.26 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 46' ' ' VAL . 77.8 t -96.25 -37.17 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 p -92.69 42.61 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.113 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -174.46 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.947 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -136.67 -148.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.51 50.85 52.81 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.932 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 p -92.66 34.33 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.657 0.265 . . . . 0.0 111.307 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.73 118.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.409 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m 63.34 57.46 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.23 -133.01 2.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.457 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.984 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m 60.2 48.07 8.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.23 164.35 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER 55.98 53.34 7.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.192 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 4' ' ' SER . 66.4 Cg_endo -72.42 -19.73 24.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.57 2.18 . . . . 0.0 112.233 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -77.32 60.71 2.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -135.64 -72.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.69 150.38 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 45.35 27.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.43 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.9 p -78.84 59.23 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.645 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.2 tt 49.54 106.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.494 0.664 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.18 58.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.886 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 71.15 168.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.9 102.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.283 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.05 132.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.88 -107.57 2.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 74.4 Cg_endo -75.91 178.92 6.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.444 2.096 . . . . 0.0 112.392 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 97.83 2.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.201 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.1 m-30 -67.9 -71.33 0.21 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.311 -178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -55.64 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -129.73 85.42 58.28 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.361 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -92.61 14.86 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.16 2.573 . . . . 0.0 112.224 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.435 ' C ' HD23 ' A' ' 24' ' ' LEU . 51.9 p -87.81 49.24 1.77 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -126.13 -178.42 0.72 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.983 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 71.7 Cg_exo -48.4 168.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.009 1.806 . . . . 0.0 111.917 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.41 123.99 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 110.757 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 51' ' ' PRO . . . 92.08 -64.64 2.33 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.632 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 76.1 m95 -32.47 136.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.57 175.85 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.354 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 27.4 ttm180 -147.36 156.06 42.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.958 0.409 . . . . 0.0 111.28 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.898 ' O ' HD23 ' A' ' 32' ' ' LEU . 26.3 tttm -166.0 161.32 17.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.022 HD13 HG13 ' A' ' 83' ' ' VAL . 6.0 mt -129.59 163.25 26.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.897 0.38 . . . . 0.0 111.355 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.9 tttt -143.7 118.99 10.19 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.991 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.515 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.9 tt0 -80.71 107.16 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 112.311 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER 178.85 -173.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.994 173.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.65 35.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.31 -94.23 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.156 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.31 -31.26 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.682 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 108.92 14.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 111.375 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.48 47.41 21.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.944 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.34 143.34 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.829 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.05 67.24 0.84 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -149.62 140.58 22.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.364 0.602 . . . . 0.0 110.536 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 9.3 m-85 -83.56 134.94 34.8 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -117.66 148.67 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.383 177.07 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 81' ' ' PHE . 5.6 p -90.33 149.29 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.007 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 12.1 m-85 -146.07 95.85 2.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.934 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.63 HD23 ' HG3' ' A' ' 30' ' ' ARG . 11.9 mt -91.61 113.15 25.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.8 mt -90.58 117.46 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.028 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.632 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 6.6 p-10 -96.82 123.52 53.42 Favored Pre-proline 0 CA--C 1.491 -1.321 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.527 ' CB ' ' HA3' ' A' ' 27' ' ' GLY . 4.7 Cg_exo -71.04 -31.97 4.55 Favored 'Cis proline' 0 C--N 1.309 -1.544 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 -26.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' O ' HG21 ' A' ' 49' ' ' ILE . 19.2 mt-30 -141.61 -27.75 0.66 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.707 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.21 -31.1 6.33 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.172 -1.013 . . . . 0.0 114.389 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 56' ' ' PHE . 41.9 tptt -99.15 125.18 44.65 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.137 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' O ' ' CD1' ' A' ' 56' ' ' PHE . . . -105.22 140.98 37.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 54' ' ' LYS . 21.9 m-85 -135.07 136.74 42.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.558 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.85 -50.63 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.379 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 177.56 7.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.201 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HE2' HD23 ' A' ' 62' ' ' LEU . 1.4 tmtp? -85.04 -43.0 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.544 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 t -51.81 -32.43 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.517 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -68.79 -32.06 71.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.7 tp -64.57 -64.88 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.299 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.443 HG13 ' CG ' ' A' ' 76' ' ' PRO . 3.5 mp -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.476 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -63.2 -41.38 99.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 110.728 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 4.8 m-30 -45.45 -32.35 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mm-40 -72.69 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.107 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.27 -19.78 23.88 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.496 HG22 ' C ' ' A' ' 66' ' ' PHE . 23.1 m -86.56 -27.75 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.259 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.37 46.07 6.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.163 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.643 ' OD2' HD11 ' A' ' 74' ' ' LEU . 10.3 p-10 -74.32 133.97 42.55 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.772 0.32 . . . . 0.0 111.514 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 t -149.98 25.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.347 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.93 32.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.29 -46.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.865 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.5 OUTLIER 63.34 125.99 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.261 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' CG ' HG13 ' A' ' 63' ' ' ILE . 53.1 Cg_exo -56.64 -31.07 86.05 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.496 2.131 . . . . 0.0 112.287 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -70.04 -7.82 44.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.644 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.5 -7.29 58.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.473 0.178 . . . . 0.0 111.406 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD2' HD21 ' A' ' 62' ' ' LEU . 51.4 m-85 -107.58 148.17 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 111.393 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.29 159.47 41.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.069 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.4 m-30 -120.72 91.42 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.0 -10.37 8.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.823 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.022 HG13 HD13 ' A' ' 32' ' ' LEU . 61.4 t 61.33 -81.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 82' ' ' THR . 18.7 p -56.41 -31.21 63.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.94 -173.66 14.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.547 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -154.21 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.58 -62.89 1.02 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 m 59.15 28.47 17.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.78 87.46 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.536 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.0 m -92.46 143.62 26.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.76 -80.34 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.573 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.02 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.56 173.92 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.72 65.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.349 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -78.87 -63.75 0.39 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.783 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 73.6 Cg_endo -74.71 -12.05 22.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.701 2.267 . . . . 0.0 112.755 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.0 84.49 3.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.644 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -118.42 -41.8 2.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 159.71 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -89.99 -178.4 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.195 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 7.1 t 52.57 42.85 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.994 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.678 HD11 ' HB2' ' A' ' 13' ' ' ARG . 3.9 tt 50.05 119.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.442 0.697 . . . . 0.0 112.488 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 12' ' ' ILE . 7.6 tp -85.51 49.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.465 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.678 ' HB2' HD11 ' A' ' 11' ' ' ILE . 49.6 mtm180 -154.33 -172.66 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.482 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -125.5 88.08 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.96 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -163.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.74 158.29 31.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.55 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HB2' HD12 ' A' ' 32' ' ' LEU . 63.8 Cg_endo -73.59 -165.87 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -161.76 129.36 4.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.216 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -94.79 -68.23 0.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.179 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.17 81.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.823 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 4.2 m-20 -117.97 91.45 39.65 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.77 13.54 1.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.058 2.505 . . . . 0.0 112.669 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 p -88.53 55.11 3.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.413 . . . . 0.0 110.887 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 28' ' ' TRP . 17.6 mt -133.27 165.23 38.25 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.582 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 73.1 Cg_exo -38.81 164.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.768 2.312 . . . . 0.0 112.909 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.2 127.11 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.34 -54.79 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.573 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 47.6 m95 -41.6 148.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.433 ' C ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -147.58 -178.41 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.837 178.473 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 20.9 ttt180 -148.2 159.59 43.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 111.635 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.6 tttt -174.25 162.85 3.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.526 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.0 mt -131.27 161.34 32.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.034 0.445 . . . . 0.0 111.411 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 8.2 tttp -136.18 117.45 14.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.082 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -70.68 171.68 9.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.244 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 41.4 ttm180 -152.62 160.64 43.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.961 0.41 . . . . 0.0 111.367 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.656 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.77 114.58 14.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.267 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 m -101.33 -20.63 15.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.719 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.91 -32.28 6.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.118 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.67 -52.47 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.929 0.395 . . . . 0.0 110.115 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.87 36.32 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.952 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.656 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -52.56 136.12 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.574 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.54 27.87 4.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.387 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.51 132.99 33.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.975 0.417 . . . . 0.0 110.961 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -106.05 159.46 16.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.671 0.748 . . . . 0.0 112.912 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -129.7 145.84 51.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.778 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -90.45 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.958 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -144.87 96.98 2.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 24' ' ' LEU . 33.1 mt -92.97 109.77 21.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 4.2 mt -85.8 134.76 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' OD1' ' CZ2' ' A' ' 28' ' ' TRP . 3.4 t30 -75.22 149.68 84.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.139 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -39.6 -59.45 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.823 2.348 . . . . 0.0 112.789 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -50.89 -25.1 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.86 31.56 2.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -101.01 117.02 34.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 111.614 -178.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.87 140.69 30.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 76.7 m-85 -129.17 127.03 40.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.488 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.483 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -52.42 2.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.779 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 6.1 p -86.07 173.46 9.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.359 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -85.77 -40.28 16.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.955 0.407 . . . . 0.0 110.839 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 46.6 t -51.86 -39.84 26.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.688 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -63.23 -28.2 69.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.161 0.505 . . . . 0.0 109.959 177.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.7 tp -70.66 -61.64 1.69 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.777 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -72.79 -57.92 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.477 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -46.54 -43.8 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.316 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' CD1' ' HD2' ' A' ' 68' ' ' LYS . 2.4 t80 -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.565 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.8 m-30 -45.61 -35.29 3.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.679 0.276 . . . . 0.0 111.283 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 65.3 mt-10 -61.22 -68.12 0.34 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.016 0.436 . . . . 0.0 110.527 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.651 ' CD ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.01 -19.73 13.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.71 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.651 HG23 ' CD ' ' A' ' 68' ' ' LYS . 7.4 t -86.36 -42.22 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.889 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.66 37.65 10.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.807 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 127.78 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 0.0 110.756 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -123.5 28.69 6.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -131.3 31.64 4.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.3 pp -154.46 -179.03 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.451 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -158.62 108.32 1.64 Allowed Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.647 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 80.1 Cg_exo -45.3 -35.47 11.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.658 2.239 . . . . 0.0 112.508 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.62 -20.0 63.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.867 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.45 -9.44 59.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.485 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 47.8 m-85 -104.85 135.09 46.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.948 0.404 . . . . 0.0 111.455 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.06 161.32 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.51 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.729 ' CD1' HG11 ' A' ' 46' ' ' VAL . 19.8 m-85 -121.82 88.5 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 p -119.1 -15.1 9.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.865 HG13 HD13 ' A' ' 32' ' ' LEU . 54.8 t 63.15 -79.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' THR . 12.5 p -52.81 -29.15 26.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.019 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 176.93 28.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -154.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.593 0.235 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.27 92.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 p -87.56 -16.99 33.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.61 0.243 . . . . 0.0 111.299 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.81 22.34 36.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.681 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.6 p -96.11 122.34 38.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.94 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.85 -176.48 18.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.518 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.883 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 p -137.73 -175.71 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.33 69.57 9.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -156.76 54.48 0.88 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.47 -76.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.746 2.297 . . . . 0.0 112.136 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -112.87 30.29 7.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.668 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -126.02 62.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.76 164.89 12.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -77.4 121.97 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.92 0.391 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 11' ' ' ILE . 1.6 t -159.46 42.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 10' ' ' SER . 2.5 tt 51.54 117.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.545 0.688 . . . . 0.0 112.441 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 12' ' ' ILE . 28.5 mm -80.63 59.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.838 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 63.35 -175.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.816 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -56.38 117.4 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.02 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.35 164.56 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.15 156.19 7.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' CB ' HD12 ' A' ' 32' ' ' LEU . 77.2 Cg_endo -77.26 -167.42 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.826 2.35 . . . . 0.0 112.02 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.61 18.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.569 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 36.23 48.39 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.433 0.635 . . . . 0.0 111.794 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 t0 -132.38 69.91 1.47 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.97 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 7.5 m-20 67.31 -99.41 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.334 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -171.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.672 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 26.2 Cg_endo -82.2 153.44 76.82 Favored 'Cis proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.252 2.197 . . . . 0.0 112.93 -13.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.599 ' O ' HD23 ' A' ' 24' ' ' LEU . 2.8 t 45.34 83.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.962 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 29' ' ' THR . 79.5 mt -138.92 154.58 72.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.92 -170.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.63 2.22 . . . . 0.0 112.257 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.5 125.45 25.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.81 -4.35 52.89 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.811 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 83.5 m95 -99.6 138.96 35.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.366 0.583 . . . . 0.0 111.711 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.907 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.58 178.73 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.027 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.882 ' CG ' HD11 ' A' ' 24' ' ' LEU . 10.5 mtm180 -142.44 141.35 32.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.878 ' C ' HD23 ' A' ' 32' ' ' LEU . 11.7 ttmt -140.73 153.3 45.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.11 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.878 HD23 ' C ' ' A' ' 31' ' ' LYS . 4.1 mt -128.43 153.86 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.124 0.487 . . . . 0.0 111.636 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -128.38 117.37 21.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -71.35 164.55 25.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.231 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -156.87 153.23 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 10.5 tptm -126.47 109.93 12.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.394 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -169.52 1.55 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.497 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.91 35.02 4.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.0 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.2 120.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.33 46.14 8.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 109.886 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -54.12 179.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.769 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 62.43 36.83 93.69 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.773 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 35' ' ' ARG . 12.3 tttt -87.5 142.52 27.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.277 0.561 . . . . 0.0 111.224 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.7 m-85 -106.46 153.51 22.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.713 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -121.54 143.45 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.075 175.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.572 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.2 p -87.87 148.51 4.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.745 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.0 m-85 -146.92 103.26 3.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.545 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.958 HD22 ' CE1' ' A' ' 81' ' ' PHE . 2.3 mp -89.43 110.63 21.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.894 -172.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.2 t-20 -87.27 137.63 32.64 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.358 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 82.4 Cg_exo -32.11 -58.56 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.774 2.982 . . . . 0.0 113.752 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -45.02 -27.72 0.59 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 111.308 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.71 22.67 3.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.503 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 tttt -94.35 174.45 7.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.733 0.301 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -142.07 133.96 27.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 62' ' ' LEU . 19.8 m-85 -127.59 127.17 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.865 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -102.19 6.51 40.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.467 177.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 61' ' ' GLU . 6.4 p -154.15 167.1 30.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 4.2 tptp -74.55 -36.87 63.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.169 0.509 . . . . 0.0 111.526 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 96.8 t -52.4 -43.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.828 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 58' ' ' SER . 5.6 mm-40 -65.92 -29.88 70.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.992 0.425 . . . . 0.0 110.154 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.87 -66.14 0.58 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.105 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -61.58 -40.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.67 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -65.46 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.582 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.78 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.1 t80 -57.78 -44.34 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.666 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 74' ' ' LEU . 8.0 m-30 -55.78 -24.38 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.75 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.4 mm-40 -73.79 -53.89 9.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 111.836 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' N ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.78 -18.51 62.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.929 -177.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.3 m -86.32 -43.96 16.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.717 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.72 54.0 1.72 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.511 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.743 ' OD2' HD11 ' A' ' 74' ' ' LEU . 35.2 p-10 -74.36 138.02 43.16 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.701 0.4 . . . . 0.0 111.852 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.4 p -149.95 22.56 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.035 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -143.47 33.03 1.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -154.54 -177.31 6.38 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -158.58 101.02 1.67 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 99.5 Cg_exo -44.08 -27.76 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.428 2.085 . . . . 0.0 112.107 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -69.93 -23.06 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.633 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.46 8.5 24.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.087 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' HD11 ' A' ' 62' ' ' LEU . 9.6 m-85 -93.74 124.15 37.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.771 0.319 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 116.44 29.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.958 ' CE1' HD22 ' A' ' 48' ' ' LEU . 8.5 m-85 -88.72 74.46 8.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -102.41 111.41 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 44' ' ' TYR . 92.4 t -79.55 -14.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.495 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.0 p -121.12 47.73 1.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.115 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.08 151.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.59 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.8 OUTLIER -121.42 -83.88 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.395 0.617 . . . . 0.0 110.712 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.05 93.37 0.03 OUTLIER Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.552 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -147.17 20.46 1.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 0.0 110.527 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.08 44.4 0.67 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.383 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.1 t -89.08 -47.07 8.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.381 . . . . 0.0 111.079 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.41 -129.18 42.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.511 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.21 179.5 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.76 177.18 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -147.82 59.76 4.86 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.621 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.91 -68.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.699 2.266 . . . . 0.0 112.419 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -108.05 61.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -133.03 108.05 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -80.75 149.05 29.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.615 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.34 167.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -168.77 80.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.139 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 48.36 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.396 0.617 . . . . 0.0 111.522 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 mm -77.75 66.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.82 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 68.02 162.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.739 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.05 162.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.108 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.53 12.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.856 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.74 92.2 0.1 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.803 ' CB ' HD12 ' A' ' 32' ' ' LEU . 84.0 Cg_endo -77.31 168.91 22.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.854 2.369 . . . . 0.0 111.54 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.492 ' HE3' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -134.54 -34.47 0.93 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 62.39 18.07 9.99 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' C ' ' HE3' ' A' ' 18' ' ' MET . 9.4 m-20 -118.72 84.89 2.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.806 ' HA ' HG22 ' A' ' 29' ' ' THR . 7.1 m-20 44.62 -94.39 0.0 OUTLIER Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-O 116.781 -1.58 . . . . 0.0 109.727 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.718 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 58.6 Cg_endo -77.0 -55.8 0.14 OUTLIER 'Cis proline' 0 N--CA 1.484 0.95 0 CA-C-N 122.908 2.074 . . . . 0.0 113.834 -6.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 32.9 p -159.35 78.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.634 HD12 ' CA ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -94.11 -175.54 0.49 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.666 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 74.8 Cg_exo -42.77 165.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.026 1.818 . . . . 0.0 112.508 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.29 125.39 14.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.007 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.79 -0.14 52.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.344 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 62.8 m95 -101.22 127.13 47.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.124 0.487 . . . . 0.0 111.469 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -134.35 172.72 12.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.608 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.801 ' HG3' HD23 ' A' ' 48' ' ' LEU . 11.7 ttm180 -140.17 150.77 44.62 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.8 0.81 . . . . 0.0 111.6 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.865 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -157.78 160.88 38.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.237 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.126 HD13 HG13 ' A' ' 83' ' ' VAL . 1.3 mt -130.85 169.79 15.28 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.9 tttt -147.91 114.14 5.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.421 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.1 tt0 -71.86 165.84 23.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.756 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 88.84 -177.8 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.554 0.742 . . . . 0.0 112.383 177.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 43' ' ' LYS . 1.7 mmtt -153.22 -88.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.78 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 6.3 m -155.12 -159.62 0.96 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.98 -31.44 25.13 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.126 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.59 149.42 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.712 0.292 . . . . 0.0 110.258 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.81 23.47 11.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -60.5 99.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.18 0.514 . . . . 0.0 111.263 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 139.23 59.68 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.825 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -141.3 147.83 38.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.919 0.39 . . . . 0.0 110.231 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.694 ' HB3' HG11 ' A' ' 83' ' ' VAL . 7.2 m-85 -89.77 141.51 28.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.16 137.21 54.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.341 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.635 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -85.85 154.7 3.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.617 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 12.5 m-85 -145.08 100.88 3.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.801 HD23 ' HG3' ' A' ' 30' ' ' ARG . 41.9 mt -92.51 104.88 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -82.37 126.39 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.619 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 30.8 p-10 -85.59 148.51 49.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.394 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -33.8 -54.55 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.764 2.976 . . . . 0.0 113.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -44.85 -27.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.37 49.32 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.047 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.41 132.43 27.82 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.017 0.437 . . . . 0.0 111.129 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.75 137.68 32.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.488 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 60.1 m-85 -122.17 121.58 37.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 5.0 mtm180 -89.92 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.23 173.54 8.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.511 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -81.95 -38.69 24.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.414 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 61' ' ' GLU . 10.7 p -51.79 -43.17 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.351 0.596 . . . . 0.0 110.217 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.2 mt-10 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.31 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.4 tp -70.42 -63.08 1.16 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.387 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -62.27 -36.53 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.83 -72.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.727 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.74 -42.93 84.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.649 ' CE2' HD13 ' A' ' 74' ' ' LEU . 7.4 m-30 -52.07 -31.49 30.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.178 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.6 mm-40 -74.24 -59.56 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.745 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -61.83 -23.63 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.737 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.1 m -86.46 -31.94 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 0.0 111.35 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.54 43.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -79.31 128.92 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.871 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 t -119.36 20.08 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -125.85 26.52 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 0.0 110.656 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -154.53 175.9 13.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.671 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -158.57 129.19 3.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.436 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 51.4 Cg_exo -55.13 -36.32 92.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.427 2.085 . . . . 0.0 112.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -70.0 -18.09 63.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.996 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.95 -4.2 59.15 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.515 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CB ' HD21 ' A' ' 62' ' ' LEU . 87.3 m-85 -107.66 85.36 2.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.016 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -80.38 128.75 33.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 46' ' ' VAL . 9.0 m-85 -84.04 90.56 7.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.38 88.71 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.796 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.126 HG13 HD13 ' A' ' 32' ' ' LEU . 88.3 t -47.09 -27.64 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.076 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 p -91.96 43.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 111.051 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.98 -156.96 0.1 Allowed Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.894 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -131.64 -150.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.62 48.33 74.05 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.931 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.85 29.73 1.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.653 0.263 . . . . 0.0 111.334 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.51 66.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.587 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.2 83.17 6.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.78 -127.97 46.54 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.24 -0.885 . . . . 0.0 110.846 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t 59.83 163.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.57 144.13 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.83 77.47 1.88 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.0 -24.39 12.87 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.673 2.249 . . . . 0.0 112.646 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -97.84 88.24 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.068 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -125.36 18.57 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.23 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 161.05 13.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.717 0.294 . . . . 0.0 110.895 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.44 113.76 8.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.2 m 57.94 31.37 20.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 14' ' ' ASP . 2.6 tt 47.29 99.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.426 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.4 mm -78.61 69.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 mtt85 60.06 78.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.75 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 11' ' ' ILE . 5.0 t0 -124.97 -162.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.224 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.17 156.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.384 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 17' ' ' PRO . . . -136.47 -136.08 3.49 Favored Glycine 0 CA--C 1.488 -1.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.349 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' HA ' ' HA3' ' A' ' 16' ' ' GLY . 60.8 Cg_endo -70.24 -174.07 9.61 Favored 'Cis proline' 0 N--CA 1.48 0.686 0 C-N-CA 125.229 -0.738 . . . . 0.0 112.395 -1.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.83 94.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.551 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.26 -70.55 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.129 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.27 89.98 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.081 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB3' ' CG ' ' A' ' 30' ' ' ARG . 6.4 t0 -118.93 83.86 24.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.808 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -102.17 21.58 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.649 2.899 . . . . 0.0 113.018 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -81.54 -33.35 31.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.235 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 30' ' ' ARG . 16.6 mt -41.87 160.41 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.573 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.4 Cg_exo -40.33 162.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.652 2.235 . . . . 0.0 112.317 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.89 136.62 2.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.083 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.48 -45.8 2.96 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.73 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 63.2 m95 -68.92 149.1 49.25 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.56 -179.65 7.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.58 175.106 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.13 169.7 23.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 110.728 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.2 ttmt -170.42 162.25 8.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HG13 ' A' ' 83' ' ' VAL . 5.7 mt -131.26 157.09 44.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.958 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -139.29 124.66 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.621 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 59.0 tt0 -74.94 166.71 23.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.065 0.46 . . . . 0.0 110.707 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER 86.69 -178.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 178.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -165.49 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.42 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.858 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 35.8 t -155.12 -162.98 1.45 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.057 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -61.64 -23.37 62.88 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.59 121.78 44.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.737 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 m 60.79 31.43 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -53.64 114.27 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' HA ' ' A' ' 35' ' ' ARG . . . 128.19 59.98 0.12 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -140.65 152.33 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.611 ' CB ' HG11 ' A' ' 83' ' ' VAL . 7.3 m-85 -90.87 142.07 28.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -118.83 148.95 42.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.644 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 81' ' ' PHE . 6.7 p -91.42 148.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.378 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.11 103.25 3.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -91.89 116.81 29.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -91.2 138.79 18.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.423 -175.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 0.2 OUTLIER -154.32 148.72 19.37 Favored Pre-proline 0 CA--C 1.484 -1.571 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -96.39 30.27 14.1 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 N-CA-C 108.305 -1.46 . . . . 0.0 108.305 -25.415 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' PRO . 48.3 mt-30 -157.02 -44.26 0.07 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.904 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 10.04 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.906 -1.14 . . . . 0.0 115.285 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 1.3 tmtt? -92.04 115.34 27.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.759 1.779 . . . . 0.0 110.42 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -92.01 154.21 18.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.251 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.568 ' CD1' ' ND2' ' A' ' 50' ' ' ASN . 42.1 m-85 -150.55 136.02 18.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 1.5 mtm-85 -97.61 -57.16 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.176 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -87.56 171.46 10.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.381 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 63' ' ' ILE . 7.3 tptp -81.24 -38.0 27.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.369 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 4.6 p -51.81 -42.12 31.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.55 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -33.2 73.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.751 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.3 tp -66.49 -61.01 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.469 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -62.96 -36.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.496 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -62.91 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.989 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.558 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.16 -53.08 61.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.257 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.507 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -50.13 -25.02 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.821 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.5 mm-40 -71.08 -63.6 1.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.695 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -23.23 65.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 65' ' ' TYR . 5.2 m -86.56 -38.33 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.353 . . . . 0.0 111.137 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.47 46.99 8.4 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.158 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.2 t0 -74.56 135.86 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -127.88 23.64 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.252 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 24.04 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.883 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 71' ' ' ASP . 1.1 pp -154.5 178.26 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.668 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -158.64 117.8 1.77 Allowed Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.491 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 62' ' ' LEU . 88.9 Cg_exo -46.3 -33.03 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.381 2.054 . . . . 0.0 112.051 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.01 -19.13 63.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.058 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.84 11.21 18.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.451 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' HB3' HD23 ' A' ' 48' ' ' LEU . 17.7 m-85 -130.34 72.1 1.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.985 0.421 . . . . 0.0 111.761 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 162.0 29.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.457 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-85 -115.68 124.59 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 111.753 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.56 HG21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -164.29 93.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.673 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.991 HG13 HD13 ' A' ' 32' ' ' LEU . 90.6 t -50.94 -28.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.698 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 p -109.91 31.34 5.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.05 170.84 0.11 Allowed Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' HB3' HG21 ' A' ' 82' ' ' THR . 0.0 OUTLIER -140.55 -154.25 0.51 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.91 -112.23 0.32 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.582 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t 57.69 21.03 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 0.0 111.197 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.65 22.93 48.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 m 63.23 122.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.19 -130.87 2.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.975 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.46 94.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.95 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.06 11.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -162.35 -66.27 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.137 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 55.7 Cg_endo -68.81 -22.2 37.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.463 2.109 . . . . 0.0 112.245 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -122.34 93.86 4.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.41 -44.64 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.68 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -92.82 146.52 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.757 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -88.68 113.65 24.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.066 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 65.68 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.6 tp -83.31 139.95 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.556 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 12' ' ' ILE . 20.9 mm -93.86 50.03 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.505 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 72.76 130.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -58.26 107.3 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 113.44 22.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.75 142.1 4.9 Favored Glycine 0 CA--C 1.486 -1.779 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.402 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HB3' HD13 ' A' ' 32' ' ' LEU . 2.7 Cg_endo -83.39 179.37 25.56 Favored 'Cis proline' 0 N--CA 1.472 0.21 0 C-N-CA 125.606 -0.581 . . . . 0.0 112.044 2.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.545 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -156.42 97.88 1.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.33 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.63 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.71 68.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.258 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.5 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 28.3 t70 -156.7 85.93 0.98 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.943 -171.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' C ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 34.95 -88.98 0.0 OUTLIER Pre-proline 0 CA--C 1.498 -1.028 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.429 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.764 ' HG2' HG22 ' A' ' 23' ' ' THR . 15.1 Cg_endo -94.44 1.46 49.64 Favored 'Cis proline' 0 N--CA 1.486 1.065 0 CA-C-N 121.851 1.697 . . . . 0.0 113.74 -2.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.764 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -159.25 -83.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.883 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HH22 ' A' ' 30' ' ' ARG . 36.8 mt 59.42 163.3 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.339 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.38 -179.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.07 2.513 . . . . 0.0 112.78 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.45 122.69 16.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.16 -1.92 53.82 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.55 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 58.0 m95 -98.83 140.51 32.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 111.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -143.55 166.36 25.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.399 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.706 HH22 HD21 ' A' ' 24' ' ' LEU . 24.1 ttm105 -136.17 154.48 50.94 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.288 0.566 . . . . 0.0 110.466 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -162.99 164.33 25.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.773 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -133.44 167.52 20.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.483 0.658 . . . . 0.0 112.697 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -147.8 112.04 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.184 178.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 45.5 tt0 -63.82 166.38 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.458 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 47.1 ttm-85 -153.05 164.35 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.815 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.864 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -112.08 -76.76 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.54 -65.13 0.24 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.655 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.58 -80.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.842 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.69 111.69 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.06 48.61 8.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.864 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -52.54 152.56 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.599 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 89.13 32.71 10.3 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.03 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 140.82 29.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.046 0.451 . . . . 0.0 111.064 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.539 ' HE2' ' HH ' ' A' ' 19' ' ' TYR . 5.2 m-85 -99.23 150.93 21.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.561 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -116.9 142.11 47.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.546 176.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG22 ' A' ' 83' ' ' VAL . 65.5 t -85.12 152.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.894 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.7 m-85 -146.14 90.6 1.98 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 79' ' ' PHE . 9.6 mt -91.22 103.36 16.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 12.6 mt -82.37 117.24 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.655 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 36.7 p-10 -84.61 152.88 60.93 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.484 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -34.97 -56.15 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.732 2.955 . . . . 0.0 113.447 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -44.65 -27.02 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.58 49.07 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.037 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.97 132.02 26.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.962 0.41 . . . . 0.0 111.479 -178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.82 144.3 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.783 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 55.9 m-85 -132.5 126.25 32.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.89 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 19.4 mtm180 -100.92 -52.82 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.262 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.89 171.78 10.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.909 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -81.81 -39.77 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.299 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 9.3 p -51.78 -42.22 31.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.307 0.575 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -61.02 -29.34 69.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.384 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -70.4 -67.29 0.51 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.482 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -58.22 -37.67 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.611 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.74 -58.5 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.64 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -66.25 -46.37 77.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.711 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.629 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 18.9 m-85 -52.08 -26.13 10.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.6 mm-40 -72.4 -62.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.772 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.09 63.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.698 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.3 m -86.64 -37.56 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 0.0 111.689 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.14 48.61 9.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.047 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 -74.62 0.19 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.927 0.87 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p 60.19 18.63 8.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.546 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -120.05 25.92 9.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.629 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -138.72 -36.6 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.6 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.97 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.651 0.263 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -51.69 -34.46 53.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.344 2.03 . . . . 0.0 112.344 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -69.12 -8.9 49.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.413 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -83.19 -9.51 59.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.903 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.621 ' CD2' HD21 ' A' ' 62' ' ' LEU . 52.6 m-85 -107.26 116.43 31.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.759 0.314 . . . . 0.0 110.554 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.99 146.88 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 22.1 m-30 -100.91 85.65 2.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.404 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 23.4 p -101.95 -16.22 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.669 HG13 HD22 ' A' ' 32' ' ' LEU . 53.5 t 67.62 -61.02 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.367 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.9 p -73.36 -2.33 21.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 169.82 18.29 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.642 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -158.86 0.68 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.946 0.403 . . . . 0.0 110.559 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.33 -83.86 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.431 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.1 m 59.3 22.63 10.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 0.0 111.095 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.04 -31.64 6.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.488 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -51.48 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.7 -155.6 6.67 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.948 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.65 123.46 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.04 60.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.7 t 54.73 68.53 2.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.005 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.63 -30.11 15.19 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.215 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 7' ' ' GLN . 64.5 mmtt -99.0 -167.9 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.437 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 13.1 pt20 43.42 80.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.823 0.344 . . . . 0.0 111.301 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -60.47 160.93 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.21 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -128.3 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.026 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 23.3 t -85.23 52.05 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.4 tt 48.1 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.484 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.66 57.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.166 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 53.06 70.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -127.14 50.13 2.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.78 122.34 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 17' ' ' PRO . . . 118.74 92.06 1.45 Allowed Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.417 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.404 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 63.2 Cg_endo -69.5 178.93 23.12 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 125.034 -0.819 . . . . 0.0 112.291 -3.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 102.03 2.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.48 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.83 -69.36 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.199 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.55 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.437 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -115.49 89.71 23.11 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.543 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -93.48 18.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.094 2.529 . . . . 0.0 112.835 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.3 p -92.8 43.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.034 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.561 HD11 ' HG2' ' A' ' 30' ' ' ARG . 11.2 mt -123.02 166.57 17.42 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.312 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 96.0 Cg_exo -45.34 173.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.786 2.324 . . . . 0.0 112.752 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 125.84 18.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.915 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.49 -2.8 51.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.694 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.517 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 50.8 m95 -99.02 139.03 35.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -144.19 -179.66 6.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.814 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.561 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.2 mtp180 -145.85 163.73 34.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.937 0.399 . . . . 0.0 111.401 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.894 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.9 ttmt -170.07 158.36 6.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.129 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 83' ' ' VAL . 3.4 mt -131.29 155.96 46.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.496 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -129.57 120.41 25.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.154 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.0 tt0 -74.41 171.26 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 3.7 ttm180 -151.91 124.24 8.25 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' HE2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -90.63 -78.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 0.0 111.431 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.99 -67.09 0.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.954 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.06 -28.68 1.84 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -62.02 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.973 0.416 . . . . 0.0 110.321 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 41.02 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.21 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB1' ' HE2' ' A' ' 36' ' ' LYS . . . -52.56 114.97 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.479 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 20.23 7.88 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.348 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmp? -87.58 132.39 34.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CB ' HG11 ' A' ' 83' ' ' VAL . 6.9 m-85 -107.84 163.66 12.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -135.09 144.0 46.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.281 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.4 p -88.0 149.51 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.899 0.381 . . . . 0.0 111.78 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 10.6 m-85 -146.06 97.32 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.255 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.8 mt -93.01 109.27 20.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.4 mt -83.81 123.74 39.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.649 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.517 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 32.4 p-10 -85.65 152.99 57.97 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -36.19 -54.74 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.741 2.96 . . . . 0.0 113.161 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.34 -26.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.34 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 48.85 1.17 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.799 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -140.86 135.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.354 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.66 134.88 33.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -115.51 123.21 47.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -104.33 -4.4 22.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.36 177.47 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.822 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 1.3 mmtp -78.84 -45.08 21.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.906 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 29.2 t -51.85 -31.42 13.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.219 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -30.87 59.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.883 176.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.885 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -63.32 -66.17 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.425 178.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.96 -41.94 87.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.0 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.49 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.587 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.72 -54.71 43.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.18 -178.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -46.58 -31.5 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 111.732 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.8 mm-40 -67.82 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.71 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -25.6 59.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.638 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.3 m -88.38 -30.79 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 111.254 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.71 81.66 0.52 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.682 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.659 ' OD2' HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -149.91 126.9 11.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -177.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -132.38 20.37 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.76 22.14 15.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.748 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -154.58 65.48 0.68 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.709 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.5 OUTLIER 61.07 -173.87 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.146 0 C-N-CA 118.512 -1.275 . . . . 0.0 107.752 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.69 ' HG3' HD12 ' A' ' 62' ' ' LEU . 80.8 Cg_exo -75.73 -157.68 1.46 Allowed 'Cis proline' 0 C--N 1.312 -1.381 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 17.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.81 19.67 9.86 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.694 -176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -145.59 -5.17 0.65 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.077 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.885 ' CD2' HD11 ' A' ' 62' ' ' LEU . 50.7 m-85 -97.57 90.94 5.2 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.229 -0.294 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.39 119.24 11.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.817 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.525 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -89.46 69.47 7.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.3 107.61 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 32' ' ' LEU . 93.8 t -59.8 -38.79 77.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.392 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -104.38 32.6 3.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.08 -171.46 2.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -123.89 43.83 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.101 0.477 . . . . 0.0 110.996 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -91.85 21.47 36.32 Favored Glycine 0 C--N 1.32 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.85 21.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.164 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.81 -49.61 1.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.357 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.41 -38.64 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.802 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.26 -75.09 1.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.898 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -139.86 36.46 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 5' ' ' PRO . . . -106.55 116.62 32.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.6 p -163.61 58.14 0.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.95 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 19.0 Cg_endo -93.38 -65.42 0.02 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.366 -1.097 . . . . 0.0 112.577 2.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 78.12 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.886 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -108.59 -67.6 0.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.745 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER -81.35 142.13 33.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 145.6 41.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.06 44.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.185 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -95.82 138.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.942 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.28 60.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.665 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 61.9 156.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.608 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -56.71 99.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.131 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.98 168.09 9.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.749 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.58 169.98 11.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 32' ' ' LEU . 47.1 Cg_endo -68.72 -164.96 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.806 2.337 . . . . 0.0 112.373 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -161.49 135.69 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.358 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CA ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -112.98 56.29 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.4 t0 -178.24 67.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.589 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.87 85.85 12.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.337 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HA ' HG23 ' A' ' 29' ' ' THR . 68.8 Cg_endo -96.15 18.1 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.273 2.649 . . . . 0.0 112.63 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -83.11 -20.16 35.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.409 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 29' ' ' THR . 51.2 mt -48.46 162.18 0.36 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 65.7 Cg_exo -38.37 161.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.707 2.272 . . . . 0.0 112.72 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.72 129.57 5.5 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . 90.91 -44.78 2.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.485 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.631 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 62.7 m95 -68.95 150.44 47.72 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -149.57 179.64 7.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.295 176.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 48' ' ' LEU . 58.2 ttp180 -153.29 163.06 40.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.36 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.92 ' O ' HD23 ' A' ' 32' ' ' LEU . 29.9 ttpt -174.68 164.95 3.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.92 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.1 mt -131.38 161.11 33.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.919 0.39 . . . . 0.0 111.474 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -138.51 120.87 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.405 -178.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 50.5 tt0 -67.91 172.85 5.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -150.36 136.0 18.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 111.337 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.852 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -138.69 117.28 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.355 179.032 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.96 20.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.584 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.54 59.34 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.959 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 116.47 18.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.54 39.1 28.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.852 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -54.53 151.06 8.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.783 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.18 21.1 50.72 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.342 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.61 134.79 33.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 110.854 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HB2' HG11 ' A' ' 83' ' ' VAL . 5.3 m-85 -101.7 164.03 11.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.554 0.692 . . . . 0.0 112.64 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -133.39 146.7 51.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.204 177.171 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.8 p -86.86 146.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.704 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 4.9 m-85 -142.84 95.97 2.86 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.027 0.441 . . . . 0.0 110.954 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 80' ' ' ASP . 7.7 mt -92.89 110.44 21.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 23.0 mt -86.29 141.35 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.515 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.631 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 0.3 OUTLIER -153.3 145.64 17.16 Favored Pre-proline 0 CA--C 1.482 -1.645 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 7.2 Cg_endo -93.9 24.04 25.61 Favored 'Cis proline' 0 N--CA 1.455 -0.737 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 -24.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -154.34 -43.72 0.09 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.543 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.11 1.85 0.11 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 119.66 -1.257 . . . . 0.0 115.661 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 65' ' ' TYR . 1.2 tmtt? -88.44 119.68 29.1 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.974 1.887 . . . . 0.0 110.741 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -101.79 148.77 24.9 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.622 ' CE1' ' ND2' ' A' ' 50' ' ' ASN . 9.2 m-85 -142.61 144.9 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.691 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.36 18.84 6.94 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 10.1 t -145.96 -86.02 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.068 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 166.25 -41.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.7 p -56.85 -39.18 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.122 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -27.56 66.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.335 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.1 tp -68.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.405 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.25 -38.26 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.72 -49.95 64.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -73.04 -61.53 1.78 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' C ' HG22 ' A' ' 69' ' ' VAL . 23.3 m-85 -42.71 -34.95 0.99 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -61.66 -69.3 0.25 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.8 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.21 -19.05 18.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.484 -176.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.8 HG13 ' HD3' ' A' ' 68' ' ' LYS . 33.9 m -91.99 -30.19 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.733 0.302 . . . . 0.0 111.158 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.48 64.21 4.59 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.8 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 72' ' ' THR . 10.5 t0 -74.39 -45.92 43.68 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.788 0.804 . . . . 0.0 111.541 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 71' ' ' ASP . 5.9 t 52.69 18.42 1.01 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.596 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.39 19.23 8.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 110.716 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.6 -177.34 6.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -158.58 118.04 1.79 Allowed Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.916 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HA ' HD23 ' A' ' 62' ' ' LEU . 89.1 Cg_exo -47.62 -32.5 16.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.198 1.932 . . . . 0.0 112.165 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.71 -20.16 63.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.141 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.51 9.26 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.612 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.03 86.7 2.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.692 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -63.73 -175.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.001 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 37.2 m-85 -145.38 73.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.94 117.47 28.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.915 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 32' ' ' LEU . 58.8 t -68.72 -56.64 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -85.77 52.28 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.44 156.69 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.47 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' A' ' 82' ' ' THR . 39.6 tpt85 -77.37 95.66 4.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.44 -80.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.6 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ARG . 6.2 t 56.08 28.07 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.842 0.353 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.71 -94.9 2.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.46 66.8 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.879 0.371 . . . . 0.0 110.954 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.78 79.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.446 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -93.38 140.44 29.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.0 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.5 171.6 8.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.5 73.65 0.61 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.989 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 -22.26 16.65 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.232 . . . . 0.0 112.571 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -105.14 97.1 7.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.794 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.3 113.05 15.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.014 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -117.51 160.61 20.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.07 111.28 23.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.205 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.5 p -166.18 45.43 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 13' ' ' ARG . 10.9 pt -89.92 15.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.708 ' O ' HG22 ' A' ' 12' ' ' ILE . 5.0 mp 45.08 27.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.763 0.792 . . . . 0.0 110.515 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' HB2' HG13 ' A' ' 11' ' ' ILE . 5.3 mtm180 -142.59 132.9 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.77 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -103.11 108.15 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.33 153.55 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.078 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 17' ' ' PRO . . . 107.0 102.51 2.81 Favored Glycine 0 CA--C 1.489 -1.558 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.929 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' CB ' HD12 ' A' ' 32' ' ' LEU . 3.4 Cg_exo -72.42 -153.84 0.78 Allowed 'Cis proline' 0 N--CA 1.474 0.358 0 CA-C-N 117.5 0.65 . . . . 0.0 112.165 -2.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.13 134.61 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.644 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -116.07 48.61 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.677 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.33 67.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.606 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -112.2 94.29 25.52 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.18 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.78 -6.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.439 2.759 . . . . 0.0 112.67 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 t -84.06 53.67 2.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.93 0.395 . . . . 0.0 111.007 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 24' ' ' LEU . 14.8 mt -113.55 164.51 15.64 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 75.6 Cg_exo -41.56 166.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.612 2.208 . . . . 0.0 112.371 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.0 121.47 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 28' ' ' TRP . . . 77.95 53.24 4.99 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.681 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 56.9 m95 -157.02 151.33 25.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.37 179.61 7.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.608 175.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.477 ' HG3' HD23 ' A' ' 48' ' ' LEU . 22.3 ttt180 -153.62 160.04 42.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.213 0.53 . . . . 0.0 112.134 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.929 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -176.01 166.24 2.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.453 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.064 HD13 HG13 ' A' ' 83' ' ' VAL . 10.6 mt -131.3 166.55 20.97 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.03 0.443 . . . . 0.0 111.583 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -135.11 118.08 16.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.149 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -69.37 171.43 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.354 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -153.06 148.17 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' CA ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -131.73 124.0 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.843 0.83 . . . . 0.0 111.749 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.13 -161.25 1.14 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.615 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.7 38.27 3.36 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.241 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.665 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.51 36.29 1.66 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.552 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' CA ' ' HE2' ' A' ' 36' ' ' LYS . . . -52.79 114.17 1.32 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.42 8.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.004 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 4.5 mmmt -87.57 133.93 33.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.814 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.5 m-85 -107.6 161.03 15.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.641 0.734 . . . . 0.0 112.582 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.52 147.77 52.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.73 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.7 p -87.13 143.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.84 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 5.4 m-85 -143.16 97.06 3.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 30' ' ' ARG . 82.1 mt -91.31 116.11 28.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 174.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.6 mt -91.5 137.53 21.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 1.9 p-10 -153.32 147.71 19.1 Favored Pre-proline 0 CA--C 1.49 -1.346 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 93.0 Cg_endo -91.67 -3.08 52.77 Favored 'Cis proline' 0 N--CA 1.448 -1.182 0 C-N-CA 125.239 -0.734 . . . . 0.0 110.863 -23.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -116.8 -35.62 4.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.999 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' CG2' ' A' ' 49' ' ' ILE . . . -176.64 21.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.741 -1.218 . . . . 0.0 114.881 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -96.81 115.71 27.9 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.348 1.574 . . . . 0.0 111.139 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.03 146.64 24.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.992 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 9.0 m-85 -150.66 137.37 18.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.728 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -105.95 11.59 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.151 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -154.49 170.17 22.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -80.41 -41.83 23.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.007 -176.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 p -50.36 -41.54 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.148 0.499 . . . . 0.0 110.606 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.08 -29.6 67.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.61 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.626 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -64.32 -63.67 1.08 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.1 mp -65.12 -38.01 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.352 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.69 -58.05 8.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.749 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -65.28 -53.71 40.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.627 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.928 ' CE2' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -43.97 -26.06 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.612 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.8 mm-40 -75.33 -65.97 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.36 -15.41 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.754 HG13 ' HD3' ' A' ' 68' ' ' LYS . 19.7 m -88.27 -28.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.227 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.99 59.69 10.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.249 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.02 -68.33 0.68 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.871 0.844 . . . . 0.0 111.899 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p 65.17 14.28 9.29 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.692 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -115.61 22.78 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 110.592 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.928 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -154.59 -174.25 4.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 13.5 t0 -158.61 113.12 1.66 Allowed Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.007 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 80.9 Cg_exo -46.02 -34.87 13.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.317 2.012 . . . . 0.0 111.954 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.539 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.6 8.1 30.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 8.6 m-85 -129.81 88.56 2.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 111.676 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 156.84 34.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.323 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 46' ' ' VAL . 18.4 m-85 -109.89 104.04 12.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 111.598 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -148.46 100.48 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.639 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.064 HG13 HD13 ' A' ' 32' ' ' LEU . 78.7 t -46.46 -38.5 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 p -117.54 57.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.99 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.54 166.19 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.75 21.51 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.52 100.34 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.622 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.93 22.39 4.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.702 0.287 . . . . 0.0 111.048 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 60.41 48.37 86.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.1 m -85.97 138.61 31.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.4 -87.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.28 154.55 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.31 31.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.464 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 3.6 m -163.15 49.62 0.24 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.068 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 4' ' ' SER . 53.4 Cg_endo -69.8 -45.73 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.621 2.214 . . . . 0.0 112.411 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -99.31 73.76 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -147.69 175.35 10.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.11 169.31 15.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 52.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.51 72.21 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 tt -137.77 144.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.2 62.52 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 58.46 177.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.913 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.88 134.76 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 100.1 11.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.55 6.14 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.497 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.8 Cg_endo -79.53 -177.39 20.6 Favored 'Cis proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.975 -0.844 . . . . 0.0 112.435 2.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.9 113.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -92.92 52.68 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.719 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.1 t0 -176.37 64.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.24 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -109.41 95.85 20.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.313 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 80.2 Cg_endo -91.54 10.53 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.117 2.544 . . . . 0.0 112.519 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -85.48 52.77 2.55 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.881 0.372 . . . . 0.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD22 ' A' ' 48' ' ' LEU . 18.6 mt -127.82 165.08 32.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.592 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 88.1 Cg_exo -47.07 177.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.561 2.174 . . . . 0.0 112.606 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.32 129.37 18.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.819 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 63.42 11.03 38.88 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.804 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.577 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 73.2 m95 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 0.0 111.742 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.66 178.69 6.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.107 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.761 ' NH2' HD11 ' A' ' 32' ' ' LEU . 4.1 ttt85 -145.37 162.35 37.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 0.0 111.661 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.945 ' O ' HD23 ' A' ' 32' ' ' LEU . 34.8 ttmt -175.08 158.32 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.602 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.945 HD23 ' O ' ' A' ' 31' ' ' LYS . 8.0 mt -131.34 163.12 28.56 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.12 0.486 . . . . 0.0 111.811 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.3 ttpt -137.76 113.18 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.169 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.87 172.72 8.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 7.9 tpt180 -150.8 123.01 8.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.951 0.405 . . . . 0.0 111.523 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.776 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.86 104.61 9.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.482 178.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -108.21 -15.52 14.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.548 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.07 35.46 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.653 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.71 -62.9 1.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.21 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.71 36.39 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.019 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.776 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -52.71 142.55 18.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.06 22.07 33.85 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.234 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.53 129.02 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.675 0.274 . . . . 0.0 110.523 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 7.2 m-85 -107.49 161.89 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -131.31 143.6 50.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.92 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.744 HG11 ' CG ' ' A' ' 81' ' ' PHE . 6.3 p -89.4 147.19 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.062 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.1 m-85 -144.98 94.32 2.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.321 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 HD11 ' A' ' 24' ' ' LEU . 70.0 mt -92.95 113.23 25.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.782 HG12 ' HB2' ' A' ' 55' ' ' ALA . 2.6 mt -89.63 122.83 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.218 -173.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.528 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 38.6 p-10 -85.71 155.66 58.88 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.569 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 27' ' ' GLY . 97.8 Cg_exo -36.73 -53.21 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.661 2.908 . . . . 0.0 113.286 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -47.56 -25.57 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.981 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.28 46.59 1.54 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.681 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.848 0.356 . . . . 0.0 111.264 -177.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -105.27 154.48 20.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.886 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CB ' HD22 ' A' ' 62' ' ' LEU . 67.4 m-85 -131.07 150.18 52.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.457 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 20.18 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.64 -4.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 77.14 -50.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.982 0.356 . . . . 0.0 111.957 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.1 p -52.49 -41.18 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.695 -0.628 . . . . 0.0 109.51 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -30.29 71.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.085 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.054 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -62.77 -72.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.041 179.197 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.515 ' CG1' ' HG3' ' A' ' 76' ' ' PRO . 7.9 mt -52.81 -43.57 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' CD ' ' A' ' 68' ' ' LYS . . . -52.82 -47.03 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.196 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -71.51 -57.55 4.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.69 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.054 ' CE2' HD12 ' A' ' 62' ' ' LEU . 27.6 m-85 -44.42 -29.73 0.74 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.136 0.493 . . . . 0.0 110.922 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.73 -47.3 85.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.91 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.8 -33.02 74.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.84 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' PHE . 6.4 m -93.5 -30.12 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.18 10.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.937 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.97 126.46 35.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.9 p -140.83 32.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -125.56 16.91 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -154.58 72.36 0.86 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 2.5 m-20 60.31 -152.93 0.01 OUTLIER Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 83.9 Cg_endo -68.19 -152.77 0.49 Allowed 'Cis proline' 0 C--N 1.311 -1.402 0 CA-C-N 121.78 1.671 . . . . 0.0 111.568 4.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.401 ' H ' ' CE ' ' A' ' 59' ' ' LYS . 3.3 m120 63.69 13.26 7.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.354 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.58 7.34 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.353 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 37.9 m-85 -99.87 63.74 1.21 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.677 0.275 . . . . 0.0 110.271 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -44.58 128.1 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.639 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.744 ' CG ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-30 -88.37 85.26 6.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 1.5 p -98.34 93.34 6.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.99 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.619 HG13 HD13 ' A' ' 32' ' ' LEU . 77.8 t -66.82 -28.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.082 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.6 p -124.79 52.18 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.17 -171.36 28.16 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.408 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 -149.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 10.2 57.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.938 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' SER . 23.8 t 58.99 17.94 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.782 0.291 . . . . 0.0 111.077 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.45 -67.38 0.16 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.725 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.9 t 59.87 99.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.354 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.33 -111.61 3.8 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.354 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.906 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.71 46.59 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.7 81.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 3.6 t -152.75 53.54 1.06 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 4' ' ' SER . 72.1 Cg_endo -76.73 -16.72 16.35 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.632 2.221 . . . . 0.0 112.684 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -85.88 54.04 2.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -124.06 -55.39 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.252 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -112.15 169.48 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.222 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.74 48.92 2.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.79 74.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.264 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 11' ' ' ILE . 12.3 tt -147.85 101.82 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.199 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.4 mm -94.28 41.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.717 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 43.91 61.94 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.287 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -123.67 44.51 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -178.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' NE ' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -133.95 176.06 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.33 -141.48 4.82 Favored Glycine 0 CA--C 1.488 -1.599 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.667 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.701 ' HB3' HD12 ' A' ' 32' ' ' LEU . 1.7 Cg_endo -77.26 -170.73 9.0 Favored 'Cis proline' 0 N--CA 1.472 0.24 0 CA-C-N 117.596 0.698 . . . . 0.0 111.841 -4.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.68 -36.2 0.44 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.117 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 81.17 -56.86 0.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.751 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -38.36 99.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.146 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -1.3 -65.42 0.0 OUTLIER Pre-proline 0 CA--C 1.477 -1.84 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -179.092 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.758 ' HG2' HG22 ' A' ' 23' ' ' THR . 63.1 Cg_endo -104.6 -4.49 8.97 Favored 'Cis proline' 0 C--N 1.314 -1.265 0 O-C-N 123.334 1.176 . . . . 0.0 112.115 -2.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.758 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -161.19 21.19 0.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.424 -174.334 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.627 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -44.15 166.85 0.1 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 0.0 111.857 -177.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HD2' HD23 ' A' ' 24' ' ' LEU . 67.9 Cg_exo -39.58 166.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.103 2.536 . . . . 0.0 113.272 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.44 119.5 2.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 76.9 -4.2 54.11 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.064 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.685 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 68.6 m95 -101.64 134.69 44.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.46 -0.435 . . . . 0.0 111.457 -178.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -147.92 142.96 27.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.244 -178.605 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 44.9 ttp180 -110.33 163.39 13.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.821 0.82 . . . . 0.0 112.345 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.898 ' C ' HD23 ' A' ' 32' ' ' LEU . 9.4 ttmt -169.31 149.38 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.898 HD23 ' C ' ' A' ' 31' ' ' LYS . 1.8 mt -124.5 164.87 18.85 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.0 111.648 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 ttmt -137.7 123.2 19.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.94 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.3 tt0 -78.75 164.36 24.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.444 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 -179.417 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -125.59 105.73 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.384 0.611 . . . . 0.0 110.472 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 1.5 t -105.15 149.97 25.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.633 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.97 -27.73 1.09 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.774 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 134.12 49.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.426 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.71 54.59 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.47 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' CB ' ' CD ' ' A' ' 36' ' ' LYS . . . -52.44 170.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.265 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 58.96 42.04 96.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.739 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.5 136.4 32.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.5 m-85 -102.04 168.9 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -142.83 140.4 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.242 176.934 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.9 p -88.66 152.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.371 . . . . 0.0 111.281 -178.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.647 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 23.6 m-85 -146.05 101.01 3.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.544 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 79' ' ' PHE . 21.2 mt -92.93 105.48 17.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.801 0.81 . . . . 0.0 109.006 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' THR . 2.8 mt -82.22 121.16 35.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.135 -174.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -85.62 152.86 57.87 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.759 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' GLY . 89.6 Cg_exo -35.29 -57.23 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 0.0 113.275 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -43.9 -27.52 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.234 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.04 49.9 1.04 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.891 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -140.83 133.66 28.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.989 0.424 . . . . 0.0 111.279 -178.418 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.647 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -89.26 146.96 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.332 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CG ' HD12 ' A' ' 62' ' ' LEU . 85.5 m-85 -128.28 126.36 40.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 ttp180 -92.01 -59.22 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.67 172.7 8.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -81.75 -42.84 19.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.381 -178.676 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 t -51.8 -26.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.32 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.63 -31.27 59.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.488 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -68.01 -60.87 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -61.3 -40.24 85.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.074 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.74 -62.06 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.657 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.886 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.05 -57.95 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.66 178.381 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.882 ' CE2' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -39.67 -38.8 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.114 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.7 mm-40 -61.04 -56.14 24.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.034 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.46 -16.41 63.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.873 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.03 -50.52 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -178.729 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 153.75 -31.4 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.455 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.67 -161.33 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.066 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 71' ' ' ASP . 3.0 t 59.47 25.42 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.915 -178.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -141.1 17.47 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.67 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.882 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -39.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 -178.392 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER 71.97 103.59 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.593 179.054 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.3 Cg_exo -48.59 -32.48 21.31 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.439 2.093 . . . . 0.0 112.549 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -70.1 -10.95 60.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.603 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.55 -3.51 58.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.511 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.1 m-85 -109.51 64.4 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.566 -178.032 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.19 137.42 58.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.519 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -87.27 91.51 8.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.073 0.463 . . . . 0.0 111.075 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 98.77 7.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.747 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 44' ' ' TYR . 93.0 t -72.0 -7.64 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.602 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.6 p -116.94 37.37 3.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.75 -178.04 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.967 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -135.7 -155.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.227 . . . . 0.0 110.404 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.16 -29.35 10.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.601 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.9 23.77 14.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.727 0.298 . . . . 0.0 110.933 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.57 75.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.57 168.19 13.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.75 160.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.906 179.971 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.84 0.353 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -83.24 88.53 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.66 92.11 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.463 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 2.3 m -163.59 -64.23 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 38.9 Cg_endo -93.2 -166.38 2.09 Favored 'Cis proline' 0 C--N 1.35 0.612 0 C-N-CA 124.544 -1.023 . . . . 0.0 112.616 -1.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 48.58 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.062 0.458 . . . . 0.0 111.005 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.63 152.0 48.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.09 -177.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 155.75 18.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -116.04 19.86 14.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.189 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 4.0 t 66.85 34.56 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 11' ' ' ILE . 2.7 tt 47.67 103.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.611 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 12' ' ' ILE . 30.9 mm -91.06 54.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.177 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 57.51 55.07 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.7 52.32 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.77 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.72 176.94 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.934 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 147.7 143.44 3.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.29 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 4.9 Cg_exo -72.02 -164.86 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.321 2.014 . . . . 0.0 112.135 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -168.91 106.01 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.502 178.854 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.66 66.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.997 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' MET . 37.4 t70 179.05 74.75 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -177.026 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.6 m-20 -115.7 80.48 8.43 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.632 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.744 ' HA ' HG23 ' A' ' 29' ' ' THR . 94.0 Cg_endo -88.43 22.37 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.852 2.368 . . . . 0.0 112.713 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 24' ' ' LEU . 52.2 p -94.8 46.43 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -125.1 176.66 2.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.479 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 81.5 Cg_exo -49.35 -179.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.729 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.52 126.83 28.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.817 -179.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.61 55.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.276 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.537 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 70.8 m95 -106.38 128.14 53.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.238 0.542 . . . . 0.0 111.787 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -135.95 -179.89 5.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.152 179.36 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 48' ' ' LEU . 29.9 ttp180 -142.09 163.08 33.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.785 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 13.4 ttmt -165.17 170.84 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.492 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.69 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.38 162.94 33.13 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.085 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -148.0 117.17 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.829 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.519 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 48.3 tt0 -75.87 107.67 8.21 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.954 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -178.02 -177.35 0.61 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.111 174.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.97 33.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 6.6 m 59.88 -162.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.25 -22.22 72.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.61 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 115.9 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 111.061 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.18 35.42 18.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -52.47 140.65 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.45 67.6 0.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.555 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -151.55 137.51 18.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 -179.129 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -77.93 122.85 26.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -175.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 149.47 24.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.319 176.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 83' ' ' VAL . 41.7 t -93.86 151.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.1 m-85 -146.05 99.88 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.606 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 30' ' ' ARG . 7.1 mt -92.88 106.8 18.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 109.624 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.1 mt -82.23 122.5 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.688 -174.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.537 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 31.2 p-10 -85.71 153.4 58.07 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.594 -178.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -37.61 -27.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.082 3.188 . . . . 0.0 113.699 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ASN . 2.6 mt-30 -80.61 12.38 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 70.98 15.94 74.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.972 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -99.05 137.51 37.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.494 0.188 . . . . 0.0 111.389 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.28 130.76 41.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.345 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 26.4 m-85 -115.8 117.83 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' CD ' ' CE2' ' A' ' 47' ' ' TYR . 8.1 mtm180 -105.03 10.06 34.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.453 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.45 164.84 38.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.836 0.351 . . . . 0.0 111.189 -178.473 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.547 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.66 -35.91 57.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 0.0 111.122 -178.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 8.2 p -54.0 -46.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.63 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.7 mt-10 -61.3 -30.59 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.88 -64.73 0.83 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -64.91 -42.42 94.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.72 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -57.04 11.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.417 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -66.69 -50.74 61.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.544 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.897 ' CE2' HD13 ' A' ' 74' ' ' LEU . 14.7 m-30 -48.81 -38.32 21.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.798 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 33.1 mt-10 -61.06 -66.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.921 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -54.17 -26.98 30.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -177.348 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.921 HG13 ' HD2' ' A' ' 68' ' ' LYS . 28.4 m -86.45 -29.32 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.786 178.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.31 55.3 28.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.881 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.666 ' HB3' HD11 ' A' ' 74' ' ' LEU . 1.4 t0 -83.46 153.22 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -131.2 3.61 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.43 27.38 8.81 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.889 0.376 . . . . 0.0 110.807 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.897 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -154.43 173.19 16.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.872 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' ASP . 2.3 t0 -158.63 111.86 1.65 Allowed Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.219 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 84.5 Cg_exo -45.17 -41.22 16.56 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.116 1.877 . . . . 0.0 112.241 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -69.97 -9.05 53.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 41.7 t0 -88.64 -6.49 57.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.13 178.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.656 ' CD2' HD11 ' A' ' 62' ' ' LEU . 45.9 m-85 -109.39 127.39 54.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.638 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' CB ' ' HD2' ' A' ' 86' ' ' ARG . 3.2 t0 -107.24 134.16 50.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.127 177.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.446 ' CE2' ' C ' ' A' ' 58' ' ' SER . 4.1 m-85 -97.45 90.2 4.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 p -141.43 142.56 33.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.69 HG13 HD22 ' A' ' 32' ' ' LEU . 87.0 t -95.5 -64.12 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -49.9 -25.38 3.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.68 -179.46 16.25 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.445 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.415 ' HD2' ' CB ' ' A' ' 80' ' ' ASP . 3.2 mtp180 -111.65 -162.19 0.79 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.564 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.23 -65.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.549 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.5 26.73 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.11 -40.84 2.96 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 m 58.39 90.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.352 . . . . 0.0 110.814 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.17 -120.3 22.18 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.899 179.879 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.78 0.324 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 p 59.22 -173.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.767 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.97 55.13 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.0 58.54 1.11 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.65 -4.76 15.92 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.678 2.252 . . . . 0.0 112.933 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.51 81.74 3.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.78 134.05 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.046 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 39.71 -164.33 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.532 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.3 52.48 8.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.4 t -169.53 82.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.6 tt 49.79 111.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.473 0.654 . . . . 0.0 111.971 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.5 mm -77.81 61.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.68 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 71.31 157.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.964 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -55.66 143.24 31.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.055 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' NH1' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -104.88 162.24 13.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.893 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.9 99.74 1.02 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.635 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 Cg_endo -87.68 -167.68 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.255 2.637 . . . . 0.0 112.449 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.458 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.99 103.73 0.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.287 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.691 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -69.5 64.64 0.18 Allowed 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.683 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 18' ' ' MET . 25.3 t0 -178.5 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.8 t70 -114.67 82.64 8.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 29' ' ' THR . 85.1 Cg_endo -86.19 0.24 8.21 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.116 2.544 . . . . 0.0 112.935 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.4 p -80.64 -23.17 39.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.771 0.319 . . . . 0.0 111.09 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 13.3 mt -46.38 161.29 0.28 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 49.1 Cg_exo -35.71 159.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.107 2.538 . . . . 0.0 113.404 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.79 120.82 2.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.183 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.78 -14.02 27.39 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.499 178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 67.4 m95 -90.69 137.05 32.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -136.64 177.94 7.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.946 179.311 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 19.3 ttp180 -141.02 160.91 39.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.518 . . . . 0.0 111.421 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -161.19 166.93 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.946 -179.36 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.995 HD22 HG13 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.875 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.42 117.33 8.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.96 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.521 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 58.2 tt0 -71.14 166.18 22.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.722 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 91.34 174.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.8 177.788 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 178.54 70.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.106 -177.89 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 20.0 m 53.49 -161.43 0.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.53 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.03 8.02 80.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.501 -0.856 . . . . 0.0 113.251 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' A' ' 40' ' ' SER . 8.3 ptp180 -101.37 -46.37 5.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.153 0.476 . . . . 0.0 110.529 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -119.91 38.95 3.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.074 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -54.72 81.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.182 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 141.44 53.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.831 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -137.33 147.94 45.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.686 -179.685 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CB ' HG11 ' A' ' 83' ' ' VAL . 5.9 m-85 -94.12 135.0 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.307 0.575 . . . . 0.0 112.385 -177.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -109.59 156.09 20.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.608 176.757 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 83' ' ' VAL . 18.3 t -98.28 149.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.509 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.499 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 14.9 m-85 -146.01 99.5 3.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.453 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 79' ' ' PHE . 20.0 mt -90.85 107.91 19.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 54' ' ' LYS . 3.2 mt -82.35 127.86 39.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.415 -171.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.3 t-20 -81.39 137.27 48.63 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.997 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 76.9 Cg_exo -33.27 -53.54 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.852 3.035 . . . . 0.0 113.322 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.23 -26.95 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.332 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.05 17.07 5.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.354 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.6 tttp -97.28 168.35 10.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.679 0.276 . . . . 0.0 111.119 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -134.95 130.42 35.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 29.2 m-85 -126.37 121.23 31.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.13 -52.58 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.443 . . . . 0.0 110.139 177.695 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.4 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -88.03 177.09 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.918 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -83.77 -41.49 17.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.338 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 21.6 t -51.81 -27.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.61 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 8.7 mm-40 -75.81 -31.69 59.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.303 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -62.84 -66.58 0.52 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.976 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.623 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -57.66 -38.4 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -58.51 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.98 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.48 ' CG ' ' HD3' ' A' ' 54' ' ' LYS . 1.5 t80 -66.37 -52.61 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.271 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.953 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.6 m-30 -44.79 -41.65 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 21.9 mt-10 -61.16 -63.9 1.13 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.886 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.726 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.67 -23.52 28.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.67 -177.522 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.4 m -92.54 -39.88 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.13 33.95 5.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.586 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.923 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -89.95 135.86 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.945 179.756 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -144.99 26.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.161 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -125.84 7.84 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.967 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.953 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -106.23 -31.87 8.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.845 0.355 . . . . 0.0 110.577 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.53 95.75 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 82.1 Cg_exo -44.39 -30.61 3.88 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.494 2.129 . . . . 0.0 112.227 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -70.12 -7.97 45.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.54 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.39 -18.52 38.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.608 0.242 . . . . 0.0 111.144 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.766 ' HB3' HD13 ' A' ' 48' ' ' LEU . 22.7 m-85 -97.77 125.13 42.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 111.341 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.71 144.41 41.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-85 -101.95 102.47 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.395 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -151.7 110.81 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.995 HG13 HD22 ' A' ' 32' ' ' LEU . 64.4 t -65.57 -71.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.1 p -49.58 -28.46 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.83 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.37 -169.47 13.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.29 -155.49 0.63 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.38 38.93 0.67 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.91 26.4 2.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.704 0.287 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.7 -4.98 57.85 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.101 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.0 p 57.14 107.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.957 0.379 . . . . 0.0 110.621 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.23 150.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.255 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.085 -179.597 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t 60.89 144.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.41 155.83 24.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.16 77.28 0.42 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.987 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.01 -62.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -91.61 45.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -120.35 -61.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.29 177.33 4.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.232 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.89 134.26 55.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -167.01 76.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.16 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.4 tt 48.0 103.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.426 0.631 . . . . 0.0 111.547 179.094 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.13 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.059 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 55.94 45.68 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.07 61.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.68 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.91 165.64 10.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.222 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.32 -126.79 1.6 Allowed Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.62 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.49 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo -71.67 -166.75 4.11 Favored 'Cis proline' 0 N--CA 1.473 0.303 0 CA-C-N 117.699 0.749 . . . . 0.0 111.918 -2.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.467 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.28 -26.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.252 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 84.17 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.433 0.293 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.54 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -114.63 112.42 45.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.197 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -109.11 37.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.943 3.095 . . . . 0.0 112.728 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.5 p -98.3 -53.72 3.27 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 1.7 mt -51.65 -177.53 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 121.489 -0.085 . . . . 0.0 111.051 -176.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 40.0 Cg_exo -41.29 157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.987 2.458 . . . . 0.0 114.6 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.23 149.98 3.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.94 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -59.29 1.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.867 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 75.8 m95 -47.8 150.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.349 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -149.09 178.11 9.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.879 178.933 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.528 ' HE ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -144.22 165.7 27.12 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.406 177.511 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm -176.37 154.59 1.34 Allowed 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.597 -176.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 10.0 mt -116.47 173.79 6.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.546 0.689 . . . . 0.0 112.828 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.83 116.94 6.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.45 176.77 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 43.8 tt0 -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.086 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -152.94 127.75 9.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 -178.338 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.61 ' HD2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.79 -67.79 0.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.287 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' CE ' ' A' ' 36' ' ' LYS . 1.7 t 56.77 -177.6 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.713 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.75 39.43 2.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.16 133.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.724 0.297 . . . . 0.0 110.803 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.0 50.48 10.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . . . -63.48 150.48 43.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 84.94 26.07 38.88 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.608 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.64 136.88 32.76 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.046 0.451 . . . . 0.0 110.66 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.2 m-85 -99.99 159.19 15.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -132.51 153.83 50.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.641 177.247 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 83' ' ' VAL . 52.5 t -101.15 148.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 8.3 m-85 -144.61 103.26 3.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.718 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.574 HD11 ' O ' ' A' ' 80' ' ' ASP . 71.3 mt -92.93 108.05 19.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.6 mt -88.23 130.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.661 -174.581 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.502 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 7.4 p-10 -82.73 154.31 68.05 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.663 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -32.51 -60.45 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.896 3.064 . . . . 0.0 113.827 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.24 -25.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 25.28 5.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.687 -179.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 47.2 tptt -99.1 124.75 44.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.19 140.26 31.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -177.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.718 ' CD2' HD12 ' A' ' 62' ' ' LEU . 25.4 m-85 -133.26 135.35 44.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.155 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -102.58 -53.54 2.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.097 178.144 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -87.0 174.19 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.486 178.337 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.41 -42.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.337 . . . . 0.0 111.756 -178.364 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 50.9 t -51.83 -25.17 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.02 -26.27 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.203 178.25 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD12 ' CD2' ' A' ' 56' ' ' PHE . 1.1 mp -76.1 -65.55 0.9 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.907 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -55.81 -38.42 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.82 -66.98 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.341 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.89 -45.63 89.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.189 -179.166 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.4 m-30 -53.41 -34.54 58.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 111.57 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.24 -70.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.674 -176.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.06 -21.04 28.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 110.357 178.23 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' TYR . 36.6 t -86.46 -25.08 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.927 -177.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 48.49 56.08 9.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.342 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.46 134.52 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.6 16.22 15.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.284 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 25.13 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.839 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -154.65 175.23 13.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.482 179.452 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.64 123.59 2.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.073 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HA ' HD23 ' A' ' 62' ' ' LEU . 39.3 Cg_exo -56.07 -33.39 89.71 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.068 1.845 . . . . 0.0 112.27 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -15.6 62.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.59 -16.42 32.57 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 0.0 111.584 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD2' HD21 ' A' ' 62' ' ' LEU . 54.9 m-85 -98.46 126.97 44.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -124.5 152.74 43.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.058 -179.536 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HA ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-85 -107.46 84.64 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 86' ' ' ARG . 6.9 p -125.05 95.37 4.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 46' ' ' VAL . 2.6 t -49.45 -48.13 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 p -89.74 51.76 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.293 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.18 -170.61 0.03 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.081 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HG2' HG21 ' A' ' 82' ' ' THR . 10.0 mtp-105 -136.66 -154.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.78 84.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.283 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.43 -13.46 58.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.552 0.215 . . . . 0.0 111.522 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.77 -94.6 0.64 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.677 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 m -157.34 103.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.971 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.13 -136.65 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.6 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.953 -179.932 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t 60.01 62.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.095 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -110.53 102.44 11.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.485 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -161.69 -66.05 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.154 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 10.3 Cg_endo -52.08 -70.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -113.16 41.09 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.211 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -145.26 175.92 9.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -173.61 4.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -141.73 177.16 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.9 m 59.65 77.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.315 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.2 tt 48.27 106.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.298 0.57 . . . . 0.0 111.97 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.3 mm -79.91 59.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.431 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mtp85 72.08 170.12 0.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.141 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -49.37 115.72 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.075 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.85 137.51 33.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.21 141.58 3.25 Favored Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HB3' HD13 ' A' ' 32' ' ' LEU . 4.4 Cg_exo -83.19 -176.03 15.54 Favored 'Cis proline' 0 N--CA 1.472 0.207 0 C-N-CA 125.487 -0.63 . . . . 0.0 112.401 2.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.514 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -160.16 102.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.756 179.457 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.725 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.98 63.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.583 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 179.38 82.15 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -176.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 1.7 m-20 -118.42 80.6 16.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.263 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.63 ' HA ' HG23 ' A' ' 29' ' ' THR . 91.1 Cg_endo -89.9 23.5 0.69 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.176 2.584 . . . . 0.0 112.54 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 p -92.02 -20.5 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.437 -179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.81 HD11 ' CG ' ' A' ' 30' ' ' ARG . 12.4 mt -56.69 165.23 1.75 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.868 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 79.8 Cg_exo -48.59 178.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.698 2.265 . . . . 0.0 113.183 -178.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.86 125.32 11.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.287 -178.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.09 0.32 55.98 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.639 178.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 63.7 m95 -101.81 135.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.166 0.508 . . . . 0.0 111.989 -178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -145.82 179.15 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.809 179.468 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.81 ' CG ' HD11 ' A' ' 24' ' ' LEU . 3.1 mtp180 -142.91 165.44 27.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.079 0.466 . . . . 0.0 111.726 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 12.7 tttm -166.09 161.53 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.98 -178.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.809 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -131.3 166.5 21.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.216 0.531 . . . . 0.0 112.12 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -147.24 115.85 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.082 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.9 168.31 8.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -153.1 147.03 25.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.026 0.441 . . . . 0.0 110.896 -178.381 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 41' ' ' ALA . 17.7 tptm -144.01 123.63 13.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.071 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.68 43.81 1.09 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.76 36.84 13.77 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.423 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.6 109.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.685 0.278 . . . . 0.0 110.428 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.64 28.3 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.0 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . . . -52.6 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.454 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 58.73 22.34 53.16 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.255 -178.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 35' ' ' ARG . 8.0 tttt -87.63 141.69 28.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.291 0.567 . . . . 0.0 110.953 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.6 m-85 -108.54 149.61 28.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.219 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.93 148.13 40.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.33 176.542 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 48' ' ' LEU . 40.4 t -90.46 148.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.837 -178.243 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 22.4 m-85 -146.16 95.64 2.65 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.25 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 79' ' ' PHE . 1.7 mt -92.95 109.15 20.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.394 0.616 . . . . 0.0 109.754 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.848 HG12 ' HB2' ' A' ' 55' ' ' ALA . 6.2 mt -82.64 121.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.482 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 46.8 p-10 -85.66 154.87 59.15 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.201 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -33.62 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.918 3.079 . . . . 0.0 113.347 -179.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.86 -26.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.414 -178.997 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 44.77 1.72 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.967 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CD ' ' CE2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.83 138.15 33.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.955 -178.469 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.848 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -103.64 145.28 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CE2' ' CD ' ' A' ' 54' ' ' LYS . 2.0 m-85 -127.83 144.94 51.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.316 177.299 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -48.45 3.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.88 174.68 8.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 1.2 tmtp? -85.69 -39.19 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.289 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 55.8 t -52.11 -38.39 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.949 0.405 . . . . 0.0 110.309 178.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 3.4 mm-40 -67.18 -30.08 69.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.469 178.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.84 -62.21 1.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 109.637 178.851 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.4 mp -67.83 -42.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.356 178.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.63 -58.98 5.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.756 -178.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.1 t80 -62.62 -55.37 27.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 110.581 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.058 ' CE2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-30 -41.2 -38.47 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.897 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -63.25 -60.55 3.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.571 -178.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HD3' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.22 -18.37 15.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.23 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.584 HG23 ' HD3' ' A' ' 68' ' ' LYS . 49.8 t -86.42 -33.68 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 107.38 -35.3 5.1 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -176.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.66 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 32.5 107.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 175.884 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -148.72 31.06 0.8 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.677 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 76.7 p -179.43 49.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.321 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.058 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.5 -36.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.992 -179.135 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.63 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 51.58 109.79 0.02 OUTLIER Pre-proline 0 N--CA 1.462 0.171 0 C-N-CA 122.593 0.357 . . . . 0.0 111.786 179.328 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 50.0 Cg_exo -50.95 -32.43 38.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.144 1.896 . . . . 0.0 112.044 178.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -68.84 -16.08 63.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.777 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -10.47 59.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.051 177.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.754 ' HB3' HD12 ' A' ' 48' ' ' LEU . 41.9 m-85 -106.92 152.26 24.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.447 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.53 148.95 40.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.603 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.7 m-30 -109.28 85.99 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.4 p -120.87 -12.44 8.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.809 HG13 HD22 ' A' ' 32' ' ' LEU . 78.3 t 63.49 -78.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 110.617 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' THR . 25.6 p -54.74 -35.44 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.3 -154.99 21.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.668 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -125.25 -154.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.76 -63.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.55 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.2 26.44 15.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.741 0.305 . . . . 0.0 110.935 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.6 107.39 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -156.27 119.71 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.2 -66.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.436 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.956 179.921 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 57.75 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.982 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.66 107.16 11.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 5' ' ' PRO . 13.0 t -163.67 62.81 1.14 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 4' ' ' SER . 43.2 Cg_endo -93.78 -80.38 0.0 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.559 0 C-N-CA 124.313 -1.12 . . . . 0.0 112.753 2.408 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 39.24 77.62 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 121.097 0.475 . . . . 0.0 111.65 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.7 148.61 30.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.871 -177.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -76.5 -172.75 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -139.26 121.29 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.38 71.06 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 tt -137.55 130.28 42.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -92.11 70.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 61.49 172.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.741 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.65 118.74 12.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.52 137.73 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.91 149.53 10.95 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.806 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 57.6 Cg_endo -71.66 -164.49 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.855 2.37 . . . . 0.0 112.415 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.6 mtm -151.8 105.85 3.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -70.81 -75.24 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.117 -178.247 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.5 p30 -61.31 83.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.715 0.293 . . . . 0.0 110.533 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -115.11 84.64 11.28 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.762 -178.509 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 29' ' ' THR . 87.7 Cg_endo -93.83 30.77 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.193 2.596 . . . . 0.0 112.591 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.7 p -81.28 -31.58 33.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 111.007 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.563 HD11 ' HG2' ' A' ' 30' ' ' ARG . 87.8 mt -50.79 165.12 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.0 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.4 Cg_exo -47.2 178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.591 2.194 . . . . 0.0 112.967 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 128.11 19.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.386 -178.651 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.34 54.84 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.75 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 60.6 m95 -101.0 133.82 44.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.188 0.494 . . . . 0.0 112.019 -178.589 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -138.75 179.19 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.275 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 24' ' ' LEU . 14.9 mtm180 -143.38 170.04 16.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.727 178.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.7 ttmm 178.57 162.37 0.7 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.189 -178.344 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.842 HD13 HG13 ' A' ' 83' ' ' VAL . 14.2 mt -128.13 173.36 10.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.27 0.557 . . . . 0.0 112.168 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -147.8 113.18 5.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.26 176.89 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.499 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.8 tt0 -66.36 167.06 11.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.804 179.059 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' HA ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 90.02 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.09 0.956 . . . . 0.0 112.475 178.078 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' CE ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -174.58 36.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.992 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 8.4 m 62.19 -165.98 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 111.677 178.454 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.3 82.1 0.68 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.658 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.66 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.8 m -99.25 38.41 1.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.21 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -54.97 80.86 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.314 -177.065 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 142.48 53.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.908 177.549 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' CB ' ' CE ' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -142.34 153.86 44.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 110.583 179.703 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -86.72 151.22 23.58 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -174.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-20 -119.53 173.27 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.071 177.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.503 ' CG2' HG23 ' A' ' 83' ' ' VAL . 54.0 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.4 -178.268 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.2 m-85 -146.36 103.27 3.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.074 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 24' ' ' LEU . 62.3 mt -92.99 107.81 19.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.442 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 54' ' ' LYS . 4.3 mt -82.33 121.77 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.549 -173.18 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 18.8 p-10 -85.73 144.59 39.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.535 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -35.39 -44.71 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.614 2.876 . . . . 0.0 112.857 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 3.5 mt-30 -49.12 -23.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.234 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.61 20.32 11.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.753 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.835 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -100.75 -179.99 4.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 111.679 -178.638 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.87 131.87 21.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.708 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 64.7 m-85 -123.28 133.25 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 0.0 111.729 -178.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.0 mtm180 -105.98 1.04 26.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.672 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.35 164.22 38.95 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -178.176 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -69.53 -47.21 64.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -176.221 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 9.2 t -51.9 -35.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.777 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -28.06 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.119 178.277 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.073 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -67.41 -69.16 0.33 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.549 179.359 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -55.45 -36.1 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -64.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.923 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.838 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.34 -59.57 4.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.008 0.432 . . . . 0.0 110.681 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.576 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.7 m-30 -35.29 -39.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.767 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 11.6 mt-10 -61.19 -66.69 0.5 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.877 0.37 . . . . 0.0 111.928 -177.225 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HE3' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.19 -19.96 23.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.58 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.53 -37.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.297 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.67 -32.28 3.22 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.801 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.44 -159.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.832 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 71' ' ' ASP . 0.6 OUTLIER 75.91 26.92 0.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.093 0.557 . . . . 0.0 110.51 -177.014 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -150.16 27.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.426 177.557 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -147.95 -41.96 0.17 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.889 -178.23 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 70.14 86.24 0.12 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.433 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 81.3 Cg_exo -49.96 -24.92 11.38 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.6 -18.6 63.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.545 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -88.52 12.49 14.34 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.833 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 1.073 ' CD2' HD21 ' A' ' 62' ' ' LEU . 3.8 m-85 -108.11 79.45 1.27 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.727 0.298 . . . . 0.0 111.004 -179.097 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 82' ' ' THR . 0.4 OUTLIER -84.57 8.0 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.751 179.905 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 10.3 m-85 49.33 -88.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.289 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 80' ' ' ASP . 2.1 p 58.28 161.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.406 . . . . 0.0 111.298 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 32' ' ' LEU . 16.9 t -132.53 -51.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.221 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.7 p -93.17 39.46 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.953 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.12 -110.01 3.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 110.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 110.949 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.73 32.33 69.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 90' ' ' SER . 5.2 t -92.76 24.3 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.51 -68.55 0.1 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.727 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.3 OUTLIER 58.62 173.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 -179.793 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.43 -166.36 7.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.427 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.914 179.788 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -147.65 143.32 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.64 42.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 73.94 8.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.87 0.52 8.74 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.713 2.275 . . . . 0.0 113.006 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -109.87 107.39 17.32 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.893 0.378 . . . . 0.0 110.829 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -135.25 87.28 2.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -116.59 169.23 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.036 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -113.93 152.5 30.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.851 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 t -81.68 56.19 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 15' ' ' ARG . 15.2 tt -89.86 132.52 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 12' ' ' ILE . 29.7 mm -91.67 50.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 50.0 45.77 24.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.022 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -130.5 61.51 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HB3' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.05 -173.29 2.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.54 148.07 15.24 Favored Glycine 0 CA--C 1.483 -1.938 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.254 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 62.2 Cg_endo -77.26 171.2 68.94 Favored 'Cis proline' 0 N--CA 1.475 0.426 0 C-N-CA 125.133 -0.778 . . . . 0.0 113.097 4.53 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.672 ' H ' HD11 ' A' ' 32' ' ' LEU . 8.1 mtm -136.18 -36.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.142 -179.105 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.723 ' CD1' HD12 ' A' ' 32' ' ' LEU . 8.5 m-85 63.44 28.24 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 35.4 t70 -175.75 82.55 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -176.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -113.31 87.94 12.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.143 178.344 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 29' ' ' THR . 96.3 Cg_endo -88.11 9.03 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.012 2.475 . . . . 0.0 112.649 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 p -86.83 51.85 2.35 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.53 HD11 ' CD ' ' A' ' 30' ' ' ARG . 29.4 mt -128.97 164.08 41.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.155 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.51 170.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.384 2.056 . . . . 0.0 112.556 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 126.24 8.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.466 -178.479 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.57 0.56 58.92 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.731 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 66.0 m95 -101.41 137.28 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 112.087 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -147.89 -172.15 3.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.789 179.902 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.581 ' H ' HG22 ' A' ' 29' ' ' THR . 1.7 mtm180 -151.33 176.27 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 111.43 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -175.53 173.52 2.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.354 -178.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -142.97 167.14 22.77 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.325 0.583 . . . . 0.0 112.409 179.879 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -148.04 101.32 3.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.979 177.792 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.6 tt0 -68.55 166.8 16.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.936 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -153.04 148.31 26.9 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.755 0.312 . . . . 0.0 110.169 179.259 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.14 65.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.498 0.666 . . . . 0.0 111.208 179.42 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -84.9 107.88 17.27 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.204 177.207 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -33.47 -34.17 0.02 OUTLIER Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.754 -176.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -96.48 110.9 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.694 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m 63.04 36.47 12.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 109.686 -176.622 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -52.59 166.34 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.448 -178.59 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' HE2' ' A' ' 36' ' ' LYS . . . 68.16 33.56 78.75 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.716 -179.014 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.56 140.49 29.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.534 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.542 ' CB ' HG11 ' A' ' 83' ' ' VAL . 9.1 m-85 -105.42 137.04 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -105.98 137.94 43.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.641 174.712 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p -93.91 154.46 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.038 0.447 . . . . 0.0 111.468 -177.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.2 m-85 -146.04 99.22 3.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 79' ' ' PHE . 8.1 mt -91.78 111.43 22.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.39 120.89 34.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.211 -171.75 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 6.5 p-10 -86.18 144.76 39.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.216 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -34.7 -51.72 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.64 2.893 . . . . 0.0 113.429 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -44.62 -27.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.389 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.24 25.07 5.97 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.602 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.751 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.0 tttt -99.17 172.47 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 111.31 -178.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 96.56 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.366 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 22.9 m-85 -90.29 129.15 36.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 111.647 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -104.85 4.27 31.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.335 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 60' ' ' VAL . 99.7 p -154.41 170.77 20.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 -177.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.23 -37.98 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -178.517 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 3.9 p -51.84 -46.48 40.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.683 -179.191 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -62.11 -31.99 72.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.221 178.594 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -65.51 -68.6 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 178.959 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -56.98 -40.42 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.696 178.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.26 -64.87 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.102 -178.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.49 -40.14 93.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.605 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 1.043 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.8 m-30 -59.8 -32.22 70.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 23.3 mt-10 -60.9 -70.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 111.522 -177.289 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.03 -21.79 33.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.559 178.393 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 65' ' ' TYR . 13.3 t -86.41 -25.9 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -177.552 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 59.84 45.19 96.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.698 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.778 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.06 136.39 33.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.738 179.395 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.8 p -138.75 23.38 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 p -124.0 24.13 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -133.51 -41.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 -179.35 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' H ' HD12 ' A' ' 74' ' ' LEU . 1.3 m-20 61.96 102.54 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.6 Cg_exo -46.59 -34.69 15.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.422 2.081 . . . . 0.0 112.424 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -70.03 -7.55 41.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.24 -14.92 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.657 0.265 . . . . 0.0 110.946 178.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 48' ' ' LEU . 47.7 m-85 -99.05 99.11 10.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.244 -179.235 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' OD2' ' NE ' ' A' ' 86' ' ' ARG . 26.0 t0 -84.78 132.31 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.689 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.16 74.24 6.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.476 -178.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 124.7 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.664 179.086 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.985 HG13 HD22 ' A' ' 32' ' ' LEU . 81.0 t -73.59 -67.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.285 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -49.82 -28.77 6.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.58 167.86 38.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.346 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' NE ' ' OD2' ' A' ' 80' ' ' ASP . 4.8 mtp180 -109.28 -154.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 110.624 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.54 -30.63 6.79 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.598 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m 65.78 22.23 11.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.65 0.262 . . . . 0.0 111.178 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 40.57 0.83 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.7 m 55.14 96.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -139.41 46.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.532 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 58.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.903 -179.906 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 t -100.77 165.69 11.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.99 149.51 43.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -163.61 -63.54 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.11 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 48.0 Cg_endo -90.75 -18.98 13.91 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.518 -1.034 . . . . 0.0 112.506 -2.232 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.92 65.87 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.52 -65.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.31 171.85 11.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.037 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.69 120.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.62 179.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 73.38 60.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -101.64 142.39 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.045 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.7 mm -84.64 56.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.029 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 63.21 157.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.17 124.36 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.97 149.83 35.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.95 149.79 14.44 Favored Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.598 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 32' ' ' LEU . 86.8 Cg_endo -80.03 -174.4 14.4 Favored 'Cis proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.85 -0.896 . . . . 0.0 112.432 3.258 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.8 118.29 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.575 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -97.38 47.44 1.03 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.67 -178.966 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t0 179.4 71.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.431 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.49 93.98 21.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.341 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 68.2 Cg_endo -95.9 23.66 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.319 2.679 . . . . 0.0 112.293 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.854 ' C ' HD23 ' A' ' 24' ' ' LEU . 16.7 p -92.31 42.83 1.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.281 -178.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.021 HD11 ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -130.31 178.55 1.67 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.377 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.1 Cg_exo -46.9 174.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.489 2.126 . . . . 0.0 112.737 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.86 44.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.16 -178.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.42 -0.12 60.97 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.393 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 55.0 m95 -102.57 133.43 47.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.942 -178.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -140.44 -176.53 4.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.416 179.789 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 1.021 ' CG ' HD11 ' A' ' 24' ' ' LEU . 2.5 mtp180 -143.25 156.98 44.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.596 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.885 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.8 ttpt -166.49 161.05 15.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.996 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.98 HD13 HG13 ' A' ' 83' ' ' VAL . 5.4 mt -130.28 166.8 19.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.252 0.549 . . . . 0.0 112.217 -178.224 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.6 tttt -139.31 115.49 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.861 -179.383 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -65.89 167.87 8.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.332 178.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 20.7 ttm180 -153.18 163.92 39.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.667 ' CD ' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -137.0 99.53 4.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.399 178.672 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -21.45 13.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.18 -83.37 0.33 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -178.383 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -45.04 67.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 110.042 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.24 41.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.939 177.805 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB1' ' CD ' ' A' ' 36' ' ' LYS . . . -52.52 115.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 103.26 34.43 3.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.311 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.68 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.026 -179.405 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.776 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.6 m-85 -104.75 153.96 20.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.461 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -120.31 144.21 47.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.215 176.245 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.712 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.6 p -85.92 148.61 4.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.13 -178.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.7 m-85 -145.35 97.95 3.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD12 ' HB3' ' A' ' 79' ' ' PHE . 7.6 mt -92.57 109.64 21.05 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.076 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.0 mt -82.23 126.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -171.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.5 p-10 -85.58 150.28 53.46 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.329 -178.598 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -38.57 -55.45 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.171 2.58 . . . . 0.0 112.802 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -46.77 -26.79 1.02 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.31 28.91 3.14 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.602 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -92.33 -178.84 5.05 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.368 0.604 . . . . 0.0 112.094 -179.406 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.2 88.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.076 177.112 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 83.2 m-85 -92.02 122.05 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.457 -177.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.496 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -92.84 -48.73 6.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.051 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 171.78 9.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.323 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 63' ' ' ILE . 7.8 tptp -88.68 -47.19 8.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 -179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 t -51.88 -26.85 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 110.147 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.59 -32.07 63.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.661 177.257 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -64.43 -62.66 1.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.84 179.371 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -61.56 -40.87 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.8 -68.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.122 -179.133 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.79 -40.55 88.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.102 -179.632 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.517 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.6 m-30 -56.47 -30.9 63.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.345 . . . . 0.0 110.641 178.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.9 mm-40 -70.42 -60.28 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.915 -177.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.36 -26.05 62.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.597 -178.124 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 65' ' ' TYR . 12.1 m -86.58 -39.92 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.4 38.99 4.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.323 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.515 ' CG ' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.1 117.53 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 -179.464 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.3 p -134.95 33.93 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 179.643 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 p -132.53 33.6 3.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.531 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.535 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -137.64 -39.04 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.494 -179.092 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER 66.75 93.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 110.57 -179.08 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 97.9 Cg_exo -44.97 -29.0 3.42 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -69.95 -7.94 44.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.386 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.25 -11.49 46.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.478 0.18 . . . . 0.0 111.291 178.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 48' ' ' LEU . 74.2 m-85 -103.4 102.36 12.29 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.485 -179.11 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.553 ' O ' HD11 ' A' ' 48' ' ' LEU . 13.6 t70 -94.0 160.35 14.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.294 178.185 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.712 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.0 m-30 -115.44 85.0 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.761 HG21 ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -124.38 96.38 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.688 179.232 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.98 HG13 HD13 ' A' ' 32' ' ' LEU . 86.5 t -66.12 -32.43 58.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 p -107.87 47.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.334 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.77 -164.87 11.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.98 179.104 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.761 ' HB3' HG21 ' A' ' 82' ' ' THR . 0.2 OUTLIER 179.14 154.41 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.373 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 -43.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.583 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m 59.37 24.83 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.18 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.45 -120.73 1.94 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.495 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t -155.34 91.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.33 28.53 69.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.498 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.815 179.702 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 5.0 Cg_exo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 120.779 0.241 . . . . 0.0 112.119 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.406 ' HG2' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -171.71 105.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.81 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 3.2 m-30 -67.35 -19.04 65.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.92 73.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.299 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -97.71 111.38 58.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -106.04 13.99 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.001 3.134 . . . . 0.0 112.617 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.639 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 p -90.65 50.06 1.76 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 30' ' ' ARG . 72.0 mt -154.17 160.33 31.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -22.79 145.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.653 3.569 . . . . 0.0 114.543 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.51 148.43 0.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.203 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.98 -58.36 2.24 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.785 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.522 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 78.7 m95 -47.42 133.44 12.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 112.087 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.52 167.72 20.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.864 ' HD2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -138.76 159.62 41.67 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.628 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.7 ttmm -157.32 167.59 29.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.994 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.011 HD22 HG12 ' A' ' 83' ' ' VAL . 6.7 mt -137.03 175.88 9.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.478 0.656 . . . . 0.0 112.258 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.0 tttm -147.81 106.59 3.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.157 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.766 -179.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.176 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.981 ' HB3' HG11 ' A' ' 83' ' ' VAL . 24.3 m-85 -100.09 164.49 11.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 5.7 m-20 -120.47 166.98 12.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.31 -1.768 . . . . 0.0 108.428 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 81' ' ' PHE . 54.2 t -128.07 147.94 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.201 0.524 . . . . 0.0 111.766 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 33.5 m-85 -149.05 102.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.139 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 6.1 mt -93.04 106.08 18.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 109.601 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.8 mt -82.3 123.62 38.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.956 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.426 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 t-20 -80.81 137.96 50.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.801 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 73.5 Cg_exo -34.02 -54.84 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.521 2.814 . . . . 0.0 113.456 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -50.99 -31.61 18.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 111.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.48 48.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.89 122.58 15.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -177.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.69 152.29 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.177 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 1.2 m-85 -129.78 167.97 17.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.64 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.16 3.49 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.87 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.49 171.63 19.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.43 -43.25 41.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.168 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 9.1 p -53.22 -44.39 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 109.873 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.1 tt0 -60.87 -27.83 68.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.3 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -69.6 -64.6 0.85 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.9 mp -65.9 -39.43 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.255 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.71 -58.0 8.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.0 t80 -68.86 -49.21 60.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 110.843 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 5.1 m-85 -46.82 -26.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.3 mm-40 -72.82 -57.06 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -16.1 63.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 65' ' ' TYR . 13.5 m -86.48 -40.18 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.174 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.62 43.73 2.86 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.514 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.954 ' OD2' HD11 ' A' ' 74' ' ' LEU . 11.4 p-10 -74.3 141.97 45.23 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 122.535 0.334 . . . . 0.0 111.562 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 t -149.86 23.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.372 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.88 52.37 0.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.954 HD11 ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -154.53 -44.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 63.66 100.81 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.435 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 86.4 Cg_exo -47.75 -31.55 15.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.469 2.112 . . . . 0.0 112.582 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -8.49 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 1.04 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 62' ' ' LEU . 66.7 m-85 -109.37 130.89 55.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.857 0.361 . . . . 0.0 111.257 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -124.17 147.64 47.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.736 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.494 ' HD1' HG11 ' A' ' 46' ' ' VAL . 22.7 m-85 -105.96 77.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.33 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.1 p -140.71 111.64 7.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.011 HG12 HD22 ' A' ' 32' ' ' LEU . 3.4 m -64.69 -41.27 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.642 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.656 HG23 HG23 ' A' ' 83' ' ' VAL . 16.3 p . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.522 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 6.1 Cg_exo . . . . . 0 N--CA 1.473 0.29 0 CA-C-O 120.768 0.237 . . . . 0.0 112.029 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtm -145.65 94.46 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.7 m-30 -67.18 -70.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.443 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 33.5 t0 -64.08 79.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' TYR . 3.2 m-20 -114.92 88.53 17.14 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 77.8 Cg_endo -97.22 14.38 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.393 2.728 . . . . 0.0 112.442 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -87.97 49.6 1.83 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.826 0.346 . . . . 0.0 111.426 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -129.65 176.23 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 94.2 Cg_exo -45.43 169.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.421 2.081 . . . . 0.0 112.824 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.16 124.09 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.141 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.77 -4.68 43.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.749 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 45.0 m95 -94.68 118.16 31.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.229 0.538 . . . . 0.0 112.069 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -118.01 -173.95 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 29' ' ' THR . 1.8 ttt180 -155.35 163.7 39.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HD23 ' A' ' 32' ' ' LEU . 7.5 tttt -172.78 158.61 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.359 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.972 HD13 ' HB ' ' A' ' 83' ' ' VAL . 6.2 mt -129.89 174.42 9.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 111.51 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -146.94 110.94 5.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.074 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.792 -179.891 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.872 0.368 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 26.2 m-85 -106.63 163.73 12.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.872 0.844 . . . . 0.0 113.11 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.93 132.74 45.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.664 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.7 p -91.53 148.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.661 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 3.4 m-85 -143.7 103.38 4.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.403 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 79' ' ' PHE . 19.7 mt -92.96 110.78 22.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -85.19 124.65 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.463 0.649 . . . . 0.0 112.064 -173.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.496 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 24.6 p-10 -85.67 151.07 54.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.754 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -37.17 -53.68 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.565 2.843 . . . . 0.0 113.259 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -45.72 -26.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.253 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.73 47.22 1.2 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.764 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.955 0.407 . . . . 0.0 111.286 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -91.35 150.26 21.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.94 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.55 119.49 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.82 5.47 43.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.569 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.2 p -154.44 159.98 41.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.167 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.664 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.6 -39.5 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.167 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 61' ' ' GLU . 4.2 p -51.83 -48.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.787 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.6 mm-40 -61.88 -29.91 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.07 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -63.37 -60.42 3.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -67.81 -42.84 86.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.683 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.94 41.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -67.35 -50.77 58.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.333 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.703 ' CE2' HD13 ' A' ' 74' ' ' LEU . 23.0 m-30 -53.67 -26.76 23.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -69.12 -60.65 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.329 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.11 -27.71 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -177.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 68' ' ' LYS . 21.2 m -86.61 -44.47 16.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.93 44.06 3.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.967 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.27 143.55 29.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.262 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -145.95 22.87 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -124.45 33.42 5.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.39 -43.48 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.3 OUTLIER 62.8 107.9 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 88.0 Cg_exo -48.13 -31.89 17.56 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.324 2.016 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.97 -7.45 40.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.614 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.38 -4.02 59.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.293 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 62' ' ' LEU . 82.8 m-85 -107.62 123.41 48.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.735 0.303 . . . . 0.0 111.172 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.99 137.13 51.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-85 -95.71 79.16 3.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.042 0.449 . . . . 0.0 111.352 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -138.42 94.83 2.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.936 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.972 ' HB ' HD13 ' A' ' 32' ' ' LEU . 23.6 m -48.29 -48.51 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.761 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.517 ' N ' HG23 ' A' ' 83' ' ' VAL . 20.6 p . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.491 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 95.5 Cg_endo . . . . . 0 N--CA 1.476 0.476 0 CA-C-O 120.578 0.157 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.436 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -157.92 -40.58 0.07 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.549 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 17' ' ' PRO . 1.9 m-85 75.14 -65.89 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.555 0.217 . . . . 0.0 111.068 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.57 89.3 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.469 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 34.4 m-20 -131.8 65.66 76.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 29' ' ' THR . 8.9 Cg_endo -82.27 9.28 4.06 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.82 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 t -85.52 55.71 3.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.029 0.443 . . . . 0.0 110.681 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.4 mt -126.39 167.08 18.22 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.028 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 76.1 Cg_exo -40.79 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.751 2.3 . . . . 0.0 112.631 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.01 121.85 3.49 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.136 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 -2.2 49.59 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.798 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 48.9 m95 -96.85 140.96 30.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.237 0.519 . . . . 0.0 112.158 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -140.38 176.07 9.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.529 ' HG3' HD23 ' A' ' 48' ' ' LEU . 17.0 ttm105 -147.36 154.01 40.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.19 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.892 ' C ' HD23 ' A' ' 32' ' ' LEU . 12.1 ttmt -168.7 164.4 12.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.228 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.079 HD13 HG13 ' A' ' 83' ' ' VAL . 3.7 mt -128.66 161.27 30.07 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.157 0.503 . . . . 0.0 111.836 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.99 125.86 32.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.922 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.135 -179.581 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.877 0.37 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 20.5 m-85 -105.52 162.81 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -134.26 144.94 48.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.353 176.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.713 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -88.06 146.89 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.896 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.519 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.5 m-85 -142.82 98.65 3.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.0 111.291 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.701 HD13 ' HD1' ' A' ' 79' ' ' PHE . 14.4 mt -92.97 113.21 25.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.461 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 37.3 mt -92.16 127.94 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 34.7 p-10 -85.58 150.05 52.93 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.901 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -32.91 -58.74 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.928 3.085 . . . . 0.0 113.383 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -44.62 -27.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.21 51.18 0.89 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.813 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -139.75 130.68 26.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.931 0.395 . . . . 0.0 110.743 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -92.37 158.43 16.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.875 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -136.96 120.15 16.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.22 10.05 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -154.51 163.35 40.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.984 -177.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 3.8 tptp -79.75 -49.27 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.881 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 12.2 t -51.96 -33.6 16.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.216 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -70.36 -29.96 66.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.03 177.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.573 HD21 ' CB ' ' A' ' 79' ' ' PHE . 1.1 tp -63.06 -59.55 4.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.0 mp -70.33 -46.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.401 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -50.14 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.5 t80 -68.97 -57.78 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 110.477 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.6 m-30 -42.54 -33.38 0.68 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.36 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.5 mm-40 -76.18 -56.47 4.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.407 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.81 -21.82 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.667 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.809 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.7 m -92.37 -25.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.012 0.434 . . . . 0.0 109.933 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 71' ' ' ASP . . . 94.83 -30.81 7.51 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.821 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.855 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 49.2 157.91 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.9 p -90.11 -22.77 21.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.32 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.62 ' O ' HD12 ' A' ' 74' ' ' LEU . 10.9 p 165.06 -76.74 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.455 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER 49.57 -166.16 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.631 -177.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -162.93 92.38 1.2 Allowed Pre-proline 0 C--N 1.31 -1.137 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.45 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 81.8 Cg_exo -47.39 -33.26 16.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.319 2.013 . . . . 0.0 111.732 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.01 -19.41 63.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.54 0.22 56.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.648 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.701 ' HD1' HD13 ' A' ' 48' ' ' LEU . 96.9 m-85 -105.18 100.61 10.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 111.459 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.17 129.22 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.384 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.3 m-85 -88.32 87.45 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 111.202 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.78 104.12 7.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.079 HG13 HD13 ' A' ' 32' ' ' LEU . 95.2 t -73.09 -67.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.644 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.8 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 88.4 Cg_endo . . . . . 0 CA--C 1.53 0.322 0 N-CA-C 112.362 0.101 . . . . 0.0 112.362 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -165.81 134.48 3.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.633 ' CD1' HD12 ' A' ' 32' ' ' LEU . 1.6 m-30 -94.52 48.34 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.0 110.184 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 32.3 t70 -175.44 79.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.84 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -112.73 85.26 7.36 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.596 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HA ' HG23 ' A' ' 29' ' ' THR . 79.9 Cg_endo -89.0 25.96 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.98 2.453 . . . . 0.0 112.78 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -93.9 23.66 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.486 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -99.79 -178.26 0.67 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.7 Cg_exo -49.17 179.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.236 1.958 . . . . 0.0 112.18 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -55.5 120.78 7.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.157 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.8 50.68 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.818 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 51.8 m95 -93.75 131.34 39.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 111.689 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -132.32 179.92 5.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.645 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.487 ' H ' HG22 ' A' ' 29' ' ' THR . 7.1 ttp-105 -139.88 165.53 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.225 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -169.83 168.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.1 167.48 21.72 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.335 0.588 . . . . 0.0 112.399 -178.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 10.7 tttp -147.81 110.73 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.232 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 54.4 tt0 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.076 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.8 m-85 -88.6 144.13 26.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 61.0 m-20 -110.62 172.16 7.03 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 113.892 -1.503 . . . . 0.0 109.519 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 70.6 t -131.64 145.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.7 m-85 -146.03 105.61 3.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.073 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 79' ' ' PHE . 15.3 mt -90.29 107.35 19.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.0 mt -82.86 123.26 38.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.112 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 6.3 t-20 -76.05 144.67 75.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.704 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 70.5 Cg_exo -37.01 -28.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.13 2.553 . . . . 0.0 113.113 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' ASN . 4.3 mm-40 -90.4 30.45 1.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 55.74 26.25 46.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.447 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.509 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -98.74 124.5 43.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.914 0.388 . . . . 0.0 110.427 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 138.15 34.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.8 m-85 -124.43 126.14 45.44 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 18.6 mtp180 -96.41 -58.36 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.497 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.35 171.9 9.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.92 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.602 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -80.58 -41.72 23.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.176 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 10.9 t -51.79 -31.58 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 -29.29 63.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 110.025 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 ' HD3' ' A' ' 59' ' ' LYS . 1.4 tp -66.52 -60.72 2.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -65.59 -45.92 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.17 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.86 -49.01 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 2.5 t80 -70.15 -57.65 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.115 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CE2' HD13 ' A' ' 74' ' ' LEU . 20.8 m-30 -46.83 -28.93 1.72 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -72.74 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.103 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.716 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.17 -23.93 50.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.495 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.7 m -91.56 -44.18 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.975 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 87.52 51.29 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.101 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.574 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.5 t70 -84.9 137.92 32.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 111.103 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 p -124.02 22.63 8.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.144 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -128.42 29.76 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.601 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.54 174.77 14.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -158.63 114.13 1.67 Allowed Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.358 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 62' ' ' LEU . 93.0 Cg_exo -46.41 -32.71 11.45 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.456 2.104 . . . . 0.0 112.0 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.04 -19.78 63.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.57 -1.94 58.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.584 ' HB3' HD13 ' A' ' 48' ' ' LEU . 94.9 m-85 -107.21 110.6 22.69 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.832 0.348 . . . . 0.0 111.085 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.38 131.75 53.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 20.3 m-30 -87.5 80.67 8.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.09 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.79 118.86 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.356 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 32' ' ' LEU . 52.2 t -65.65 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.235 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.3 . . . . 0.0 111.021 -178.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 7.8 Cg_exo . . . . . 0 N--CA 1.474 0.363 0 CA-C-O 120.871 0.28 . . . . 0.0 112.085 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mtm -148.28 102.54 3.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -79.85 -67.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.776 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.2 83.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.579 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 6.2 m-20 -118.75 85.39 27.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.389 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' HG23 ' A' ' 29' ' ' THR . 61.8 Cg_endo -95.66 14.03 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.239 2.626 . . . . 0.0 112.503 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HD23 ' A' ' 24' ' ' LEU . 5.0 p -86.16 51.2 2.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.33 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 23' ' ' THR . 1.1 mt -132.3 179.07 1.47 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.073 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 95.6 Cg_exo -45.14 166.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.362 2.041 . . . . 0.0 112.546 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 126.0 5.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.847 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.4 -52.66 4.37 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.506 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 m95 -44.86 142.29 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 112.323 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -144.85 -169.98 3.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.731 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 29' ' ' THR . 43.8 ttp180 -156.9 161.96 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.861 ' C ' HD23 ' A' ' 32' ' ' LEU . 5.4 ttmt -168.97 160.11 9.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.249 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.045 HD13 HG13 ' A' ' 83' ' ' VAL . 1.6 mt -131.31 163.51 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.169 0.509 . . . . 0.0 111.368 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.24 116.89 12.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.18 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.499 179.276 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.862 0.363 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.788 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.8 m-85 -103.68 163.21 12.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.679 0.752 . . . . 0.0 112.977 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.97 140.16 48.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.743 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.0 p -91.98 148.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.3 m-85 -146.19 103.42 3.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.685 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.903 HD13 ' HB3' ' A' ' 79' ' ' PHE . 7.0 mt -92.62 114.44 26.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -87.35 127.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.804 0.811 . . . . 0.0 113.149 -171.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 54' ' ' LYS . 13.0 t-20 -82.44 135.01 47.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.506 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 85.6 Cg_exo -32.86 -51.7 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.666 2.91 . . . . 0.0 113.631 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -46.94 -26.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.374 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.12 18.14 6.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.332 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.501 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.6 tttt -96.67 147.91 23.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.552 0.215 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' LYS . . . -114.97 108.8 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.991 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.5 m-85 -92.72 124.2 36.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -93.14 -9.45 39.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.416 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.58 176.71 11.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.984 0.421 . . . . 0.0 111.558 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HD2' HD11 ' A' ' 63' ' ' ILE . 2.2 mmtp -79.15 -42.72 25.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.166 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 20.2 t -51.85 -35.48 18.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.676 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.41 ' OE1' ' CA ' ' A' ' 61' ' ' GLU . 2.3 mm-40 -72.79 -27.08 61.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.092 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -68.17 -65.45 0.69 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -56.4 -41.17 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.92 -66.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.484 ' CD2' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.76 -50.2 74.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.423 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.4 m-30 -51.79 -29.69 20.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.391 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.2 mm-40 -67.0 -64.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.053 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.26 -24.68 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.6 -177.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.42 -33.28 5.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 42.69 9.96 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.715 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB3' HD21 ' A' ' 74' ' ' LEU . 1.1 t0 -82.96 121.65 27.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.716 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -127.37 34.25 4.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.16 25.7 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -133.65 -39.51 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 6.8 m-20 60.45 101.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.513 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 85.6 Cg_exo -47.52 -31.29 13.46 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.35 2.033 . . . . 0.0 112.404 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -7.79 43.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -19.46 35.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.614 0.245 . . . . 0.0 110.858 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.5 m-85 -96.63 116.47 29.17 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.655 ' O ' HD11 ' A' ' 48' ' ' LEU . 7.4 t0 -103.8 151.46 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.555 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.578 ' CE1' HD12 ' A' ' 48' ' ' LEU . 16.9 m-85 -109.18 88.84 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 111.378 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 142.43 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.65 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.045 HG13 HD13 ' A' ' 32' ' ' LEU . 94.7 t -114.07 -34.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.817 179.795 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.905 ' CB ' HD12 ' A' ' 32' ' ' LEU . 96.7 Cg_endo . . . . . 0 C--O 1.232 0.194 0 N-CA-C 111.822 -0.107 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.416 ' CE ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -136.74 -14.84 1.61 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 52.94 46.03 27.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.281 0.562 . . . . 0.0 110.0 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.488 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.8 t0 -137.7 77.68 1.65 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.806 ' CG ' HG23 ' A' ' 29' ' ' THR . 2.5 m-20 56.09 -96.46 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.777 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.7 Cg_endo -92.11 -5.0 46.16 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 CA-C-N 123.14 2.157 . . . . 0.0 113.739 -8.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 22' ' ' PRO . 1.7 t -156.43 15.68 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' THR . 5.7 mt -53.27 160.39 1.74 Allowed Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.085 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.5 Cg_exo -44.77 172.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.371 2.048 . . . . 0.0 111.993 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 123.24 6.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.696 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.54 -44.22 3.31 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.862 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.536 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 64.9 m95 -54.05 142.55 24.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.145 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -143.22 167.77 21.34 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.489 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 2.0 ptm85 -122.09 153.27 38.9 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.103 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.963 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.3 tttt -151.17 152.06 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.356 1.66 . . . . 0.0 109.612 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 31' ' ' LYS . 9.7 mt -131.39 157.33 43.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.7 115.94 18.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.326 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.989 178.617 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.106 0 CA-C-O 120.934 0.397 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.691 ' HB2' HG11 ' A' ' 83' ' ' VAL . 7.1 m-85 -106.69 164.57 11.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -133.54 147.37 51.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.362 176.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.63 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.8 p -89.04 146.69 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.018 0.437 . . . . 0.0 112.025 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m-85 -146.09 101.05 3.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.363 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -91.03 108.22 19.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 3.6 mt -82.23 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.061 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.4 t-20 -83.69 135.99 42.58 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.747 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 77.3 Cg_exo -34.47 -54.68 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.531 2.821 . . . . 0.0 113.261 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -50.35 -32.61 17.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.526 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HD2' ' CD2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -138.84 129.14 25.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.76 150.88 22.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.938 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 49.4 m-85 -133.85 131.67 39.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.955 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -105.84 -9.38 17.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.764 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.26 172.16 18.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 111.384 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.08 -39.74 75.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.728 -177.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 3.2 t -55.29 -44.32 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.04 -27.5 69.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.696 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -65.41 -65.17 0.71 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.001 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 ' HD2' ' A' ' 59' ' ' LYS . 4.4 mp -62.94 -42.38 96.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.48 -47.76 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 3.0 t80 -72.72 -59.23 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.415 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.014 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.5 m-30 -44.03 -32.61 1.21 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.24 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.6 mm-40 -65.68 -60.96 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.934 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.87 -21.13 41.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.125 -178.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.934 HG13 ' HD3' ' A' ' 68' ' ' LYS . 20.2 m -95.35 -48.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.16 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 106.92 34.54 2.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.9 t0 -89.39 142.2 27.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.988 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -148.41 25.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.03 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.73 31.81 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.014 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -130.31 -32.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.559 -178.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.02 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.469 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 44.6 Cg_exo -52.06 -35.86 63.32 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.185 1.923 . . . . 0.0 112.279 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.03 -12.09 61.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.537 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.67 10.58 15.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.508 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' HD12 ' A' ' 48' ' ' LEU . 67.8 m-85 -113.18 92.93 4.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.26 134.88 35.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 33.5 m-85 -96.76 99.44 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.07 92.17 2.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 44' ' ' TYR . 60.7 t -54.7 -21.14 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.436 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 -179.655 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.684 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.6 Cg_endo . . . . . 0 N--CA 1.475 0.386 0 N-CA-C 112.509 0.157 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.464 ' HE2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -145.2 101.75 3.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.737 0.304 . . . . 0.0 111.274 -178.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -91.98 64.25 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.5 t70 175.65 72.19 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.625 ' CB ' ' HA ' ' A' ' 22' ' ' PRO 0.254 0.0 OUTLIER 55.69 -94.12 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.475 0 CA-C-O 115.598 -2.144 . . . . 0.0 106.97 -171.659 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HG2' HG22 ' A' ' 23' ' ' THR . 7.7 Cg_endo -96.69 -2.62 32.5 Favored 'Cis proline' 0 N--CA 1.479 0.668 0 CA-C-N 122.772 2.026 . . . . 0.0 113.403 -10.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.658 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -148.55 66.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 111.114 -178.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 30' ' ' ARG . 12.5 mt -116.24 165.36 15.09 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.54 170.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.492 2.128 . . . . 0.0 112.269 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.03 123.22 9.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.819 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.92 -1.71 58.0 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.501 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 53.5 m95 -99.45 138.52 36.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.545 HG22 ' CA ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -138.43 166.91 23.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.631 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.568 ' HB2' HD11 ' A' ' 24' ' ' LEU . 24.3 ttm180 -135.49 154.48 51.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.937 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -159.5 157.51 30.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.977 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.937 HD23 ' O ' ' A' ' 31' ' ' LYS . 5.0 mt -131.34 155.56 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.041 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -125.57 117.16 22.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.691 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 -179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.866 0.365 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.471 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.7 m-85 -106.77 163.77 12.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.49 0.662 . . . . 0.0 112.773 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -134.22 144.01 48.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 175.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.658 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -86.31 149.76 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.318 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.1 102.54 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -92.98 112.72 24.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.7 mt -88.49 122.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.354 -176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 11.7 p-10 -84.66 159.83 57.36 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.41 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 88.2 Cg_exo -40.03 -27.75 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.26 2.64 . . . . 0.0 113.163 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.62 32.84 1.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.997 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.17 28.21 12.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.166 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -99.07 121.4 40.93 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.059 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.06 149.25 21.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.546 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 68.7 m-85 -147.82 129.69 15.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.662 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -103.57 -52.12 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.64 177.91 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.669 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.53 ' HE2' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.82 -42.89 10.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.641 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -51.89 -29.55 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.897 0.38 . . . . 0.0 110.697 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.88 -29.69 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -68.61 -68.32 0.4 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.481 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.616 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -54.99 -40.49 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -54.99 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.263 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -67.45 -58.92 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 74' ' ' LEU . 16.4 m-30 -44.65 -28.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.783 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.0 mm-40 -61.13 -69.8 0.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.68 -16.99 18.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.991 0.424 . . . . 0.0 110.676 177.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 65' ' ' TYR . 87.1 t -84.39 -69.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.663 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.32 56.17 0.33 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.758 ' OD2' HD11 ' A' ' 74' ' ' LEU . 4.7 p-10 -74.23 134.9 42.7 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 111.852 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -149.97 26.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.037 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -164.64 45.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -154.53 -35.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.01 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 50.27 102.33 0.03 OUTLIER Pre-proline 0 C--O 1.231 0.117 0 CA-C-O 120.519 0.2 . . . . 0.0 111.35 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 74.9 Cg_exo -43.61 -32.94 4.21 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.386 2.057 . . . . 0.0 112.432 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.34 -20.41 64.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.26 -7.68 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.539 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 62' ' ' LEU . 72.2 m-85 -102.65 97.86 7.99 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.406 ' OD1' HG23 ' A' ' 82' ' ' THR . 1.1 t70 -91.7 134.04 35.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.658 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-30 -96.08 70.83 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.011 0.434 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 p -101.92 -9.53 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.359 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.807 HG13 HD13 ' A' ' 32' ' ' LEU . 54.6 t 67.59 -58.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 82' ' ' THR . 73.1 p . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.652 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.0 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 N-CA-C 111.594 -0.195 . . . . 0.0 111.594 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.458 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -129.05 -18.73 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 66.97 -74.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 -1.29 76.15 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR 0.251 0.0 OUTLIER 46.35 -93.3 0.0 OUTLIER Pre-proline 0 CA--C 1.494 -1.179 0 CA-C-O 116.677 -1.63 . . . . 0.0 109.666 -179.49 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.821 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.3 Cg_endo -100.84 -2.26 18.28 Favored 'Cis proline' 0 N--CA 1.477 0.532 0 CA-C-N 122.688 1.996 . . . . 0.0 113.452 -5.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.821 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -159.37 82.72 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.125 -176.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -126.28 156.33 72.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -179.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.857 2.371 . . . . 0.0 112.551 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -56.79 120.86 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.44 -5.73 49.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.291 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.513 ' HB3' HD12 ' A' ' 24' ' ' LEU . 59.9 m95 -96.71 143.41 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.992 0.396 . . . . 0.0 111.15 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -149.58 172.36 15.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.733 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' CD ' HD21 ' A' ' 24' ' ' LEU . 2.3 mtp180 -132.07 142.17 49.44 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.965 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.4 ttmt -151.71 160.56 43.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.516 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.974 HD13 HG13 ' A' ' 83' ' ' VAL . 10.2 mt -131.88 153.25 50.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.26 0.552 . . . . 0.0 111.901 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -120.33 118.34 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.514 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 50.1 tt0 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.542 0.687 . . . . 0.0 111.3 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.61 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.1 m-85 -97.7 153.07 18.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -129.97 147.04 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.461 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' HD22 ' A' ' 32' ' ' LEU . 8.2 p -87.47 145.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.767 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 13.2 m-85 -146.1 102.14 3.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.086 0.469 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 79' ' ' PHE . 10.3 mt -92.93 110.38 21.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 29' ' ' THR . 4.3 mt -85.25 125.11 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.047 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.508 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.9 p-10 -85.81 153.55 57.9 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.868 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 87.2 Cg_exo -39.78 -51.97 2.8 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 113.169 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -48.16 -24.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.88 49.05 1.19 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.996 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.94 135.47 31.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.862 0.363 . . . . 0.0 111.568 -178.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.767 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -90.07 149.52 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 96.3 m-85 -130.46 133.86 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.117 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mtp180 -99.32 -60.58 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 24.9 p -88.49 177.11 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.933 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -85.98 -41.33 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 24.9 t -51.98 -28.43 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.659 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 1.6 mm-40 -74.88 -32.4 61.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.282 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -65.35 -61.38 2.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.446 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.593 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.77 -38.06 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.497 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.94 -66.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CD1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -57.9 -48.22 80.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 74' ' ' LEU . 22.0 m-30 -53.02 -30.36 35.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.799 0.333 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.4 mm-40 -69.31 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.968 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.2 -25.57 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.702 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 70' ' ' GLY . 11.9 m -86.79 -44.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.813 0.34 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.94 43.77 3.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.482 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.9 134.89 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 p -139.83 27.83 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 t -128.07 30.66 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -140.0 -41.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.616 ' H ' HD12 ' A' ' 74' ' ' LEU . 3.4 m-20 64.18 109.04 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.5 Cg_exo -50.59 -31.42 31.67 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.321 2.014 . . . . 0.0 112.176 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.16 -8.62 51.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.505 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.18 -13.47 41.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.224 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.588 ' CD2' HD21 ' A' ' 62' ' ' LEU . 86.0 m-85 -99.0 114.28 26.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.804 0.335 . . . . 0.0 111.133 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.29 145.51 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.01 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.502 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.4 m-85 -102.73 96.14 6.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.17 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.04 88.43 2.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.906 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.974 HG13 HD13 ' A' ' 32' ' ' LEU . 62.5 t -52.29 -32.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 111.063 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.8 p . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.633 -178.323 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 41.9 Cg_endo . . . . . 0 N--CA 1.466 -0.112 0 CA-C-O 120.902 0.293 . . . . 0.0 112.2 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 102.79 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.32 -73.91 0.13 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -177.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.0 m-20 -62.04 83.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.544 0.211 . . . . 0.0 110.665 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB2' ' A' ' 30' ' ' ARG . 2.4 t0 -113.07 88.77 12.69 Favored Pre-proline 0 C--N 1.332 -0.159 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.426 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 29' ' ' THR . 63.2 Cg_endo -93.3 18.75 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.194 2.596 . . . . 0.0 112.641 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.5 p -92.82 21.74 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.507 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.0 mt -98.63 164.04 17.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.895 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -40.86 167.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.19 2.593 . . . . 0.0 112.597 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.24 126.33 7.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.2 -1.27 56.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.665 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 64.2 m95 -100.85 143.89 30.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.349 0.574 . . . . 0.0 112.152 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -147.72 -178.93 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.008 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.594 ' CD ' HD22 ' A' ' 48' ' ' LEU . 5.3 mtm180 -144.14 170.79 15.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 0.0 111.326 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.704 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.0 ttmt -177.91 159.25 1.35 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.421 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 31' ' ' LYS . 4.5 mt -128.24 173.74 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.826 0.822 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.34 106.39 3.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.688 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.831 -178.629 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 tttt . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.912 0.387 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.701 ' CB ' HG11 ' A' ' 83' ' ' VAL . 30.3 m-85 -106.11 160.51 15.26 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -127.1 142.14 51.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.676 174.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 81' ' ' PHE . 44.9 t -91.39 148.05 4.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.79 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.9 m-85 -146.05 91.18 2.04 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.85 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -93.04 109.82 21.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.323 0.582 . . . . 0.0 109.464 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.519 HG12 ' HB2' ' A' ' 55' ' ' ALA . 10.8 mt -84.77 122.78 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.104 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.4 p-10 -85.61 163.22 45.16 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.361 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 66.0 Cg_exo -37.79 -29.48 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.248 2.632 . . . . 0.0 113.288 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -91.69 34.54 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.649 0.262 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 47.79 25.45 3.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.102 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 51.7 tptt -99.1 121.94 41.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -95.23 147.82 23.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.08 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.3 m-85 -134.04 149.7 51.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.822 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.7 -39.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 8.4 t -85.63 -77.43 0.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.968 -176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER 161.18 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 28.3 t -55.2 -29.09 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.16 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.7 -33.58 74.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.991 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -65.15 -68.38 0.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.48 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -54.26 -45.14 67.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.86 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.75 -54.11 38.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.6 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -66.27 -53.02 41.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.431 -179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.673 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -53.18 -23.02 7.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.9 mm-40 -71.19 -61.85 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.864 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.703 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -54.68 -26.23 32.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.636 -177.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.703 HG13 ' CD ' ' A' ' 68' ' ' LYS . 9.6 m -91.1 -45.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.901 0.382 . . . . 0.0 111.062 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 95.56 37.27 5.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.294 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.761 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -90.0 146.41 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.033 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -148.99 18.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.75 23.52 11.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.037 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -154.48 67.54 0.71 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER 60.85 -174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.149 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.743 ' HG3' HD12 ' A' ' 62' ' ' LEU . 84.6 Cg_exo -75.83 -158.08 1.56 Allowed 'Cis proline' 0 C--N 1.308 -1.598 0 N-CA-C 115.385 1.264 . . . . 0.0 115.385 17.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 20.49 9.25 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.866 -177.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.416 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 2.2 m-20 -146.2 -12.17 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 62' ' ' LEU . 50.3 m-85 -86.76 83.07 7.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.028 0.376 . . . . 0.0 110.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.21 98.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.575 ' HA ' HG11 ' A' ' 46' ' ' VAL . 4.3 m-30 -85.47 52.92 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -115.2 131.51 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.438 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.701 HG11 ' CB ' ' A' ' 44' ' ' TYR . 23.1 m -64.56 -49.23 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.745 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.496 ' N ' HG23 ' A' ' 83' ' ' VAL . 16.8 p . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.131 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 12.3 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 CA-C-O 120.607 0.17 . . . . 0.0 112.157 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.501 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -169.19 109.07 0.45 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.453 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -78.43 80.22 4.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 39.1 t70 -154.57 64.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.038 -170.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.797 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 64.88 -103.39 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -0.993 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 Cg_endo -84.04 130.91 16.13 Favored 'Cis proline' 0 N--CA 1.479 0.64 0 CA-C-N 123.617 2.327 . . . . 0.0 113.803 -6.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.524 ' N ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 41.37 84.05 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.131 173.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.955 HD11 ' HG3' ' A' ' 30' ' ' ARG . 8.0 mt -124.53 166.65 18.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 87.0 Cg_exo -47.45 165.59 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 125.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.234 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.66 -2.7 53.02 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.964 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.5 m95 -100.17 139.94 35.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.366 0.583 . . . . 0.0 112.067 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.877 ' CA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.41 171.64 16.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.19 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.955 ' HG3' HD11 ' A' ' 24' ' ' LEU . 14.7 mtm180 -132.62 144.44 50.36 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.573 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -135.16 177.04 8.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.977 -177.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' LYS . 15.0 mt -148.74 155.71 41.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.254 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.75 118.78 8.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.274 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.4 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.164 0.507 . . . . 0.0 110.718 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 6.5 m-85 -88.71 133.16 34.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -104.92 156.28 18.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.566 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 83' ' ' VAL . 44.7 t -95.11 147.42 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.3 m-85 -147.2 102.37 3.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.797 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.9 mt -92.79 106.77 18.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.6 mt -82.18 122.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.106 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 16.6 p-10 -85.95 146.27 42.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.307 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -36.0 -48.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.451 2.767 . . . . 0.0 113.087 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -46.09 -26.86 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.16 6.58 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.109 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.1 tttt -98.99 170.83 8.44 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.49 0.186 . . . . 0.0 110.995 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.82 96.79 3.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.0 m-85 -95.13 122.78 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.775 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -91.6 -46.09 8.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 50.7 p -87.24 165.73 15.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.965 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.22 -36.34 34.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.42 HG12 ' OG ' ' A' ' 58' ' ' SER . 4.1 p -52.04 -42.34 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.16 0.505 . . . . 0.0 110.52 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 2.4 mm-40 -61.12 -32.04 71.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.639 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -67.5 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.6 mp -58.13 -37.24 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.415 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.81 -70.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.655 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.89 -38.29 81.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.8 m-30 -58.6 -28.79 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.8 mm-40 -72.47 -60.18 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.779 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.29 -25.81 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.265 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.5 m -88.61 -45.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.089 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.43 42.19 4.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.551 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.618 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.3 t0 -84.06 133.25 34.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.779 0.323 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.2 p -140.02 25.84 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -126.09 24.66 6.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.862 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -135.23 -40.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER 64.29 107.65 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.104 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.2 Cg_exo -49.49 -32.53 27.37 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.464 2.11 . . . . 0.0 112.474 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.77 -13.98 62.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.02 -9.47 58.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.232 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 78.6 m-85 -100.64 97.25 7.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.55 140.09 29.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.964 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-30 -94.13 110.61 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -145.67 131.26 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 46' ' ' VAL . 77.8 t -96.25 -37.17 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.113 -179.294 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 74.4 Cg_endo . . . . . 0 N--CA 1.464 -0.234 0 CA-C-O 120.959 0.316 . . . . 0.0 112.392 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 97.83 2.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.201 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.1 m-30 -67.9 -71.33 0.21 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.311 -178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -55.64 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -129.73 85.42 58.28 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.361 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -92.61 14.86 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.16 2.573 . . . . 0.0 112.224 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.435 ' C ' HD23 ' A' ' 24' ' ' LEU . 51.9 p -87.81 49.24 1.77 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -126.13 -178.42 0.72 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.983 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 71.7 Cg_exo -48.4 168.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.009 1.806 . . . . 0.0 111.917 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.41 123.99 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 110.757 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 51' ' ' PRO . . . 92.08 -64.64 2.33 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.632 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 76.1 m95 -32.47 136.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.57 175.85 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.354 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 27.4 ttm180 -147.36 156.06 42.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.958 0.409 . . . . 0.0 111.28 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.898 ' O ' HD23 ' A' ' 32' ' ' LEU . 26.3 tttm -166.0 161.32 17.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.022 HD13 HG13 ' A' ' 83' ' ' VAL . 6.0 mt -129.59 163.25 26.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.897 0.38 . . . . 0.0 111.355 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.9 tttt -143.7 118.99 10.19 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.991 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.515 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.9 tt0 . . . . . 0 CA--C 1.518 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 112.311 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 C--O 1.224 -0.248 0 CA-C-O 121.364 0.602 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 9.3 m-85 -83.56 134.94 34.8 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -117.66 148.67 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.383 177.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 81' ' ' PHE . 5.6 p -90.33 149.29 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.007 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 12.1 m-85 -146.07 95.85 2.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.934 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.63 HD23 ' HG3' ' A' ' 30' ' ' ARG . 11.9 mt -91.61 113.15 25.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.8 mt -90.58 117.46 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.028 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.632 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 6.6 p-10 -96.82 123.52 53.42 Favored Pre-proline 0 CA--C 1.491 -1.321 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.527 ' CB ' ' HA3' ' A' ' 27' ' ' GLY . 4.7 Cg_exo -71.04 -31.97 4.55 Favored 'Cis proline' 0 C--N 1.309 -1.544 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 -26.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.403 ' O ' HG21 ' A' ' 49' ' ' ILE . 19.2 mt-30 -141.61 -27.75 0.66 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.707 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.21 -31.1 6.33 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.172 -1.013 . . . . 0.0 114.389 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 56' ' ' PHE . 41.9 tptt -99.15 125.18 44.65 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.137 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' O ' ' CD1' ' A' ' 56' ' ' PHE . . . -105.22 140.98 37.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 54' ' ' LYS . 21.9 m-85 -135.07 136.74 42.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.558 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.85 -50.63 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.379 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 177.56 7.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.201 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HE2' HD23 ' A' ' 62' ' ' LEU . 1.4 tmtp? -85.04 -43.0 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.544 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 t -51.81 -32.43 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.517 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -68.79 -32.06 71.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.7 tp -64.57 -64.88 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.299 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.443 HG13 ' CG ' ' A' ' 76' ' ' PRO . 3.5 mp -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.476 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -63.2 -41.38 99.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 110.728 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 4.8 m-30 -45.45 -32.35 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mm-40 -72.69 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.107 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.27 -19.78 23.88 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.496 HG22 ' C ' ' A' ' 66' ' ' PHE . 23.1 m -86.56 -27.75 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.259 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.37 46.07 6.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.163 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.643 ' OD2' HD11 ' A' ' 74' ' ' LEU . 10.3 p-10 -74.32 133.97 42.55 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.772 0.32 . . . . 0.0 111.514 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 t -149.98 25.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.347 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.93 32.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.29 -46.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.865 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.5 OUTLIER 63.34 125.99 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.261 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' CG ' HG13 ' A' ' 63' ' ' ILE . 53.1 Cg_exo -56.64 -31.07 86.05 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.496 2.131 . . . . 0.0 112.287 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.04 -7.82 44.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.644 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.5 -7.29 58.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.473 0.178 . . . . 0.0 111.406 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD2' HD21 ' A' ' 62' ' ' LEU . 51.4 m-85 -107.58 148.17 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 111.393 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.29 159.47 41.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.069 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.4 m-30 -120.72 91.42 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.0 -10.37 8.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.823 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.022 HG13 HD13 ' A' ' 32' ' ' LEU . 61.4 t 61.33 -81.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 82' ' ' THR . 18.7 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HB2' HD12 ' A' ' 32' ' ' LEU . 63.8 Cg_endo . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.888 0.286 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -161.76 129.36 4.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.216 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -94.79 -68.23 0.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.179 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.17 81.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.823 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 4.2 m-20 -117.97 91.45 39.65 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.77 13.54 1.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.058 2.505 . . . . 0.0 112.669 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 p -88.53 55.11 3.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.413 . . . . 0.0 110.887 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 28' ' ' TRP . 17.6 mt -133.27 165.23 38.25 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.582 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 73.1 Cg_exo -38.81 164.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.768 2.312 . . . . 0.0 112.909 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.2 127.11 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.34 -54.79 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.573 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 47.6 m95 -41.6 148.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.433 ' C ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -147.58 -178.41 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.837 178.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 20.9 ttt180 -148.2 159.59 43.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 111.635 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.6 tttt -174.25 162.85 3.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.526 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.0 mt -131.27 161.34 32.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.034 0.445 . . . . 0.0 111.411 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 8.2 tttp -136.18 117.45 14.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.082 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.244 179.14 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.975 0.417 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -106.05 159.46 16.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.671 0.748 . . . . 0.0 112.912 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -129.7 145.84 51.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.778 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -90.45 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.958 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -144.87 96.98 2.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 24' ' ' LEU . 33.1 mt -92.97 109.77 21.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 4.2 mt -85.8 134.76 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.459 ' OD1' ' CZ2' ' A' ' 28' ' ' TRP . 3.4 t30 -75.22 149.68 84.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.139 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -39.6 -59.45 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.823 2.348 . . . . 0.0 112.789 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -50.89 -25.1 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.86 31.56 2.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -101.01 117.02 34.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 111.614 -178.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.87 140.69 30.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 76.7 m-85 -129.17 127.03 40.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.488 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.483 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -52.42 2.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.779 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 6.1 p -86.07 173.46 9.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.359 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -85.77 -40.28 16.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.955 0.407 . . . . 0.0 110.839 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 46.6 t -51.86 -39.84 26.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.688 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -63.23 -28.2 69.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.161 0.505 . . . . 0.0 109.959 177.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.7 tp -70.66 -61.64 1.69 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.777 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -72.79 -57.92 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.477 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -46.54 -43.8 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.316 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' CD1' ' HD2' ' A' ' 68' ' ' LYS . 2.4 t80 -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.565 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.8 m-30 -45.61 -35.29 3.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.679 0.276 . . . . 0.0 111.283 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 65.3 mt-10 -61.22 -68.12 0.34 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.016 0.436 . . . . 0.0 110.527 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.651 ' CD ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.01 -19.73 13.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.71 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.651 HG23 ' CD ' ' A' ' 68' ' ' LYS . 7.4 t -86.36 -42.22 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.889 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.66 37.65 10.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.807 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 127.78 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 0.0 110.756 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -123.5 28.69 6.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -131.3 31.64 4.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.3 pp -154.46 -179.03 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.451 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -158.62 108.32 1.64 Allowed Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.647 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 80.1 Cg_exo -45.3 -35.47 11.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.658 2.239 . . . . 0.0 112.508 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.62 -20.0 63.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.867 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.45 -9.44 59.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.485 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 47.8 m-85 -104.85 135.09 46.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.948 0.404 . . . . 0.0 111.455 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.06 161.32 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.51 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.729 ' CD1' HG11 ' A' ' 46' ' ' VAL . 19.8 m-85 -121.82 88.5 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 p -119.1 -15.1 9.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.865 HG13 HD13 ' A' ' 32' ' ' LEU . 54.8 t 63.15 -79.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' THR . 12.5 p . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.019 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.614 ' CB ' HD12 ' A' ' 32' ' ' LEU . 77.2 Cg_endo . . . . . 0 N--CA 1.465 -0.158 0 CA-C-O 120.661 0.192 . . . . 0.0 112.02 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.61 18.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.569 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 36.23 48.39 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.433 0.635 . . . . 0.0 111.794 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 t0 -132.38 69.91 1.47 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.97 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 7.5 m-20 67.31 -99.41 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.334 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -171.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.672 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 26.2 Cg_endo -82.2 153.44 76.82 Favored 'Cis proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.252 2.197 . . . . 0.0 112.93 -13.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.599 ' O ' HD23 ' A' ' 24' ' ' LEU . 2.8 t 45.34 83.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.962 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 29' ' ' THR . 79.5 mt -138.92 154.58 72.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.92 -170.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.63 2.22 . . . . 0.0 112.257 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.5 125.45 25.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.81 -4.35 52.89 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.811 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 83.5 m95 -99.6 138.96 35.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.366 0.583 . . . . 0.0 111.711 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.907 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.58 178.73 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.027 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.882 ' CG ' HD11 ' A' ' 24' ' ' LEU . 10.5 mtm180 -142.44 141.35 32.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.878 ' C ' HD23 ' A' ' 32' ' ' LEU . 11.7 ttmt -140.73 153.3 45.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.11 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.878 HD23 ' C ' ' A' ' 31' ' ' LYS . 4.1 mt -128.43 153.86 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.124 0.487 . . . . 0.0 111.636 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -128.38 117.37 21.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.231 178.831 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 tttt . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 121.277 0.561 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.7 m-85 -106.46 153.51 22.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.713 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -121.54 143.45 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.075 175.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.572 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.2 p -87.87 148.51 4.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.745 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.0 m-85 -146.92 103.26 3.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.545 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.958 HD22 ' CE1' ' A' ' 81' ' ' PHE . 2.3 mp -89.43 110.63 21.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.894 -172.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.2 t-20 -87.27 137.63 32.64 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.358 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 82.4 Cg_exo -32.11 -58.56 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.774 2.982 . . . . 0.0 113.752 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -45.02 -27.72 0.59 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 111.308 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.71 22.67 3.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.503 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 tttt -94.35 174.45 7.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.733 0.301 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -142.07 133.96 27.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 62' ' ' LEU . 19.8 m-85 -127.59 127.17 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.865 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -102.19 6.51 40.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.467 177.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 61' ' ' GLU . 6.4 p -154.15 167.1 30.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 4.2 tptp -74.55 -36.87 63.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.169 0.509 . . . . 0.0 111.526 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 96.8 t -52.4 -43.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.828 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 58' ' ' SER . 5.6 mm-40 -65.92 -29.88 70.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.992 0.425 . . . . 0.0 110.154 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.87 -66.14 0.58 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.105 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -61.58 -40.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.67 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -65.46 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.582 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.78 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.1 t80 -57.78 -44.34 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.666 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 74' ' ' LEU . 8.0 m-30 -55.78 -24.38 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.75 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.4 mm-40 -73.79 -53.89 9.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 111.836 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.471 ' N ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.78 -18.51 62.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.929 -177.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.3 m -86.32 -43.96 16.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.717 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.72 54.0 1.72 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.511 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.743 ' OD2' HD11 ' A' ' 74' ' ' LEU . 35.2 p-10 -74.36 138.02 43.16 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.701 0.4 . . . . 0.0 111.852 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.4 p -149.95 22.56 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.035 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -143.47 33.03 1.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -154.54 -177.31 6.38 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -158.58 101.02 1.67 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 99.5 Cg_exo -44.08 -27.76 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.428 2.085 . . . . 0.0 112.107 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.93 -23.06 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.633 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.46 8.5 24.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.087 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' HD11 ' A' ' 62' ' ' LEU . 9.6 m-85 -93.74 124.15 37.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.771 0.319 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 116.44 29.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.958 ' CE1' HD22 ' A' ' 48' ' ' LEU . 8.5 m-85 -88.72 74.46 8.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.41 111.41 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 44' ' ' TYR . 92.4 t -79.55 -14.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.495 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.115 -179.537 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.803 ' CB ' HD12 ' A' ' 32' ' ' LEU . 84.0 Cg_endo . . . . . 0 C--O 1.23 0.123 0 N-CA-C 111.54 -0.215 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.492 ' HE3' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -134.54 -34.47 0.93 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 62.39 18.07 9.99 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' C ' ' HE3' ' A' ' 18' ' ' MET . 9.4 m-20 -118.72 84.89 2.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.806 ' HA ' HG22 ' A' ' 29' ' ' THR . 7.1 m-20 44.62 -94.39 0.0 OUTLIER Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-O 116.781 -1.58 . . . . 0.0 109.727 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.718 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 58.6 Cg_endo -77.0 -55.8 0.14 OUTLIER 'Cis proline' 0 N--CA 1.484 0.95 0 CA-C-N 122.908 2.074 . . . . 0.0 113.834 -6.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 32.9 p -159.35 78.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.634 HD12 ' CA ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -94.11 -175.54 0.49 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.666 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 74.8 Cg_exo -42.77 165.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.026 1.818 . . . . 0.0 112.508 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.29 125.39 14.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.007 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.79 -0.14 52.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.344 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.512 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 62.8 m95 -101.22 127.13 47.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.124 0.487 . . . . 0.0 111.469 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -134.35 172.72 12.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.608 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.801 ' HG3' HD23 ' A' ' 48' ' ' LEU . 11.7 ttm180 -140.17 150.77 44.62 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.8 0.81 . . . . 0.0 111.6 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.865 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -157.78 160.88 38.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.237 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.126 HD13 HG13 ' A' ' 83' ' ' VAL . 1.3 mt -130.85 169.79 15.28 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.9 tttt -147.91 114.14 5.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.421 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 52.1 tt0 . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.756 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.919 0.39 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.694 ' HB3' HG11 ' A' ' 83' ' ' VAL . 7.2 m-85 -89.77 141.51 28.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.16 137.21 54.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.341 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.635 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -85.85 154.7 3.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.617 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 12.5 m-85 -145.08 100.88 3.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.801 HD23 ' HG3' ' A' ' 30' ' ' ARG . 41.9 mt -92.51 104.88 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -82.37 126.39 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.619 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 30.8 p-10 -85.59 148.51 49.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.394 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -33.8 -54.55 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.764 2.976 . . . . 0.0 113.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -44.85 -27.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.37 49.32 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.047 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.41 132.43 27.82 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.017 0.437 . . . . 0.0 111.129 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.75 137.68 32.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.488 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 60.1 m-85 -122.17 121.58 37.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 5.0 mtm180 -89.92 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.23 173.54 8.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.511 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -81.95 -38.69 24.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.414 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 61' ' ' GLU . 10.7 p -51.79 -43.17 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.351 0.596 . . . . 0.0 110.217 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.2 mt-10 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.31 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.4 tp -70.42 -63.08 1.16 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.387 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -62.27 -36.53 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.83 -72.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.727 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.74 -42.93 84.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.649 ' CE2' HD13 ' A' ' 74' ' ' LEU . 7.4 m-30 -52.07 -31.49 30.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.178 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.6 mm-40 -74.24 -59.56 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.745 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -61.83 -23.63 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.737 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.1 m -86.46 -31.94 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 0.0 111.35 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.54 43.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -79.31 128.92 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.871 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 t -119.36 20.08 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -125.85 26.52 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 0.0 110.656 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -154.53 175.9 13.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.671 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -158.57 129.19 3.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.436 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 51.4 Cg_exo -55.13 -36.32 92.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.427 2.085 . . . . 0.0 112.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.0 -18.09 63.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.996 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.95 -4.2 59.15 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.515 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CB ' HD21 ' A' ' 62' ' ' LEU . 87.3 m-85 -107.66 85.36 2.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.016 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -80.38 128.75 33.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 46' ' ' VAL . 9.0 m-85 -84.04 90.56 7.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.38 88.71 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.796 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.126 HG13 HD13 ' A' ' 32' ' ' LEU . 88.3 t -47.09 -27.64 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.076 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 111.051 -179.513 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.48 0.686 0 CA-C-O 120.939 0.308 . . . . 0.0 112.395 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.83 94.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.551 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.26 -70.55 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.129 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.27 89.98 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.081 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB3' ' CG ' ' A' ' 30' ' ' ARG . 6.4 t0 -118.93 83.86 24.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.808 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -102.17 21.58 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.649 2.899 . . . . 0.0 113.018 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -81.54 -33.35 31.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.235 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 30' ' ' ARG . 16.6 mt -41.87 160.41 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.573 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.4 Cg_exo -40.33 162.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.652 2.235 . . . . 0.0 112.317 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.89 136.62 2.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.083 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.48 -45.8 2.96 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.73 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 63.2 m95 -68.92 149.1 49.25 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.56 -179.65 7.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.58 175.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.739 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.13 169.7 23.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 110.728 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.2 ttmt -170.42 162.25 8.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HG13 ' A' ' 83' ' ' VAL . 5.7 mt -131.26 157.09 44.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.958 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -139.29 124.66 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.621 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.462 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 59.0 tt0 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 121.065 0.46 . . . . 0.0 110.707 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.042 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.611 ' CB ' HG11 ' A' ' 83' ' ' VAL . 7.3 m-85 -90.87 142.07 28.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -118.83 148.95 42.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.644 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 81' ' ' PHE . 6.7 p -91.42 148.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.378 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.11 103.25 3.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -91.89 116.81 29.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -91.2 138.79 18.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.423 -175.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -154.32 148.72 19.37 Favored Pre-proline 0 CA--C 1.484 -1.571 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -96.39 30.27 14.1 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 N-CA-C 108.305 -1.46 . . . . 0.0 108.305 -25.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' PRO . 48.3 mt-30 -157.02 -44.26 0.07 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.904 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 10.04 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.906 -1.14 . . . . 0.0 115.285 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 1.3 tmtt? -92.04 115.34 27.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.759 1.779 . . . . 0.0 110.42 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -92.01 154.21 18.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.251 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 42.1 m-85 -150.55 136.02 18.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 1.5 mtm-85 -97.61 -57.16 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.176 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -87.56 171.46 10.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.381 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 63' ' ' ILE . 7.3 tptp -81.24 -38.0 27.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.369 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 4.6 p -51.81 -42.12 31.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.55 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -33.2 73.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.751 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.3 tp -66.49 -61.01 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.469 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -62.96 -36.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.496 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -62.91 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.989 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.558 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.16 -53.08 61.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.257 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.507 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -50.13 -25.02 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.821 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.5 mm-40 -71.08 -63.6 1.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.695 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -23.23 65.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 65' ' ' TYR . 5.2 m -86.56 -38.33 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.353 . . . . 0.0 111.137 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.47 46.99 8.4 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.158 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.2 t0 -74.56 135.86 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -127.88 23.64 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.252 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 24.04 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.883 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 71' ' ' ASP . 1.1 pp -154.5 178.26 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.668 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -158.64 117.8 1.77 Allowed Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.491 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 62' ' ' LEU . 88.9 Cg_exo -46.3 -33.03 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.381 2.054 . . . . 0.0 112.051 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -19.13 63.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.058 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.84 11.21 18.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.451 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.859 ' HB3' HD23 ' A' ' 48' ' ' LEU . 17.7 m-85 -130.34 72.1 1.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.985 0.421 . . . . 0.0 111.761 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 162.0 29.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.457 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-85 -115.68 124.59 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 111.753 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.29 93.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.673 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.991 HG13 HD13 ' A' ' 32' ' ' LEU . 90.6 t -50.94 -28.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.698 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 p . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 179.782 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HB3' HD13 ' A' ' 32' ' ' LEU . 2.7 Cg_endo . . . . . 0 N--CA 1.472 0.21 0 CA-C-O 120.473 0.114 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.545 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -156.42 97.88 1.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.33 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.63 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.71 68.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.5 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 28.3 t70 -156.7 85.93 0.98 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.943 -171.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' C ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 34.95 -88.98 0.0 OUTLIER Pre-proline 0 CA--C 1.498 -1.028 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.429 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.764 ' HG2' HG22 ' A' ' 23' ' ' THR . 15.1 Cg_endo -94.44 1.46 49.64 Favored 'Cis proline' 0 N--CA 1.486 1.065 0 CA-C-N 121.851 1.697 . . . . 0.0 113.74 -2.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.764 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -159.25 -83.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.883 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HH22 ' A' ' 30' ' ' ARG . 36.8 mt 59.42 163.3 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.339 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.38 -179.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.07 2.513 . . . . 0.0 112.78 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.45 122.69 16.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.16 -1.92 53.82 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.55 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 58.0 m95 -98.83 140.51 32.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 111.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -143.55 166.36 25.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.399 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.706 HH22 HD21 ' A' ' 24' ' ' LEU . 24.1 ttm105 -136.17 154.48 50.94 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.288 0.566 . . . . 0.0 110.466 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -162.99 164.33 25.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.773 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -133.44 167.52 20.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.483 0.658 . . . . 0.0 112.697 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -147.8 112.04 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.184 178.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.458 -179.335 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.046 0.451 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.539 ' HE2' ' HH ' ' A' ' 19' ' ' TYR . 5.2 m-85 -99.23 150.93 21.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.561 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -116.9 142.11 47.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.546 176.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG22 ' A' ' 83' ' ' VAL . 65.5 t -85.12 152.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.894 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.7 m-85 -146.14 90.6 1.98 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 79' ' ' PHE . 9.6 mt -91.22 103.36 16.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 12.6 mt -82.37 117.24 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.655 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 36.7 p-10 -84.61 152.88 60.93 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.484 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -34.97 -56.15 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.732 2.955 . . . . 0.0 113.447 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -44.65 -27.02 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.58 49.07 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.037 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.97 132.02 26.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.962 0.41 . . . . 0.0 111.479 -178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.82 144.3 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.783 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 55.9 m-85 -132.5 126.25 32.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.89 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.491 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 19.4 mtm180 -100.92 -52.82 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.262 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.89 171.78 10.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.909 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -81.81 -39.77 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.299 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 9.3 p -51.78 -42.22 31.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.307 0.575 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -61.02 -29.34 69.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.384 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -70.4 -67.29 0.51 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.482 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -58.22 -37.67 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.611 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.74 -58.5 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.64 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -66.25 -46.37 77.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.711 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.629 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 18.9 m-85 -52.08 -26.13 10.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.6 mm-40 -72.4 -62.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.772 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.09 63.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.698 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.3 m -86.64 -37.56 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 0.0 111.689 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.14 48.61 9.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.047 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 -74.62 0.19 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.927 0.87 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p 60.19 18.63 8.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.546 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -120.05 25.92 9.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.629 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -138.72 -36.6 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.6 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.97 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.651 0.263 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -51.69 -34.46 53.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.344 2.03 . . . . 0.0 112.344 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.12 -8.9 49.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.413 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -83.19 -9.51 59.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.903 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.621 ' CD2' HD21 ' A' ' 62' ' ' LEU . 52.6 m-85 -107.26 116.43 31.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.759 0.314 . . . . 0.0 110.554 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.99 146.88 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 22.1 m-30 -100.91 85.65 2.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.404 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 23.4 p -101.95 -16.22 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.669 HG13 HD22 ' A' ' 32' ' ' LEU . 53.5 t 67.62 -61.02 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.367 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.9 p . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.432 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 N--CA 1.481 0.768 0 CA-C-O 120.847 0.27 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 102.03 2.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.48 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.83 -69.36 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.199 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.55 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.437 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -115.49 89.71 23.11 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.543 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -93.48 18.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.094 2.529 . . . . 0.0 112.835 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.3 p -92.8 43.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.034 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.561 HD11 ' HG2' ' A' ' 30' ' ' ARG . 11.2 mt -123.02 166.57 17.42 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.312 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 96.0 Cg_exo -45.34 173.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.786 2.324 . . . . 0.0 112.752 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 125.84 18.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.915 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.49 -2.8 51.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.694 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.517 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 50.8 m95 -99.02 139.03 35.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -144.19 -179.66 6.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.814 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.561 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.2 mtp180 -145.85 163.73 34.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.937 0.399 . . . . 0.0 111.401 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.894 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.9 ttmt -170.07 158.36 6.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.129 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 83' ' ' VAL . 3.4 mt -131.29 155.96 46.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.496 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -129.57 120.41 25.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.154 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.759 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmp? . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CB ' HG11 ' A' ' 83' ' ' VAL . 6.9 m-85 -107.84 163.66 12.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -135.09 144.0 46.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.281 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.4 p -88.0 149.51 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.899 0.381 . . . . 0.0 111.78 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.545 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 10.6 m-85 -146.06 97.32 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.255 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.8 mt -93.01 109.27 20.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.4 mt -83.81 123.74 39.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.649 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.517 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 32.4 p-10 -85.65 152.99 57.97 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -36.19 -54.74 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.741 2.96 . . . . 0.0 113.161 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.34 -26.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.34 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 48.85 1.17 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.799 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -140.86 135.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.354 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.66 134.88 33.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -115.51 123.21 47.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -104.33 -4.4 22.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.36 177.47 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.822 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 1.3 mmtp -78.84 -45.08 21.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.906 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 29.2 t -51.85 -31.42 13.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.219 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -30.87 59.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.883 176.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.885 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -63.32 -66.17 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.425 178.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.96 -41.94 87.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.0 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.49 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.587 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.72 -54.71 43.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.18 -178.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -46.58 -31.5 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 111.732 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.8 mm-40 -67.82 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.71 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -25.6 59.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.638 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.3 m -88.38 -30.79 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 111.254 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.71 81.66 0.52 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.682 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.659 ' OD2' HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -149.91 126.9 11.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -177.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -132.38 20.37 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.76 22.14 15.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.748 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -154.58 65.48 0.68 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.709 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.5 OUTLIER 61.07 -173.87 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.146 0 C-N-CA 118.512 -1.275 . . . . 0.0 107.752 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.69 ' HG3' HD12 ' A' ' 62' ' ' LEU . 80.8 Cg_exo -75.73 -157.68 1.46 Allowed 'Cis proline' 0 C--N 1.312 -1.381 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 17.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.81 19.67 9.86 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.694 -176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -145.59 -5.17 0.65 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.885 ' CD2' HD11 ' A' ' 62' ' ' LEU . 50.7 m-85 -97.57 90.94 5.2 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.229 -0.294 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.39 119.24 11.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.817 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.525 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -89.46 69.47 7.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.3 107.61 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 32' ' ' LEU . 93.8 t -59.8 -38.79 77.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.392 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.307 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 32' ' ' LEU . 47.1 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.797 0.249 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -161.49 135.69 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.358 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CA ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -112.98 56.29 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.4 t0 -178.24 67.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.589 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.87 85.85 12.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.337 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HA ' HG23 ' A' ' 29' ' ' THR . 68.8 Cg_endo -96.15 18.1 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.273 2.649 . . . . 0.0 112.63 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -83.11 -20.16 35.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.409 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 29' ' ' THR . 51.2 mt -48.46 162.18 0.36 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 65.7 Cg_exo -38.37 161.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.707 2.272 . . . . 0.0 112.72 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.72 129.57 5.5 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . 90.91 -44.78 2.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.485 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.631 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 62.7 m95 -68.95 150.44 47.72 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -149.57 179.64 7.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.295 176.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 48' ' ' LEU . 58.2 ttp180 -153.29 163.06 40.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.36 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.92 ' O ' HD23 ' A' ' 32' ' ' LEU . 29.9 ttpt -174.68 164.95 3.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.92 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.1 mt -131.38 161.11 33.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.919 0.39 . . . . 0.0 111.474 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -138.51 120.87 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.405 -178.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.813 177.915 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HB2' HG11 ' A' ' 83' ' ' VAL . 5.3 m-85 -101.7 164.03 11.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.554 0.692 . . . . 0.0 112.64 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -133.39 146.7 51.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.204 177.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.8 p -86.86 146.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.704 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 4.9 m-85 -142.84 95.97 2.86 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.027 0.441 . . . . 0.0 110.954 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 80' ' ' ASP . 7.7 mt -92.89 110.44 21.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 23.0 mt -86.29 141.35 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.515 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.631 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -153.3 145.64 17.16 Favored Pre-proline 0 CA--C 1.482 -1.645 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 7.2 Cg_endo -93.9 24.04 25.61 Favored 'Cis proline' 0 N--CA 1.455 -0.737 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 -24.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -154.34 -43.72 0.09 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.543 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.11 1.85 0.11 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 119.66 -1.257 . . . . 0.0 115.661 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 65' ' ' TYR . 1.2 tmtt? -88.44 119.68 29.1 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.974 1.887 . . . . 0.0 110.741 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.423 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -101.79 148.77 24.9 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CE1' ' OD1' ' A' ' 50' ' ' ASN . 9.2 m-85 -142.61 144.9 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.691 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.36 18.84 6.94 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 10.1 t -145.96 -86.02 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.068 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 166.25 -41.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.7 p -56.85 -39.18 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.122 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -27.56 66.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.335 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.1 tp -68.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.405 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.25 -38.26 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.72 -49.95 64.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -73.04 -61.53 1.78 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.484 ' C ' HG22 ' A' ' 69' ' ' VAL . 23.3 m-85 -42.71 -34.95 0.99 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -61.66 -69.3 0.25 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.8 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.21 -19.05 18.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.484 -176.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.8 HG13 ' HD3' ' A' ' 68' ' ' LYS . 33.9 m -91.99 -30.19 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.733 0.302 . . . . 0.0 111.158 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.48 64.21 4.59 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.8 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 72' ' ' THR . 10.5 t0 -74.39 -45.92 43.68 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.788 0.804 . . . . 0.0 111.541 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 71' ' ' ASP . 5.9 t 52.69 18.42 1.01 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.596 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.39 19.23 8.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 110.716 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.6 -177.34 6.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -158.58 118.04 1.79 Allowed Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.916 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HA ' HD23 ' A' ' 62' ' ' LEU . 89.1 Cg_exo -47.62 -32.5 16.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.198 1.932 . . . . 0.0 112.165 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.71 -20.16 63.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.141 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.51 9.26 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.612 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.03 86.7 2.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.692 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -63.73 -175.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.001 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 37.2 m-85 -145.38 73.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.94 117.47 28.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.915 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 32' ' ' LEU . 58.8 t -68.72 -56.64 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.894 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' CB ' HD12 ' A' ' 32' ' ' LEU . 3.4 Cg_exo . . . . . 0 N--CA 1.474 0.358 0 CA-C-O 120.747 0.228 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.13 134.61 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.644 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -116.07 48.61 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.677 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.33 67.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.606 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -112.2 94.29 25.52 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.18 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.78 -6.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.439 2.759 . . . . 0.0 112.67 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 t -84.06 53.67 2.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.93 0.395 . . . . 0.0 111.007 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 24' ' ' LEU . 14.8 mt -113.55 164.51 15.64 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 75.6 Cg_exo -41.56 166.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.612 2.208 . . . . 0.0 112.371 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.0 121.47 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 28' ' ' TRP . . . 77.95 53.24 4.99 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.681 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 56.9 m95 -157.02 151.33 25.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.37 179.61 7.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.608 175.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.477 ' HG3' HD23 ' A' ' 48' ' ' LEU . 22.3 ttt180 -153.62 160.04 42.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.213 0.53 . . . . 0.0 112.134 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.929 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -176.01 166.24 2.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.453 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.064 HD13 HG13 ' A' ' 83' ' ' VAL . 10.6 mt -131.3 166.55 20.97 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.03 0.443 . . . . 0.0 111.583 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -135.11 118.08 16.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.149 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.354 179.273 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.814 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.5 m-85 -107.6 161.03 15.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.641 0.734 . . . . 0.0 112.582 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.52 147.77 52.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.73 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.7 p -87.13 143.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.84 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 5.4 m-85 -143.16 97.06 3.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 30' ' ' ARG . 82.1 mt -91.31 116.11 28.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 174.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.6 mt -91.5 137.53 21.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 1.9 p-10 -153.32 147.71 19.1 Favored Pre-proline 0 CA--C 1.49 -1.346 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 93.0 Cg_endo -91.67 -3.08 52.77 Favored 'Cis proline' 0 N--CA 1.448 -1.182 0 C-N-CA 125.239 -0.734 . . . . 0.0 110.863 -23.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -116.8 -35.62 4.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.999 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' CG2' ' A' ' 49' ' ' ILE . . . -176.64 21.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.741 -1.218 . . . . 0.0 114.881 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -96.81 115.71 27.9 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.348 1.574 . . . . 0.0 111.139 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.03 146.64 24.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.992 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 9.0 m-85 -150.66 137.37 18.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.728 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -105.95 11.59 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.151 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -154.49 170.17 22.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -80.41 -41.83 23.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.007 -176.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 p -50.36 -41.54 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.148 0.499 . . . . 0.0 110.606 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.08 -29.6 67.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.61 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.626 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -64.32 -63.67 1.08 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.1 mp -65.12 -38.01 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.352 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.69 -58.05 8.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.749 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -65.28 -53.71 40.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.627 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.928 ' CE2' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -43.97 -26.06 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.612 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.8 mm-40 -75.33 -65.97 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.36 -15.41 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.754 HG13 ' HD3' ' A' ' 68' ' ' LYS . 19.7 m -88.27 -28.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.227 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.99 59.69 10.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.249 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.02 -68.33 0.68 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.871 0.844 . . . . 0.0 111.899 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p 65.17 14.28 9.29 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.692 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -115.61 22.78 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 110.592 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.928 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -154.59 -174.25 4.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 13.5 t0 -158.61 113.12 1.66 Allowed Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.007 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 80.9 Cg_exo -46.02 -34.87 13.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.317 2.012 . . . . 0.0 111.954 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.539 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.6 8.1 30.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 8.6 m-85 -129.81 88.56 2.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 111.676 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 156.84 34.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.323 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 46' ' ' VAL . 18.4 m-85 -109.89 104.04 12.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 111.598 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -148.46 100.48 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.639 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.064 HG13 HD13 ' A' ' 32' ' ' LEU . 78.7 t -46.46 -38.5 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.99 179.658 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.8 Cg_endo . . . . . 0 N--CA 1.472 0.263 0 CA-C-O 120.762 0.234 . . . . 0.0 112.435 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.9 113.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -92.92 52.68 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.719 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.1 t0 -176.37 64.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.24 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -109.41 95.85 20.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.313 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 80.2 Cg_endo -91.54 10.53 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.117 2.544 . . . . 0.0 112.519 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -85.48 52.77 2.55 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.881 0.372 . . . . 0.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD22 ' A' ' 48' ' ' LEU . 18.6 mt -127.82 165.08 32.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.592 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 88.1 Cg_exo -47.07 177.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.561 2.174 . . . . 0.0 112.606 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.32 129.37 18.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.819 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 63.42 11.03 38.88 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.804 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.577 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 73.2 m95 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 0.0 111.742 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.66 178.69 6.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.107 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.761 ' NH2' HD11 ' A' ' 32' ' ' LEU . 4.1 ttt85 -145.37 162.35 37.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 0.0 111.661 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.945 ' O ' HD23 ' A' ' 32' ' ' LEU . 34.8 ttmt -175.08 158.32 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.602 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.945 HD23 ' O ' ' A' ' 31' ' ' LYS . 8.0 mt -131.34 163.12 28.56 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.12 0.486 . . . . 0.0 111.811 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.3 ttpt -137.76 113.18 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.169 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.245 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.675 0.274 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 7.2 m-85 -107.49 161.89 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -131.31 143.6 50.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.92 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.744 HG11 ' CG ' ' A' ' 81' ' ' PHE . 6.3 p -89.4 147.19 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.062 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.1 m-85 -144.98 94.32 2.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.321 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 HD11 ' A' ' 24' ' ' LEU . 70.0 mt -92.95 113.23 25.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.782 HG12 ' HB2' ' A' ' 55' ' ' ALA . 2.6 mt -89.63 122.83 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.218 -173.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.528 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 38.6 p-10 -85.71 155.66 58.88 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.569 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 27' ' ' GLY . 97.8 Cg_exo -36.73 -53.21 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.661 2.908 . . . . 0.0 113.286 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -47.56 -25.57 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.981 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.28 46.59 1.54 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.681 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.848 0.356 . . . . 0.0 111.264 -177.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -105.27 154.48 20.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.886 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CB ' HD22 ' A' ' 62' ' ' LEU . 67.4 m-85 -131.07 150.18 52.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.457 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 20.18 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.64 -4.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 77.14 -50.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.982 0.356 . . . . 0.0 111.957 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.1 p -52.49 -41.18 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.695 -0.628 . . . . 0.0 109.51 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -30.29 71.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.085 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.054 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -62.77 -72.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.041 179.197 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.515 ' CG1' ' HG3' ' A' ' 76' ' ' PRO . 7.9 mt -52.81 -43.57 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' CD ' ' A' ' 68' ' ' LYS . . . -52.82 -47.03 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.196 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -71.51 -57.55 4.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.69 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.054 ' CE2' HD12 ' A' ' 62' ' ' LEU . 27.6 m-85 -44.42 -29.73 0.74 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.136 0.493 . . . . 0.0 110.922 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.73 -47.3 85.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.91 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.8 -33.02 74.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.84 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' PHE . 6.4 m -93.5 -30.12 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.18 10.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.937 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.97 126.46 35.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.9 p -140.83 32.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -125.56 16.91 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -154.58 72.36 0.86 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 2.5 m-20 60.31 -152.93 0.01 OUTLIER Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 83.9 Cg_endo -68.19 -152.77 0.49 Allowed 'Cis proline' 0 C--N 1.311 -1.402 0 CA-C-N 121.78 1.671 . . . . 0.0 111.568 4.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.401 ' H ' ' CE ' ' A' ' 59' ' ' LYS . 2.1 m-80 63.69 13.26 7.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.354 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.58 7.34 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.353 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 37.9 m-85 -99.87 63.74 1.21 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.677 0.275 . . . . 0.0 110.271 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -44.58 128.1 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.639 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.744 ' CG ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-30 -88.37 85.26 6.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 1.5 p -98.34 93.34 6.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.99 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.619 HG13 HD13 ' A' ' 32' ' ' LEU . 77.8 t -66.82 -28.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.082 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 179.746 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.701 ' HB3' HD12 ' A' ' 32' ' ' LEU . 1.7 Cg_endo . . . . . 0 N--CA 1.472 0.24 0 N-CA-C 111.841 -0.099 . . . . 0.0 111.841 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.68 -36.2 0.44 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.117 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 81.17 -56.86 0.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -38.36 99.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.146 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -1.3 -65.42 0.0 OUTLIER Pre-proline 0 CA--C 1.477 -1.84 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -179.092 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.758 ' HG2' HG22 ' A' ' 23' ' ' THR . 63.1 Cg_endo -104.6 -4.49 8.97 Favored 'Cis proline' 0 C--N 1.314 -1.265 0 O-C-N 123.334 1.176 . . . . 0.0 112.115 -2.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.758 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -161.19 21.19 0.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.424 -174.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.627 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -44.15 166.85 0.1 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 0.0 111.857 -177.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HD2' HD23 ' A' ' 24' ' ' LEU . 67.9 Cg_exo -39.58 166.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.103 2.536 . . . . 0.0 113.272 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.44 119.5 2.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 76.9 -4.2 54.11 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.064 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.685 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 68.6 m95 -101.64 134.69 44.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.46 -0.435 . . . . 0.0 111.457 -178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -147.92 142.96 27.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.244 -178.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 44.9 ttp180 -110.33 163.39 13.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.821 0.82 . . . . 0.0 112.345 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.898 ' C ' HD23 ' A' ' 32' ' ' LEU . 9.4 ttmt -169.31 149.38 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.898 HD23 ' C ' ' A' ' 31' ' ' LYS . 1.8 mt -124.5 164.87 18.85 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.0 111.648 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 ttmt -137.7 123.2 19.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.94 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.444 179.2 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.5 m-85 -102.04 168.9 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -142.83 140.4 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.242 176.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.9 p -88.66 152.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.371 . . . . 0.0 111.281 -178.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.647 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 23.6 m-85 -146.05 101.01 3.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.544 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 79' ' ' PHE . 21.2 mt -92.93 105.48 17.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.801 0.81 . . . . 0.0 109.006 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' THR . 2.8 mt -82.22 121.16 35.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.135 -174.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -85.62 152.86 57.87 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.759 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' GLY . 89.6 Cg_exo -35.29 -57.23 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 0.0 113.275 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -43.9 -27.52 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.234 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.04 49.9 1.04 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.891 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -140.83 133.66 28.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.989 0.424 . . . . 0.0 111.279 -178.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.647 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -89.26 146.96 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.332 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CG ' HD12 ' A' ' 62' ' ' LEU . 85.5 m-85 -128.28 126.36 40.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 ttp180 -92.01 -59.22 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.67 172.7 8.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -81.75 -42.84 19.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.381 -178.676 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 t -51.8 -26.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.32 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.63 -31.27 59.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.488 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -68.01 -60.87 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -61.3 -40.24 85.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.074 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.74 -62.06 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.657 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.886 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.05 -57.95 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.66 178.381 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.882 ' CE2' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -39.67 -38.8 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.114 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.7 mm-40 -61.04 -56.14 24.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.034 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.46 -16.41 63.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.03 -50.52 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -178.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 153.75 -31.4 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.455 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.67 -161.33 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.066 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 71' ' ' ASP . 3.0 t 59.47 25.42 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.915 -178.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -141.1 17.47 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.67 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.882 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -39.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 -178.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.625 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER 71.97 103.59 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.593 179.054 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.3 Cg_exo -48.59 -32.48 21.31 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.439 2.093 . . . . 0.0 112.549 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.1 -10.95 60.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.603 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.55 -3.51 58.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.511 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.1 m-85 -109.51 64.4 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.566 -178.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.19 137.42 58.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.519 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -87.27 91.51 8.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.073 0.463 . . . . 0.0 111.075 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 98.77 7.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.747 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 44' ' ' TYR . 93.0 t -72.0 -7.64 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.602 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.6 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.919 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 4.9 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.886 0.286 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -168.91 106.01 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.502 178.854 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.631 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.66 66.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.997 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' MET . 37.4 t70 179.05 74.75 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -177.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.6 m-20 -115.7 80.48 8.43 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.632 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.744 ' HA ' HG23 ' A' ' 29' ' ' THR . 94.0 Cg_endo -88.43 22.37 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.852 2.368 . . . . 0.0 112.713 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 24' ' ' LEU . 52.2 p -94.8 46.43 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -125.1 176.66 2.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.479 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 81.5 Cg_exo -49.35 -179.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.729 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.52 126.83 28.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.817 -179.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.61 55.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.276 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.537 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 70.8 m95 -106.38 128.14 53.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.238 0.542 . . . . 0.0 111.787 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -135.95 -179.89 5.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.152 179.36 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 48' ' ' LEU . 29.9 ttp180 -142.09 163.08 33.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.785 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 13.4 ttmt -165.17 170.84 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.492 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.69 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.38 162.94 33.13 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.085 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -148.0 117.17 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.829 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.519 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 48.3 tt0 . . . . . 0 CA--C 1.515 -0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.954 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -77.93 122.85 26.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -175.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 149.47 24.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.319 176.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 83' ' ' VAL . 41.7 t -93.86 151.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.1 m-85 -146.05 99.88 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.606 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 30' ' ' ARG . 7.1 mt -92.88 106.8 18.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 109.624 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.1 mt -82.23 122.5 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.688 -174.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.537 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 31.2 p-10 -85.71 153.4 58.07 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.594 -178.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -37.61 -27.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.082 3.188 . . . . 0.0 113.699 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ASN . 2.6 mt-30 -80.61 12.38 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 70.98 15.94 74.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.972 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.521 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -99.05 137.51 37.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.494 0.188 . . . . 0.0 111.389 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.28 130.76 41.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.345 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 26.4 m-85 -115.8 117.83 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' CD ' ' CE2' ' A' ' 47' ' ' TYR . 8.1 mtm180 -105.03 10.06 34.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.453 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.45 164.84 38.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.836 0.351 . . . . 0.0 111.189 -178.473 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.547 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.66 -35.91 57.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 0.0 111.122 -178.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 8.2 p -54.0 -46.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.63 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.7 mt-10 -61.3 -30.59 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.88 -64.73 0.83 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.594 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -64.91 -42.42 94.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.72 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -57.04 11.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.417 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -66.69 -50.74 61.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.544 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.897 ' CE2' HD13 ' A' ' 74' ' ' LEU . 14.7 m-30 -48.81 -38.32 21.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.798 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 33.1 mt-10 -61.06 -66.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.921 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -54.17 -26.98 30.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -177.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.921 HG13 ' HD2' ' A' ' 68' ' ' LYS . 28.4 m -86.45 -29.32 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.786 178.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.31 55.3 28.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.881 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.666 ' HB3' HD11 ' A' ' 74' ' ' LEU . 1.4 t0 -83.46 153.22 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -131.2 3.61 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.43 27.38 8.81 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.889 0.376 . . . . 0.0 110.807 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.897 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -154.43 173.19 16.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.872 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' ASP . 2.3 t0 -158.63 111.86 1.65 Allowed Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.219 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 84.5 Cg_exo -45.17 -41.22 16.56 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.116 1.877 . . . . 0.0 112.241 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -69.97 -9.05 53.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 41.7 t0 -88.64 -6.49 57.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.13 178.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.656 ' CD2' HD11 ' A' ' 62' ' ' LEU . 45.9 m-85 -109.39 127.39 54.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.638 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -107.24 134.16 50.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.127 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.446 ' CE2' ' C ' ' A' ' 58' ' ' SER . 4.1 m-85 -97.45 90.2 4.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 p -141.43 142.56 33.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.69 HG13 HD22 ' A' ' 32' ' ' LEU . 87.0 t -95.5 -64.12 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.539 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 Cg_endo . . . . . 0 N--CA 1.456 -0.693 0 CA-C-O 120.884 0.285 . . . . 0.0 112.449 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.458 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.99 103.73 0.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.287 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.691 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -69.5 64.64 0.18 Allowed 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.683 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 18' ' ' MET . 25.3 t0 -178.5 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.8 t70 -114.67 82.64 8.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 29' ' ' THR . 85.1 Cg_endo -86.19 0.24 8.21 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.116 2.544 . . . . 0.0 112.935 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.4 p -80.64 -23.17 39.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.771 0.319 . . . . 0.0 111.09 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 13.3 mt -46.38 161.29 0.28 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 49.1 Cg_exo -35.71 159.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.107 2.538 . . . . 0.0 113.404 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.79 120.82 2.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.183 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.78 -14.02 27.39 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.499 178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 67.4 m95 -90.69 137.05 32.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -136.64 177.94 7.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.946 179.311 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 19.3 ttp180 -141.02 160.91 39.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.518 . . . . 0.0 111.421 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -161.19 166.93 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.946 -179.36 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.995 HD22 HG13 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.875 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.42 117.33 8.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.96 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.409 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 58.2 tt0 . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.722 179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 120.925 0.393 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CB ' HG11 ' A' ' 83' ' ' VAL . 5.9 m-85 -94.12 135.0 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.307 0.575 . . . . 0.0 112.385 -177.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -109.59 156.09 20.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.608 176.757 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 83' ' ' VAL . 18.3 t -98.28 149.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.509 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.499 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 14.9 m-85 -146.01 99.5 3.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.453 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 79' ' ' PHE . 20.0 mt -90.85 107.91 19.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 54' ' ' LYS . 3.2 mt -82.35 127.86 39.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.415 -171.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.3 t-20 -81.39 137.27 48.63 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.997 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 76.9 Cg_exo -33.27 -53.54 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.852 3.035 . . . . 0.0 113.322 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.23 -26.95 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.332 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.05 17.07 5.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.354 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.6 tttp -97.28 168.35 10.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.679 0.276 . . . . 0.0 111.119 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -134.95 130.42 35.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 29.2 m-85 -126.37 121.23 31.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.13 -52.58 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.443 . . . . 0.0 110.139 177.695 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.4 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -88.03 177.09 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.918 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -83.77 -41.49 17.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.338 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 21.6 t -51.81 -27.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.61 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 8.7 mm-40 -75.81 -31.69 59.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.303 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -62.84 -66.58 0.52 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.976 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.623 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -57.66 -38.4 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -58.51 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.98 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.48 ' CG ' ' HD3' ' A' ' 54' ' ' LYS . 1.5 t80 -66.37 -52.61 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.271 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.953 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.6 m-30 -44.79 -41.65 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 21.9 mt-10 -61.16 -63.9 1.13 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.886 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.726 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.67 -23.52 28.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.67 -177.522 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.4 m -92.54 -39.88 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.13 33.95 5.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.586 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.923 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -89.95 135.86 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.945 179.756 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -144.99 26.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.161 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -125.84 7.84 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.967 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.953 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -106.23 -31.87 8.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.845 0.355 . . . . 0.0 110.577 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.53 95.75 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 82.1 Cg_exo -44.39 -30.61 3.88 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.494 2.129 . . . . 0.0 112.227 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.12 -7.97 45.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.54 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.39 -18.52 38.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.608 0.242 . . . . 0.0 111.144 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.766 ' HB3' HD13 ' A' ' 48' ' ' LEU . 22.7 m-85 -97.77 125.13 42.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 111.341 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.71 144.41 41.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-85 -101.95 102.47 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.395 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -151.7 110.81 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.995 HG13 HD22 ' A' ' 32' ' ' LEU . 64.4 t -65.57 -71.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.83 179.742 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.49 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo . . . . . 0 N--CA 1.473 0.303 0 CA-C-O 120.755 0.231 . . . . 0.0 111.918 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.467 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.28 -26.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.252 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 84.17 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.433 0.293 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.54 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -114.63 112.42 45.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.197 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -109.11 37.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.943 3.095 . . . . 0.0 112.728 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.5 p -98.3 -53.72 3.27 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 1.7 mt -51.65 -177.53 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 121.489 -0.085 . . . . 0.0 111.051 -176.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 40.0 Cg_exo -41.29 157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.987 2.458 . . . . 0.0 114.6 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.23 149.98 3.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.94 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -59.29 1.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.867 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 75.8 m95 -47.8 150.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.349 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -149.09 178.11 9.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.879 178.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.528 ' HE ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -144.22 165.7 27.12 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.406 177.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm -176.37 154.59 1.34 Allowed 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.597 -176.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.49 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 10.0 mt -116.47 173.79 6.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.546 0.689 . . . . 0.0 112.828 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.83 116.94 6.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.45 176.77 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.086 179.01 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.046 0.451 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.2 m-85 -99.99 159.19 15.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -132.51 153.83 50.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.641 177.247 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 83' ' ' VAL . 52.5 t -101.15 148.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 8.3 m-85 -144.61 103.26 3.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.718 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.574 HD11 ' O ' ' A' ' 80' ' ' ASP . 71.3 mt -92.93 108.05 19.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.6 mt -88.23 130.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.661 -174.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.502 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 7.4 p-10 -82.73 154.31 68.05 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.663 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -32.51 -60.45 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.896 3.064 . . . . 0.0 113.827 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.24 -25.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 25.28 5.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.687 -179.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 47.2 tptt -99.1 124.75 44.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.19 140.26 31.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -177.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.718 ' CD2' HD12 ' A' ' 62' ' ' LEU . 25.4 m-85 -133.26 135.35 44.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.155 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -102.58 -53.54 2.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.097 178.144 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -87.0 174.19 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.486 178.337 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.41 -42.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.337 . . . . 0.0 111.756 -178.364 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 50.9 t -51.83 -25.17 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.02 -26.27 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.203 178.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.718 HD12 ' CD2' ' A' ' 56' ' ' PHE . 1.1 mp -76.1 -65.55 0.9 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.907 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -55.81 -38.42 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.82 -66.98 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.341 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.89 -45.63 89.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.189 -179.166 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.4 m-30 -53.41 -34.54 58.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 111.57 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.24 -70.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.674 -176.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.06 -21.04 28.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 110.357 178.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' TYR . 36.6 t -86.46 -25.08 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.927 -177.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 48.49 56.08 9.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.342 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.46 134.52 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.6 16.22 15.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.284 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 25.13 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.839 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -154.65 175.23 13.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.482 179.452 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.64 123.59 2.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.073 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HA ' HD23 ' A' ' 62' ' ' LEU . 39.3 Cg_exo -56.07 -33.39 89.71 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.068 1.845 . . . . 0.0 112.27 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.435 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -70.61 -15.6 62.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.59 -16.42 32.57 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 0.0 111.584 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD2' HD21 ' A' ' 62' ' ' LEU . 54.9 m-85 -98.46 126.97 44.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -124.5 152.74 43.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.058 -179.536 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HA ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-85 -107.46 84.64 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.9 p -125.05 95.37 4.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -179.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 46' ' ' VAL . 2.6 t -49.45 -48.13 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 p . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.293 -179.082 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HB3' HD13 ' A' ' 32' ' ' LEU . 4.4 Cg_exo . . . . . 0 N--CA 1.472 0.207 0 CA-C-O 120.913 0.297 . . . . 0.0 112.401 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.514 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -160.16 102.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.756 179.457 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.725 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.98 63.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.583 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 179.38 82.15 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -176.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 1.7 m-20 -118.42 80.6 16.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.263 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.63 ' HA ' HG23 ' A' ' 29' ' ' THR . 91.1 Cg_endo -89.9 23.5 0.69 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.176 2.584 . . . . 0.0 112.54 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 p -92.02 -20.5 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.437 -179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.81 HD11 ' CG ' ' A' ' 30' ' ' ARG . 12.4 mt -56.69 165.23 1.75 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.868 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 79.8 Cg_exo -48.59 178.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.698 2.265 . . . . 0.0 113.183 -178.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.86 125.32 11.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.287 -178.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.09 0.32 55.98 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.639 178.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 63.7 m95 -101.81 135.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.166 0.508 . . . . 0.0 111.989 -178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -145.82 179.15 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.809 179.468 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.81 ' CG ' HD11 ' A' ' 24' ' ' LEU . 3.1 mtp180 -142.91 165.44 27.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.079 0.466 . . . . 0.0 111.726 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 12.7 tttm -166.09 161.53 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.98 -178.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.809 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -131.3 166.5 21.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.216 0.531 . . . . 0.0 112.12 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -147.24 115.85 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.082 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.522 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 tttt . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.291 0.567 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.6 m-85 -108.54 149.61 28.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.219 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.93 148.13 40.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.33 176.542 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 48' ' ' LEU . 40.4 t -90.46 148.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.837 -178.243 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 22.4 m-85 -146.16 95.64 2.65 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 79' ' ' PHE . 1.7 mt -92.95 109.15 20.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.394 0.616 . . . . 0.0 109.754 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.848 HG12 ' HB2' ' A' ' 55' ' ' ALA . 6.2 mt -82.64 121.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.482 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 46.8 p-10 -85.66 154.87 59.15 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.201 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -33.62 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.918 3.079 . . . . 0.0 113.347 -179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.86 -26.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.414 -178.997 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 44.77 1.72 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.967 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CD ' ' CE2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.83 138.15 33.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.955 -178.469 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.848 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -103.64 145.28 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CE2' ' CD ' ' A' ' 54' ' ' LYS . 2.0 m-85 -127.83 144.94 51.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.316 177.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -48.45 3.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.88 174.68 8.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 1.2 tmtp? -85.69 -39.19 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.289 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 55.8 t -52.11 -38.39 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.949 0.405 . . . . 0.0 110.309 178.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 3.4 mm-40 -67.18 -30.08 69.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.469 178.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.84 -62.21 1.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 109.637 178.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.4 mp -67.83 -42.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.356 178.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.63 -58.98 5.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.756 -178.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.1 t80 -62.62 -55.37 27.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 110.581 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.058 ' CE2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-30 -41.2 -38.47 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.897 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -63.25 -60.55 3.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.571 -178.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HD3' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.22 -18.37 15.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.23 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.584 HG23 ' HD3' ' A' ' 68' ' ' LYS . 49.8 t -86.42 -33.68 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 107.38 -35.3 5.1 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -176.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.66 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 32.5 107.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 175.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -148.72 31.06 0.8 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.677 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 76.7 p -179.43 49.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.321 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.058 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.5 -36.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.992 -179.135 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.63 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 51.58 109.79 0.02 OUTLIER Pre-proline 0 N--CA 1.462 0.171 0 C-N-CA 122.593 0.357 . . . . 0.0 111.786 179.328 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 50.0 Cg_exo -50.95 -32.43 38.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.144 1.896 . . . . 0.0 112.044 178.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.84 -16.08 63.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.777 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -10.47 59.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.051 177.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.754 ' HB3' HD12 ' A' ' 48' ' ' LEU . 41.9 m-85 -106.92 152.26 24.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.447 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.53 148.95 40.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.603 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.7 m-30 -109.28 85.99 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.4 p -120.87 -12.44 8.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.809 HG13 HD22 ' A' ' 32' ' ' LEU . 78.3 t 63.49 -78.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 110.617 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' THR . 25.6 p . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 57.6 Cg_endo . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.826 0.261 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.6 mtm -151.8 105.85 3.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -70.81 -75.24 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.117 -178.247 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.5 p30 -61.31 83.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.715 0.293 . . . . 0.0 110.533 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -115.11 84.64 11.28 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.762 -178.509 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 29' ' ' THR . 87.7 Cg_endo -93.83 30.77 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.193 2.596 . . . . 0.0 112.591 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.7 p -81.28 -31.58 33.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 111.007 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.563 HD11 ' HG2' ' A' ' 30' ' ' ARG . 87.8 mt -50.79 165.12 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.0 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.4 Cg_exo -47.2 178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.591 2.194 . . . . 0.0 112.967 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 128.11 19.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.386 -178.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.34 54.84 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.75 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 60.6 m95 -101.0 133.82 44.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.188 0.494 . . . . 0.0 112.019 -178.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -138.75 179.19 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.275 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 24' ' ' LEU . 14.9 mtm180 -143.38 170.04 16.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.727 178.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.7 ttmm 178.57 162.37 0.7 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.189 -178.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.842 HD13 HG13 ' A' ' 83' ' ' VAL . 14.2 mt -128.13 173.36 10.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.27 0.557 . . . . 0.0 112.168 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -147.8 113.18 5.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.26 176.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 52.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.804 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.176 0 CA-C-O 121.057 0.456 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -86.72 151.22 23.58 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -174.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-20 -119.53 173.27 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.071 177.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.503 ' CG2' HG23 ' A' ' 83' ' ' VAL . 54.0 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.4 -178.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.2 m-85 -146.36 103.27 3.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.074 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 24' ' ' LEU . 62.3 mt -92.99 107.81 19.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 54' ' ' LYS . 4.3 mt -82.33 121.77 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.549 -173.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 18.8 p-10 -85.73 144.59 39.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.535 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -35.39 -44.71 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.614 2.876 . . . . 0.0 112.857 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 3.5 mt-30 -49.12 -23.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.234 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.61 20.32 11.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.753 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.835 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -100.75 -179.99 4.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 111.679 -178.638 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.87 131.87 21.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.708 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 64.7 m-85 -123.28 133.25 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 0.0 111.729 -178.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.0 mtm180 -105.98 1.04 26.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.672 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.35 164.22 38.95 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -178.176 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -69.53 -47.21 64.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -176.221 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 9.2 t -51.9 -35.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.777 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -28.06 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.119 178.277 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.073 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -67.41 -69.16 0.33 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.549 179.359 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -55.45 -36.1 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -64.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.923 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.838 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.34 -59.57 4.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.008 0.432 . . . . 0.0 110.681 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.576 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.7 m-30 -35.29 -39.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.767 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 11.6 mt-10 -61.19 -66.69 0.5 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.877 0.37 . . . . 0.0 111.928 -177.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HE3' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.19 -19.96 23.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.58 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.53 -37.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.297 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.67 -32.28 3.22 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.801 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.44 -159.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.832 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 71' ' ' ASP . 0.6 OUTLIER 75.91 26.92 0.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.093 0.557 . . . . 0.0 110.51 -177.014 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -150.16 27.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.426 177.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -147.95 -41.96 0.17 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.889 -178.23 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 70.14 86.24 0.12 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.433 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 81.3 Cg_exo -49.96 -24.92 11.38 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -69.6 -18.6 63.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.545 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -88.52 12.49 14.34 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.833 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 1.073 ' CD2' HD21 ' A' ' 62' ' ' LEU . 3.8 m-85 -108.11 79.45 1.27 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.727 0.298 . . . . 0.0 111.004 -179.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 82' ' ' THR . 0.4 OUTLIER -84.57 8.0 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.751 179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 10.3 m-85 49.33 -88.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.289 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 80' ' ' ASP . 2.1 p 58.28 161.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.406 . . . . 0.0 111.298 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 32' ' ' LEU . 16.9 t -132.53 -51.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.221 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.953 -179.841 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 62.2 Cg_endo . . . . . 0 N--CA 1.475 0.426 0 N-CA-C 113.097 0.384 . . . . 0.0 113.097 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.672 ' H ' HD11 ' A' ' 32' ' ' LEU . 8.1 mtm -136.18 -36.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.142 -179.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.723 ' CD1' HD12 ' A' ' 32' ' ' LEU . 8.5 m-85 63.44 28.24 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 35.4 t70 -175.75 82.55 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -176.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -113.31 87.94 12.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.143 178.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 29' ' ' THR . 96.3 Cg_endo -88.11 9.03 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.012 2.475 . . . . 0.0 112.649 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 p -86.83 51.85 2.35 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.53 HD11 ' CD ' ' A' ' 30' ' ' ARG . 29.4 mt -128.97 164.08 41.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.155 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.51 170.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.384 2.056 . . . . 0.0 112.556 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 126.24 8.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.466 -178.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.57 0.56 58.92 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.731 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 66.0 m95 -101.41 137.28 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 112.087 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -147.89 -172.15 3.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.789 179.902 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.581 ' H ' HG22 ' A' ' 29' ' ' THR . 1.7 mtm180 -151.33 176.27 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 111.43 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -175.53 173.52 2.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.354 -178.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -142.97 167.14 22.77 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.325 0.583 . . . . 0.0 112.409 179.879 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -148.04 101.32 3.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.979 177.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.936 179.732 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.542 ' CB ' HG11 ' A' ' 83' ' ' VAL . 9.1 m-85 -105.42 137.04 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -105.98 137.94 43.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.641 174.712 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p -93.91 154.46 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.038 0.447 . . . . 0.0 111.468 -177.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.2 m-85 -146.04 99.22 3.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 79' ' ' PHE . 8.1 mt -91.78 111.43 22.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.39 120.89 34.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.211 -171.75 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 6.5 p-10 -86.18 144.76 39.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.216 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -34.7 -51.72 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.64 2.893 . . . . 0.0 113.429 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -44.62 -27.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.389 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.24 25.07 5.97 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.602 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.751 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.0 tttt -99.17 172.47 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 111.31 -178.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 96.56 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.366 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 22.9 m-85 -90.29 129.15 36.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 111.647 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -104.85 4.27 31.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.335 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 60' ' ' VAL . 99.7 p -154.41 170.77 20.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 -177.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.531 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.23 -37.98 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -178.517 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 3.9 p -51.84 -46.48 40.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.683 -179.191 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -62.11 -31.99 72.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.221 178.594 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -65.51 -68.6 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 178.959 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -56.98 -40.42 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.696 178.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.26 -64.87 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.102 -178.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.49 -40.14 93.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.605 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 1.043 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.8 m-30 -59.8 -32.22 70.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 23.3 mt-10 -60.9 -70.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 111.522 -177.289 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.03 -21.79 33.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.559 178.393 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 65' ' ' TYR . 13.3 t -86.41 -25.9 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -177.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 59.84 45.19 96.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.698 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.778 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.06 136.39 33.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.738 179.395 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.8 p -138.75 23.38 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 p -124.0 24.13 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -133.51 -41.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 -179.35 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.604 ' H ' HD12 ' A' ' 74' ' ' LEU . 1.3 m-20 61.96 102.54 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.6 Cg_exo -46.59 -34.69 15.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.422 2.081 . . . . 0.0 112.424 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.03 -7.55 41.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.24 -14.92 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.657 0.265 . . . . 0.0 110.946 178.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 48' ' ' LEU . 47.7 m-85 -99.05 99.11 10.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.244 -179.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -84.78 132.31 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.689 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.16 74.24 6.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.476 -178.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 124.7 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.664 179.086 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.985 HG13 HD22 ' A' ' 32' ' ' LEU . 81.0 t -73.59 -67.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.285 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.424 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 32' ' ' LEU . 86.8 Cg_endo . . . . . 0 N--CA 1.472 0.263 0 CA-C-O 120.819 0.258 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.8 118.29 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.575 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -97.38 47.44 1.03 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.67 -178.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t0 179.4 71.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.431 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.49 93.98 21.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.341 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 68.2 Cg_endo -95.9 23.66 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.319 2.679 . . . . 0.0 112.293 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.854 ' C ' HD23 ' A' ' 24' ' ' LEU . 16.7 p -92.31 42.83 1.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.281 -178.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.021 HD11 ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -130.31 178.55 1.67 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.377 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.1 Cg_exo -46.9 174.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.489 2.126 . . . . 0.0 112.737 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.86 44.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.16 -178.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.42 -0.12 60.97 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.393 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 55.0 m95 -102.57 133.43 47.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.942 -178.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -140.44 -176.53 4.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.416 179.789 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 1.021 ' CG ' HD11 ' A' ' 24' ' ' LEU . 2.5 mtp180 -143.25 156.98 44.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.596 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.885 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.8 ttpt -166.49 161.05 15.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.996 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.98 HD13 HG13 ' A' ' 83' ' ' VAL . 5.4 mt -130.28 166.8 19.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.252 0.549 . . . . 0.0 112.217 -178.224 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.6 tttt -139.31 115.49 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.861 -179.383 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 . . . . . 0 C--N 1.325 -0.496 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.332 178.955 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.002 0.43 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.776 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.6 m-85 -104.75 153.96 20.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.461 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -120.31 144.21 47.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.215 176.245 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.712 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.6 p -85.92 148.61 4.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.13 -178.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.7 m-85 -145.35 97.95 3.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.853 HD12 ' HB3' ' A' ' 79' ' ' PHE . 7.6 mt -92.57 109.64 21.05 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.076 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.0 mt -82.23 126.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -171.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.5 p-10 -85.58 150.28 53.46 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.329 -178.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -38.57 -55.45 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.171 2.58 . . . . 0.0 112.802 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -46.77 -26.79 1.02 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.31 28.91 3.14 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.602 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -92.33 -178.84 5.05 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.368 0.604 . . . . 0.0 112.094 -179.406 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.2 88.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.076 177.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 83.2 m-85 -92.02 122.05 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.457 -177.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.496 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -92.84 -48.73 6.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.051 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 171.78 9.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.323 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 63' ' ' ILE . 7.8 tptp -88.68 -47.19 8.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 -179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 t -51.88 -26.85 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 110.147 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.59 -32.07 63.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.661 177.257 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -64.43 -62.66 1.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.84 179.371 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -61.56 -40.87 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.8 -68.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.122 -179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.532 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.79 -40.55 88.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.102 -179.632 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.517 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.6 m-30 -56.47 -30.9 63.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.345 . . . . 0.0 110.641 178.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.9 mm-40 -70.42 -60.28 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.915 -177.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.36 -26.05 62.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.597 -178.124 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 65' ' ' TYR . 12.1 m -86.58 -39.92 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.4 38.99 4.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.323 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.515 ' CG ' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.1 117.53 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 -179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.3 p -134.95 33.93 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 179.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 p -132.53 33.6 3.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.531 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.535 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -137.64 -39.04 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.494 -179.092 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.535 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER 66.75 93.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 110.57 -179.08 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 97.9 Cg_exo -44.97 -29.0 3.42 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.95 -7.94 44.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.386 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.25 -11.49 46.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.478 0.18 . . . . 0.0 111.291 178.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 48' ' ' LEU . 74.2 m-85 -103.4 102.36 12.29 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.485 -179.11 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.553 ' O ' HD11 ' A' ' 48' ' ' LEU . 13.6 t70 -94.0 160.35 14.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.294 178.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.712 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.0 m-30 -115.44 85.0 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.38 96.38 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.688 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.98 HG13 HD13 ' A' ' 32' ' ' LEU . 86.5 t -66.12 -32.43 58.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.334 -179.548 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.861 0.362 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 77.8 p -154.74 118.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.49 160.08 37.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.3 m -159.65 59.62 1.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.86 -169.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.751 2.301 . . . . 0.0 112.298 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt 43.09 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.057 0.456 . . . . 0.0 111.058 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -122.39 131.28 53.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.224 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 67.6 mtm-85 -93.67 128.59 39.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -122.04 82.1 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.9 p -164.62 65.64 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.841 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 8.2 tp -83.4 145.25 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -94.32 40.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.449 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 78.97 121.54 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.6 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -45.54 96.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.441 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.35 137.31 29.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.803 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.46 -154.26 20.56 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.235 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 5.0 Cg_exo -79.62 -155.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.174 2.582 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.406 ' HG2' ' OD2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -171.71 105.37 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.81 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 3.2 m-30 -67.35 -19.04 65.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.92 73.19 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.299 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -97.71 111.38 58.66 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.191 -178.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -106.04 13.99 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.001 3.134 . . . . 0.0 112.617 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.639 ' O ' HD23 ' A' ' 24' ' ' LEU . 1.1 p -90.65 50.06 1.76 Allowed 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.864 HD12 ' HD2' ' A' ' 30' ' ' ARG . 72.0 mt -154.17 160.33 31.05 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 31.2 Cg_exo -22.79 145.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.653 3.569 . . . . 0.0 114.543 -178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -41.51 148.43 0.15 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.166 -0.924 . . . . 0.0 112.203 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.98 -58.36 2.24 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.785 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.522 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 78.7 m95 -47.42 133.44 12.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 112.087 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.52 167.72 20.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.864 ' HD2' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -138.76 159.62 41.67 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.628 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.7 ttmm -157.32 167.59 29.84 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.994 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.011 HD22 HG12 ' A' ' 83' ' ' VAL . 6.7 mt -137.03 175.88 9.22 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.478 0.656 . . . . 0.0 112.258 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.0 tttm -147.81 106.59 3.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.157 176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.3 tt0 -67.38 169.3 9.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.766 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 42' ' ' GLY . 13.0 ttp180 -152.92 129.03 10.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.615 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.902 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -124.38 110.09 14.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 110.921 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.5 p -105.37 -31.31 9.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.228 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.595 ' H ' ' HB2' ' A' ' 41' ' ' ALA . . . 122.51 -23.67 7.07 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.112 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -70.29 0.8 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.013 0.435 . . . . 0.0 109.889 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -98.72 31.89 2.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.533 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.902 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -52.5 166.06 0.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.784 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 73.22 22.35 78.95 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.511 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.26 133.92 33.61 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.981 ' HB3' HG11 ' A' ' 83' ' ' VAL . 24.3 m-85 -100.09 164.49 11.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -174.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 5.7 m-20 -120.47 166.98 12.86 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 113.31 -1.768 . . . . 0.0 108.428 176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.494 HG11 ' HD1' ' A' ' 81' ' ' PHE . 54.2 t -128.07 147.94 32.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.201 0.524 . . . . 0.0 111.766 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 33.5 m-85 -149.05 102.24 3.23 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.139 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 79' ' ' PHE . 6.1 mt -93.04 106.08 18.09 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 109.601 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.8 mt -82.3 123.62 38.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.091 -0.958 . . . . 0.0 111.956 -176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.426 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.7 t-20 -80.81 137.96 50.4 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.801 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 73.5 Cg_exo -34.02 -54.84 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.521 2.814 . . . . 0.0 113.456 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -50.99 -31.61 18.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.909 0.385 . . . . 0.0 111.227 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.48 48.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.806 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HD3' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.89 122.58 15.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -177.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -101.69 152.29 21.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.177 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.537 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 1.2 m-85 -129.78 167.97 17.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.64 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mtt180 -132.16 3.49 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.87 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.49 171.63 19.08 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.826 0.346 . . . . 0.0 110.792 -178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HD2' ' CD1' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.43 -43.25 41.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.168 -178.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 9.1 p -53.22 -44.39 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.371 0.605 . . . . 0.0 109.873 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.1 tt0 -60.87 -27.83 68.41 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.3 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -69.6 -64.6 0.85 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.668 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.9 mp -65.9 -39.43 84.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.255 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.71 -58.0 8.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.0 t80 -68.86 -49.21 60.27 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.0 0.429 . . . . 0.0 110.843 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.796 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 5.1 m-85 -46.82 -26.44 0.96 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.618 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.3 mm-40 -72.82 -57.06 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -177.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -16.1 63.0 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 65' ' ' TYR . 13.5 m -86.48 -40.18 14.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.174 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.62 43.73 2.86 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.514 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.954 ' OD2' HD11 ' A' ' 74' ' ' LEU . 11.4 p-10 -74.3 141.97 45.23 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 122.535 0.334 . . . . 0.0 111.562 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.9 t -149.86 23.75 0.86 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.372 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -152.88 52.37 0.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.954 HD11 ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -154.53 -44.03 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 63.66 100.81 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.435 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.442 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 86.4 Cg_exo -47.75 -31.55 15.02 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.469 2.112 . . . . 0.0 112.582 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -8.49 49.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.505 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 1.04 55.5 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.347 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 62' ' ' LEU . 66.7 m-85 -109.37 130.89 55.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.857 0.361 . . . . 0.0 111.257 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -124.17 147.64 47.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.736 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.494 ' HD1' HG11 ' A' ' 46' ' ' VAL . 22.7 m-85 -105.96 77.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.33 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.1 p -140.71 111.64 7.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.111 0.481 . . . . 0.0 110.693 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.011 HG12 HD22 ' A' ' 32' ' ' LEU . 3.4 m -64.69 -41.27 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.642 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.656 HG23 HG23 ' A' ' 83' ' ' VAL . 16.3 p -99.39 46.14 0.98 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.159 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 47.96 -175.42 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.691 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.74 -156.0 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.69 -103.88 0.4 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.79 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 p 58.17 25.3 12.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.766 0.317 . . . . 0.0 110.764 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -91.01 -41.63 5.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.49 -29.38 15.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.858 0.361 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -152.29 -152.92 6.09 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.52 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.914 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.807 0.337 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t 58.56 88.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.22 143.66 10.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.119 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.2 t -157.07 71.78 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -87.07 24.66 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.967 2.445 . . . . 0.0 113.075 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.69 79.14 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.752 0.31 . . . . 0.0 110.746 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -108.67 -54.43 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.111 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -101.88 174.97 5.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.955 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER 45.84 63.05 1.96 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.43 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -76.81 59.19 1.55 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' A' ' 9' ' ' ARG . 3.8 tt -138.23 119.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.899 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.1 mm -93.43 52.6 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.802 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 54.81 82.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.869 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -115.16 50.05 1.01 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.944 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -123.15 -170.51 2.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.719 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -145.21 -101.83 0.33 Allowed Glycine 0 CA--C 1.488 -1.601 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.142 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.522 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -79.8 -170.26 8.53 Favored 'Cis proline' 0 N--CA 1.473 0.29 0 C-N-CA 125.465 -0.64 . . . . 0.0 112.029 1.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 13.8 mtm -145.65 94.46 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.605 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.7 m-30 -67.18 -70.13 0.27 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.443 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 33.5 t0 -64.08 79.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 19' ' ' TYR . 3.2 m-20 -114.92 88.53 17.14 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.583 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 77.8 Cg_endo -97.22 14.38 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.393 2.728 . . . . 0.0 112.442 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.2 p -87.97 49.6 1.83 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.826 0.346 . . . . 0.0 111.426 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -129.65 176.23 2.99 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.093 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 94.2 Cg_exo -45.43 169.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.421 2.081 . . . . 0.0 112.824 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.16 124.09 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.141 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.77 -4.68 43.29 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.749 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.496 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 45.0 m95 -94.68 118.16 31.27 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.229 0.538 . . . . 0.0 112.069 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -118.01 -173.95 2.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.903 177.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.534 ' H ' HG22 ' A' ' 29' ' ' THR . 1.8 ttt180 -155.35 163.7 39.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.791 0.329 . . . . 0.0 111.019 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' O ' HD23 ' A' ' 32' ' ' LEU . 7.5 tttt -172.78 158.61 4.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.359 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.972 HD13 ' HB ' ' A' ' 83' ' ' VAL . 6.2 mt -129.89 174.42 9.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.055 0.455 . . . . 0.0 111.51 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -146.94 110.94 5.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.074 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -73.63 169.71 16.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.792 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 42' ' ' GLY . 19.5 ttm180 -153.06 146.06 24.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.972 0.415 . . . . 0.0 110.787 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' CE ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -105.02 -71.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.742 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.29 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.051 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' HA2' ' CE ' ' A' ' 36' ' ' LYS . . . 165.09 -34.19 0.26 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.768 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 127.8 55.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.6 m 57.45 39.43 28.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.067 0.461 . . . . 0.0 109.902 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.53 179.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.203 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 60.06 27.64 65.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.185 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.59 135.35 33.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.368 . . . . 0.0 110.676 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.522 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 26.2 m-85 -106.63 163.73 12.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.872 0.844 . . . . 0.0 113.11 -177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -130.93 132.74 45.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.922 -1.49 . . . . 0.0 107.664 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.7 p -91.53 148.23 4.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.692 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.661 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 3.4 m-85 -143.7 103.38 4.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.403 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' A' ' 79' ' ' PHE . 19.7 mt -92.96 110.78 22.25 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.4 OUTLIER -85.19 124.65 40.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.463 0.649 . . . . 0.0 112.064 -173.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.496 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 24.6 p-10 -85.67 151.07 54.97 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.754 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -37.17 -53.68 1.23 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.565 2.843 . . . . 0.0 113.259 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -45.72 -26.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.253 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.73 47.22 1.2 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.764 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 120.955 0.407 . . . . 0.0 111.286 -177.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.661 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -91.35 150.26 21.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.94 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.55 119.49 23.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -100.82 5.47 43.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.569 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.2 p -154.44 159.98 41.36 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.167 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.664 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -72.6 -39.5 67.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.167 -178.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 61' ' ' GLU . 4.2 p -51.83 -48.45 38.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.787 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' N ' HG13 ' A' ' 60' ' ' VAL . 3.6 mm-40 -61.88 -29.91 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.07 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -63.37 -60.42 3.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.252 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.664 HD11 ' HD2' ' A' ' 59' ' ' LYS . 5.3 mp -67.81 -42.84 86.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.683 178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.8 -53.94 41.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.116 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 0.2 OUTLIER -67.35 -50.77 58.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.333 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.703 ' CE2' HD13 ' A' ' 74' ' ' LEU . 23.0 m-30 -53.67 -26.76 23.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.067 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -69.12 -60.65 2.21 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.329 -177.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.11 -27.71 54.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.985 -177.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' HD2' ' A' ' 68' ' ' LYS . 21.2 m -86.61 -44.47 16.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.839 0.352 . . . . 0.0 111.196 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.93 44.06 3.69 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.967 -178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.27 143.55 29.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.262 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -145.95 22.87 1.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.945 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -124.45 33.42 5.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.946 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.703 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.39 -43.48 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.514 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.3 OUTLIER 62.8 107.9 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.953 179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 88.0 Cg_exo -48.13 -31.89 17.56 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.324 2.016 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.97 -7.45 40.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.614 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -87.38 -4.02 59.03 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.293 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.672 ' CD2' HD21 ' A' ' 62' ' ' LEU . 82.8 m-85 -107.62 123.41 48.43 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.735 0.303 . . . . 0.0 111.172 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.99 137.13 51.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.532 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-85 -95.71 79.16 3.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.042 0.449 . . . . 0.0 111.352 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -138.42 94.83 2.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.936 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.972 ' HB ' HD13 ' A' ' 32' ' ' LEU . 23.6 m -48.29 -48.51 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.761 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.517 ' N ' HG23 ' A' ' 83' ' ' VAL . 20.6 p -66.45 -44.28 83.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 135.29 173.8 13.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.637 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 -154.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.32 101.3 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.724 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.1 p -147.17 20.39 1.23 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.872 0.368 . . . . 0.0 110.509 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.15 -57.26 1.02 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.528 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 m 62.36 119.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.96 0.41 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.12 -134.4 52.27 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.663 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.938 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.747 0.308 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -146.59 160.87 41.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -108.05 2.87 23.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.79 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.471 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -163.55 -64.44 0.01 OUTLIER Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.471 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 55.3 Cg_endo -89.73 -39.09 0.52 Allowed 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.565 -1.015 . . . . 0.0 112.872 -1.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -108.44 -158.99 0.67 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.506 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 63.09 87.11 0.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.194 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -67.95 136.65 54.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -133.3 58.54 1.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.961 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.7 80.67 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.055 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 tt -86.53 138.32 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.8 mm -91.46 67.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.77 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 63.87 175.63 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.036 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.72 81.95 4.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.364 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.92 157.95 20.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.849 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.93 145.08 4.39 Favored Glycine 0 CA--C 1.488 -1.654 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.904 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.491 ' HB2' ' CE1' ' A' ' 19' ' ' TYR . 95.5 Cg_endo -77.18 -164.77 4.07 Favored 'Cis proline' 0 N--CA 1.476 0.476 0 C-N-CA 125.097 -0.793 . . . . 0.0 112.205 2.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.436 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -157.92 -40.58 0.07 Allowed 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.549 179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 17' ' ' PRO . 1.9 m-85 75.14 -65.89 0.32 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.555 0.217 . . . . 0.0 111.068 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.57 89.3 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.469 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 34.4 m-20 -131.8 65.66 76.16 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.62 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.565 ' HA ' HG23 ' A' ' 29' ' ' THR . 8.9 Cg_endo -82.27 9.28 4.06 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.708 2.272 . . . . 0.0 112.82 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.3 t -85.52 55.71 3.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.029 0.443 . . . . 0.0 110.681 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 24' ' ' LEU . 12.4 mt -126.39 167.08 18.22 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.028 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 76.1 Cg_exo -40.79 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.751 2.3 . . . . 0.0 112.631 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.01 121.85 3.49 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.136 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.72 -2.2 49.59 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.793 -0.64 . . . . 0.0 113.798 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 48.9 m95 -96.85 140.96 30.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 117.237 0.519 . . . . 0.0 112.158 -178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -140.38 176.07 9.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.583 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.529 ' HG3' HD23 ' A' ' 48' ' ' LEU . 17.0 ttm105 -147.36 154.01 40.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.972 0.415 . . . . 0.0 111.19 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.892 ' C ' HD23 ' A' ' 32' ' ' LEU . 12.1 ttmt -168.7 164.4 12.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.228 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.079 HD13 HG13 ' A' ' 83' ' ' VAL . 3.7 mt -128.66 161.27 30.07 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.157 0.503 . . . . 0.0 111.836 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.99 125.86 32.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.922 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 50.9 tt0 -77.97 167.13 21.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.135 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 34.2 ttm180 -152.98 164.78 37.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.935 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' CE ' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -136.97 110.73 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.671 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.29 -163.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.762 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.1 30.51 8.94 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.217 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.38 -47.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.892 0.377 . . . . 0.0 110.628 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 t -95.21 49.44 1.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.474 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.564 ' HB2' ' CE ' ' A' ' 36' ' ' LYS . . . -57.2 115.06 2.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.56 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 110.19 36.3 1.99 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.754 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -87.52 136.85 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 111.092 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 20.5 m-85 -105.52 162.81 13.16 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.509 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -134.26 144.94 48.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.353 176.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.713 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -88.06 146.89 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.896 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.519 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.5 m-85 -142.82 98.65 3.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.895 0.379 . . . . 0.0 111.291 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.701 HD13 ' HD1' ' A' ' 79' ' ' PHE . 14.4 mt -92.97 113.21 25.42 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.461 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 37.3 mt -92.16 127.94 44.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 34.7 p-10 -85.58 150.05 52.93 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.901 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -32.91 -58.74 0.27 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.928 3.085 . . . . 0.0 113.383 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -44.62 -27.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.536 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.21 51.18 0.89 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.813 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -139.75 130.68 26.2 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.931 0.395 . . . . 0.0 110.743 -177.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -92.37 158.43 16.08 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.875 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -136.96 120.15 16.71 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.157 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.22 10.05 39.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -154.51 163.35 40.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.984 -177.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 3.8 tptp -79.75 -49.27 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.881 -176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 12.2 t -51.96 -33.6 16.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.216 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -70.36 -29.96 66.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.03 177.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.573 HD21 ' CB ' ' A' ' 79' ' ' PHE . 1.1 tp -63.06 -59.55 4.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.0 mp -70.33 -46.41 71.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.401 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -50.14 64.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.866 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 1.5 t80 -68.97 -57.78 5.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 110.477 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.506 ' CD2' HD13 ' A' ' 74' ' ' LEU . 13.6 m-30 -42.54 -33.38 0.68 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.36 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.5 mm-40 -76.18 -56.47 4.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.407 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.564 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.81 -21.82 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.667 -178.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.809 HG23 ' H ' ' A' ' 71' ' ' ASP . 3.7 m -92.37 -25.6 5.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.012 0.434 . . . . 0.0 109.933 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 71' ' ' ASP . . . 94.83 -30.81 7.51 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.821 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.855 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 49.2 157.91 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 176.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.9 p -90.11 -22.77 21.61 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.32 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.62 ' O ' HD12 ' A' ' 74' ' ' LEU . 10.9 p 165.06 -76.74 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.455 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.855 HD11 ' HB2' ' A' ' 71' ' ' ASP . 0.0 OUTLIER 49.57 -166.16 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.631 -177.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -162.93 92.38 1.2 Allowed Pre-proline 0 C--N 1.31 -1.137 0 C-N-CA 118.952 -1.099 . . . . 0.0 112.351 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.45 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 81.8 Cg_exo -47.39 -33.26 16.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.319 2.013 . . . . 0.0 111.732 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -70.01 -19.41 63.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.54 0.22 56.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.648 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.701 ' HD1' HD13 ' A' ' 48' ' ' LEU . 96.9 m-85 -105.18 100.61 10.19 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.894 0.378 . . . . 0.0 111.459 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -100.17 129.22 46.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.384 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.713 ' CD1' HG11 ' A' ' 46' ' ' VAL . 20.3 m-85 -88.32 87.45 7.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.996 0.426 . . . . 0.0 111.202 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.654 HG21 ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -126.78 104.12 7.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.079 HG13 HD13 ' A' ' 32' ' ' LEU . 95.2 t -73.09 -67.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.644 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 64.8 p -58.29 -20.74 45.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.103 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 87' ' ' GLY . . . 126.33 163.94 11.64 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.307 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.654 ' HA ' HG21 ' A' ' 82' ' ' THR . 0.1 OUTLIER -53.68 89.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.094 0.473 . . . . 0.0 110.788 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 85' ' ' GLY . . . -98.81 89.23 0.9 Allowed Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.732 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 98.8 p -89.45 14.98 10.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.588 0.233 . . . . 0.0 111.208 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.44 30.16 67.68 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.599 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.18 112.93 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.933 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.36 109.82 3.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.503 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.943 -179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.759 0.314 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -150.24 55.02 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.922 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.85 171.45 13.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.4 69.03 9.5 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.845 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.67 -12.07 30.61 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.66 2.24 . . . . 0.0 112.756 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.79 82.09 3.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.841 0.353 . . . . 0.0 111.14 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -129.4 153.7 47.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.87 174.52 7.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.923 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.64 88.63 2.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.02 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m 70.22 76.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.1 tt -86.25 143.36 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 mm -89.22 52.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.785 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.2 mtt85 53.35 -172.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.461 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -51.5 129.89 26.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.791 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.23 134.56 41.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.002 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 162.32 152.88 6.91 Favored Glycine 0 CA--C 1.482 -2.01 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.696 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 88.4 Cg_endo -80.69 -160.19 2.27 Favored 'Cis proline' 0 CA--C 1.53 0.322 0 C-N-CA 124.738 -0.943 . . . . 0.0 112.362 3.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.422 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -165.81 134.48 3.14 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.742 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.633 ' CD1' HD12 ' A' ' 32' ' ' LEU . 1.6 m-30 -94.52 48.34 1.22 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.0 110.184 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 32.3 t70 -175.44 79.84 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.84 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -112.73 85.26 7.36 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.596 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.606 ' HA ' HG23 ' A' ' 29' ' ' THR . 79.9 Cg_endo -89.0 25.96 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.98 2.453 . . . . 0.0 112.78 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 30.9 p -93.9 23.66 4.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.801 0.334 . . . . 0.0 111.264 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.486 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -99.79 -178.26 0.67 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.202 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 74.7 Cg_exo -49.17 179.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.236 1.958 . . . . 0.0 112.18 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -55.5 120.78 7.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.157 -178.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.16 -3.8 50.68 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.818 177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 51.8 m95 -93.75 131.34 39.2 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.118 0.485 . . . . 0.0 111.689 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -132.32 179.92 5.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.645 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' H ' HG22 ' A' ' 29' ' ' THR . 7.1 ttp-105 -139.88 165.53 27.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.225 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -169.83 168.45 8.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.1 167.48 21.72 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.335 0.588 . . . . 0.0 112.399 -178.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 10.7 tttp -147.81 110.73 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.232 178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.5 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 54.4 tt0 -67.77 166.47 15.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.5 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 1.8 ttm180 90.08 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.694 0.798 . . . . 0.0 112.304 177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 176.41 85.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.0 -178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 5.9 m 54.96 -158.71 0.2 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.87 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.83 -21.22 21.82 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.838 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -78.1 -39.63 40.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.377 . . . . 0.0 111.032 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -120.42 33.4 5.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.792 178.46 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -54.4 85.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.106 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 139.02 58.17 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.226 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -138.65 146.91 42.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.8 m-85 -88.6 144.13 26.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -174.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 61.0 m-20 -110.62 172.16 7.03 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 113.892 -1.503 . . . . 0.0 109.519 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 70.6 t -131.64 145.34 35.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.7 m-85 -146.03 105.61 3.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.073 -178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 79' ' ' PHE . 15.3 mt -90.29 107.35 19.09 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 29' ' ' THR . 3.0 mt -82.86 123.26 38.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.979 -1.01 . . . . 0.0 113.112 -172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.485 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 6.3 t-20 -76.05 144.67 75.98 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.704 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 70.5 Cg_exo -37.01 -28.96 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.13 2.553 . . . . 0.0 113.113 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 50' ' ' ASN . 4.3 mm-40 -90.4 30.45 1.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.45 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 55.74 26.25 46.26 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.447 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.509 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -98.74 124.5 43.63 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 120.914 0.388 . . . . 0.0 110.427 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -96.76 138.15 34.76 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.509 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 76.8 m-85 -124.43 126.14 45.44 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.112 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 18.6 mtp180 -96.41 -58.36 2.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.497 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.35 171.9 9.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.92 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.602 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -80.58 -41.72 23.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.176 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 10.9 t -51.79 -31.58 13.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.796 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.41 -29.29 63.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 0.0 110.025 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD22 ' HD3' ' A' ' 59' ' ' LYS . 1.4 tp -66.52 -60.72 2.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.504 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -65.59 -45.92 91.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.17 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.86 -49.01 66.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.118 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 54' ' ' LYS . 2.5 t80 -70.15 -57.65 4.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.115 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' CE2' HD13 ' A' ' 74' ' ' LEU . 20.8 m-30 -46.83 -28.93 1.72 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -72.74 -59.98 2.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.103 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.716 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.17 -23.93 50.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.495 -178.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.716 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.7 m -91.56 -44.18 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 0.0 110.975 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 87.52 51.29 3.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.101 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.574 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.5 t70 -84.9 137.92 32.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.831 0.348 . . . . 0.0 111.103 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.3 p -124.02 22.63 8.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.144 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 87.4 p -128.42 29.76 5.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.601 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.54 174.77 14.48 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.153 179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -158.63 114.13 1.67 Allowed Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.358 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HA ' HD23 ' A' ' 62' ' ' LEU . 93.0 Cg_exo -46.41 -32.71 11.45 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.456 2.104 . . . . 0.0 112.0 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.04 -19.78 63.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.02 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.57 -1.94 58.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.681 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.584 ' HB3' HD13 ' A' ' 48' ' ' LEU . 94.9 m-85 -107.21 110.6 22.69 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.832 0.348 . . . . 0.0 111.085 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.38 131.75 53.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.825 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.489 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 20.3 m-30 -87.5 80.67 8.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.95 0.405 . . . . 0.0 111.09 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.79 118.86 28.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.356 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.699 HG13 HD13 ' A' ' 32' ' ' LEU . 52.2 t -65.65 -74.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.235 -178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.9 p -58.18 -28.26 64.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.3 . . . . 0.0 111.021 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 134.43 -165.36 24.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.726 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -89.84 -148.08 0.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 66.23 44.0 91.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.314 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.82 10.89 21.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.476 0.179 . . . . 0.0 111.465 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.76 81.92 0.07 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.7 t 60.15 125.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.89 0.376 . . . . 0.0 111.147 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -98.37 26.95 21.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.449 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.949 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.806 0.336 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t 60.18 88.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.604 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.48 74.83 0.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.659 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.403 ' CB ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -76.41 -57.62 1.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 4' ' ' SER . 84.6 Cg_endo -80.64 -21.43 7.25 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.61 2.207 . . . . 0.0 112.141 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.81 70.75 10.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -157.72 55.15 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.065 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -97.35 153.02 18.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.083 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.1 mtt85 -135.32 172.58 12.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.858 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 50.9 91.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.9 tp -83.37 140.37 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.483 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.2 mm -94.28 57.45 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 45.07 47.72 9.66 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.997 0.427 . . . . 0.0 110.961 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -97.52 -166.92 1.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.168 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.74 164.33 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.475 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 17' ' ' PRO . . . -170.04 -142.51 3.6 Favored Glycine 0 CA--C 1.49 -1.495 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.766 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 7.8 Cg_exo -69.36 -179.75 19.31 Favored 'Cis proline' 0 N--CA 1.474 0.363 0 C-N-CA 125.097 -0.793 . . . . 0.0 112.085 -3.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.4 mtm -148.28 102.54 3.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.601 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -79.85 -67.64 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.776 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.2 83.63 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.579 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 6.2 m-20 -118.75 85.39 27.57 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.389 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HA ' HG23 ' A' ' 29' ' ' THR . 61.8 Cg_endo -95.66 14.03 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.239 2.626 . . . . 0.0 112.503 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.603 ' O ' HD23 ' A' ' 24' ' ' LEU . 5.0 p -86.16 51.2 2.15 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.787 0.327 . . . . 0.0 111.33 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 23' ' ' THR . 1.1 mt -132.3 179.07 1.47 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.073 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 95.6 Cg_exo -45.14 166.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.362 2.041 . . . . 0.0 112.546 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.49 126.0 5.1 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.847 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.4 -52.66 4.37 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.506 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 61.1 m95 -44.86 142.29 1.84 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.325 0.583 . . . . 0.0 112.323 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -144.85 -169.98 3.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.731 178.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 29' ' ' THR . 43.8 ttp180 -156.9 161.96 39.65 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.861 ' C ' HD23 ' A' ' 32' ' ' LEU . 5.4 ttmt -168.97 160.11 9.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.249 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.045 HD13 HG13 ' A' ' 83' ' ' VAL . 1.6 mt -131.31 163.51 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.169 0.509 . . . . 0.0 111.368 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.24 116.89 12.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.18 -178.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -71.38 167.65 19.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.499 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 42' ' ' GLY . 17.3 ttp85 -153.06 133.32 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 0.0 111.163 -178.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 38' ' ' GLY . 5.9 tptt -87.37 -40.64 14.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.488 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.42 -84.02 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.385 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . 158.77 -24.6 0.35 Allowed Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.988 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -123.66 -49.61 1.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 110.586 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.02 48.67 0.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.085 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.44 177.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.598 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 53.57 23.93 22.32 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.636 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.5 131.91 34.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.0 110.529 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.788 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.8 m-85 -103.68 163.21 12.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.679 0.752 . . . . 0.0 112.977 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.97 140.16 48.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.743 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 81' ' ' PHE . 7.0 p -91.98 148.81 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.047 0.451 . . . . 0.0 111.841 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.3 m-85 -146.19 103.42 3.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.685 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.903 HD13 ' HB3' ' A' ' 79' ' ' PHE . 7.0 mt -92.62 114.44 26.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.5 OUTLIER -87.35 127.05 41.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.804 0.811 . . . . 0.0 113.149 -171.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 54' ' ' LYS . 13.0 t-20 -82.44 135.01 47.25 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.495 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.506 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 85.6 Cg_exo -32.86 -51.7 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.666 2.91 . . . . 0.0 113.631 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -46.94 -26.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.374 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.12 18.14 6.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.332 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.501 ' HG2' ' CE1' ' A' ' 56' ' ' PHE . 3.6 tttt -96.67 147.91 23.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 120.552 0.215 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' LYS . . . -114.97 108.8 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.991 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.501 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.5 m-85 -92.72 124.2 36.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.104 0.478 . . . . 0.0 111.55 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -93.14 -9.45 39.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.416 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.58 176.71 11.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.984 0.421 . . . . 0.0 111.558 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HD2' HD11 ' A' ' 63' ' ' ILE . 2.2 mmtp -79.15 -42.72 25.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.166 -176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 20.2 t -51.85 -35.48 18.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.676 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.41 ' OE1' ' CA ' ' A' ' 61' ' ' GLU . 2.3 mm-40 -72.79 -27.08 61.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.092 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.8 OUTLIER -68.17 -65.45 0.69 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -56.4 -41.17 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.539 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.92 -66.84 0.32 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.484 ' CD2' ' HD3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -57.76 -50.2 74.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.423 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 62' ' ' LEU . 22.4 m-30 -51.79 -29.69 20.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.391 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.2 mm-40 -67.0 -64.58 0.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.399 . . . . 0.0 112.053 -177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.26 -24.68 56.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.6 -177.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 m -90.42 -33.28 5.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.819 0.343 . . . . 0.0 111.324 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 42.69 9.96 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.715 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.539 ' HB3' HD21 ' A' ' 74' ' ' LEU . 1.1 t0 -82.96 121.65 27.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.716 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -127.37 34.25 4.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.118 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.16 25.7 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.828 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.628 HD12 ' N ' ' A' ' 75' ' ' ASP . 0.5 OUTLIER -133.65 -39.51 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.196 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.628 ' N ' HD12 ' A' ' 74' ' ' LEU . 6.8 m-20 60.45 101.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.513 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 85.6 Cg_exo -47.52 -31.29 13.46 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.35 2.033 . . . . 0.0 112.404 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -7.79 43.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.68 -19.46 35.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.614 0.245 . . . . 0.0 110.858 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.903 ' HB3' HD13 ' A' ' 48' ' ' LEU . 63.5 m-85 -96.63 116.47 29.17 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.883 0.373 . . . . 0.0 111.26 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.655 ' O ' HD11 ' A' ' 48' ' ' LEU . 7.4 t0 -103.8 151.46 23.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.555 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.578 ' CE1' HD12 ' A' ' 48' ' ' LEU . 16.9 m-85 -109.18 88.84 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.95 0.405 . . . . 0.0 111.378 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 142.43 44.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.65 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.045 HG13 HD13 ' A' ' 32' ' ' LEU . 94.7 t -114.07 -34.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 39.0 p -95.37 35.13 1.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.18 -174.61 53.64 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.378 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -131.6 -158.98 0.93 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.871 0.367 . . . . 0.0 110.503 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -152.63 -62.85 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.412 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m 55.6 24.57 7.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.327 . . . . 0.0 110.897 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.97 -83.27 1.72 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.481 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.5 p -85.52 74.27 10.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -89.19 -124.72 2.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.492 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.961 -179.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.787 0.327 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 t -90.31 91.21 8.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.951 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.44 71.88 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.042 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.1 p -151.6 88.87 4.21 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -77.42 3.19 6.99 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.696 2.264 . . . . 0.0 112.998 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.86 91.02 5.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.816 0.341 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -128.21 -162.73 1.21 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.644 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mtm105 -73.88 125.64 28.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.971 0.415 . . . . 0.0 111.062 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -96.13 83.26 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.032 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.448 ' C ' HG22 ' A' ' 11' ' ' ILE . 94.2 p -83.81 57.95 4.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.097 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.599 HD11 ' NE ' ' A' ' 15' ' ' ARG . 2.6 tt 47.01 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.261 0.553 . . . . 0.0 111.376 178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.9 mm -90.5 57.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.951 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 mtt85 49.08 60.22 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.898 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -114.75 51.19 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.041 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.599 ' NE ' HD11 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -118.27 141.09 48.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.893 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.44 97.22 0.2 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.968 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.905 ' CB ' HD12 ' A' ' 32' ' ' LEU . 96.7 Cg_endo -76.23 154.23 36.66 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.768 2.312 . . . . 0.0 111.822 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.416 ' CE ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -136.74 -14.84 1.61 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 52.94 46.03 27.6 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.281 0.562 . . . . 0.0 110.0 179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.488 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.8 t0 -137.7 77.68 1.65 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -172.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.806 ' CG ' HG23 ' A' ' 29' ' ' THR . 2.5 m-20 56.09 -96.46 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-O 116.191 -1.861 . . . . 0.0 107.777 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.7 Cg_endo -92.11 -5.0 46.16 Favored 'Cis proline' 0 N--CA 1.492 1.424 0 CA-C-N 123.14 2.157 . . . . 0.0 113.739 -8.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 22' ' ' PRO . 1.7 t -156.43 15.68 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' THR . 5.7 mt -53.27 160.39 1.74 Allowed Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.085 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.5 Cg_exo -44.77 172.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.371 2.048 . . . . 0.0 111.993 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.48 123.24 6.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.696 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.54 -44.22 3.31 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.862 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.536 ' CG ' ' HD3' ' A' ' 51' ' ' PRO . 64.9 m95 -54.05 142.55 24.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.145 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.806 HG23 ' CG ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -143.22 167.77 21.34 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.489 179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 2.0 ptm85 -122.09 153.27 38.9 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.103 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.963 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.3 tttt -151.17 152.06 32.79 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.356 1.66 . . . . 0.0 109.612 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.963 HD23 ' O ' ' A' ' 31' ' ' LYS . 9.7 mt -131.39 157.33 43.72 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.005 0.431 . . . . 0.0 111.405 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.7 115.94 18.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.326 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.2 tt0 -70.21 171.31 9.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.989 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -151.57 143.59 23.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.064 0.459 . . . . 0.0 110.902 -178.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 41' ' ' ALA . 16.4 tptm -137.08 128.82 28.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.98 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.26 -51.19 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.322 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 140.2 45.36 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.215 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.55 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.961 0.41 . . . . 0.0 110.341 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.44 32.98 2.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.936 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . . . -52.57 -170.99 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.571 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 50.86 24.42 8.17 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.961 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.54 133.03 33.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.934 0.397 . . . . 0.0 110.805 -179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.691 ' HB2' HG11 ' A' ' 83' ' ' VAL . 7.1 m-85 -106.69 164.57 11.98 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -133.54 147.37 51.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.362 176.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.63 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.8 p -89.04 146.69 5.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.018 0.437 . . . . 0.0 112.025 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 11.9 m-85 -146.09 101.05 3.47 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.363 178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -91.03 108.22 19.72 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.481 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 3.6 mt -82.23 129.74 36.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.085 -0.961 . . . . 0.0 113.061 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.4 t-20 -83.69 135.99 42.58 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.747 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 77.3 Cg_exo -34.47 -54.68 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.531 2.821 . . . . 0.0 113.261 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -50.35 -32.61 17.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.328 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.526 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HD2' ' CD2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -138.84 129.14 25.64 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.89 0.376 . . . . 0.0 111.126 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -89.76 150.88 22.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.938 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HD3' ' A' ' 54' ' ' LYS . 49.4 m-85 -133.85 131.67 39.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.955 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -105.84 -9.38 17.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.764 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.479 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.26 172.16 18.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.057 0.456 . . . . 0.0 111.384 -178.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.638 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -70.08 -39.74 75.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.728 -177.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 3.2 t -55.29 -44.32 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.203 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.04 -27.5 69.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.419 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.696 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -65.41 -65.17 0.71 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.001 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.638 HD11 ' HD2' ' A' ' 59' ' ' LYS . 4.4 mp -62.94 -42.38 96.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.47 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.48 -47.76 66.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.084 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' CD2' ' HD2' ' A' ' 54' ' ' LYS . 3.0 t80 -72.72 -59.23 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.415 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.014 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.5 m-30 -44.03 -32.61 1.21 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.24 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.6 mm-40 -65.68 -60.96 2.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.934 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.87 -21.13 41.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.125 -178.253 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.934 HG13 ' HD3' ' A' ' 68' ' ' LYS . 20.2 m -95.35 -48.33 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 111.16 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.564 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 106.92 34.54 2.98 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.661 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.677 ' HB3' HD11 ' A' ' 74' ' ' LEU . 2.9 t0 -89.39 142.2 27.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 110.988 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -148.41 25.85 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.03 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.73 31.81 4.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.208 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.014 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -130.31 -32.02 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.559 -178.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.02 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.602 0.239 . . . . 0.0 110.469 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 44.6 Cg_exo -52.06 -35.86 63.32 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.185 1.923 . . . . 0.0 112.279 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.03 -12.09 61.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.537 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -86.67 10.58 15.23 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.508 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.683 ' HB3' HD12 ' A' ' 48' ' ' LEU . 67.8 m-85 -113.18 92.93 4.18 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.742 0.306 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -81.26 134.88 35.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.942 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 33.5 m-85 -96.76 99.44 11.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.07 92.17 2.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 44' ' ' TYR . 60.7 t -54.7 -21.14 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.436 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.2 p -105.9 51.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.53 -141.86 3.32 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.866 -0.607 . . . . 0.0 113.056 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 173.63 162.73 0.16 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.95 0.405 . . . . 0.0 110.168 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -86.44 47.08 3.68 Favored Glycine 0 C--N 1.32 -0.321 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -19.28 44.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.658 0.266 . . . . 0.0 111.024 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -92.82 -84.07 1.53 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.512 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 t 62.59 85.89 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.829 0.347 . . . . 0.0 111.1 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -100.27 -103.29 2.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.631 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.9 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.434 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.822 0.344 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.4 t 61.77 96.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.94 53.71 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.081 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.457 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -163.55 -64.28 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 50.2 Cg_endo -90.08 -36.77 0.74 Allowed 'Cis proline' 0 C--N 1.349 0.582 0 C-N-CA 124.596 -1.002 . . . . 0.0 113.03 -1.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.8 80.76 1.42 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.836 0.351 . . . . 0.0 111.1 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -127.25 123.38 36.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.83 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mtt85 -69.96 165.18 22.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.931 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.7 ttm-85 -121.23 63.46 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.848 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 4.7 m -156.79 91.46 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 48.69 103.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.415 0.626 . . . . 0.0 111.583 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 mm -79.79 70.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.846 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.3 mtm180 59.7 -176.07 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -50.47 121.23 5.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.8 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 140.52 30.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 165.96 146.67 4.9 Favored Glycine 0 CA--C 1.487 -1.704 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.603 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.684 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.6 Cg_endo -78.05 176.91 41.22 Favored 'Cis proline' 0 N--CA 1.475 0.386 0 C-N-CA 125.014 -0.828 . . . . 0.0 112.509 3.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.464 ' HE2' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -145.2 101.75 3.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.737 0.304 . . . . 0.0 111.274 -178.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -91.98 64.25 4.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.517 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 21.5 t70 175.65 72.19 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.625 ' CB ' ' HA ' ' A' ' 22' ' ' PRO 0.254 0.0 OUTLIER 55.69 -94.12 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.475 0 CA-C-O 115.598 -2.144 . . . . 0.0 106.97 -171.659 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HG2' HG22 ' A' ' 23' ' ' THR . 7.7 Cg_endo -96.69 -2.62 32.5 Favored 'Cis proline' 0 N--CA 1.479 0.668 0 CA-C-N 122.772 2.026 . . . . 0.0 113.403 -10.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.658 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -148.55 66.7 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 0.0 111.114 -178.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 30' ' ' ARG . 12.5 mt -116.24 165.36 15.09 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -47.54 170.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.241 0 C-N-CA 122.492 2.128 . . . . 0.0 112.269 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.03 123.22 9.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.819 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.92 -1.71 58.0 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.501 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.467 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 53.5 m95 -99.45 138.52 36.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.318 0.58 . . . . 0.0 112.053 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.545 HG22 ' CA ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -138.43 166.91 23.06 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.631 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.568 ' HB2' HD11 ' A' ' 24' ' ' LEU . 24.3 ttm180 -135.49 154.48 51.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.937 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -159.5 157.51 30.16 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.977 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.937 HD23 ' O ' ' A' ' 31' ' ' LYS . 5.0 mt -131.34 155.56 47.02 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.214 0.53 . . . . 0.0 112.041 -178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.8 OUTLIER -125.57 117.16 22.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.691 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -72.77 171.34 12.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.54 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.417 ' O ' ' CA ' ' A' ' 42' ' ' GLY . 1.2 tpt85 -153.08 152.69 31.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -123.2 108.82 13.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.566 0.698 . . . . 0.0 111.803 -179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 41' ' ' ALA . 1.9 m -134.65 132.4 38.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.122 177.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.74 -26.96 1.23 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.518 -0.849 . . . . 0.0 113.015 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.48 -48.42 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.927 0.394 . . . . 0.0 110.291 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -102.22 47.3 0.9 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.542 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 37' ' ' SER . . . -52.81 96.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.687 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 98.8 43.55 2.63 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.813 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -86.54 136.46 33.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.866 0.365 . . . . 0.0 110.515 179.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.7 m-85 -106.77 163.77 12.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.49 0.662 . . . . 0.0 112.773 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -134.22 144.01 48.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.862 175.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.658 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.7 p -86.31 149.76 4.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.506 -0.478 . . . . 0.0 111.318 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.1 102.54 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.496 HD13 ' HG3' ' A' ' 30' ' ' ARG . 0.7 OUTLIER -92.98 112.72 24.79 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.7 mt -88.49 122.02 39.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.354 -176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 11.7 p-10 -84.66 159.83 57.36 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.41 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 88.2 Cg_exo -40.03 -27.75 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.26 2.64 . . . . 0.0 113.163 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -91.62 32.84 1.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.695 0.283 . . . . 0.0 110.997 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.17 28.21 12.71 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.166 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -99.07 121.4 40.93 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 120.839 0.352 . . . . 0.0 111.059 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -92.06 149.25 21.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.546 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.42 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 68.7 m-85 -147.82 129.69 15.26 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.662 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -103.57 -52.12 3.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 179.297 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.64 177.91 7.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.669 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.53 ' HE2' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.82 -42.89 10.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.641 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 48.3 t -51.89 -29.55 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.897 0.38 . . . . 0.0 110.697 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -72.88 -29.69 63.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.228 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -68.61 -68.32 0.4 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.481 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.616 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.6 mp -54.99 -40.49 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.73 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -54.99 25.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.263 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.873 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -67.45 -58.92 3.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.867 0.365 . . . . 0.0 111.117 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.871 ' CE2' HD13 ' A' ' 74' ' ' LEU . 16.4 m-30 -44.65 -28.38 0.6 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.783 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.0 mm-40 -61.13 -69.8 0.22 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.901 -178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.472 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.68 -16.99 18.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.991 0.424 . . . . 0.0 110.676 177.124 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 65' ' ' TYR . 87.1 t -84.39 -69.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.663 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.32 56.17 0.33 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.758 ' OD2' HD11 ' A' ' 74' ' ' LEU . 4.7 p-10 -74.23 134.9 42.7 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 111.852 -176.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.1 t -149.97 26.13 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.037 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -164.64 45.66 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.871 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.0 OUTLIER -154.53 -35.0 0.1 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.01 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 50.27 102.33 0.03 OUTLIER Pre-proline 0 C--O 1.231 0.117 0 CA-C-O 120.519 0.2 . . . . 0.0 111.35 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 74.9 Cg_exo -43.61 -32.94 4.21 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.386 2.057 . . . . 0.0 112.432 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -68.34 -20.41 64.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.26 -7.68 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.539 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.653 ' CD2' HD21 ' A' ' 62' ' ' LEU . 72.2 m-85 -102.65 97.86 7.99 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 0.0 111.35 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.406 ' OD1' HG23 ' A' ' 82' ' ' THR . 1.1 t70 -91.7 134.04 35.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.727 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.658 ' CD1' HG11 ' A' ' 46' ' ' VAL . 16.6 m-30 -96.08 70.83 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.011 0.434 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.407 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 6.3 p -101.92 -9.53 20.61 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.359 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.807 HG13 HD13 ' A' ' 32' ' ' LEU . 54.6 t 67.59 -58.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.06 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 82' ' ' THR . 73.1 p -83.52 28.25 0.56 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 65.41 168.11 2.06 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.848 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.65 -155.83 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.07 109.12 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.412 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.93 22.14 5.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.715 0.293 . . . . 0.0 111.205 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.82 98.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.426 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.7 m -82.95 142.16 31.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.043 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.25 -154.53 29.88 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.401 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 88.2 m . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.861 179.943 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.943 0.401 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 p -141.91 138.57 32.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.63 154.31 24.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.23 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.02 88.9 4.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.58 -170.05 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.717 2.278 . . . . 0.0 112.628 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mtpp 40.08 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.647 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -138.39 143.54 39.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.033 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -102.49 128.04 49.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.28 176.02 0.2 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.993 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 10.9 t -166.6 38.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.639 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.668 HD11 ' HB2' ' A' ' 13' ' ' ARG . 3.8 tt 50.54 119.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.466 0.706 . . . . 0.0 112.46 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 12' ' ' ILE . 8.0 tp -84.85 48.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.888 176.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.668 ' HB2' HD11 ' A' ' 11' ' ' ILE . 35.5 mtt180 -148.14 92.38 2.03 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.784 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -89.4 98.06 11.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.39 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.23 175.62 7.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.308 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 169.54 83.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.239 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.652 ' CB ' HD12 ' A' ' 32' ' ' LEU . 97.0 Cg_endo -84.18 137.93 7.49 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.888 2.392 . . . . 0.0 111.594 178.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.458 ' C ' ' CG ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -129.05 -18.73 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.13 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.557 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 66.97 -74.15 0.07 Allowed 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.537 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 2.5 m-20 -1.29 76.15 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.691 ' HA ' HG22 ' A' ' 29' ' ' THR 0.251 0.0 OUTLIER 46.35 -93.3 0.0 OUTLIER Pre-proline 0 CA--C 1.494 -1.179 0 CA-C-O 116.677 -1.63 . . . . 0.0 109.666 -179.49 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.821 ' HG2' HG22 ' A' ' 23' ' ' THR . 8.3 Cg_endo -100.84 -2.26 18.28 Favored 'Cis proline' 0 N--CA 1.477 0.532 0 CA-C-N 122.688 1.996 . . . . 0.0 113.452 -5.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.821 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -159.37 82.72 0.76 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.125 -176.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 28' ' ' TRP . 0.1 OUTLIER -126.28 156.33 72.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 120.847 0.356 . . . . 0.0 111.617 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.87 -179.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.857 2.371 . . . . 0.0 112.551 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -56.79 120.86 8.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.425 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.44 -5.73 49.37 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.291 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.513 ' HB3' HD12 ' A' ' 24' ' ' LEU . 59.9 m95 -96.71 143.41 27.67 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.992 0.396 . . . . 0.0 111.15 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.691 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -149.58 172.36 15.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.733 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' CD ' HD21 ' A' ' 24' ' ' LEU . 2.3 mtp180 -132.07 142.17 49.44 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.965 ' O ' HD23 ' A' ' 32' ' ' LEU . 1.4 ttmt -151.71 160.56 43.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.516 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.974 HD13 HG13 ' A' ' 83' ' ' VAL . 10.2 mt -131.88 153.25 50.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.26 0.552 . . . . 0.0 111.901 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -120.33 118.34 30.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.514 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 44' ' ' TYR . 50.1 tt0 -80.15 136.78 36.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.542 0.687 . . . . 0.0 111.3 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.535 ' HA ' ' HE2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.06 88.02 7.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.316 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -29.94 -89.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.026 0.829 . . . . 0.0 111.885 177.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -91.36 -84.3 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.825 0.345 . . . . 0.0 110.194 176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' ARG . . . 72.85 -65.91 1.45 Allowed Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 164.1 -34.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -95.14 -16.25 22.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.936 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 36' ' ' LYS . . . 56.75 128.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.576 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.84 28.3 57.07 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.258 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.2 OUTLIER -87.75 124.67 33.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.012 0.434 . . . . 0.0 111.122 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.61 ' CB ' HG11 ' A' ' 83' ' ' VAL . 10.1 m-85 -97.7 153.07 18.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -129.97 147.04 51.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.461 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.656 ' HA ' HD22 ' A' ' 32' ' ' LEU . 8.2 p -87.47 145.56 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.767 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 13.2 m-85 -146.1 102.14 3.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.086 0.469 . . . . 0.0 111.125 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 79' ' ' PHE . 10.3 mt -92.93 110.38 21.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 29' ' ' THR . 4.3 mt -85.25 125.11 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.047 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.508 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 24.9 p-10 -85.81 153.55 57.9 Favored Pre-proline 0 C--O 1.235 0.334 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.868 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' CG ' ' A' ' 28' ' ' TRP . 87.2 Cg_exo -39.78 -51.97 2.8 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.658 2.905 . . . . 0.0 113.169 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -48.16 -24.66 1.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.982 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.88 49.05 1.19 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.996 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' CD ' ' CZ ' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.94 135.47 31.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 120.862 0.363 . . . . 0.0 111.568 -178.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.767 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -90.07 149.52 22.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.152 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.503 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 96.3 m-85 -130.46 133.86 46.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.02 0.438 . . . . 0.0 111.117 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 6.1 mtp180 -99.32 -60.58 1.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.822 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 24.9 p -88.49 177.11 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.933 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -85.98 -41.33 14.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.922 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 24.9 t -51.98 -28.43 10.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.659 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 1.6 mm-40 -74.88 -32.4 61.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.282 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.588 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -65.35 -61.38 2.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.446 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.593 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.77 -38.06 74.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.497 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.94 -66.14 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.735 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CD1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -57.9 -48.22 80.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.068 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.575 ' CE2' HD13 ' A' ' 74' ' ' LEU . 22.0 m-30 -53.02 -30.36 35.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.799 0.333 . . . . 0.0 111.165 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.4 mm-40 -69.31 -62.83 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.968 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HE2' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.2 -25.57 59.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.702 -177.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 70' ' ' GLY . 11.9 m -86.79 -44.27 16.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.813 0.34 . . . . 0.0 111.153 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.94 43.77 3.48 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.482 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.9 134.89 33.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.971 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 69.7 p -139.83 27.83 2.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.902 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 t -128.07 30.66 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.067 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.616 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -140.0 -41.57 0.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.616 ' H ' HD12 ' A' ' 74' ' ' LEU . 3.4 m-20 64.18 109.04 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.5 Cg_exo -50.59 -31.42 31.67 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.321 2.014 . . . . 0.0 112.176 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.16 -8.62 51.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.505 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -88.18 -13.47 41.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.828 -0.169 . . . . 0.0 111.224 178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.588 ' CD2' HD21 ' A' ' 62' ' ' LEU . 86.0 m-85 -99.0 114.28 26.87 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.804 0.335 . . . . 0.0 111.133 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -104.29 145.51 30.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.01 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.502 ' CD1' HG11 ' A' ' 46' ' ' VAL . 14.4 m-85 -102.73 96.14 6.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.17 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.04 88.43 2.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.906 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.974 HG13 HD13 ' A' ' 32' ' ' LEU . 62.5 t -52.29 -32.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 111.063 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.8 p -90.31 43.76 1.16 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.633 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 41.53 -160.24 0.03 OUTLIER Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.155 -0.545 . . . . 0.0 113.227 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -151.39 -155.27 0.6 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -149.42 66.52 0.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.34 -18.89 54.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.24 . . . . 0.0 111.366 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 60.53 97.81 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.487 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.5 t -152.66 -64.28 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.994 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.1 -150.95 42.91 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.373 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.966 179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 p -142.17 117.68 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.93 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.017 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.0 81.45 0.23 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.92 -167.24 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.567 2.178 . . . . 0.0 112.264 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mttp 41.94 82.47 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.391 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -132.22 -51.06 0.95 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.127 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.31 176.38 0.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.702 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mmt-85 -118.28 115.02 23.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.038 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 t 68.61 71.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.94 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 11' ' ' ILE . 4.4 tt -137.54 108.9 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 12' ' ' ILE . 27.6 mm -94.3 53.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.295 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.27 46.46 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.973 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -134.32 50.04 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.08 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -75.73 -177.06 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.987 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.91 172.22 15.04 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.408 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.523 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 41.9 Cg_endo -66.72 -166.54 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.783 2.322 . . . . 0.0 112.2 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.38 102.79 2.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.32 -73.91 0.13 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -177.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.0 m-20 -62.04 83.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.544 0.211 . . . . 0.0 110.665 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' CB ' ' HB2' ' A' ' 30' ' ' ARG . 2.4 t0 -113.07 88.77 12.69 Favored Pre-proline 0 C--N 1.332 -0.159 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.426 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.517 ' HA ' HG23 ' A' ' 29' ' ' THR . 63.2 Cg_endo -93.3 18.75 0.91 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.194 2.596 . . . . 0.0 112.641 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.5 p -92.82 21.74 5.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.507 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' CD1' ' HG2' ' A' ' 30' ' ' ARG . 16.0 mt -98.63 164.04 17.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.895 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -40.86 167.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.19 2.593 . . . . 0.0 112.597 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.24 126.33 7.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.2 -1.27 56.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.665 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 64.2 m95 -100.85 143.89 30.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 117.349 0.574 . . . . 0.0 112.152 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.517 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -147.72 -178.93 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.008 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.594 ' CD ' HD22 ' A' ' 48' ' ' LEU . 5.3 mtm180 -144.14 170.79 15.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.832 0.348 . . . . 0.0 111.326 178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.704 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.0 ttmt -177.91 159.25 1.35 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.421 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 31' ' ' LYS . 4.5 mt -128.24 173.74 9.87 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.826 0.822 . . . . 0.0 113.015 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.34 106.39 3.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.688 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.13 172.1 8.58 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.831 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.84 125.46 8.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.537 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.517 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 1.3 mmpt? -93.21 -88.69 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.401 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.54 -67.97 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 110.957 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 36' ' ' LYS . . . 154.51 -76.42 0.22 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.0 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 110.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.792 0.33 . . . . 0.0 110.545 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.96 34.81 19.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.405 -178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -52.5 151.58 4.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.124 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.15 24.05 23.23 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.058 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -85.0 136.15 33.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.532 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.701 ' CB ' HG11 ' A' ' 83' ' ' VAL . 30.3 m-85 -106.11 160.51 15.26 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -127.1 142.14 51.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.113 -1.403 . . . . 0.0 108.676 174.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.575 HG11 ' HA ' ' A' ' 81' ' ' PHE . 44.9 t -91.39 148.05 4.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.79 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.9 m-85 -146.05 91.18 2.04 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.85 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.6 mt -93.04 109.82 21.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.323 0.582 . . . . 0.0 109.464 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.519 HG12 ' HB2' ' A' ' 55' ' ' ALA . 10.8 mt -84.77 122.78 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.104 -175.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.4 p-10 -85.61 163.22 45.16 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.361 -178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 50' ' ' ASN . 66.0 Cg_exo -37.79 -29.48 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.248 2.632 . . . . 0.0 113.288 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -91.69 34.54 0.98 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.649 0.262 . . . . 0.0 111.062 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 47.79 25.45 3.54 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.102 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.547 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 51.7 tptt -99.1 121.94 41.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 111.323 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -95.23 147.82 23.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.08 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CZ ' ' CG ' ' A' ' 54' ' ' LYS . 25.3 m-85 -134.04 149.7 51.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.822 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' O ' ' CD2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -133.7 -39.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 8.4 t -85.63 -77.43 0.3 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.968 -176.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 76' ' ' PRO . 0.5 OUTLIER 161.18 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 28.3 t -55.2 -29.09 22.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.16 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -68.7 -33.58 74.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.991 177.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -65.15 -68.38 0.37 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.48 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -54.26 -45.14 67.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.86 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.75 -54.11 38.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.6 -178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -66.27 -53.02 41.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.431 -179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.673 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -53.18 -23.02 7.44 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.069 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.9 mm-40 -71.19 -61.85 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.864 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.703 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -54.68 -26.23 32.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.636 -177.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.703 HG13 ' CD ' ' A' ' 68' ' ' LYS . 9.6 m -91.1 -45.54 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.901 0.382 . . . . 0.0 111.062 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.469 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 95.56 37.27 5.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.294 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.761 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -90.0 146.41 24.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.311 . . . . 0.0 111.033 -179.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.0 t -148.99 18.32 0.98 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.534 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.75 23.52 11.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.037 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -154.48 67.54 0.71 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.695 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER 60.85 -174.25 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.149 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.743 ' HG3' HD12 ' A' ' 62' ' ' LEU . 84.6 Cg_exo -75.83 -158.08 1.56 Allowed 'Cis proline' 0 C--N 1.308 -1.598 0 N-CA-C 115.385 1.264 . . . . 0.0 115.385 17.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.74 20.49 9.25 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.866 -177.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.416 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 2.2 m-20 -146.2 -12.17 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 62' ' ' LEU . 50.3 m-85 -86.76 83.07 7.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 118.028 0.376 . . . . 0.0 110.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.21 98.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.121 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.575 ' HA ' HG11 ' A' ' 46' ' ' VAL . 4.3 m-30 -85.47 52.92 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.076 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 82.1 p -115.2 131.51 56.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.438 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.701 HG11 ' CB ' ' A' ' 44' ' ' TYR . 23.1 m -64.56 -49.23 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.745 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.496 ' N ' HG23 ' A' ' 83' ' ' VAL . 16.8 p -88.18 45.48 1.29 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.131 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 48.27 -150.68 3.08 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.55 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.417 ' N ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -133.72 49.41 2.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.092 0.472 . . . . 0.0 110.805 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -91.64 64.2 2.52 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.555 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 p -82.16 -18.55 42.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.6 0.238 . . . . 0.0 111.219 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.48 103.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.3 m 57.13 61.76 2.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.814 0.34 . . . . 0.0 110.764 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -84.09 178.11 51.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.611 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.941 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.1 m -88.4 -178.32 5.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.948 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.42 76.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 t 65.53 72.47 0.46 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.62 -170.83 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.639 2.226 . . . . 0.0 112.279 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 41.08 79.89 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.509 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -128.92 -165.15 1.47 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.16 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -105.4 -179.56 3.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.84 27.48 8.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.009 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 49.87 43.72 25.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.005 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 11' ' ' ILE . 10.9 tt -92.49 105.85 17.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.9 mm -89.46 69.61 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' ARG . 46.0 mtm180 64.31 -178.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -52.06 90.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.718 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -75.95 156.12 34.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.208 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.09 77.5 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.011 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 12.3 Cg_endo -87.29 179.28 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.008 2.472 . . . . 0.0 112.157 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.501 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -169.19 109.07 0.45 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.215 0.531 . . . . 0.0 110.453 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -78.43 80.22 4.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 39.1 t70 -154.57 64.4 0.67 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.038 -170.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.797 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 1.0 OUTLIER 64.88 -103.39 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -0.993 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.607 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.797 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 Cg_endo -84.04 130.91 16.13 Favored 'Cis proline' 0 N--CA 1.479 0.64 0 CA-C-N 123.617 2.327 . . . . 0.0 113.803 -6.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.524 ' N ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 41.37 84.05 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.954 -1.021 . . . . 0.0 112.131 173.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.955 HD11 ' HG3' ' A' ' 30' ' ' ARG . 8.0 mt -124.53 166.65 18.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.945 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 87.0 Cg_exo -47.45 165.59 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.495 2.13 . . . . 0.0 112.336 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 125.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.234 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.66 -2.7 53.02 Favored Glycine 0 CA--C 1.519 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.0 113.964 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' CE2' ' CZ ' ' A' ' 79' ' ' PHE . 61.5 m95 -100.17 139.94 35.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.366 0.583 . . . . 0.0 112.067 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.877 ' CA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.41 171.64 16.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.19 -179.019 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.955 ' HG3' HD11 ' A' ' 24' ' ' LEU . 14.7 mtm180 -132.62 144.44 50.36 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.573 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -135.16 177.04 8.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.977 -177.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD23 ' O ' ' A' ' 31' ' ' LYS . 15.0 mt -148.74 155.71 41.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.986 0.422 . . . . 0.0 111.254 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.75 118.78 8.79 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.274 -179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.4 tt0 -69.0 166.49 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.164 0.507 . . . . 0.0 110.718 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.505 ' HA ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 88.28 -174.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.801 177.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.19 -88.89 0.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.828 -177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -155.07 -56.99 0.1 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.987 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.31 -40.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.67 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.55 -67.31 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.009 0.433 . . . . 0.0 110.413 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -96.23 43.2 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.236 178.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.96 80.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.771 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.505 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 151.91 55.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.169 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' O ' ' N ' ' A' ' 35' ' ' ARG . 2.8 mtpt -141.0 152.34 44.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.766 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.513 ' CE2' ' HG2' ' A' ' 17' ' ' PRO . 6.5 m-85 -88.71 133.16 34.3 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -104.92 156.28 18.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.566 176.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 83' ' ' VAL . 44.7 t -95.11 147.42 5.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.3 m-85 -147.2 102.37 3.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.797 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.801 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.9 mt -92.79 106.77 18.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.6 mt -82.18 122.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.071 -0.968 . . . . 0.0 113.106 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.493 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 16.6 p-10 -85.95 146.27 42.85 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.307 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -36.0 -48.59 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.451 2.767 . . . . 0.0 113.087 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -46.09 -26.86 0.82 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.89 23.16 6.58 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.109 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.1 tttt -98.99 170.83 8.44 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.49 0.186 . . . . 0.0 110.995 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.82 96.79 3.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.493 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 38.0 m-85 -95.13 122.78 38.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.775 -178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -91.6 -46.09 8.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.149 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.424 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 50.7 p -87.24 165.73 15.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.965 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER -80.22 -36.34 34.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.055 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.42 HG12 ' OG ' ' A' ' 58' ' ' SER . 4.1 p -52.04 -42.34 34.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.16 0.505 . . . . 0.0 110.52 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' CG ' ' OG ' ' A' ' 58' ' ' SER . 2.4 mm-40 -61.12 -32.04 71.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.639 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.1 tp -67.5 -65.54 0.67 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.499 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.405 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.6 mp -58.13 -37.24 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.415 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.81 -70.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.168 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.655 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.89 -38.29 81.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.251 -179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.862 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.8 m-30 -58.6 -28.79 65.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.899 0.381 . . . . 0.0 110.948 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.405 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 4.8 mm-40 -72.47 -60.18 2.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.779 -177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.29 -25.81 59.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.265 -178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.5 m -88.61 -45.07 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.089 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 94.43 42.19 4.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.551 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.618 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.3 t0 -84.06 133.25 34.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.779 0.323 . . . . 0.0 110.846 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.2 p -140.02 25.84 2.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.017 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -126.09 24.66 6.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.862 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -135.23 -40.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.177 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER 64.29 107.65 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.104 179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 72.2 Cg_exo -49.49 -32.53 27.37 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.464 2.11 . . . . 0.0 112.474 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -69.77 -13.98 62.55 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.654 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.02 -9.47 58.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.768 -0.196 . . . . 0.0 111.232 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.801 ' HB3' HD12 ' A' ' 48' ' ' LEU . 78.6 m-85 -100.64 97.25 7.94 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.8 0.333 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.55 140.09 29.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.964 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-30 -94.13 110.61 22.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.915 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -145.67 131.26 18.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.731 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.542 HG23 HG23 ' A' ' 46' ' ' VAL . 77.8 t -96.25 -37.17 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.887 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 p -92.69 42.61 1.1 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.113 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 52.07 -174.46 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.947 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -136.67 -148.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.51 50.85 52.81 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.932 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 p -92.66 34.33 1.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.657 0.265 . . . . 0.0 111.307 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.73 118.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.409 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m 63.34 57.46 1.52 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.859 0.361 . . . . 0.0 110.93 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.23 -133.01 2.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.457 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.984 179.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.77 0.319 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m 60.2 48.07 8.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.783 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.23 164.35 12.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.135 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER 55.98 53.34 7.99 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.192 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 4' ' ' SER . 66.4 Cg_endo -72.42 -19.73 24.83 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.57 2.18 . . . . 0.0 112.233 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -77.32 60.71 2.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -135.64 -72.26 0.46 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.999 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.69 150.38 31.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 45.35 27.57 0.37 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.43 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.435 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.9 p -78.84 59.23 2.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.645 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.2 tt 49.54 106.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.494 0.664 . . . . 0.0 111.674 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.18 58.52 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.886 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 71.15 168.04 0.31 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -47.9 102.98 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.283 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.05 132.71 34.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.968 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.88 -107.57 2.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 74.4 Cg_endo -75.91 178.92 6.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.444 2.096 . . . . 0.0 112.392 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 97.83 2.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.201 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.1 m-30 -67.9 -71.33 0.21 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.311 -178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -55.64 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.936 0.398 . . . . 0.0 110.765 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -129.73 85.42 58.28 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.361 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -92.61 14.86 1.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.16 2.573 . . . . 0.0 112.224 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.435 ' C ' HD23 ' A' ' 24' ' ' LEU . 51.9 p -87.81 49.24 1.77 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.402 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.466 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.1 mt -126.13 -178.42 0.72 Allowed Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.983 178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' CD ' ' CB ' ' A' ' 24' ' ' LEU . 71.7 Cg_exo -48.4 168.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.009 1.806 . . . . 0.0 111.917 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.41 123.99 8.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.953 0.406 . . . . 0.0 110.757 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 51' ' ' PRO . . . 92.08 -64.64 2.33 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.632 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 76.1 m95 -32.47 136.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -177.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.57 175.85 9.23 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.293 -1.322 . . . . 0.0 109.354 176.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.63 ' HG3' HD23 ' A' ' 48' ' ' LEU . 27.4 ttm180 -147.36 156.06 42.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.958 0.409 . . . . 0.0 111.28 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.898 ' O ' HD23 ' A' ' 32' ' ' LEU . 26.3 tttm -166.0 161.32 17.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.333 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.022 HD13 HG13 ' A' ' 83' ' ' VAL . 6.0 mt -129.59 163.25 26.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.897 0.38 . . . . 0.0 111.355 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 7.9 tttt -143.7 118.99 10.19 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.991 -177.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.515 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 53.9 tt0 -80.71 107.16 13.29 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.618 0.723 . . . . 0.0 112.311 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.407 ' CG ' ' O ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER 178.85 -173.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.994 173.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.65 35.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.856 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.31 -94.23 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.156 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.31 -31.26 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.682 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.37 108.92 14.38 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 111.375 -179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 55.48 47.41 21.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.944 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.34 143.34 11.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.829 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.05 67.24 0.84 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -149.62 140.58 22.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.364 0.602 . . . . 0.0 110.536 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 9.3 m-85 -83.56 134.94 34.8 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.516 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -117.66 148.67 41.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.383 177.07 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.707 HG11 ' CD1' ' A' ' 81' ' ' PHE . 5.6 p -90.33 149.29 4.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.007 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.516 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 12.1 m-85 -146.07 95.85 2.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.934 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.63 HD23 ' HG3' ' A' ' 30' ' ' ARG . 11.9 mt -91.61 113.15 25.34 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 4.8 mt -90.58 117.46 33.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.117 -0.947 . . . . 0.0 113.028 -171.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.632 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 6.6 p-10 -96.82 123.52 53.42 Favored Pre-proline 0 CA--C 1.491 -1.321 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.527 ' CB ' ' HA3' ' A' ' 27' ' ' GLY . 4.7 Cg_exo -71.04 -31.97 4.55 Favored 'Cis proline' 0 C--N 1.309 -1.544 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 -26.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.403 ' O ' HG21 ' A' ' 49' ' ' ILE . 19.2 mt-30 -141.61 -27.75 0.66 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.707 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.21 -31.1 6.33 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.172 -1.013 . . . . 0.0 114.389 -173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 56' ' ' PHE . 41.9 tptt -99.15 125.18 44.65 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.137 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' O ' ' CD1' ' A' ' 56' ' ' PHE . . . -105.22 140.98 37.56 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 54' ' ' LYS . 21.9 m-85 -135.07 136.74 42.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.558 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -101.85 -50.63 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.379 178.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 177.56 7.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.201 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HE2' HD23 ' A' ' 62' ' ' LEU . 1.4 tmtp? -85.04 -43.0 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.544 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 t -51.81 -32.43 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.0 110.517 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -68.79 -32.06 71.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.882 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.602 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.7 tp -64.57 -64.88 0.76 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.299 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.443 HG13 ' CG ' ' A' ' 76' ' ' PRO . 3.5 mp -60.83 -33.42 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.887 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.476 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -63.2 -41.38 99.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.98 0.419 . . . . 0.0 110.728 179.152 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.767 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 4.8 m-30 -45.45 -32.35 2.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.6 mm-40 -72.69 -64.13 1.02 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.107 -177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.27 -19.78 23.88 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -177.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.496 HG22 ' C ' ' A' ' 66' ' ' PHE . 23.1 m -86.56 -27.75 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.259 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.37 46.07 6.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.163 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.643 ' OD2' HD11 ' A' ' 74' ' ' LEU . 10.3 p-10 -74.32 133.97 42.55 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 120.772 0.32 . . . . 0.0 111.514 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.1 t -149.98 25.54 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.347 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.93 32.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.767 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -144.29 -46.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.767 0.318 . . . . 0.0 110.865 178.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' N ' HD12 ' A' ' 74' ' ' LEU . 0.5 OUTLIER 63.34 125.99 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.261 178.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' CG ' HG13 ' A' ' 63' ' ' ILE . 53.1 Cg_exo -56.64 -31.07 86.05 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.496 2.131 . . . . 0.0 112.287 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -70.04 -7.82 44.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.644 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -86.5 -7.29 58.52 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.473 0.178 . . . . 0.0 111.406 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.602 ' CD2' HD21 ' A' ' 62' ' ' LEU . 51.4 m-85 -107.58 148.17 29.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 120.905 0.383 . . . . 0.0 111.393 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.29 159.47 41.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.069 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.707 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.4 m-30 -120.72 91.42 3.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 84' ' ' THR . 0.2 OUTLIER -123.0 -10.37 8.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.823 -179.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.022 HG13 HD13 ' A' ' 32' ' ' LEU . 61.4 t 61.33 -81.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.854 0.359 . . . . 0.0 110.485 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 82' ' ' THR . 18.7 p -56.41 -31.21 63.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.714 179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 116.94 -173.66 14.81 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.547 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.44 -154.21 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.58 -62.89 1.02 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.486 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.4 m 59.15 28.47 17.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.78 87.46 0.18 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.536 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 63.0 m -92.46 143.62 26.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.82 0.343 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -143.76 -80.34 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.573 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.02 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.77 0.319 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.56 173.92 11.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.765 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.72 65.26 1.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.349 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.477 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -78.87 -63.75 0.39 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.783 179.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 73.6 Cg_endo -74.71 -12.05 22.12 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.701 2.267 . . . . 0.0 112.755 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -99.0 84.49 3.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.644 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -118.42 -41.8 2.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.158 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.9 159.71 22.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -89.99 -178.4 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.195 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 7.1 t 52.57 42.85 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.994 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.678 HD11 ' HB2' ' A' ' 13' ' ' ARG . 3.9 tt 50.05 119.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.442 0.697 . . . . 0.0 112.488 179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.692 ' O ' HG23 ' A' ' 12' ' ' ILE . 7.6 tp -85.51 49.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.465 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.678 ' HB2' HD11 ' A' ' 11' ' ' ILE . 49.6 mtm180 -154.33 -172.66 4.29 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.482 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -125.5 88.08 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.96 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -163.95 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.74 158.29 31.0 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.55 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HB2' HD12 ' A' ' 32' ' ' LEU . 63.8 Cg_endo -73.59 -165.87 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.723 2.282 . . . . 0.0 112.337 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -161.76 129.36 4.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.216 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -94.79 -68.23 0.81 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.179 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -61.17 81.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.829 0.347 . . . . 0.0 110.823 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 4.2 m-20 -117.97 91.45 39.65 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.209 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.77 13.54 1.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.058 2.505 . . . . 0.0 112.669 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 p -88.53 55.11 3.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.966 0.413 . . . . 0.0 110.887 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 28' ' ' TRP . 17.6 mt -133.27 165.23 38.25 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.582 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 73.1 Cg_exo -38.81 164.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.768 2.312 . . . . 0.0 112.909 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.2 127.11 5.45 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.896 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.34 -54.79 4.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.373 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.573 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 47.6 m95 -41.6 148.63 0.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.433 ' C ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -147.58 -178.41 6.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.837 178.473 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 31' ' ' LYS . 20.9 ttt180 -148.2 159.59 43.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 0.0 111.635 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.6 tttt -174.25 162.85 3.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.526 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.0 mt -131.27 161.34 32.5 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.034 0.445 . . . . 0.0 111.411 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 8.2 tttp -136.18 117.45 14.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.082 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -70.68 171.68 9.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.244 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 41.4 ttm180 -152.62 160.64 43.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.961 0.41 . . . . 0.0 111.367 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.656 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -132.77 114.58 14.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.267 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.0 m -101.33 -20.63 15.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.719 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.91 -32.28 6.08 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.118 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.67 -52.47 2.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.929 0.395 . . . . 0.0 110.115 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.87 36.32 1.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.952 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.656 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -52.56 136.12 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.574 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.54 27.87 4.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.387 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.51 132.99 33.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.975 0.417 . . . . 0.0 110.961 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -106.05 159.46 16.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.671 0.748 . . . . 0.0 112.912 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -129.7 145.84 51.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.47 -1.241 . . . . 0.0 108.778 175.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -90.45 148.94 4.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.958 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 5.5 m-85 -144.87 96.98 2.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.041 0.448 . . . . 0.0 111.04 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.427 HD22 HD11 ' A' ' 24' ' ' LEU . 33.1 mt -92.97 109.77 21.22 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 175.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 4.2 mt -85.8 134.76 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.459 ' OD1' ' CZ2' ' A' ' 28' ' ' TRP . 3.4 t30 -75.22 149.68 84.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.139 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -39.6 -59.45 0.67 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.823 2.348 . . . . 0.0 112.789 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -50.89 -25.1 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.961 0.41 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.86 31.56 2.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -101.01 117.02 34.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 111.614 -178.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.87 140.69 30.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.835 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.508 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 76.7 m-85 -129.17 127.03 40.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.488 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.483 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -52.42 2.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.779 177.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 61' ' ' GLU . 6.1 p -86.07 173.46 9.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.359 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -85.77 -40.28 16.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.955 0.407 . . . . 0.0 110.839 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 64' ' ' ALA . 46.6 t -51.86 -39.84 26.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.688 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -63.23 -28.2 69.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.161 0.505 . . . . 0.0 109.959 177.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.7 tp -70.66 -61.64 1.69 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.777 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -72.79 -57.92 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.477 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 60' ' ' VAL . . . -46.54 -43.8 17.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.316 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' CD1' ' HD2' ' A' ' 68' ' ' LYS . 2.4 t80 -73.01 -59.23 2.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.565 178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.637 ' CE2' HD13 ' A' ' 74' ' ' LEU . 18.8 m-30 -45.61 -35.29 3.95 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.679 0.276 . . . . 0.0 111.283 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 65.3 mt-10 -61.22 -68.12 0.34 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.016 0.436 . . . . 0.0 110.527 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.651 ' CD ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -56.01 -19.73 13.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.71 178.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.651 HG23 ' CD ' ' A' ' 68' ' ' LYS . 7.4 t -86.36 -42.22 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.889 -177.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.66 37.65 10.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.807 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.05 127.78 34.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.704 0.288 . . . . 0.0 110.756 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 p -123.5 28.69 6.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.369 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -131.3 31.64 4.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.982 0.42 . . . . 0.0 110.497 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD13 ' CE2' ' A' ' 66' ' ' PHE . 1.3 pp -154.46 -179.03 7.57 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.451 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -158.62 108.32 1.64 Allowed Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.647 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 80.1 Cg_exo -45.3 -35.47 11.5 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.658 2.239 . . . . 0.0 112.508 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -69.62 -20.0 63.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.867 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -80.45 -9.44 59.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.485 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.573 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 47.8 m-85 -104.85 135.09 46.85 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.948 0.404 . . . . 0.0 111.455 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.06 161.32 27.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.51 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.729 ' CD1' HG11 ' A' ' 46' ' ' VAL . 19.8 m-85 -121.82 88.5 2.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 84' ' ' THR . 1.4 p -119.1 -15.1 9.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.647 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.865 HG13 HD13 ' A' ' 32' ' ' LEU . 54.8 t 63.15 -79.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.563 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' THR . 12.5 p -52.81 -29.15 26.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.019 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.46 176.93 28.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.459 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -154.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.593 0.235 . . . . 0.0 110.521 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.27 92.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.6 p -87.56 -16.99 33.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.61 0.243 . . . . 0.0 111.299 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -93.81 22.34 36.52 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.681 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.6 p -96.11 122.34 38.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.871 0.367 . . . . 0.0 110.94 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.85 -176.48 18.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.518 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.883 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.867 0.365 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 p -137.73 -175.71 4.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.992 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.33 69.57 9.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.169 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -156.76 54.48 0.88 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.47 -76.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.746 2.297 . . . . 0.0 112.136 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 pttt -112.87 30.29 7.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.668 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -126.02 62.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.109 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.76 164.89 12.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.587 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -77.4 121.97 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.92 0.391 . . . . 0.0 111.033 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 11' ' ' ILE . 1.6 t -159.46 42.85 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.918 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 10' ' ' SER . 2.5 tt 51.54 117.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.545 0.688 . . . . 0.0 112.441 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 12' ' ' ILE . 28.5 mm -80.63 59.0 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.838 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 mtt85 63.35 -175.56 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.816 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -56.38 117.4 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.02 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.35 164.56 11.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 159.15 156.19 7.96 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.614 ' CB ' HD12 ' A' ' 32' ' ' LEU . 77.2 Cg_endo -77.26 -167.42 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.826 2.35 . . . . 0.0 112.02 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.61 18.21 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.569 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.0 OUTLIER 36.23 48.39 0.56 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.433 0.635 . . . . 0.0 111.794 176.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 52.6 t0 -132.38 69.91 1.47 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.97 -176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.672 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 7.5 m-20 67.31 -99.41 0.0 OUTLIER Pre-proline 0 CA--C 1.49 -1.334 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -171.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.672 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 26.2 Cg_endo -82.2 153.44 76.82 Favored 'Cis proline' 0 C--N 1.326 -0.639 0 CA-C-N 123.252 2.197 . . . . 0.0 112.93 -13.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.599 ' O ' HD23 ' A' ' 24' ' ' LEU . 2.8 t 45.34 83.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.962 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 29' ' ' THR . 79.5 mt -138.92 154.58 72.84 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.851 0.358 . . . . 0.0 111.725 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.92 -170.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.63 2.22 . . . . 0.0 112.257 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.5 125.45 25.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.088 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.81 -4.35 52.89 Favored Glycine 0 CA--C 1.519 0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.811 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.582 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 83.5 m95 -99.6 138.96 35.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.366 0.583 . . . . 0.0 111.711 -178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.907 ' HA ' HD12 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -149.58 178.73 8.57 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.027 -178.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.882 ' CG ' HD11 ' A' ' 24' ' ' LEU . 10.5 mtm180 -142.44 141.35 32.18 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 172.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.878 ' C ' HD23 ' A' ' 32' ' ' LEU . 11.7 ttmt -140.73 153.3 45.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.11 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.878 HD23 ' C ' ' A' ' 31' ' ' LYS . 4.1 mt -128.43 153.86 46.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.124 0.487 . . . . 0.0 111.636 -178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -128.38 117.37 21.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -71.35 164.55 25.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.231 178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -156.87 153.23 27.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.3 -178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 10.5 tptm -126.47 109.93 12.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.394 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.22 -169.52 1.55 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.497 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.91 35.02 4.43 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.0 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.2 120.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 61.33 46.14 8.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.053 0.454 . . . . 0.0 109.886 -177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.442 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -54.12 179.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.769 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 62.43 36.83 93.69 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.773 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 35' ' ' ARG . 12.3 tttt -87.5 142.52 27.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.277 0.561 . . . . 0.0 111.224 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.593 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.7 m-85 -106.46 153.51 22.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.713 -178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -121.54 143.45 49.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.075 175.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.572 ' HA ' HD22 ' A' ' 32' ' ' LEU . 5.2 p -87.87 148.51 4.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.745 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.0 m-85 -146.92 103.26 3.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.545 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.958 HD22 ' CE1' ' A' ' 81' ' ' PHE . 2.3 mp -89.43 110.63 21.43 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.894 -172.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.501 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 11.2 t-20 -87.27 137.63 32.64 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 113.763 -1.562 . . . . 0.0 111.358 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 82.4 Cg_exo -32.11 -58.56 0.23 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.774 2.982 . . . . 0.0 113.752 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -45.02 -27.72 0.59 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.882 0.373 . . . . 0.0 111.308 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.71 22.67 3.91 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.503 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 tttt -94.35 174.45 7.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.733 0.301 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -142.07 133.96 27.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.359 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CD2' HD22 ' A' ' 62' ' ' LEU . 19.8 m-85 -127.59 127.17 43.42 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.865 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -102.19 6.51 40.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.467 177.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.415 ' OG ' ' HG2' ' A' ' 61' ' ' GLU . 6.4 p -154.15 167.1 30.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 4.2 tptp -74.55 -36.87 63.11 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.169 0.509 . . . . 0.0 111.526 -176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 96.8 t -52.4 -43.6 41.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.828 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG2' ' OG ' ' A' ' 58' ' ' SER . 5.6 mm-40 -65.92 -29.88 70.37 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.992 0.425 . . . . 0.0 110.154 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.725 HD11 ' CE2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.87 -66.14 0.58 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.105 178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -61.58 -40.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.67 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -65.46 0.55 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.582 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.78 ' O ' HG13 ' A' ' 69' ' ' VAL . 3.1 t80 -57.78 -44.34 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.666 179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.906 ' CE2' HD13 ' A' ' 74' ' ' LEU . 8.0 m-30 -55.78 -24.38 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.75 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.431 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.4 mm-40 -73.79 -53.89 9.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.831 0.348 . . . . 0.0 111.836 -177.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.471 ' N ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.78 -18.51 62.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.929 -177.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.3 m -86.32 -43.96 16.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.717 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 93.72 54.0 1.72 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.511 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.743 ' OD2' HD11 ' A' ' 74' ' ' LEU . 35.2 p-10 -74.36 138.02 43.16 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 122.701 0.4 . . . . 0.0 111.852 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.4 p -149.95 22.56 0.87 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.035 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 t -143.47 33.03 1.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.881 0.372 . . . . 0.0 110.702 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.906 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -154.54 -177.31 6.38 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -158.58 101.02 1.67 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.554 -0.459 . . . . 0.0 111.401 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.515 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 99.5 Cg_exo -44.08 -27.76 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.428 2.085 . . . . 0.0 112.107 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.93 -23.06 63.15 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.633 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.46 8.5 24.5 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.087 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' HD11 ' A' ' 62' ' ' LEU . 9.6 m-85 -93.74 124.15 37.54 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.771 0.319 . . . . 0.0 110.754 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.86 116.44 29.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.879 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.958 ' CE1' HD22 ' A' ' 48' ' ' LEU . 8.5 m-85 -88.72 74.46 8.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -102.41 111.41 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 44' ' ' TYR . 92.4 t -79.55 -14.12 13.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.495 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.0 p -121.12 47.73 1.78 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.86 0.362 . . . . 0.0 111.115 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.08 151.05 0.01 OUTLIER Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.59 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.42 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.8 OUTLIER -121.42 -83.88 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.395 0.617 . . . . 0.0 110.712 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.05 93.37 0.03 OUTLIER Glycine 0 C--N 1.311 -0.841 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.552 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -147.17 20.46 1.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 0.0 110.527 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -151.08 44.4 0.67 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.383 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.1 t -89.08 -47.07 8.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.899 0.381 . . . . 0.0 111.079 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.41 -129.18 42.46 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.511 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.832 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.995 0.426 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.21 179.5 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.76 177.18 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -147.82 59.76 4.86 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.621 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.91 -68.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.699 2.266 . . . . 0.0 112.419 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 pttt -108.05 61.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -133.03 108.05 8.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.153 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 mtt85 -80.75 149.05 29.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.615 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.34 167.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -168.77 80.49 0.14 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.139 -179.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.5 tt 48.36 104.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 121.396 0.617 . . . . 0.0 111.522 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.7 mm -77.75 66.68 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.82 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 68.02 162.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.739 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -49.05 162.15 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.108 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.81 164.53 12.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.856 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -171.74 92.2 0.1 OUTLIER Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.012 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.803 ' CB ' HD12 ' A' ' 32' ' ' LEU . 84.0 Cg_endo -77.31 168.91 22.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.854 2.369 . . . . 0.0 111.54 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.492 ' HE3' ' C ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -134.54 -34.47 0.93 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 62.39 18.07 9.99 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -177.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' C ' ' HE3' ' A' ' 18' ' ' MET . 9.4 m-20 -118.72 84.89 2.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -173.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.806 ' HA ' HG22 ' A' ' 29' ' ' THR . 7.1 m-20 44.62 -94.39 0.0 OUTLIER Pre-proline 0 CA--C 1.504 -0.819 0 CA-C-O 116.781 -1.58 . . . . 0.0 109.727 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.718 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 58.6 Cg_endo -77.0 -55.8 0.14 OUTLIER 'Cis proline' 0 N--CA 1.484 0.95 0 CA-C-N 122.908 2.074 . . . . 0.0 113.834 -6.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 22' ' ' PRO . 32.9 p -159.35 78.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.852 0.358 . . . . 0.0 111.034 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.634 HD12 ' CA ' ' A' ' 29' ' ' THR . 0.2 OUTLIER -94.11 -175.54 0.49 Allowed Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.666 179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 74.8 Cg_exo -42.77 165.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.026 1.818 . . . . 0.0 112.508 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.29 125.39 14.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.007 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.79 -0.14 52.39 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.344 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.512 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 62.8 m95 -101.22 127.13 47.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.124 0.487 . . . . 0.0 111.469 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -134.35 172.72 12.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.608 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.801 ' HG3' HD23 ' A' ' 48' ' ' LEU . 11.7 ttm180 -140.17 150.77 44.62 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-O 121.8 0.81 . . . . 0.0 111.6 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.865 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -157.78 160.88 38.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.237 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.126 HD13 HG13 ' A' ' 83' ' ' VAL . 1.3 mt -130.85 169.79 15.28 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.9 tttt -147.91 114.14 5.88 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.421 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.1 tt0 -71.86 165.84 23.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.914 0.388 . . . . 0.0 110.756 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.502 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 88.84 -177.8 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.554 0.742 . . . . 0.0 112.383 177.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG2' ' HB2' ' A' ' 43' ' ' LYS . 1.7 mmtt -153.22 -88.24 0.06 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.78 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 6.3 m -155.12 -159.62 0.96 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.016 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -50.98 -31.44 25.13 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.126 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.59 149.42 39.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.712 0.292 . . . . 0.0 110.258 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.81 23.47 11.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.819 0.342 . . . . 0.0 110.393 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -60.5 99.33 0.08 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.18 0.514 . . . . 0.0 111.263 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 139.23 59.68 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.825 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -141.3 147.83 38.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.919 0.39 . . . . 0.0 110.231 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.694 ' HB3' HG11 ' A' ' 83' ' ' VAL . 7.2 m-85 -89.77 141.51 28.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -174.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.16 137.21 54.96 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.341 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.635 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.8 p -85.85 154.7 3.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.617 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 12.5 m-85 -145.08 100.88 3.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.969 0.414 . . . . 0.0 110.377 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.801 HD23 ' HG3' ' A' ' 30' ' ' ARG . 41.9 mt -92.51 104.88 17.15 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 29' ' ' THR . 8.4 mt -82.37 126.39 39.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.619 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 30.8 p-10 -85.59 148.51 49.27 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.394 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -33.8 -54.55 0.47 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.764 2.976 . . . . 0.0 113.433 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -44.85 -27.1 0.48 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.398 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.37 49.32 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.047 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.41 132.43 27.82 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.017 0.437 . . . . 0.0 111.129 -178.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.614 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.75 137.68 32.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.488 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 60.1 m-85 -122.17 121.58 37.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 5.0 mtm180 -89.92 -56.58 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.23 173.54 8.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.166 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.511 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -81.95 -38.69 24.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.414 -179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 61' ' ' GLU . 10.7 p -51.79 -43.17 33.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.351 0.596 . . . . 0.0 110.217 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.2 mt-10 -60.92 -28.46 68.95 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.31 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.4 tp -70.42 -63.08 1.16 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.387 179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.434 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -62.27 -36.53 75.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.584 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.83 -72.17 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.662 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.727 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.74 -42.93 84.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.655 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.649 ' CE2' HD13 ' A' ' 74' ' ' LEU . 7.4 m-30 -52.07 -31.49 30.57 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.178 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.6 mm-40 -74.24 -59.56 2.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.745 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -61.83 -23.63 66.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.737 -178.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 ' O ' ' A' ' 65' ' ' TYR . 7.1 m -86.46 -31.94 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.829 0.347 . . . . 0.0 111.35 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.73 45.54 43.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.698 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -79.31 128.92 33.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.871 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 t -119.36 20.08 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -125.85 26.52 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.055 0.455 . . . . 0.0 110.656 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD11 ' HB3' ' A' ' 71' ' ' ASP . 0.8 OUTLIER -154.53 175.9 13.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.671 179.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -158.57 129.19 3.58 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.436 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HA ' HD23 ' A' ' 62' ' ' LEU . 51.4 Cg_exo -55.13 -36.32 92.78 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.427 2.085 . . . . 0.0 112.136 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -70.0 -18.09 63.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.996 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.95 -4.2 59.15 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.515 178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' CB ' HD21 ' A' ' 62' ' ' LEU . 87.3 m-85 -107.66 85.36 2.11 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 120.813 0.339 . . . . 0.0 111.016 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -80.38 128.75 33.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.635 ' CD1' HG11 ' A' ' 46' ' ' VAL . 9.0 m-85 -84.04 90.56 7.46 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.839 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.38 88.71 2.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.796 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.126 HG13 HD13 ' A' ' 32' ' ' LEU . 88.3 t -47.09 -27.64 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.076 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 14.7 p -91.96 43.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.875 0.369 . . . . 0.0 111.051 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.98 -156.96 0.1 Allowed Glycine 0 C--N 1.333 0.404 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.894 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -131.64 -150.52 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 64.62 48.33 74.05 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.931 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.85 29.73 1.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.653 0.263 . . . . 0.0 111.334 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -152.51 66.15 0.34 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.587 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.2 83.17 6.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.804 0.335 . . . . 0.0 110.964 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.78 -127.97 46.54 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.24 -0.885 . . . . 0.0 110.846 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.843 0.354 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t 59.83 163.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.57 144.13 19.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.035 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.83 77.47 1.88 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.801 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.0 -24.39 12.87 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.673 2.249 . . . . 0.0 112.646 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -97.84 88.24 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.068 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -125.36 18.57 8.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.23 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 161.05 13.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.717 0.294 . . . . 0.0 110.895 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.44 113.76 8.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.96 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.2 m 57.94 31.37 20.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.746 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 14' ' ' ASP . 2.6 tt 47.29 99.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.426 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.4 mm -78.61 69.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.1 mtt85 60.06 78.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.75 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB2' HG13 ' A' ' 11' ' ' ILE . 5.0 t0 -124.97 -162.59 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.224 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -37.17 156.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.384 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 17' ' ' PRO . . . -136.47 -136.08 3.49 Favored Glycine 0 CA--C 1.488 -1.622 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.349 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.428 ' HA ' ' HA3' ' A' ' 16' ' ' GLY . 60.8 Cg_endo -70.24 -174.07 9.61 Favored 'Cis proline' 0 N--CA 1.48 0.686 0 C-N-CA 125.229 -0.738 . . . . 0.0 112.395 -1.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.83 94.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.551 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.528 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.2 m-30 -67.26 -70.55 0.25 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.129 -178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.27 89.98 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.081 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB3' ' CG ' ' A' ' 30' ' ' ARG . 6.4 t0 -118.93 83.86 24.44 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.808 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -102.17 21.58 0.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.649 2.899 . . . . 0.0 113.018 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 66.7 p -81.54 -33.35 31.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.894 0.378 . . . . 0.0 111.235 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 30' ' ' ARG . 16.6 mt -41.87 160.41 0.17 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.573 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 67.4 Cg_exo -40.33 162.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.652 2.235 . . . . 0.0 112.317 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.89 136.62 2.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.083 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 51' ' ' PRO . . . 90.48 -45.8 2.96 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.266 -0.968 . . . . 0.0 112.73 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.63 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 63.2 m95 -68.92 149.1 49.25 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -149.56 -179.65 7.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.58 175.106 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.739 ' HG2' HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -155.13 169.7 23.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.927 0.394 . . . . 0.0 110.728 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 32' ' ' LEU . 9.2 ttmt -170.42 162.25 8.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.267 -179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.991 HD13 HG13 ' A' ' 83' ' ' VAL . 5.7 mt -131.26 157.09 44.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.853 0.358 . . . . 0.0 110.958 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.6 OUTLIER -139.29 124.66 19.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.621 -178.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 59.0 tt0 -74.94 166.71 23.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.065 0.46 . . . . 0.0 110.707 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.1 OUTLIER 86.69 -178.22 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.977 178.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 37' ' ' SER . 0.5 OUTLIER -165.49 -82.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.42 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.858 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 35.8 t -155.12 -162.98 1.45 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.057 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' N ' ' OG ' ' A' ' 37' ' ' SER . . . -61.64 -23.37 62.88 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.283 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -104.59 121.78 44.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 110.737 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.7 m 60.79 31.43 20.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -53.64 114.27 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' CA ' ' HA ' ' A' ' 35' ' ' ARG . . . 128.19 59.98 0.12 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -140.65 152.33 45.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.795 0.331 . . . . 0.0 110.465 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.611 ' CB ' HG11 ' A' ' 83' ' ' VAL . 7.3 m-85 -90.87 142.07 28.15 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.775 0.658 . . . . 0.0 112.775 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.3 OUTLIER -118.83 148.95 42.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.644 177.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.546 HG11 ' CD1' ' A' ' 81' ' ' PHE . 6.7 p -91.42 148.9 4.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.378 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 10.9 m-85 -146.11 103.25 3.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.972 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD22 ' CE1' ' A' ' 81' ' ' PHE . 0.6 OUTLIER -91.89 116.81 29.23 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' O ' ' CE3' ' A' ' 28' ' ' TRP . 0.6 OUTLIER -91.2 138.79 18.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.423 -175.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.63 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -154.32 148.72 19.37 Favored Pre-proline 0 CA--C 1.484 -1.571 0 N-CA-C 116.183 1.919 . . . . 0.0 116.183 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -96.39 30.27 14.1 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 N-CA-C 108.305 -1.46 . . . . 0.0 108.305 -25.415 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 51' ' ' PRO . 48.3 mt-30 -157.02 -44.26 0.07 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.904 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.91 10.04 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 119.906 -1.14 . . . . 0.0 115.285 -179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HG3' ' CE2' ' A' ' 65' ' ' TYR . 1.3 tmtt? -92.04 115.34 27.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 119.759 1.779 . . . . 0.0 110.42 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -92.01 154.21 18.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.251 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 54' ' ' LYS . 42.1 m-85 -150.55 136.02 18.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 1.5 mtm-85 -97.61 -57.16 2.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.176 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 83.5 p -87.56 171.46 10.48 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.381 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 63' ' ' ILE . 7.3 tptp -81.24 -38.0 27.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.369 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 4.6 p -51.81 -42.12 31.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.55 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.0 -33.2 73.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.751 179.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.3 tp -66.49 -61.01 2.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.469 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.8 mp -62.96 -36.08 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.496 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.88 -62.91 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.989 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.558 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.16 -53.08 61.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.257 -179.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.507 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 21.6 m-30 -50.13 -25.02 3.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.821 -178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.5 mm-40 -71.08 -63.6 1.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.695 -178.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -23.23 65.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.826 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 65' ' ' TYR . 5.2 m -86.56 -38.33 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.84 0.353 . . . . 0.0 111.137 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.47 46.99 8.4 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.158 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' CG ' HD21 ' A' ' 74' ' ' LEU . 1.2 t0 -74.56 135.86 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 t -127.88 23.64 6.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.252 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.84 24.04 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.892 0.377 . . . . 0.0 110.883 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 71' ' ' ASP . 1.1 pp -154.5 178.26 10.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.668 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -158.64 117.8 1.77 Allowed Pre-proline 0 C--N 1.323 -0.549 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.491 -178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 62' ' ' LEU . 88.9 Cg_exo -46.3 -33.03 11.53 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.381 2.054 . . . . 0.0 112.051 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.01 -19.13 63.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.058 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.84 11.21 18.52 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.451 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.859 ' HB3' HD23 ' A' ' 48' ' ' LEU . 17.7 m-85 -130.34 72.1 1.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.985 0.421 . . . . 0.0 111.761 -176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 162.0 29.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.457 178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.862 ' CE1' HD22 ' A' ' 48' ' ' LEU . 15.5 m-85 -115.68 124.59 51.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.138 0.494 . . . . 0.0 111.753 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.56 HG21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -164.29 93.87 0.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.673 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.991 HG13 HD13 ' A' ' 32' ' ' LEU . 90.6 t -50.94 -28.73 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.698 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 4.7 p -109.91 31.34 5.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.237 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.05 170.84 0.11 Allowed Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' HB3' HG21 ' A' ' 82' ' ' THR . 0.0 OUTLIER -140.55 -154.25 0.51 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -158.91 -112.23 0.32 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.582 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t 57.69 21.03 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 0.0 111.197 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 57.65 22.93 48.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 m 63.23 122.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.92 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.19 -130.87 2.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.498 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.975 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.854 0.359 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.46 94.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.95 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.71 120.06 11.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -162.35 -66.27 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.137 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 55.7 Cg_endo -68.81 -22.2 37.12 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.463 2.109 . . . . 0.0 112.245 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -122.34 93.86 4.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.96 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -116.41 -44.64 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.68 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -92.82 146.52 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.757 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -88.68 113.65 24.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.066 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.74 65.68 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.584 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.6 tp -83.31 139.95 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.556 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 12' ' ' ILE . 20.9 mm -93.86 50.03 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.505 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 72.76 130.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -58.26 107.3 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.005 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.22 113.44 22.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.822 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.75 142.1 4.9 Favored Glycine 0 CA--C 1.486 -1.779 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.402 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.562 ' HB3' HD13 ' A' ' 32' ' ' LEU . 2.7 Cg_endo -83.39 179.37 25.56 Favored 'Cis proline' 0 N--CA 1.472 0.21 0 C-N-CA 125.606 -0.581 . . . . 0.0 112.044 2.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.545 ' HE1' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -156.42 97.88 1.79 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.33 -179.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.63 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -70.71 68.39 0.4 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 176.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.5 ' O ' ' CA ' ' A' ' 22' ' ' PRO . 28.3 t70 -156.7 85.93 0.98 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.943 -171.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' ' C ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 34.95 -88.98 0.0 OUTLIER Pre-proline 0 CA--C 1.498 -1.028 0 CA-C-O 117.401 -1.285 . . . . 0.0 111.429 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.764 ' HG2' HG22 ' A' ' 23' ' ' THR . 15.1 Cg_endo -94.44 1.46 49.64 Favored 'Cis proline' 0 N--CA 1.486 1.065 0 CA-C-N 121.851 1.697 . . . . 0.0 113.74 -2.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.764 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -159.25 -83.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.883 -179.856 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD21 HH22 ' A' ' 30' ' ' ARG . 36.8 mt 59.42 163.3 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.339 176.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.38 -179.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.07 2.513 . . . . 0.0 112.78 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.45 122.69 16.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.753 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.16 -1.92 53.82 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.55 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.544 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 58.0 m95 -98.83 140.51 32.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.186 0.517 . . . . 0.0 111.619 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -143.55 166.36 25.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.399 -178.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.706 HH22 HD21 ' A' ' 24' ' ' LEU . 24.1 ttm105 -136.17 154.48 50.94 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.288 0.566 . . . . 0.0 110.466 175.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -162.99 164.33 25.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.773 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.669 HD22 HG13 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -133.44 167.52 20.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.483 0.658 . . . . 0.0 112.697 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -147.8 112.04 5.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.184 178.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 45.5 tt0 -63.82 166.38 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.458 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.449 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 47.1 ttm-85 -153.05 164.35 38.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.815 -178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.864 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -112.08 -76.76 0.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.885 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.54 -65.13 0.24 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.655 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.58 -80.5 0.2 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.842 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.69 111.69 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.06 48.61 8.35 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.864 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -52.54 152.56 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.599 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 89.13 32.71 10.3 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.03 -179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 140.82 29.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.046 0.451 . . . . 0.0 111.064 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.539 ' HE2' ' HH ' ' A' ' 19' ' ' TYR . 5.2 m-85 -99.23 150.93 21.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.561 -178.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -116.9 142.11 47.37 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.546 176.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.568 HG23 HG22 ' A' ' 83' ' ' VAL . 65.5 t -85.12 152.03 3.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.894 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 15.7 m-85 -146.14 90.6 1.98 Allowed 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 79' ' ' PHE . 9.6 mt -91.22 103.36 16.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.454 ' N ' ' O ' ' A' ' 29' ' ' THR . 12.6 mt -82.37 117.24 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.655 -175.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.497 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 36.7 p-10 -84.61 152.88 60.93 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.484 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -34.97 -56.15 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.732 2.955 . . . . 0.0 113.447 -178.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -44.65 -27.02 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.26 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.58 49.07 1.06 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.037 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.526 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -140.97 132.02 26.23 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 120.962 0.41 . . . . 0.0 111.479 -178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -84.82 144.3 28.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.783 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.526 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 55.9 m-85 -132.5 126.25 32.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.89 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.491 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 19.4 mtm180 -100.92 -52.82 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.262 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.89 171.78 10.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.909 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -81.81 -39.77 23.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.299 -179.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 9.3 p -51.78 -42.22 31.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.307 0.575 . . . . 0.0 110.21 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' N ' HG13 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -61.02 -29.34 69.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.384 178.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -70.4 -67.29 0.51 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.482 179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.59 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -58.22 -37.67 64.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.611 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.74 -58.5 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.859 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.64 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -66.25 -46.37 77.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.711 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.629 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 18.9 m-85 -52.08 -26.13 10.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.974 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.6 mm-40 -72.4 -62.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.772 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -24.09 63.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.698 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 65' ' ' TYR . 4.3 m -86.64 -37.56 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 0.0 111.689 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.14 48.61 9.45 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.047 -178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.64 -74.62 0.19 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.927 0.87 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p 60.19 18.63 8.02 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 113.987 -1.46 . . . . 0.0 111.546 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -120.05 25.92 9.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.629 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -138.72 -36.6 0.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.6 -178.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 68.97 105.08 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-O 120.651 0.263 . . . . 0.0 110.603 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 53.1 Cg_exo -51.69 -34.46 53.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.344 2.03 . . . . 0.0 112.344 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.12 -8.9 49.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.413 -178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -83.19 -9.51 59.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.903 177.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.621 ' CD2' HD21 ' A' ' 62' ' ' LEU . 52.6 m-85 -107.26 116.43 31.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.759 0.314 . . . . 0.0 110.554 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.99 146.88 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.976 0.417 . . . . 0.0 111.186 -179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.491 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 22.1 m-30 -100.91 85.65 2.91 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.941 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.404 ' O ' ' HB ' ' A' ' 83' ' ' VAL . 23.4 p -101.95 -16.22 16.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.452 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.669 HG13 HD22 ' A' ' 32' ' ' LEU . 53.5 t 67.62 -61.02 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.367 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 79.9 p -73.36 -2.33 21.77 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.1 169.82 18.29 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.642 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -158.86 0.68 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.946 0.403 . . . . 0.0 110.559 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.33 -83.86 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.431 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.1 m 59.3 22.63 10.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 0.0 111.095 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.04 -31.64 6.5 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.488 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.78 -51.48 5.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -147.7 -155.6 6.67 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.527 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 28.7 p . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.948 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.65 123.46 33.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.95 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.04 60.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.7 t 54.73 68.53 2.57 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.005 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.63 -30.11 15.19 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.215 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' O ' ' CG ' ' A' ' 7' ' ' GLN . 64.5 mmtt -99.0 -167.9 1.55 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.437 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 13.1 pt20 43.42 80.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.823 0.344 . . . . 0.0 111.301 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.7 mtt85 -60.47 160.93 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.21 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -128.3 30.56 5.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.026 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 23.3 t -85.23 52.05 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.4 tt 48.1 101.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-O 121.328 0.585 . . . . 0.0 111.484 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -83.66 57.17 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.166 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 53.06 70.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -127.14 50.13 2.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.78 122.34 44.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.202 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 17' ' ' PRO . . . 118.74 92.06 1.45 Allowed Glycine 0 CA--C 1.485 -1.798 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.417 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.404 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 63.2 Cg_endo -69.5 178.93 23.12 Favored 'Cis proline' 0 N--CA 1.481 0.768 0 C-N-CA 125.034 -0.819 . . . . 0.0 112.291 -3.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 102.03 2.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.48 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 1.0 OUTLIER -76.83 -69.36 0.52 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.199 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.55 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.437 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -115.49 89.71 23.11 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.543 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -93.48 18.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.094 2.529 . . . . 0.0 112.835 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 71.3 p -92.8 43.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.034 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.561 HD11 ' HG2' ' A' ' 30' ' ' ARG . 11.2 mt -123.02 166.57 17.42 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.312 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 96.0 Cg_exo -45.34 173.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.786 2.324 . . . . 0.0 112.752 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.0 125.84 18.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.915 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.49 -2.8 51.75 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.974 -0.631 . . . . 0.0 113.694 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.517 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 50.8 m95 -99.02 139.03 35.27 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.22 0.533 . . . . 0.0 111.948 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -144.19 -179.66 6.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.814 178.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.561 ' HG2' HD11 ' A' ' 24' ' ' LEU . 1.2 mtp180 -145.85 163.73 34.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.937 0.399 . . . . 0.0 111.401 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.894 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.9 ttmt -170.07 158.36 6.99 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.129 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.061 HD13 HG13 ' A' ' 83' ' ' VAL . 3.4 mt -131.29 155.96 46.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 111.496 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -129.57 120.41 25.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.154 -178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.0 tt0 -74.41 171.26 14.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 3.7 ttm180 -151.91 124.24 8.25 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.945 0.402 . . . . 0.0 110.801 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' HE2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -90.63 -78.1 0.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.322 0.582 . . . . 0.0 111.431 -179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.99 -67.09 0.2 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.954 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 145.06 -28.68 1.84 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.451 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -62.02 1.47 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.973 0.416 . . . . 0.0 110.321 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.15 41.02 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.21 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB1' ' HE2' ' A' ' 36' ' ' LYS . . . -52.56 114.97 1.55 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.479 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.53 20.23 7.88 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.348 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 tmmp? -87.58 132.39 34.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 0.0 111.063 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.512 ' CB ' HG11 ' A' ' 83' ' ' VAL . 6.9 m-85 -107.84 163.66 12.92 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -135.09 144.0 46.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.281 177.108 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.4 p -88.0 149.51 4.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.899 0.381 . . . . 0.0 111.78 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.545 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 10.6 m-85 -146.06 97.32 2.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.255 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 79' ' ' PHE . 5.8 mt -93.01 109.27 20.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 8.4 mt -83.81 123.74 39.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.649 -174.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.517 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 32.4 p-10 -85.65 152.99 57.97 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.771 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -36.19 -54.74 0.83 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.741 2.96 . . . . 0.0 113.161 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.34 -26.53 0.54 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.34 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 48.85 1.17 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.799 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -140.86 135.27 31.19 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.354 -178.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -87.66 134.88 33.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -115.51 123.21 47.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -104.33 -4.4 22.96 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.36 177.47 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.822 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 59' ' ' LYS . 1.3 mmtp -78.84 -45.08 21.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.906 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 29.2 t -51.85 -31.42 13.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.219 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -30.87 59.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.883 176.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.885 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -63.32 -66.17 0.58 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.425 178.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -59.96 -41.94 87.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.0 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.78 -67.53 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.49 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.587 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -57.72 -54.71 43.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.18 -178.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -46.58 -31.5 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.734 0.302 . . . . 0.0 111.732 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 2.8 mm-40 -67.82 -66.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.71 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -25.6 59.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.638 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 65' ' ' TYR . 3.3 m -88.38 -30.79 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 111.254 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.71 81.66 0.52 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.682 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.659 ' OD2' HD11 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -149.91 126.9 11.18 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.73 0.3 . . . . 0.0 110.889 -177.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 t -132.38 20.37 4.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.358 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.76 22.14 15.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.748 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD12 ' H ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -154.58 65.48 0.68 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.709 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 0.5 OUTLIER 61.07 -173.87 0.03 OUTLIER Pre-proline 0 CA--C 1.495 -1.146 0 C-N-CA 118.512 -1.275 . . . . 0.0 107.752 -179.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.69 ' HG3' HD12 ' A' ' 62' ' ' LEU . 80.8 Cg_exo -75.73 -157.68 1.46 Allowed 'Cis proline' 0 C--N 1.312 -1.381 0 N-CA-C 115.277 1.222 . . . . 0.0 115.277 17.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.81 19.67 9.86 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.694 -176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.413 ' CB ' ' OD1' ' A' ' 75' ' ' ASP . 0.8 OUTLIER -145.59 -5.17 0.65 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.077 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.885 ' CD2' HD11 ' A' ' 62' ' ' LEU . 50.7 m-85 -97.57 90.94 5.2 Favored 'General case' 0 C--N 1.333 -0.149 0 O-C-N 122.229 -0.294 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.39 119.24 11.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.817 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.525 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -89.46 69.47 7.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.3 107.61 16.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.955 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.061 HG13 HD13 ' A' ' 32' ' ' LEU . 93.8 t -59.8 -38.79 77.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.392 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.8 p -104.38 32.6 3.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.791 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.08 -171.46 2.01 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -123.89 43.83 2.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.101 0.477 . . . . 0.0 110.996 179.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -91.85 21.47 36.32 Favored Glycine 0 C--N 1.32 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.479 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.85 21.46 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.164 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.81 -49.61 1.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.357 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.41 -38.64 12.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 0.0 110.802 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.26 -75.09 1.19 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.488 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.898 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.839 0.352 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HB3' ' HB3' ' A' ' 8' ' ' ARG . 0.4 OUTLIER -139.86 36.46 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.022 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 5' ' ' PRO . . . -106.55 116.62 32.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.6 p -163.61 58.14 0.68 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.95 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' O ' ' HB1' ' A' ' 3' ' ' ALA . 19.0 Cg_endo -93.38 -65.42 0.02 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.618 0 C-N-CA 124.366 -1.097 . . . . 0.0 112.577 2.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.04 78.12 1.53 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.886 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -108.59 -67.6 0.96 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.745 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER -81.35 142.13 33.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.716 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 145.6 41.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.06 44.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.185 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.8 tt -95.82 138.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.942 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.9 mm -84.28 60.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.665 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 61.9 156.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.608 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -56.71 99.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.131 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.98 168.09 9.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.749 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.58 169.98 11.77 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.943 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.718 ' HB2' HD12 ' A' ' 32' ' ' LEU . 47.1 Cg_endo -68.72 -164.96 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.806 2.337 . . . . 0.0 112.373 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.402 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -161.49 135.69 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.358 179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CA ' ' HG3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -112.98 56.29 0.68 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -178.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.4 t0 -178.24 67.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.589 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.87 85.85 12.42 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.337 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.658 ' HA ' HG23 ' A' ' 29' ' ' THR . 68.8 Cg_endo -96.15 18.1 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.273 2.649 . . . . 0.0 112.63 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.4 p -83.11 -20.16 35.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.409 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD12 ' C ' ' A' ' 29' ' ' THR . 51.2 mt -48.46 162.18 0.36 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.9 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 65.7 Cg_exo -38.37 161.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.707 2.272 . . . . 0.0 112.72 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.72 129.57 5.5 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . 90.91 -44.78 2.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.485 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.631 ' CZ3' ' HB3' ' A' ' 50' ' ' ASN . 62.7 m95 -68.95 150.44 47.72 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -149.57 179.64 7.82 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.295 176.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 48' ' ' LEU . 58.2 ttp180 -153.29 163.06 40.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.913 0.387 . . . . 0.0 111.36 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.92 ' O ' HD23 ' A' ' 32' ' ' LEU . 29.9 ttpt -174.68 164.95 3.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.653 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.92 HD23 ' O ' ' A' ' 31' ' ' LYS . 6.1 mt -131.38 161.11 33.17 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.919 0.39 . . . . 0.0 111.474 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -138.51 120.87 15.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.405 -178.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 50.5 tt0 -67.91 172.85 5.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.813 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -150.36 136.0 18.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 111.337 -178.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.852 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -138.69 117.28 12.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.355 179.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.96 20.03 1.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.584 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.54 59.34 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.959 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.72 116.47 18.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.766 0.317 . . . . 0.0 110.569 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.54 39.1 28.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.077 0.465 . . . . 0.0 110.014 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.852 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -54.53 151.06 8.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.783 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.18 21.1 50.72 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.342 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.61 134.79 33.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 110.854 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.699 ' HB2' HG11 ' A' ' 83' ' ' VAL . 5.3 m-85 -101.7 164.03 11.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.554 0.692 . . . . 0.0 112.64 -178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -133.39 146.7 51.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.204 177.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.533 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.8 p -86.86 146.79 5.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.704 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 4.9 m-85 -142.84 95.97 2.86 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.027 0.441 . . . . 0.0 110.954 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.692 HD11 ' O ' ' A' ' 80' ' ' ASP . 7.7 mt -92.89 110.44 21.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 23.0 mt -86.29 141.35 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.515 -176.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.631 ' HB3' ' CZ3' ' A' ' 28' ' ' TRP . 1.6 p-10 -153.3 145.64 17.16 Favored Pre-proline 0 CA--C 1.482 -1.645 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HB2' ' HA3' ' A' ' 27' ' ' GLY . 7.2 Cg_endo -93.9 24.04 25.61 Favored 'Cis proline' 0 N--CA 1.455 -0.737 0 N-CA-C 108.851 -1.25 . . . . 0.0 108.851 -24.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -154.34 -43.72 0.09 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.543 -175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.11 1.85 0.11 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 119.66 -1.257 . . . . 0.0 115.661 -178.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HG3' ' CD2' ' A' ' 65' ' ' TYR . 1.2 tmtt? -88.44 119.68 29.1 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.974 1.887 . . . . 0.0 110.741 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.423 ' C ' ' CD1' ' A' ' 56' ' ' PHE . . . -101.79 148.77 24.9 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' CE1' ' OD1' ' A' ' 50' ' ' ASN . 9.2 m-85 -142.61 144.9 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.691 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.36 18.84 6.94 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.472 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 10.1 t -145.96 -86.02 0.11 Allowed 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.068 -176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.5 OUTLIER 166.25 -41.33 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 1.7 p -56.85 -39.18 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.122 177.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -27.56 66.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.335 177.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 76' ' ' PRO . 1.1 tp -68.35 -64.06 0.94 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.405 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mp -61.25 -38.26 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.72 -49.95 64.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.912 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -73.04 -61.53 1.78 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.484 ' C ' HG22 ' A' ' 69' ' ' VAL . 23.3 m-85 -42.71 -34.95 0.99 Allowed 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -176.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -61.66 -69.3 0.25 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.8 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.21 -19.05 18.61 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.484 -176.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.8 HG13 ' HD3' ' A' ' 68' ' ' LYS . 33.9 m -91.99 -30.19 4.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.733 0.302 . . . . 0.0 111.158 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.48 64.21 4.59 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.8 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.66 ' O ' HG22 ' A' ' 72' ' ' THR . 10.5 t0 -74.39 -45.92 43.68 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.788 0.804 . . . . 0.0 111.541 -176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.66 HG22 ' O ' ' A' ' 71' ' ' ASP . 5.9 t 52.69 18.42 1.01 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.596 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.39 19.23 8.16 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.927 0.394 . . . . 0.0 110.716 179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.6 -177.34 6.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -158.58 118.04 1.79 Allowed Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.167 -0.613 . . . . 0.0 111.916 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.566 ' HA ' HD23 ' A' ' 62' ' ' LEU . 89.1 Cg_exo -47.62 -32.5 16.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.198 1.932 . . . . 0.0 112.165 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -69.71 -20.16 63.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.141 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.51 9.26 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.612 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 17.7 m-85 -130.03 86.7 2.43 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -176.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.692 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -63.73 -175.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.001 178.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.49 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 37.2 m-85 -145.38 73.15 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -118.94 117.47 28.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.915 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 32' ' ' LEU . 58.8 t -68.72 -56.64 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.881 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -85.77 52.28 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.924 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.44 156.69 0.94 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.47 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.491 ' HA ' HG21 ' A' ' 82' ' ' THR . 39.6 tpt85 -77.37 95.66 4.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.184 0.516 . . . . 0.0 110.622 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.44 -80.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.6 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 86' ' ' ARG . 6.2 t 56.08 28.07 12.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.842 0.353 . . . . 0.0 110.846 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -99.71 -94.9 2.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.46 66.8 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.879 0.371 . . . . 0.0 110.954 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.78 79.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.446 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 70.8 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.793 0.33 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -93.38 140.44 29.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.0 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -94.5 171.6 8.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.07 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.5 73.65 0.61 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.989 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.31 -22.26 16.65 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.232 . . . . 0.0 112.571 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -105.14 97.1 7.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.794 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.3 113.05 15.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.014 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mmm-85 -117.51 160.61 20.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.07 111.28 23.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.205 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.5 p -166.18 45.43 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.517 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 13' ' ' ARG . 10.9 pt -89.92 15.95 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.708 ' O ' HG22 ' A' ' 12' ' ' ILE . 5.0 mp 45.08 27.67 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.763 0.792 . . . . 0.0 110.515 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' HB2' HG13 ' A' ' 11' ' ' ILE . 5.3 mtm180 -142.59 132.9 24.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.77 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -103.11 108.15 19.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.33 153.55 43.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.078 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 17' ' ' PRO . . . 107.0 102.51 2.81 Favored Glycine 0 CA--C 1.489 -1.558 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.929 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' CB ' HD12 ' A' ' 32' ' ' LEU . 3.4 Cg_exo -72.42 -153.84 0.78 Allowed 'Cis proline' 0 N--CA 1.474 0.358 0 CA-C-N 117.5 0.65 . . . . 0.0 112.165 -2.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.13 134.61 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.644 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' HB3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -116.07 48.61 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.677 -179.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -175.33 67.0 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.606 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -112.2 94.29 25.52 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.18 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -94.78 -6.09 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.439 2.759 . . . . 0.0 112.67 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.3 t -84.06 53.67 2.68 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.93 0.395 . . . . 0.0 111.007 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 24' ' ' LEU . 14.8 mt -113.55 164.51 15.64 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.59 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 75.6 Cg_exo -41.56 166.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.612 2.208 . . . . 0.0 112.371 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.0 121.47 6.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.602 ' O ' ' CD1' ' A' ' 28' ' ' TRP . . . 77.95 53.24 4.99 Favored Glycine 0 C--O 1.219 -0.82 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.681 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.624 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 56.9 m95 -157.02 151.33 25.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -147.37 179.61 7.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.608 175.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.477 ' HG3' HD23 ' A' ' 48' ' ' LEU . 22.3 ttt180 -153.62 160.04 42.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.213 0.53 . . . . 0.0 112.134 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.929 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -176.01 166.24 2.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.453 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.064 HD13 HG13 ' A' ' 83' ' ' VAL . 10.6 mt -131.3 166.55 20.97 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.03 0.443 . . . . 0.0 111.583 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -135.11 118.08 16.33 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.149 -179.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -69.37 171.43 8.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.354 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -153.06 148.17 26.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HE2' ' CA ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -131.73 124.0 28.86 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.843 0.83 . . . . 0.0 111.749 -179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -136.13 -161.25 1.14 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.615 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.7 38.27 3.36 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.241 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.53 -39.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.862 0.363 . . . . 0.0 110.665 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.51 36.29 1.66 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.552 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.456 ' CA ' ' HE2' ' A' ' 36' ' ' LYS . . . -52.79 114.17 1.32 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.72 33.42 8.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.004 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 4.5 mmmt -87.57 133.93 33.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.881 0.372 . . . . 0.0 110.814 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.625 ' HB2' HG11 ' A' ' 83' ' ' VAL . 19.5 m-85 -107.6 161.03 15.23 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.641 0.734 . . . . 0.0 112.582 -178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -131.52 147.77 52.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.73 176.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.567 ' HA ' HD22 ' A' ' 32' ' ' LEU . 4.7 p -87.13 143.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.84 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 5.4 m-85 -143.16 97.06 3.02 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.477 HD23 ' HG3' ' A' ' 30' ' ' ARG . 82.1 mt -91.31 116.11 28.57 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 174.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 5.6 mt -91.5 137.53 21.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.138 -174.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.584 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 1.9 p-10 -153.32 147.71 19.1 Favored Pre-proline 0 CA--C 1.49 -1.346 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 93.0 Cg_endo -91.67 -3.08 52.77 Favored 'Cis proline' 0 N--CA 1.448 -1.182 0 C-N-CA 125.239 -0.734 . . . . 0.0 110.863 -23.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -116.8 -35.62 4.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.999 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.445 ' HA2' ' CG2' ' A' ' 49' ' ' ILE . . . -176.64 21.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.741 -1.218 . . . . 0.0 114.881 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -96.81 115.71 27.9 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.348 1.574 . . . . 0.0 111.139 178.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.03 146.64 24.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.992 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' LYS . 9.0 m-85 -150.66 137.37 18.96 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.728 179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.8 mtm180 -105.95 11.59 31.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.151 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -154.49 170.17 22.06 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.994 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -80.41 -41.83 23.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.007 -176.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 7.6 p -50.36 -41.54 19.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.148 0.499 . . . . 0.0 110.606 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.08 -29.6 67.74 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.61 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.626 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -64.32 -63.67 1.08 Allowed 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.204 0.526 . . . . 0.0 109.952 177.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.1 mp -65.12 -38.01 81.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.352 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.69 -58.05 8.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.749 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -65.28 -53.71 40.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.627 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.928 ' CE2' HD13 ' A' ' 74' ' ' LEU . 6.1 m-30 -43.97 -26.06 0.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.612 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 1.8 mm-40 -75.33 -65.97 0.82 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.754 ' HD3' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.36 -15.41 48.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.754 HG13 ' HD3' ' A' ' 68' ' ' LYS . 19.7 m -88.27 -28.24 5.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.749 0.309 . . . . 0.0 111.227 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 57.99 59.69 10.36 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.249 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -80.02 -68.33 0.68 Allowed 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.871 0.844 . . . . 0.0 111.899 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 p 65.17 14.28 9.29 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.692 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -115.61 22.78 12.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.068 0.461 . . . . 0.0 110.592 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.928 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -154.59 -174.25 4.9 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 13.5 t0 -158.61 113.12 1.66 Allowed Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.007 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.445 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 80.9 Cg_exo -46.02 -34.87 13.57 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.317 2.012 . . . . 0.0 111.954 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -70.04 -15.54 63.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.539 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.6 8.1 30.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.624 ' CZ ' ' CZ2' ' A' ' 28' ' ' TRP . 8.6 m-85 -129.81 88.56 2.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.906 0.384 . . . . 0.0 111.676 -177.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.61 156.84 34.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.323 178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.514 ' CD1' HG11 ' A' ' 46' ' ' VAL . 18.4 m-85 -109.89 104.04 12.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.119 0.485 . . . . 0.0 111.598 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -148.46 100.48 3.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.639 179.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.064 HG13 HD13 ' A' ' 32' ' ' LEU . 78.7 t -46.46 -38.5 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.036 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.2 p -117.54 57.46 0.81 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.99 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.54 166.19 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.75 21.51 17.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.856 0.36 . . . . 0.0 111.389 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -153.52 100.34 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.622 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.93 22.39 4.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.702 0.287 . . . . 0.0 111.048 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 60.41 48.37 86.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.471 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.1 m -85.97 138.61 31.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.4 -87.62 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.547 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.894 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.28 154.55 19.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.31 31.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.464 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 3.6 m -163.15 49.62 0.24 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.068 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 4' ' ' SER . 53.4 Cg_endo -69.8 -45.73 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.621 2.214 . . . . 0.0 112.411 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -99.31 73.76 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -147.69 175.35 10.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.11 169.31 15.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.94 52.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.51 72.21 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 tt -137.77 144.37 31.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.0 mm -90.2 62.52 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.845 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 58.46 177.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.913 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -67.88 134.76 51.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 100.1 11.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.555 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.81 145.55 6.14 Favored Glycine 0 CA--C 1.483 -1.907 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.497 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 84.8 Cg_endo -79.53 -177.39 20.6 Favored 'Cis proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.975 -0.844 . . . . 0.0 112.435 2.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.9 113.5 1.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.749 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -92.92 52.68 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.719 -179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 1.1 t0 -176.37 64.4 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.24 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -109.41 95.85 20.37 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.313 -178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 80.2 Cg_endo -91.54 10.53 2.64 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.117 2.544 . . . . 0.0 112.519 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 p -85.48 52.77 2.55 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.881 0.372 . . . . 0.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.645 HD11 HD22 ' A' ' 48' ' ' LEU . 18.6 mt -127.82 165.08 32.61 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.592 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 88.1 Cg_exo -47.07 177.49 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.561 2.174 . . . . 0.0 112.606 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.32 129.37 18.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.819 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 63.42 11.03 38.88 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.804 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.577 ' CZ2' ' CZ ' ' A' ' 79' ' ' PHE . 73.2 m95 -105.62 132.84 51.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 0.0 111.742 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.66 178.69 6.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.107 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.761 ' NH2' HD11 ' A' ' 32' ' ' LEU . 4.1 ttt85 -145.37 162.35 37.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 0.0 111.661 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.945 ' O ' HD23 ' A' ' 32' ' ' LEU . 34.8 ttmt -175.08 158.32 2.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.602 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.945 HD23 ' O ' ' A' ' 31' ' ' LYS . 8.0 mt -131.34 163.12 28.56 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.12 0.486 . . . . 0.0 111.811 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.3 ttpt -137.76 113.18 9.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.169 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.87 172.72 8.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.47 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 36' ' ' LYS . 7.9 tpt180 -150.8 123.01 8.31 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.951 0.405 . . . . 0.0 111.523 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.776 ' HG2' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -120.86 104.61 9.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.482 178.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -108.21 -15.52 14.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.548 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.42 -9.07 35.46 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.653 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.71 -62.9 1.21 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.965 0.412 . . . . 0.0 110.21 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.71 36.39 1.94 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.019 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.776 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -52.71 142.55 18.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.436 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.06 22.07 33.85 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.234 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.53 129.02 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.675 0.274 . . . . 0.0 110.523 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.42 ' CE2' ' HG3' ' A' ' 17' ' ' PRO . 7.2 m-85 -107.49 161.89 14.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -131.31 143.6 50.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.92 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.744 HG11 ' CG ' ' A' ' 81' ' ' PHE . 6.3 p -89.4 147.19 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.062 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.549 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 5.1 m-85 -144.98 94.32 2.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.321 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.645 HD22 HD11 ' A' ' 24' ' ' LEU . 70.0 mt -92.95 113.23 25.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.782 HG12 ' HB2' ' A' ' 55' ' ' ALA . 2.6 mt -89.63 122.83 41.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.218 -173.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.528 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 38.6 p-10 -85.71 155.66 58.88 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.569 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.424 ' N ' ' O ' ' A' ' 27' ' ' GLY . 97.8 Cg_exo -36.73 -53.21 1.16 Allowed 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.661 2.908 . . . . 0.0 113.286 -178.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -47.56 -25.57 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.981 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.28 46.59 1.54 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.681 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.848 0.356 . . . . 0.0 111.264 -177.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.782 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -105.27 154.48 20.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.886 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' CB ' HD22 ' A' ' 62' ' ' LEU . 67.4 m-85 -131.07 150.18 52.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.457 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.07 20.18 3.76 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -176.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.64 -4.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER 77.14 -50.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.982 0.356 . . . . 0.0 111.957 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 7.1 p -52.49 -41.18 35.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 O-C-N 121.695 -0.628 . . . . 0.0 109.51 177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.98 -30.29 71.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.085 177.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.054 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -62.77 -72.73 0.12 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.041 179.197 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.515 ' CG1' ' HG3' ' A' ' 76' ' ' PRO . 7.9 mt -52.81 -43.57 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' O ' ' CD ' ' A' ' 68' ' ' LYS . . . -52.82 -47.03 67.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.196 -178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.467 ' CD1' ' HE3' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -71.51 -57.55 4.31 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.381 -0.528 . . . . 0.0 111.69 -179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.054 ' CE2' HD12 ' A' ' 62' ' ' LEU . 27.6 m-85 -44.42 -29.73 0.74 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.136 0.493 . . . . 0.0 110.922 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.73 -47.3 85.88 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.91 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -65.8 -33.02 74.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.84 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' PHE . 6.4 m -93.5 -30.12 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.83 34.18 10.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.937 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.97 126.46 35.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.666 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.9 p -140.83 32.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.112 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -125.56 16.91 8.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.213 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' CD1' ' O ' ' A' ' 74' ' ' LEU . 0.3 OUTLIER -154.58 72.36 0.86 Allowed 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.725 ' HB2' ' CE2' ' A' ' 79' ' ' PHE . 2.5 m-20 60.31 -152.93 0.01 OUTLIER Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.609 ' HA ' ' CB ' ' A' ' 75' ' ' ASP . 83.9 Cg_endo -68.19 -152.77 0.49 Allowed 'Cis proline' 0 C--N 1.311 -1.402 0 CA-C-N 121.78 1.671 . . . . 0.0 111.568 4.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.401 ' H ' ' CE ' ' A' ' 59' ' ' LYS . 2.1 m-80 63.69 13.26 7.24 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.354 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.58 7.34 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.353 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 75' ' ' ASP . 37.9 m-85 -99.87 63.74 1.21 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.677 0.275 . . . . 0.0 110.271 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -44.58 128.1 6.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.884 0.373 . . . . 0.0 111.639 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.744 ' CG ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-30 -88.37 85.26 6.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.531 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.422 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 1.5 p -98.34 93.34 6.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.99 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.619 HG13 HD13 ' A' ' 32' ' ' LEU . 77.8 t -66.82 -28.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.082 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 30.6 p -124.79 52.18 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.901 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.17 -171.36 28.16 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.408 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.81 -149.39 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 67.64 10.2 57.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.938 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 90' ' ' SER . 23.8 t 58.99 17.94 5.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.782 0.291 . . . . 0.0 111.077 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.45 -67.38 0.16 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.725 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 10.9 t 59.87 99.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.842 0.354 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.33 -111.61 3.8 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.354 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.906 -179.981 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.814 0.34 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.71 46.59 11.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.13 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.7 81.85 1.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.407 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 3.6 t -152.75 53.54 1.06 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.827 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 4' ' ' SER . 72.1 Cg_endo -76.73 -16.72 16.35 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.632 2.221 . . . . 0.0 112.684 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -85.88 54.04 2.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -124.06 -55.39 1.68 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.252 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -112.15 169.48 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.222 -179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.74 48.92 2.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 48.79 74.88 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.264 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.629 ' O ' HG23 ' A' ' 11' ' ' ILE . 12.3 tt -147.85 101.82 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.199 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.4 mm -94.28 41.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.919 0.39 . . . . 0.0 110.717 178.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 43.91 61.94 2.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.287 -179.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -123.67 44.51 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.427 -178.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.469 ' NE ' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -133.95 176.06 8.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 179.33 -141.48 4.82 Favored Glycine 0 CA--C 1.488 -1.599 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.667 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.701 ' HB3' HD12 ' A' ' 32' ' ' LEU . 1.7 Cg_endo -77.26 -170.73 9.0 Favored 'Cis proline' 0 N--CA 1.472 0.24 0 CA-C-N 117.596 0.698 . . . . 0.0 111.841 -4.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.68 -36.2 0.44 Allowed 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.117 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 81.17 -56.86 0.29 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -177.751 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -38.36 99.0 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 118.429 -0.796 . . . . 0.0 111.146 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.8 ' CB ' HG22 ' A' ' 29' ' ' THR . 0.0 OUTLIER -1.3 -65.42 0.0 OUTLIER Pre-proline 0 CA--C 1.477 -1.84 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -179.092 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.758 ' HG2' HG22 ' A' ' 23' ' ' THR . 63.1 Cg_endo -104.6 -4.49 8.97 Favored 'Cis proline' 0 C--N 1.314 -1.265 0 O-C-N 123.334 1.176 . . . . 0.0 112.115 -2.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.758 HG22 ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -161.19 21.19 0.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.424 -174.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.627 HD23 ' HD2' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -44.15 166.85 0.1 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.796 0.331 . . . . 0.0 111.857 -177.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.627 ' HD2' HD23 ' A' ' 24' ' ' LEU . 67.9 Cg_exo -39.58 166.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.103 2.536 . . . . 0.0 113.272 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.44 119.5 2.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.858 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 51' ' ' PRO . . . 76.9 -4.2 54.11 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.064 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.685 ' HZ2' HD22 ' A' ' 74' ' ' LEU . 68.6 m95 -101.64 134.69 44.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 122.46 -0.435 . . . . 0.0 111.457 -178.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.8 HG22 ' CB ' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -147.92 142.96 27.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.244 -178.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 21' ' ' ASP . 44.9 ttp180 -110.33 163.39 13.7 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.821 0.82 . . . . 0.0 112.345 177.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.898 ' C ' HD23 ' A' ' 32' ' ' LEU . 9.4 ttmt -169.31 149.38 4.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.898 HD23 ' C ' ' A' ' 31' ' ' LYS . 1.8 mt -124.5 164.87 18.85 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.0 111.648 -179.52 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 44' ' ' TYR . 6.9 ttmt -137.7 123.2 19.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.94 -178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 53.3 tt0 -78.75 164.36 24.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.444 179.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -158.64 160.16 36.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.851 0.358 . . . . 0.0 110.916 -179.417 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -125.59 105.73 9.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.384 0.611 . . . . 0.0 110.472 178.046 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' HE3' ' A' ' 36' ' ' LYS . 1.5 t -105.15 149.97 25.44 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.633 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.97 -27.73 1.09 Allowed Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.774 -179.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 134.12 49.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.655 0.264 . . . . 0.0 110.426 178.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 61.71 54.59 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.99 0.424 . . . . 0.0 110.47 -178.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' CB ' ' CD ' ' A' ' 36' ' ' LYS . . . -52.44 170.11 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.265 -179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 35' ' ' ARG . . . 58.96 42.04 96.64 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.739 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.5 136.4 32.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.93 0.395 . . . . 0.0 110.909 179.743 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' HB2' HG11 ' A' ' 83' ' ' VAL . 10.5 m-85 -102.04 168.9 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -142.83 140.4 31.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.242 176.934 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.609 HG11 ' CD1' ' A' ' 81' ' ' PHE . 9.9 p -88.66 152.59 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.371 . . . . 0.0 111.281 -178.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.647 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 23.6 m-85 -146.05 101.01 3.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.544 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.797 HD13 ' HB3' ' A' ' 79' ' ' PHE . 21.2 mt -92.93 105.48 17.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.801 0.81 . . . . 0.0 109.006 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 29' ' ' THR . 2.8 mt -82.22 121.16 35.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.115 -1.402 . . . . 0.0 112.135 -174.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -85.62 152.86 57.87 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.759 -179.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 27' ' ' GLY . 89.6 Cg_exo -35.29 -57.23 0.48 Allowed 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.626 2.884 . . . . 0.0 113.275 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -43.9 -27.52 0.36 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.234 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.04 49.9 1.04 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.891 -179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -140.83 133.66 28.99 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.989 0.424 . . . . 0.0 111.279 -178.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.647 ' HB1' ' HB3' ' A' ' 47' ' ' TYR . . . -89.26 146.96 24.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.332 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.49 ' CG ' HD12 ' A' ' 62' ' ' LEU . 85.5 m-85 -128.28 126.36 40.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 3.6 ttp180 -92.01 -59.22 2.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.798 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.67 172.7 8.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.145 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.427 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -81.75 -42.84 19.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.381 -178.676 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.0 t -51.8 -26.23 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.32 179.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -75.63 -31.27 59.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.488 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 79' ' ' PHE . 1.2 tp -68.01 -60.87 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.651 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.7 mp -61.3 -40.24 85.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.074 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.74 -62.06 1.89 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.787 0.327 . . . . 0.0 110.657 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.886 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.05 -57.95 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.66 178.381 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.882 ' CE2' HD13 ' A' ' 74' ' ' LEU . 10.9 m-30 -39.67 -38.8 0.67 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.114 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 5.7 mm-40 -61.04 -56.14 24.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.034 -176.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.518 ' HE3' ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -69.46 -16.41 63.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -178.873 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.03 -50.52 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.881 0.372 . . . . 0.0 110.668 -178.729 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 69' ' ' VAL . . . 153.75 -31.4 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.455 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.777 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.67 -161.33 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.066 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.777 HG22 ' O ' ' A' ' 71' ' ' ASP . 3.0 t 59.47 25.42 14.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.915 -178.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.8 t -141.1 17.47 2.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.67 178.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.882 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -154.53 -39.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.111 -178.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.625 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER 71.97 103.59 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.593 179.054 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.3 Cg_exo -48.59 -32.48 21.31 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.439 2.093 . . . . 0.0 112.549 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.1 -10.95 60.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.603 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.55 -3.51 58.79 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.511 178.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.797 ' HB3' HD13 ' A' ' 48' ' ' LEU . 56.1 m-85 -109.51 64.4 0.61 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 111.566 -178.032 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.19 137.42 58.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.519 179.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.609 ' CD1' HG11 ' A' ' 46' ' ' VAL . 8.3 m-85 -87.27 91.51 8.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.073 0.463 . . . . 0.0 111.075 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.95 98.77 7.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.747 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 44' ' ' TYR . 93.0 t -72.0 -7.64 9.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.602 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.6 p -116.94 37.37 3.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.823 0.344 . . . . 0.0 111.028 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 50.75 -178.04 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.967 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -135.7 -155.31 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.578 0.227 . . . . 0.0 110.404 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.16 -29.35 10.42 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.601 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 62.9 23.77 14.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.727 0.298 . . . . 0.0 110.933 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -98.57 75.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.559 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.57 168.19 13.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.802 0.334 . . . . 0.0 110.873 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.75 160.55 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.3 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.906 179.971 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.84 0.353 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -83.24 88.53 6.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.008 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -126.66 92.11 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.463 ' CB ' ' CA ' ' A' ' 5' ' ' PRO . 2.3 m -163.59 -64.23 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.463 ' CA ' ' CB ' ' A' ' 4' ' ' SER . 38.9 Cg_endo -93.2 -166.38 2.09 Favored 'Cis proline' 0 C--N 1.35 0.612 0 C-N-CA 124.544 -1.023 . . . . 0.0 112.616 -1.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 48.58 93.63 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.062 0.458 . . . . 0.0 111.005 179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.63 152.0 48.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.09 -177.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.35 155.75 18.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.949 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -116.04 19.86 14.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.189 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 4.0 t 66.85 34.56 5.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.802 0.334 . . . . 0.0 110.92 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 11' ' ' ILE . 2.7 tt 47.67 103.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.611 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' HG22 ' A' ' 12' ' ' ILE . 30.9 mm -91.06 54.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.177 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 57.51 55.07 5.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -118.7 52.32 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.77 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.72 176.94 4.97 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.934 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . 147.7 143.44 3.83 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.29 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HG2' ' CE2' ' A' ' 44' ' ' TYR . 4.9 Cg_exo -72.02 -164.86 0.18 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.321 2.014 . . . . 0.0 112.135 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 18' ' ' MET . 0.1 OUTLIER -168.91 106.01 0.42 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.502 178.854 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.631 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -68.66 66.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.997 -179.851 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 18' ' ' MET . 37.4 t70 179.05 74.75 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.004 -177.026 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.6 m-20 -115.7 80.48 8.43 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.632 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.744 ' HA ' HG23 ' A' ' 29' ' ' THR . 94.0 Cg_endo -88.43 22.37 0.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.852 2.368 . . . . 0.0 112.713 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.704 ' C ' HD23 ' A' ' 24' ' ' LEU . 52.2 p -94.8 46.43 1.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.704 HD23 ' C ' ' A' ' 23' ' ' THR . 0.8 OUTLIER -125.1 176.66 2.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.479 179.701 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 81.5 Cg_exo -49.35 -179.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.505 2.137 . . . . 0.0 112.729 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.52 126.83 28.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.817 -179.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.61 55.9 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.276 179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.537 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 70.8 m95 -106.38 128.14 53.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.238 0.542 . . . . 0.0 111.787 -178.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -135.95 -179.89 5.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.152 179.36 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.524 ' HG3' HD23 ' A' ' 48' ' ' LEU . 29.9 ttp180 -142.09 163.08 33.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.785 178.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 13.4 ttmt -165.17 170.84 14.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.492 -179.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.69 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -138.38 162.94 33.13 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.085 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -148.0 117.17 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.829 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.519 ' HB2' ' CE1' ' A' ' 44' ' ' TYR . 48.3 tt0 -75.87 107.67 8.21 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.669 0.747 . . . . 0.0 111.954 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -178.02 -177.35 0.61 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.111 174.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.97 33.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.137 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.719 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 6.6 m 59.88 -162.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.816 -179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.25 -22.22 72.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.61 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.81 115.9 29.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 111.061 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 61.18 35.42 18.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.014 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -52.47 140.65 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.0 110.908 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.45 67.6 0.9 Allowed Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.555 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -151.55 137.51 18.16 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.042 0.449 . . . . 0.0 111.104 -179.129 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 7.3 m-85 -77.93 122.85 26.05 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -175.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.01 149.47 24.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.319 176.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 83' ' ' VAL . 41.7 t -93.86 151.33 3.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.1 m-85 -146.05 99.88 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.606 -179.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD23 ' HG3' ' A' ' 30' ' ' ARG . 7.1 mt -92.88 106.8 18.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.28 0.562 . . . . 0.0 109.624 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 54' ' ' LYS . 7.1 mt -82.23 122.5 37.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.688 -174.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.537 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 31.2 p-10 -85.71 153.4 58.07 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.594 -178.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -37.61 -27.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.082 3.188 . . . . 0.0 113.699 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' ASN . 2.6 mt-30 -80.61 12.38 3.15 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 50' ' ' ASN . . . 70.98 15.94 74.46 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.972 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.521 ' CD ' ' CE1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -99.05 137.51 37.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.494 0.188 . . . . 0.0 111.389 -179.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -95.28 130.76 41.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.345 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.521 ' CE1' ' CD ' ' A' ' 54' ' ' LYS . 26.4 m-85 -115.8 117.83 31.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' CD ' ' CE2' ' A' ' 47' ' ' TYR . 8.1 mtm180 -105.03 10.06 34.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.453 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -154.45 164.84 38.04 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.836 0.351 . . . . 0.0 111.189 -178.473 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.547 ' HD2' HD11 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -76.66 -35.91 57.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.049 0.452 . . . . 0.0 111.122 -178.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 61' ' ' GLU . 8.2 p -54.0 -46.87 65.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.63 179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 60' ' ' VAL . 4.7 mt-10 -61.3 -30.59 70.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.328 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.3 OUTLIER -62.88 -64.73 0.83 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 178.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.594 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -64.91 -42.42 94.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.72 178.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -57.04 11.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.417 -178.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 0.1 OUTLIER -66.69 -50.74 61.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.544 -179.212 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.897 ' CE2' HD13 ' A' ' 74' ' ' LEU . 14.7 m-30 -48.81 -38.32 21.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.888 0.375 . . . . 0.0 111.798 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 33.1 mt-10 -61.06 -66.42 0.54 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -174.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.921 ' HD2' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -54.17 -26.98 30.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -177.348 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.921 HG13 ' HD2' ' A' ' 68' ' ' LYS . 28.4 m -86.45 -29.32 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.811 0.339 . . . . 0.0 110.786 178.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.31 55.3 28.46 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.881 -178.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.666 ' HB3' HD11 ' A' ' 74' ' ' LEU . 1.4 t0 -83.46 153.22 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 0.0 111.293 -179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 t -131.2 3.61 4.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.767 179.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.43 27.38 8.81 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.889 0.376 . . . . 0.0 110.807 179.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.897 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -154.43 173.19 16.57 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.872 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 78' ' ' ASP . 2.3 t0 -158.63 111.86 1.65 Allowed Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.219 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 84.5 Cg_exo -45.17 -41.22 16.56 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.116 1.877 . . . . 0.0 112.241 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -69.97 -9.05 53.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.397 -179.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 41.7 t0 -88.64 -6.49 57.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.13 178.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.656 ' CD2' HD11 ' A' ' 62' ' ' LEU . 45.9 m-85 -109.39 127.39 54.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 111.638 -178.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' CB ' ' HD2' ' A' ' 86' ' ' ARG . 3.2 t0 -107.24 134.16 50.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.127 177.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.446 ' CE2' ' C ' ' A' ' 58' ' ' SER . 4.1 m-85 -97.45 90.2 4.97 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.856 -179.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 p -141.43 142.56 33.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.226 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.69 HG13 HD22 ' A' ' 32' ' ' LEU . 87.0 t -95.5 -64.12 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -49.9 -25.38 3.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.118 -179.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.68 -179.46 16.25 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.445 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.415 ' HD2' ' CB ' ' A' ' 80' ' ' ASP . 3.2 mtp180 -111.65 -162.19 0.79 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.564 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -95.23 -65.6 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.549 -179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.5 26.73 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.835 -179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.11 -40.84 2.96 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.634 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 m 58.39 90.03 0.05 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.838 0.352 . . . . 0.0 110.814 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.17 -120.3 22.18 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 -179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.899 179.879 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.78 0.324 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 p 59.22 -173.23 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.767 -179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.97 55.13 1.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.953 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.0 58.54 1.11 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.65 -4.76 15.92 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.678 2.252 . . . . 0.0 112.933 -179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.51 81.74 3.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.839 0.352 . . . . 0.0 110.6 -179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.78 134.05 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.237 -179.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 39.71 -164.33 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.532 177.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 45.3 52.48 8.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.54 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.4 t -169.53 82.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.6 tt 49.79 111.52 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 121.473 0.654 . . . . 0.0 111.971 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.5 mm -77.81 61.66 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.68 179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 71.31 157.09 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.964 -179.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -55.66 143.24 31.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.055 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.401 ' NH1' HG13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -104.88 162.24 13.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.893 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.9 99.74 1.02 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.635 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 Cg_endo -87.68 -167.68 0.35 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.255 2.637 . . . . 0.0 112.449 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.458 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -170.99 103.73 0.22 Allowed 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.287 179.396 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.691 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -69.5 64.64 0.18 Allowed 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.683 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 18' ' ' MET . 25.3 t0 -178.5 79.77 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' ARG . 1.8 t70 -114.67 82.64 8.19 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 175.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.641 ' HA ' HG23 ' A' ' 29' ' ' THR . 85.1 Cg_endo -86.19 0.24 8.21 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.116 2.544 . . . . 0.0 112.935 -179.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.4 p -80.64 -23.17 39.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.771 0.319 . . . . 0.0 111.09 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 13.3 mt -46.38 161.29 0.28 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.997 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 49.1 Cg_exo -35.71 159.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.107 2.538 . . . . 0.0 113.404 -178.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.79 120.82 2.45 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.183 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.78 -14.02 27.39 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.499 178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.474 ' CH2' ' HB2' ' A' ' 50' ' ' ASN . 67.4 m95 -90.69 137.05 32.66 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -136.64 177.94 7.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.946 179.311 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.522 ' HB3' ' CB ' ' A' ' 21' ' ' ASP . 19.3 ttp180 -141.02 160.91 39.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.518 . . . . 0.0 111.421 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.462 ' CG ' ' HB3' ' A' ' 19' ' ' TYR . 0.7 OUTLIER -161.19 166.93 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.946 -179.36 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.995 HD22 HG13 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -133.28 162.04 32.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.875 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -145.42 117.33 8.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.96 179.611 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.521 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 58.2 tt0 -71.14 166.18 22.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.015 0.436 . . . . 0.0 110.722 179.43 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 91.34 174.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.8 177.788 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 178.54 70.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.106 -177.89 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 20.0 m 53.49 -161.43 0.12 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.53 179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.03 8.02 80.29 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.501 -0.856 . . . . 0.0 113.251 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' A' ' 40' ' ' SER . 8.3 ptp180 -101.37 -46.37 5.03 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 117.153 0.476 . . . . 0.0 110.529 179.263 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -119.91 38.95 3.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.074 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -54.72 81.53 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.182 -177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 141.44 53.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.831 178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' H ' ' CA ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -137.33 147.94 45.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 110.686 -179.685 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CB ' HG11 ' A' ' 83' ' ' VAL . 5.9 m-85 -94.12 135.0 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.307 0.575 . . . . 0.0 112.385 -177.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -109.59 156.09 20.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.608 176.757 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.583 HG23 ' CG2' ' A' ' 83' ' ' VAL . 18.3 t -98.28 149.01 5.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.509 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.499 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 14.9 m-85 -146.01 99.5 3.26 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.453 -178.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.766 HD13 ' HB3' ' A' ' 79' ' ' PHE . 20.0 mt -90.85 107.91 19.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.708 HG23 ' O ' ' A' ' 54' ' ' LYS . 3.2 mt -82.35 127.86 39.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.762 -1.108 . . . . 0.0 113.415 -171.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.474 ' HB2' ' CH2' ' A' ' 28' ' ' TRP . 10.3 t-20 -81.39 137.27 48.63 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.997 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' CD ' ' OD1' ' A' ' 50' ' ' ASN . 76.9 Cg_exo -33.27 -53.54 0.44 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.852 3.035 . . . . 0.0 113.322 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -46.23 -26.95 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.332 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.05 17.07 5.95 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.354 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.708 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.6 tttp -97.28 168.35 10.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 120.679 0.276 . . . . 0.0 111.119 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -134.95 130.42 35.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.51 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 29.2 m-85 -126.37 121.23 31.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.417 -179.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -90.13 -52.58 4.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.029 0.443 . . . . 0.0 110.139 177.695 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.4 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -88.03 177.09 7.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.918 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' CE ' ' O ' ' A' ' 76' ' ' PRO . 0.0 OUTLIER -83.77 -41.49 17.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.338 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.614 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 21.6 t -51.81 -27.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.61 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 8.7 mm-40 -75.81 -31.69 59.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.303 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.656 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.4 OUTLIER -62.84 -66.58 0.52 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.976 178.349 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.623 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -57.66 -38.4 64.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 178.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.7 -58.51 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.98 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.48 ' CG ' ' HD3' ' A' ' 54' ' ' LYS . 1.5 t80 -66.37 -52.61 45.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.271 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.953 ' CE2' HD13 ' A' ' 74' ' ' LEU . 12.6 m-30 -44.79 -41.65 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.096 0.474 . . . . 0.0 111.061 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 21.9 mt-10 -61.16 -63.9 1.13 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.886 -178.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.726 ' CD ' HG13 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -55.67 -23.52 28.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.67 -177.522 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.726 HG13 ' CD ' ' A' ' 68' ' ' LYS . 12.4 m -92.54 -39.88 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.844 0.354 . . . . 0.0 110.877 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.13 33.95 5.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.586 179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.923 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.6 OUTLIER -89.95 135.86 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.945 179.756 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -144.99 26.62 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.161 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.1 m -125.84 7.84 7.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.967 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.953 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -106.23 -31.87 8.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.845 0.355 . . . . 0.0 110.577 179.784 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.53 95.75 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.77 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.439 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 82.1 Cg_exo -44.39 -30.61 3.88 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.494 2.129 . . . . 0.0 112.227 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -70.12 -7.97 45.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.54 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.39 -18.52 38.51 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.608 0.242 . . . . 0.0 111.144 179.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.766 ' HB3' HD13 ' A' ' 48' ' ' LEU . 22.7 m-85 -97.77 125.13 42.43 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.88 0.371 . . . . 0.0 111.341 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.567 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -111.71 144.41 41.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.819 179.69 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 19.6 m-85 -101.95 102.47 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.395 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.528 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -151.7 110.81 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.868 179.5 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.995 HG13 HD22 ' A' ' 32' ' ' LEU . 64.4 t -65.57 -71.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 37.1 p -49.58 -28.46 5.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.83 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 118.37 -169.47 13.41 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.29 -155.49 0.63 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.38 38.93 0.67 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.91 26.4 2.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.704 0.287 . . . . 0.0 111.207 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.7 -4.98 57.85 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.101 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.0 p 57.14 107.89 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.957 0.379 . . . . 0.0 110.621 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.23 150.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.255 -179.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.085 -179.597 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t 60.89 144.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.41 155.83 24.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.066 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.16 77.28 0.42 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.987 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.01 -62.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.025 2.483 . . . . 0.0 112.376 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmm -91.61 45.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -120.35 -61.49 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.261 -179.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.29 177.33 4.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.935 0.398 . . . . 0.0 111.232 -179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.89 134.26 55.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -167.01 76.33 0.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.16 -179.815 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 10' ' ' SER . 2.4 tt 48.0 103.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.426 0.631 . . . . 0.0 111.547 179.094 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.13 66.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.059 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 55.94 45.68 23.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.03 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.07 61.81 1.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.68 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.91 165.64 10.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.222 -179.108 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.32 -126.79 1.6 Allowed Glycine 0 CA--C 1.491 -1.412 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.62 179.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.49 ' CB ' ' CD1' ' A' ' 32' ' ' LEU . 4.4 Cg_exo -71.67 -166.75 4.11 Favored 'Cis proline' 0 N--CA 1.473 0.303 0 CA-C-N 117.699 0.749 . . . . 0.0 111.918 -2.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.467 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -141.28 -26.57 0.7 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.252 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.3 OUTLIER 84.17 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 122.433 0.293 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -61.54 87.44 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.469 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.3 OUTLIER -114.63 112.42 45.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.197 179.834 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -109.11 37.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.943 3.095 . . . . 0.0 112.728 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.5 p -98.3 -53.72 3.27 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -175.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 1.7 mt -51.65 -177.53 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 121.489 -0.085 . . . . 0.0 111.051 -176.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 40.0 Cg_exo -41.29 157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.987 2.458 . . . . 0.0 114.6 -175.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.23 149.98 3.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.94 179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.33 -59.29 1.94 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.867 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.502 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 75.8 m95 -47.8 150.45 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.965 0.412 . . . . 0.0 111.349 179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -149.09 178.11 9.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.879 178.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.528 ' HE ' HD12 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -144.22 165.7 27.12 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.406 177.511 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 6.7 ttmm -176.37 154.59 1.34 Allowed 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.597 -176.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' CD1' ' CB ' ' A' ' 17' ' ' PRO . 10.0 mt -116.47 173.79 6.42 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.546 0.689 . . . . 0.0 112.828 -178.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -147.83 116.94 6.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.45 176.77 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.408 ' CG ' ' N ' ' A' ' 35' ' ' ARG . 43.8 tt0 -70.76 168.34 16.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.086 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -152.94 127.75 9.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 -178.338 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.61 ' HD2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.79 -67.79 0.81 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.287 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.412 ' O ' ' CE ' ' A' ' 36' ' ' LYS . 1.7 t 56.77 -177.6 0.05 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.713 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -94.75 39.43 2.89 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.551 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.16 133.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.724 0.297 . . . . 0.0 110.803 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.0 50.48 10.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 110.492 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . . . -63.48 150.48 43.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.628 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 84.94 26.07 38.88 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.608 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.64 136.88 32.76 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.046 0.451 . . . . 0.0 110.66 179.537 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.2 m-85 -99.99 159.19 15.28 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -132.51 153.83 50.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.641 177.247 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 83' ' ' VAL . 52.5 t -101.15 148.15 7.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.185 -178.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 8.3 m-85 -144.61 103.26 3.92 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.718 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.574 HD11 ' O ' ' A' ' 80' ' ' ASP . 71.3 mt -92.93 108.05 19.69 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 8.6 mt -88.23 130.48 37.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.661 -174.581 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.502 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 7.4 p-10 -82.73 154.31 68.05 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.663 178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -32.51 -60.45 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.896 3.064 . . . . 0.0 113.827 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.24 -25.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.795 0.331 . . . . 0.0 111.546 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 25.28 5.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.687 -179.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.564 ' CG ' ' CZ ' ' A' ' 56' ' ' PHE . 47.2 tptt -99.1 124.75 44.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.8 0.333 . . . . 0.0 110.755 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . . . -96.19 140.26 31.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -177.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.718 ' CD2' HD12 ' A' ' 62' ' ' LEU . 25.4 m-85 -133.26 135.35 44.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.155 179.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.501 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -102.58 -53.54 2.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.097 178.144 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.408 ' C ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -87.0 174.19 8.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.486 178.337 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HE3' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -82.41 -42.66 18.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.807 0.337 . . . . 0.0 111.756 -178.364 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 50.9 t -51.83 -25.17 5.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.728 -179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -76.02 -26.27 56.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.203 178.25 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.718 HD12 ' CD2' ' A' ' 56' ' ' PHE . 1.1 mp -76.1 -65.55 0.9 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.907 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -55.81 -38.42 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.673 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.82 -66.98 0.29 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.341 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.89 -45.63 89.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.189 -179.166 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.562 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.4 m-30 -53.41 -34.54 58.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 111.57 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.2 mm-40 -61.24 -70.1 0.2 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.674 -176.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.06 -21.04 28.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.167 0.508 . . . . 0.0 110.357 178.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 65' ' ' TYR . 36.6 t -86.46 -25.08 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.927 -177.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 48.49 56.08 9.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.342 -179.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.504 ' OD2' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.46 134.52 34.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 0.0 111.169 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.6 16.22 15.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.284 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 25.13 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.839 179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.562 HD13 ' CZ ' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -154.65 175.23 13.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.482 179.452 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.64 123.59 2.26 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.073 -179.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' HA ' HD23 ' A' ' 62' ' ' LEU . 39.3 Cg_exo -56.07 -33.39 89.71 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.068 1.845 . . . . 0.0 112.27 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.435 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.6 OUTLIER -70.61 -15.6 62.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.362 -179.694 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.59 -16.42 32.57 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.628 0.251 . . . . 0.0 111.584 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD2' HD21 ' A' ' 62' ' ' LEU . 54.9 m-85 -98.46 126.97 44.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.867 0.365 . . . . 0.0 111.237 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.574 ' O ' HD11 ' A' ' 48' ' ' LEU . 0.7 OUTLIER -124.5 152.74 43.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.058 -179.536 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.657 ' HA ' HG11 ' A' ' 46' ' ' VAL . 11.8 m-85 -107.46 84.64 2.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 86' ' ' ARG . 6.9 p -125.05 95.37 4.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.823 HG23 HG23 ' A' ' 46' ' ' VAL . 2.6 t -49.45 -48.13 19.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.611 179.399 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.6 p -89.74 51.76 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.293 -179.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 46.18 -170.61 0.03 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.107 -0.568 . . . . 0.0 113.081 178.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.47 ' HG2' HG21 ' A' ' 82' ' ' THR . 10.0 mtp-105 -136.66 -154.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.91 35.78 84.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.283 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.43 -13.46 58.21 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.552 0.215 . . . . 0.0 111.522 -179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.77 -94.6 0.64 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.677 -179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 m -157.34 103.49 1.98 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.836 0.351 . . . . 0.0 110.971 -179.754 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.13 -136.65 3.11 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.6 -179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.953 -179.932 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.84 0.353 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.0 t 60.01 62.18 1.71 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.095 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -110.53 102.44 11.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.881 179.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.485 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.4 OUTLIER -161.69 -66.05 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.154 -179.863 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 4' ' ' SER . 10.3 Cg_endo -52.08 -70.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.561 2.174 . . . . 0.0 112.479 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -113.16 41.09 2.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.211 -179.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.5 mm-40 -145.26 175.92 9.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -173.61 4.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.763 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -141.73 177.16 8.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.438 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 2.9 m 59.65 77.03 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.315 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.438 ' CG2' ' O ' ' A' ' 10' ' ' SER . 3.2 tt 48.27 106.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-O 121.298 0.57 . . . . 0.0 111.97 178.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.3 mm -79.91 59.32 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.431 177.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 mtp85 72.08 170.12 0.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.141 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -49.37 115.72 1.44 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.075 -179.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.85 137.51 33.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.079 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.21 141.58 3.25 Favored Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.708 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.582 ' HB3' HD13 ' A' ' 32' ' ' LEU . 4.4 Cg_exo -83.19 -176.03 15.54 Favored 'Cis proline' 0 N--CA 1.472 0.207 0 C-N-CA 125.487 -0.63 . . . . 0.0 112.401 2.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.514 ' H ' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -160.16 102.18 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.756 179.457 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.725 ' HD1' HD12 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -70.98 63.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.583 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 179.38 82.15 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.491 -176.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 1.7 m-20 -118.42 80.6 16.52 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.263 178.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.63 ' HA ' HG23 ' A' ' 29' ' ' THR . 91.1 Cg_endo -89.9 23.5 0.69 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.176 2.584 . . . . 0.0 112.54 -179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.5 p -92.02 -20.5 21.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.437 -179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.81 HD11 ' CG ' ' A' ' 30' ' ' ARG . 12.4 mt -56.69 165.23 1.75 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.868 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 79.8 Cg_exo -48.59 178.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.698 2.265 . . . . 0.0 113.183 -178.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.86 125.32 11.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.287 -178.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.09 0.32 55.98 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.846 -0.615 . . . . 0.0 113.639 178.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.515 ' CH2' ' HB3' ' A' ' 50' ' ' ASN . 63.7 m95 -101.81 135.99 42.41 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.166 0.508 . . . . 0.0 111.989 -178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -145.82 179.15 7.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.809 179.468 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.81 ' CG ' HD11 ' A' ' 24' ' ' LEU . 3.1 mtp180 -142.91 165.44 27.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.079 0.466 . . . . 0.0 111.726 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 19' ' ' TYR . 12.7 tttm -166.09 161.53 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.98 -178.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.809 HD22 HG13 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -131.3 166.5 21.08 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.216 0.531 . . . . 0.0 112.12 -179.634 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -147.24 115.85 6.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.082 179.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.9 168.31 8.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.577 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -153.1 147.03 25.36 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.026 0.441 . . . . 0.0 110.896 -178.381 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 41' ' ' ALA . 17.7 tptm -144.01 123.63 13.28 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.071 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.68 43.81 1.09 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.31 -179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 47.76 36.84 13.77 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.423 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.6 109.78 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.685 0.278 . . . . 0.0 110.428 -179.32 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.64 28.3 15.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.0 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.555 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . . . -52.6 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.454 -178.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 58.73 22.34 53.16 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.255 -178.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 35' ' ' ARG . 8.0 tttt -87.63 141.69 28.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.291 0.567 . . . . 0.0 110.953 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.505 ' HB2' HG11 ' A' ' 83' ' ' VAL . 3.6 m-85 -108.54 149.61 28.61 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.219 -178.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -115.93 148.13 40.38 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.33 176.542 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.677 ' CG1' HD21 ' A' ' 48' ' ' LEU . 40.4 t -90.46 148.01 4.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.837 -178.243 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.608 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . 22.4 m-85 -146.16 95.64 2.65 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.82 -179.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.754 HD12 ' HB3' ' A' ' 79' ' ' PHE . 1.7 mt -92.95 109.15 20.59 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.394 0.616 . . . . 0.0 109.754 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.848 HG12 ' HB2' ' A' ' 55' ' ' ALA . 6.2 mt -82.64 121.62 36.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.482 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.515 ' HB3' ' CH2' ' A' ' 28' ' ' TRP . 46.8 p-10 -85.66 154.87 59.15 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.201 179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -33.62 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.918 3.079 . . . . 0.0 113.347 -179.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' OE1' ' N ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -45.86 -26.51 0.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.414 -178.997 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 44.77 1.72 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.967 -179.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' CD ' ' CE2' ' A' ' 56' ' ' PHE . 0.6 OUTLIER -140.83 138.15 33.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.803 0.335 . . . . 0.0 110.955 -178.469 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.848 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -103.64 145.28 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.545 ' CE2' ' CD ' ' A' ' 54' ' ' LYS . 2.0 m-85 -127.83 144.94 51.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.316 177.299 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.492 ' O ' ' CE2' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -105.91 -48.45 3.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.276 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.88 174.68 8.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 76' ' ' PRO . 1.2 tmtp? -85.69 -39.19 17.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.289 -178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' CB ' ' A' ' 64' ' ' ALA . 55.8 t -52.11 -38.39 24.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.949 0.405 . . . . 0.0 110.309 178.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 56' ' ' PHE . 3.4 mm-40 -67.18 -30.08 69.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.469 178.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -62.84 -62.21 1.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.189 0.518 . . . . 0.0 109.637 178.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 3.4 mp -67.83 -42.25 85.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.356 178.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 60' ' ' VAL . . . -52.63 -58.98 5.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.756 -178.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.511 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.1 t80 -62.62 -55.37 27.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.322 0.582 . . . . 0.0 110.581 178.544 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.058 ' CE2' HD13 ' A' ' 74' ' ' LEU . 5.0 m-30 -41.2 -38.47 1.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.897 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.7 mm-40 -63.25 -60.55 3.25 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.571 -178.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HD3' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.22 -18.37 15.63 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 176.23 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.584 HG23 ' HD3' ' A' ' 68' ' ' LYS . 49.8 t -86.42 -33.68 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.658 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 107.38 -35.3 5.1 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -176.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.66 ' HB2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 32.5 107.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 175.884 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.7 t -148.72 31.06 0.8 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.677 179.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 76.7 p -179.43 49.78 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.321 179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.058 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.4 OUTLIER -154.5 -36.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.992 -179.135 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.63 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER 51.58 109.79 0.02 OUTLIER Pre-proline 0 N--CA 1.462 0.171 0 C-N-CA 122.593 0.357 . . . . 0.0 111.786 179.328 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 50.0 Cg_exo -50.95 -32.43 38.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.144 1.896 . . . . 0.0 112.044 178.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -68.84 -16.08 63.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.777 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.18 -10.47 59.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.051 177.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.754 ' HB3' HD12 ' A' ' 48' ' ' LEU . 41.9 m-85 -106.92 152.26 24.17 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.447 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.53 148.95 40.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.603 179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 57' ' ' ARG . 11.7 m-30 -109.28 85.99 2.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 84' ' ' THR . 2.4 p -120.87 -12.44 8.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.765 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.809 HG13 HD22 ' A' ' 32' ' ' LEU . 78.3 t 63.49 -78.78 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 120.737 0.303 . . . . 0.0 110.617 -179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 82' ' ' THR . 25.6 p -54.74 -35.44 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.058 -179.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 133.3 -154.99 21.47 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.668 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 24.6 mmm-85 -125.25 -154.25 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.76 -63.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.55 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 59.2 26.44 15.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.741 0.305 . . . . 0.0 110.935 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.6 107.39 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.482 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -156.27 119.71 4.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.368 . . . . 0.0 111.01 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -90.2 -66.99 1.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.436 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.956 179.921 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -92.92 57.75 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.982 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.66 107.16 11.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 5' ' ' PRO . 13.0 t -163.67 62.81 1.14 Allowed Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' O ' ' N ' ' A' ' 4' ' ' SER . 43.2 Cg_endo -93.78 -80.38 0.0 OUTLIER 'Cis proline' 0 N--CA 1.459 -0.559 0 C-N-CA 124.313 -1.12 . . . . 0.0 112.753 2.408 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 39.24 77.62 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 121.097 0.475 . . . . 0.0 111.65 179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.7 148.61 30.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.871 -177.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -76.5 -172.75 2.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -139.26 121.29 15.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -179.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.38 71.06 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 tt -137.55 130.28 42.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.007 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.1 mm -92.11 70.22 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.83 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 61.49 172.1 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.741 -179.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -68.65 118.74 12.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -88.52 137.73 32.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.853 179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -173.91 149.53 10.95 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.806 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 57.6 Cg_endo -71.66 -164.49 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.855 2.37 . . . . 0.0 112.415 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.6 mtm -151.8 105.85 3.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.831 179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 2.0 m-30 -70.81 -75.24 0.13 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.117 -178.247 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 3.5 p30 -61.31 83.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.715 0.293 . . . . 0.0 110.533 179.323 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 19' ' ' TYR . 0.3 OUTLIER -115.11 84.64 11.28 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.762 -178.509 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 29' ' ' THR . 87.7 Cg_endo -93.83 30.77 0.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.193 2.596 . . . . 0.0 112.591 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.7 p -81.28 -31.58 33.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.002 0.43 . . . . 0.0 111.007 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.563 HD11 ' HG2' ' A' ' 30' ' ' ARG . 87.8 mt -50.79 165.12 0.38 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.0 179.78 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.4 Cg_exo -47.2 178.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.591 2.194 . . . . 0.0 112.967 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.46 128.11 19.19 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.386 -178.651 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.89 -1.34 54.84 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.75 177.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.519 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 60.6 m95 -101.0 133.82 44.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.188 0.494 . . . . 0.0 112.019 -178.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -138.75 179.19 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.439 179.275 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.563 ' HG2' HD11 ' A' ' 24' ' ' LEU . 14.9 mtm180 -143.38 170.04 16.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.727 178.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 32' ' ' LEU . 6.7 ttmm 178.57 162.37 0.7 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.189 -178.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.842 HD13 HG13 ' A' ' 83' ' ' VAL . 14.2 mt -128.13 173.36 10.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.27 0.557 . . . . 0.0 112.168 -179.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER -147.8 113.18 5.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.26 176.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.499 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.8 tt0 -66.36 167.06 11.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.917 0.389 . . . . 0.0 110.804 179.059 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' HA ' ' N ' ' A' ' 42' ' ' GLY . 0.0 OUTLIER 90.02 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.09 0.956 . . . . 0.0 112.475 178.078 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' CE ' ' CB ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -174.58 36.45 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.992 -177.704 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 8.4 m 62.19 -165.98 0.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 111.677 178.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.3 82.1 0.68 Allowed Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.658 -179.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.66 -77.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 42' ' ' GLY . 3.8 m -99.25 38.41 1.41 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 37' ' ' SER . . . -54.97 80.86 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.314 -177.065 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 35' ' ' ARG . . . 142.48 53.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.908 177.549 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' CB ' ' CE ' ' A' ' 36' ' ' LYS . 0.2 OUTLIER -142.34 153.86 44.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 0.0 110.583 179.703 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 34' ' ' GLN . 5.9 m-85 -86.72 151.22 23.58 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -174.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' O ' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-20 -119.53 173.27 7.09 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.071 177.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.503 ' CG2' HG23 ' A' ' 83' ' ' VAL . 54.0 t -127.53 145.41 34.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.4 -178.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.559 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 9.2 m-85 -146.36 103.27 3.68 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.074 -179.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD22 HD11 ' A' ' 24' ' ' LEU . 62.3 mt -92.99 107.81 19.51 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 175.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.835 HG23 ' O ' ' A' ' 54' ' ' LYS . 4.3 mt -82.33 121.77 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.45 -0.796 . . . . 0.0 112.549 -173.18 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 18.8 p-10 -85.73 144.59 39.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.535 -179.183 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -35.39 -44.71 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.614 2.876 . . . . 0.0 112.857 179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.439 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 3.5 mt-30 -49.12 -23.52 1.28 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.234 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.61 20.32 11.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.152 -0.547 . . . . 0.0 111.753 -179.104 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.835 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -100.75 -179.99 4.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.757 0.313 . . . . 0.0 111.679 -178.638 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -143.87 131.87 21.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.708 179.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CZ ' ' CD ' ' A' ' 54' ' ' LYS . 64.7 m-85 -123.28 133.25 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.066 0.46 . . . . 0.0 111.729 -178.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 2.0 mtm180 -105.98 1.04 26.23 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.672 179.585 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -154.35 164.22 38.95 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.844 0.354 . . . . 0.0 111.067 -178.176 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.605 ' HD3' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -69.53 -47.21 64.49 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -176.221 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 64' ' ' ALA . 9.2 t -51.9 -35.66 18.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.777 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -28.06 65.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.119 178.277 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.073 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -67.41 -69.16 0.33 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.549 179.359 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 63' ' ' ILE . 4.5 mp -55.45 -36.1 40.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.804 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' VAL . . . -52.77 -64.35 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.923 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.838 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -62.34 -59.57 4.81 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.008 0.432 . . . . 0.0 110.681 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.576 ' CZ ' HD13 ' A' ' 74' ' ' LEU . 20.7 m-30 -35.29 -39.84 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.767 179.399 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 11.6 mt-10 -61.19 -66.69 0.5 Allowed 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.877 0.37 . . . . 0.0 111.928 -177.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.426 ' HE3' ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -57.19 -19.96 23.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.58 -178.669 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.838 HG13 ' O ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -86.53 -37.51 11.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.93 0.395 . . . . 0.0 110.297 -179.924 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.67 -32.28 3.22 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.801 179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.781 ' O ' HG22 ' A' ' 72' ' ' THR . 0.0 OUTLIER 39.44 -159.38 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 177.832 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.781 HG22 ' O ' ' A' ' 71' ' ' ASP . 0.6 OUTLIER 75.91 26.92 0.99 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.093 0.557 . . . . 0.0 110.51 -177.014 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -150.16 27.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.426 177.557 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -147.95 -41.96 0.17 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.889 -178.23 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 70.14 86.24 0.12 Allowed Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.433 179.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HA ' ' CD1' ' A' ' 79' ' ' PHE . 81.3 Cg_exo -49.96 -24.92 11.38 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.642 2.228 . . . . 0.0 111.879 178.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -69.6 -18.6 63.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.545 -178.812 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -88.52 12.49 14.34 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.833 176.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 1.073 ' CD2' HD21 ' A' ' 62' ' ' LEU . 3.8 m-85 -108.11 79.45 1.27 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.727 0.298 . . . . 0.0 111.004 -179.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.577 ' O ' HG23 ' A' ' 82' ' ' THR . 0.4 OUTLIER -84.57 8.0 18.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.751 179.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.487 ' CE2' ' HA ' ' A' ' 58' ' ' SER . 10.3 m-85 49.33 -88.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.289 179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 80' ' ' ASP . 2.1 p 58.28 161.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.954 0.406 . . . . 0.0 111.298 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.842 HG13 HD13 ' A' ' 32' ' ' LEU . 16.9 t -132.53 -51.47 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.221 179.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 40.7 p -93.17 39.46 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.953 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.12 -110.01 3.93 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.378 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.01 110.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.788 0.328 . . . . 0.0 110.949 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 58.73 32.33 69.47 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.097 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 90' ' ' SER . 5.2 t -92.76 24.3 3.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.736 0.303 . . . . 0.0 111.293 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.51 -68.55 0.1 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.727 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.3 OUTLIER 58.62 173.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.75 0.309 . . . . 0.0 110.88 -179.793 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.43 -166.36 7.06 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.427 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.914 179.788 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -147.65 143.32 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.64 42.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 73.94 8.82 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.889 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.87 0.52 8.74 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.713 2.275 . . . . 0.0 113.006 -179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -109.87 107.39 17.32 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.893 0.378 . . . . 0.0 110.829 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -135.25 87.28 2.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -116.59 169.23 9.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.036 -179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.5 mmm-85 -113.93 152.5 30.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.851 179.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.9 t -81.68 56.19 2.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.439 HD11 ' HB3' ' A' ' 15' ' ' ARG . 15.2 tt -89.86 132.52 34.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 12' ' ' ILE . 29.7 mm -91.67 50.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 50.0 45.77 24.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.022 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -130.5 61.51 1.6 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.003 179.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HB3' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -112.05 -173.29 2.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.087 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.54 148.07 15.24 Favored Glycine 0 CA--C 1.483 -1.938 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.254 179.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HB2' ' CD1' ' A' ' 32' ' ' LEU . 62.2 Cg_endo -77.26 171.2 68.94 Favored 'Cis proline' 0 N--CA 1.475 0.426 0 C-N-CA 125.133 -0.778 . . . . 0.0 113.097 4.53 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.672 ' H ' HD11 ' A' ' 32' ' ' LEU . 8.1 mtm -136.18 -36.43 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.142 -179.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.723 ' CD1' HD12 ' A' ' 32' ' ' LEU . 8.5 m-85 63.44 28.24 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 35.4 t70 -175.75 82.55 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.282 -176.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.458 ' HB2' ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -113.31 87.94 12.0 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.143 178.344 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HA ' HG23 ' A' ' 29' ' ' THR . 96.3 Cg_endo -88.11 9.03 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.012 2.475 . . . . 0.0 112.649 179.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.2 p -86.83 51.85 2.35 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.977 0.418 . . . . 0.0 110.734 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.53 HD11 ' CD ' ' A' ' 30' ' ' ARG . 29.4 mt -128.97 164.08 41.29 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.155 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 92.8 Cg_exo -43.51 170.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.384 2.056 . . . . 0.0 112.556 -179.456 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.91 126.24 8.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.466 -178.479 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.57 0.56 58.92 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.731 177.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.503 ' CE3' ' HA ' ' A' ' 50' ' ' ASN . 66.0 m95 -101.41 137.28 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.263 0.554 . . . . 0.0 112.087 -178.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -147.89 -172.15 3.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.789 179.902 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.581 ' H ' HG22 ' A' ' 29' ' ' THR . 1.7 mtm180 -151.33 176.27 11.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 111.43 178.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 ttmt -175.53 173.52 2.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.354 -178.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.985 HD22 HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -142.97 167.14 22.77 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.325 0.583 . . . . 0.0 112.409 179.879 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -148.04 101.32 3.28 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.979 177.792 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HG2' ' N ' ' A' ' 35' ' ' ARG . 52.6 tt0 -68.55 166.8 16.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.936 179.732 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' N ' ' HG2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -153.04 148.31 26.9 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.755 0.312 . . . . 0.0 110.169 179.259 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HD3' ' HB1' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -105.14 65.63 0.73 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.498 0.666 . . . . 0.0 111.208 179.42 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -84.9 107.88 17.27 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.204 177.207 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -33.47 -34.17 0.02 OUTLIER Glycine 0 C--N 1.337 0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 113.754 -176.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -96.48 110.9 23.19 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.694 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m 63.04 36.47 12.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.142 0.496 . . . . 0.0 109.686 -176.622 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB1' ' HD3' ' A' ' 36' ' ' LYS . . . -52.59 166.34 0.2 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.448 -178.59 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' N ' ' HE2' ' A' ' 36' ' ' LYS . . . 68.16 33.56 78.75 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.716 -179.014 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.56 140.49 29.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.925 0.393 . . . . 0.0 110.534 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.542 ' CB ' HG11 ' A' ' 83' ' ' VAL . 9.1 m-85 -105.42 137.04 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -105.98 137.94 43.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.641 174.712 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' CD1' ' A' ' 47' ' ' TYR . 9.9 p -93.91 154.46 3.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.038 0.447 . . . . 0.0 111.468 -177.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 33' ' ' LYS . 7.2 m-85 -146.04 99.22 3.22 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.109 179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 79' ' ' PHE . 8.1 mt -91.78 111.43 22.96 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.117 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.751 HG23 ' O ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -82.39 120.89 34.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.168 -0.924 . . . . 0.0 113.211 -171.75 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.503 ' HA ' ' CE3' ' A' ' 28' ' ' TRP . 6.5 p-10 -86.18 144.76 39.09 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.216 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -34.7 -51.72 0.68 Allowed 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.64 2.893 . . . . 0.0 113.429 -179.312 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -44.62 -27.04 0.43 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.875 0.369 . . . . 0.0 111.389 -179.476 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.24 25.07 5.97 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.602 -179.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.751 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.0 tttt -99.17 172.47 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 111.31 -178.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -134.7 96.56 3.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.366 178.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 22.9 m-85 -90.29 129.15 36.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.096 0.474 . . . . 0.0 111.647 -178.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -104.85 4.27 31.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.335 179.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.409 ' OG ' HG12 ' A' ' 60' ' ' VAL . 99.7 p -154.41 170.77 20.59 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.729 0.3 . . . . 0.0 111.084 -177.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.531 ' O ' HD12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -73.23 -37.98 66.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -178.517 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 61' ' ' GLU . 3.9 p -51.84 -46.48 40.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.683 -179.191 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.43 ' N ' ' CG1' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -62.11 -31.99 72.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.221 178.594 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 HD11 ' CD2' ' A' ' 79' ' ' PHE . 0.6 OUTLIER -65.51 -68.6 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 178.959 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.3 mp -56.98 -40.42 72.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.696 178.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.26 -64.87 0.68 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.102 -178.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -61.49 -40.14 93.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.605 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 1.043 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.8 m-30 -59.8 -32.22 70.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.873 -179.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 63' ' ' ILE . 23.3 mt-10 -60.9 -70.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 111.522 -177.289 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -57.03 -21.79 33.73 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.559 178.393 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 65' ' ' TYR . 13.3 t -86.41 -25.9 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.038 -177.552 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 66' ' ' PHE . . . 59.84 45.19 96.23 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.698 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.778 ' HB3' HD11 ' A' ' 74' ' ' LEU . 0.9 OUTLIER -90.06 136.39 33.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.761 0.315 . . . . 0.0 110.738 179.395 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 72.8 p -138.75 23.38 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.177 -179.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.7 p -124.0 24.13 8.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 179.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 ' CE2' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -133.51 -41.6 0.86 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 -179.35 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.604 ' H ' HD12 ' A' ' 74' ' ' LEU . 1.3 m-20 61.96 102.54 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.957 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' O ' ' CE ' ' A' ' 59' ' ' LYS . 71.6 Cg_exo -46.59 -34.69 15.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.422 2.081 . . . . 0.0 112.424 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -70.03 -7.55 41.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.549 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.24 -14.92 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.657 0.265 . . . . 0.0 110.946 178.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 48' ' ' LEU . 47.7 m-85 -99.05 99.11 10.09 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.244 -179.235 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.421 ' OD2' ' NE ' ' A' ' 86' ' ' ARG . 26.0 t0 -84.78 132.31 34.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.689 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.16 74.24 6.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.476 -178.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.77 124.7 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.664 179.086 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.985 HG13 HD22 ' A' ' 32' ' ' LEU . 81.0 t -73.59 -67.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.285 -179.415 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 33.1 p -49.82 -28.77 6.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.58 167.86 38.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.346 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' NE ' ' OD2' ' A' ' 80' ' ' ASP . 4.8 mtp180 -109.28 -154.86 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 110.624 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -98.54 -30.63 6.79 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.598 -179.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m 65.78 22.23 11.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.65 0.262 . . . . 0.0 111.178 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -150.19 40.57 0.83 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.7 m 55.14 96.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.93 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -139.41 46.6 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.532 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 58.4 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.903 -179.906 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.857 0.36 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 t -100.77 165.69 11.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.99 149.51 43.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.481 ' OG ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -163.61 -63.54 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.11 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HA ' ' OG ' ' A' ' 4' ' ' SER . 48.0 Cg_endo -90.75 -18.98 13.91 Favored 'Cis proline' 0 C--N 1.349 0.56 0 C-N-CA 124.518 -1.034 . . . . 0.0 112.506 -2.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.92 65.87 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 179.872 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.52 -65.29 1.02 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.31 171.85 11.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.037 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.69 120.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.62 179.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.4 t 73.38 60.41 0.1 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.027 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.7 tt -101.64 142.39 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.045 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.7 mm -84.64 56.48 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.029 179.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 63.21 157.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.918 -179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.17 124.36 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.017 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -76.97 149.83 35.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.822 179.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.95 149.79 14.44 Favored Glycine 0 CA--C 1.482 -1.981 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.598 179.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HB2' HD12 ' A' ' 32' ' ' LEU . 86.8 Cg_endo -80.03 -174.4 14.4 Favored 'Cis proline' 0 N--CA 1.472 0.263 0 C-N-CA 124.85 -0.896 . . . . 0.0 112.432 3.258 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.8 118.29 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.575 179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -97.38 47.44 1.03 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.67 -178.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 10.4 t0 179.4 71.85 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.431 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.49 93.98 21.28 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.341 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 20' ' ' ASP . 68.2 Cg_endo -95.9 23.66 0.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.319 2.679 . . . . 0.0 112.293 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.854 ' C ' HD23 ' A' ' 24' ' ' LEU . 16.7 p -92.31 42.83 1.11 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.281 -178.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.021 HD11 ' CG ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER -130.31 178.55 1.67 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.43 179.377 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 24' ' ' LEU . 85.1 Cg_exo -46.9 174.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.489 2.126 . . . . 0.0 112.737 -179.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.86 44.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.16 -178.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.42 -0.12 60.97 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.393 178.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.492 ' CH2' ' CB ' ' A' ' 50' ' ' ASN . 55.0 m95 -102.57 133.43 47.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.083 0.468 . . . . 0.0 111.942 -178.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.484 HG22 ' H ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -140.44 -176.53 4.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.416 179.789 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 1.021 ' CG ' HD11 ' A' ' 24' ' ' LEU . 2.5 mtp180 -143.25 156.98 44.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.596 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.885 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.8 ttpt -166.49 161.05 15.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.996 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.98 HD13 HG13 ' A' ' 83' ' ' VAL . 5.4 mt -130.28 166.8 19.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.252 0.549 . . . . 0.0 112.217 -178.224 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.6 tttt -139.31 115.49 10.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.861 -179.383 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -65.89 167.87 8.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.332 178.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' CG ' ' N ' ' A' ' 36' ' ' LYS . 20.7 ttm180 -153.18 163.92 39.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.827 -179.409 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.667 ' CD ' ' HB1' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -137.0 99.53 4.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.399 178.672 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -21.45 13.39 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.091 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.18 -83.37 0.33 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 -178.383 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.97 -45.04 67.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.069 0.461 . . . . 0.0 110.042 177.52 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.24 41.54 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.939 177.805 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB1' ' CD ' ' A' ' 36' ' ' LYS . . . -52.52 115.86 1.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.285 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 35' ' ' ARG . . . 103.26 34.43 3.93 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.311 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -87.68 139.13 30.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.002 0.43 . . . . 0.0 111.026 -179.405 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.776 ' HB2' HG11 ' A' ' 83' ' ' VAL . 9.6 m-85 -104.75 153.96 20.62 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.461 ' HB3' ' CE1' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -120.31 144.21 47.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.215 176.245 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.712 HG11 ' CD1' ' A' ' 81' ' ' PHE . 4.6 p -85.92 148.61 4.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.13 -178.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.461 ' CE1' ' HB3' ' A' ' 45' ' ' ASP . 9.7 m-85 -145.35 97.95 3.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.414 179.381 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.853 HD12 ' HB3' ' A' ' 79' ' ' PHE . 7.6 mt -92.57 109.64 21.05 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.076 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.859 HG23 ' O ' ' A' ' 54' ' ' LYS . 8.0 mt -82.23 126.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.68 -171.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 28' ' ' TRP . 1.5 p-10 -85.58 150.28 53.46 Favored Pre-proline 0 C--O 1.235 0.298 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.329 -178.598 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -38.57 -55.45 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.171 2.58 . . . . 0.0 112.802 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -46.77 -26.79 1.02 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 0.0 111.034 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.31 28.91 3.14 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.602 179.088 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.859 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -92.33 -178.84 5.05 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.368 0.604 . . . . 0.0 112.094 -179.406 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -146.2 88.66 1.81 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.076 177.112 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' CE1' ' HG2' ' A' ' 54' ' ' LYS . 83.2 m-85 -92.02 122.05 34.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.457 -177.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.496 ' O ' ' CZ ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -92.84 -48.73 6.41 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.051 -179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.18 171.78 9.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.323 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HZ3' HD11 ' A' ' 63' ' ' ILE . 7.8 tptp -88.68 -47.19 8.43 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 -179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.3 t -51.88 -26.85 8.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.036 0.446 . . . . 0.0 110.147 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.59 -32.07 63.91 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.661 177.257 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' A' ' 79' ' ' PHE . 0.9 OUTLIER -64.43 -62.66 1.46 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.84 179.371 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.6 ' H ' HD12 ' A' ' 63' ' ' ILE . 5.2 mp -61.56 -40.87 88.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 68' ' ' LYS . . . -52.8 -68.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.122 -179.133 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.532 ' O ' HG13 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -59.79 -40.55 88.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.102 -179.632 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.517 ' CE2' HD13 ' A' ' 74' ' ' LEU . 9.6 m-30 -56.47 -30.9 63.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.826 0.345 . . . . 0.0 110.641 178.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 63' ' ' ILE . 3.9 mm-40 -70.42 -60.28 2.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.915 -177.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -58.36 -26.05 62.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.597 -178.124 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 65' ' ' TYR . 12.1 m -86.58 -39.92 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.845 0.355 . . . . 0.0 111.317 -179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.4 38.99 4.08 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.323 -179.425 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.515 ' CG ' HD21 ' A' ' 74' ' ' LEU . 3.4 t0 -89.1 117.53 28.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 -179.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.3 p -134.95 33.93 3.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.029 179.643 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.0 p -132.53 33.6 3.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.531 179.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.535 HD12 ' H ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -137.64 -39.04 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.494 -179.092 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.535 ' H ' HD12 ' A' ' 74' ' ' LEU . 0.9 OUTLIER 66.75 93.67 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 110.57 -179.08 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HE2' ' A' ' 59' ' ' LYS . 97.9 Cg_exo -44.97 -29.0 3.42 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.611 2.207 . . . . 0.0 112.447 -179.56 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -69.95 -7.94 44.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.386 -179.258 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.25 -11.49 46.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.478 0.18 . . . . 0.0 111.291 178.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.853 ' HB3' HD12 ' A' ' 48' ' ' LEU . 74.2 m-85 -103.4 102.36 12.29 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.713 0.292 . . . . 0.0 111.485 -179.11 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.553 ' O ' HD11 ' A' ' 48' ' ' LEU . 13.6 t70 -94.0 160.35 14.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.294 178.185 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.712 ' CD1' HG11 ' A' ' 46' ' ' VAL . 22.0 m-30 -115.44 85.0 2.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 111.098 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.761 HG21 ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -124.38 96.38 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.688 179.232 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.98 HG13 HD13 ' A' ' 32' ' ' LEU . 86.5 t -66.12 -32.43 58.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.1 p -107.87 47.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.797 0.332 . . . . 0.0 111.334 -179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.77 -164.87 11.98 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.98 179.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.761 ' HB3' HG21 ' A' ' 82' ' ' THR . 0.2 OUTLIER 179.14 154.41 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.929 0.395 . . . . 0.0 110.373 -179.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.16 -43.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.583 -179.697 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m 59.37 24.83 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.18 179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -137.45 -120.73 1.94 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.495 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.8 t -155.34 91.53 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.841 0.353 . . . . 0.0 110.834 -179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.33 28.53 69.49 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.498 -179.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.815 179.702 . . . . . . . . 0 0 . 1 stop_ save_